"","barcode","patient","sample","shortLetterCode","definition","sample_submitter_id","sample_type_id","tumor_descriptor","sample_id","sample_type","composition","state","preservation_method","intermediate_dimension","pathology_report_uuid","submitter_id","shortest_dimension","specimen_type","longest_dimension","is_ffpe","tissue_type","morphology","treatments","tissue_or_organ_of_origin","age_at_diagnosis","primary_diagnosis","classification_of_tumor","tumor_of_origin","diagnosis_id","site_of_resection_or_biopsy","prior_treatment","diagnosis_is_primary_disease","days_to_diagnosis","figo_stage","synchronous_malignancy","laterality","prior_malignancy","year_of_diagnosis","method_of_diagnosis","icd_10_code","tumor_grade","residual_disease","race","gender","ethnicity","vital_status","age_at_index","days_to_birth","demographic_id","age_is_obfuscated","days_to_death","population_group","bcr_patient_barcode","primary_site","project_id","disease_type","name","releasable","released","days_to_collection","initial_weight","oct_embedded","ajcc_pathologic_t","ajcc_pathologic_n","ajcc_pathologic_m","ajcc_staging_system_edition","country_of_residence_at_enrollment","days_to_sample_procurement","figo_staging_edition_year","sample.aux"
"TCGA-13-1489-02A-01R-1565-13","TCGA-13-1489-02A-01R-1565-13","TCGA-13-1489","TCGA-13-1489-02A","TR","Recurrent Solid Tumor","TCGA-13-1489-02A","02","Recurrence","cba94907-4590-492b-88db-613d97208ccf","Recurrent Tumor","Not Reported","released","Unknown",0.8,"639712E8-5C63-433C-8F23-4C78FF37D8FC","TCGA-13-1489",0.4,"Unknown",1,FALSE,"Tumor","8441/3","833; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 194bb7f1-f5a5-444a-8fc6-e2ef1b3e2397; 24623334-22f3-429b-ad25-6e485766f467; 63a1427d-732c-45b9-885c-24fe7162f353; TCGA-13-1489_treatment13; TCGA-13-1489_treatment12; TCGA-13-1489_treatment11; Surgery, NOS; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; released; yes; no; yes; 2025-01-06T20:06:02.619309-06:00; 2025-01-06T20:06:02.619309-06:00; 2025-01-06T20:06:02.619309-06:00; Unknown; Unknown; Unknown","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-13-1489_diagnosis","18019ed5-8e39-416a-9f1a-d82eab745478","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",70,-25768,"39bca6ab-f7fe-59fd-b376-b16f300c341d",FALSE,2553,NA,"TCGA-13-1489-02A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1489-02"
"TCGA-23-1023-01R-01R-1564-13","TCGA-23-1023-01R-01R-1564-13","TCGA-23-1023","TCGA-23-1023-01R","TP","Primary solid Tumor","TCGA-23-1023-01R","02","Recurrence","8a53cd24-5041-418b-811b-33b72c165798","Recurrent Tumor",NA,"released","Unknown",0.6,"98EBC356-C54E-4C1E-9726-BA61397DDA38","TCGA-23-1023",0.3,"Unknown",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 8f52fe8b-401b-444e-a5d9-6a48d380faa8; bf246123-0716-4de3-8225-66ca6ac21a83; cd577fe3-9a4f-44b9-9a7c-b5a412e69f4c; TCGA-23-1023_treatment18; TCGA-23-1023_treatment19; TCGA-23-1023_treatment20; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; Surgery, NOS; released; released; released; yes; no; yes; 2025-01-06T21:12:25.530396-06:00; 2025-01-06T21:12:25.530396-06:00; 2025-01-06T21:12:25.530396-06:00; Unknown; Unknown; Unknown; NA; NA; 1209","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-23-1023_diagnosis","70c1f438-89c0-4ce7-a69e-1c03d515f76a","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",65,-23826,"5401c2e3-25c5-547a-a9df-fce704e3b3f4",FALSE,NA,NA,"TCGA-23-1023-01R","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1023-01"
"TCGA-24-2298-01A-01R-1569-13","TCGA-24-2298-01A-01R-1569-13","TCGA-24-2298","TCGA-24-2298-01A","TP","Primary solid Tumor","TCGA-24-2298-01A","01","Primary","96e08856-06cc-463d-b2c5-5ed29204f66e","Primary Tumor","Not Reported","released","Unknown",0.4,"fe9d7bf4-a278-4842-b911-018d0127ef20","TCGA-24-2298",0.4,"Unknown",1,FALSE,"Tumor","8441/3","726; NA; 1568; 218; 1328; NA; 1328; 218; 817; 2477; 1984; 308; 3605; 424; NA; 731; 5830; 28; 474; 474; 1454; 12; 986; NA; 986; 12; 762; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 42a31c9b-aa8c-4740-ad09-7d54a8693204; 436a72ca-b298-41fc-ae25-73dd201a114c; 5d8058bd-49e3-5610-b7f5-2c424cb4966d; 6497f7ec-d39d-4ce6-813b-a8c635d7914a; 80b9d9a8-1c97-4178-b6e6-71d5278440b5; cf236c87-eb93-4a3e-910e-81baf3c29039; d72f638e-da70-4e7f-ba5e-bb2dba723b46; eda1397a-c156-4585-8dea-db41fa3df541; fc5e42ac-3a4a-4347-91eb-e9733890bb88; TCGA-24-2298_treatment2; TCGA-24-2298_treatment3; TCGA-24-2298_treatment; TCGA-24-2298_treatment6; TCGA-24-2298_treatment5; TCGA-24-2298_treatment9; TCGA-24-2298_treatment8; TCGA-24-2298_treatment4; TCGA-24-2298_treatment7; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; 12; 12; 5; 8; 13; NA; 13; 8; 2; Carboplatin; Paclitaxel; Pegylated Liposomal Doxorubicin Hydrochloride; Carboplatin; Carboplatin; NA; Vinorelbine Tartrate; Cyclophosphamide; Topotecan; yes; yes; yes; yes; yes; no; yes; yes; yes; 2025-01-06T21:44:19.625308-06:00; 2025-01-06T21:44:19.625308-06:00; NA; 2025-01-06T21:44:19.625308-06:00; 2025-01-06T21:44:19.625308-06:00; 2025-01-06T21:44:19.625308-06:00; 2025-01-06T21:44:19.625308-06:00; 2025-01-06T21:44:19.625308-06:00; 2025-01-06T21:44:19.625308-06:00; Recurrent Disease; Recurrent Disease; Progressive Disease; NA; Progressive Disease; NA; Progressive Disease; NA; Progressive Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; mg; mg; mg; mg; mg; NA; mg; mg; mg; NA; NA; NA; Adjuvant; NA; Adjuvant; NA; Adjuvant; NA","Ovary",20453,"Serous cystadenocarcinoma, NOS","primary",NA,"13e8bf35-e57d-57bc-a649-ba968b92dd9d","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1993,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",55,-20453,"38d463fa-52e1-5bde-ba99-892ae69ef237",FALSE,1620,NA,"TCGA-24-2298-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2298-01"
"TCGA-24-2293-01A-01R-1568-13","TCGA-24-2293-01A-01R-1568-13","TCGA-24-2293","TCGA-24-2293-01A","TP","Primary solid Tumor","TCGA-24-2293-01A","01","Primary","542c8797-ff2c-49c6-955b-ef8222194b6d","Primary Tumor","Not Reported","released","Unknown",1.1,"caf7dd79-d1f9-4061-8b50-aa8e5a4f18b7","TCGA-24-2293",0.3,"Unknown",1.3,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 7efc4244-34c4-4cba-bc63-efdf4606a3f6; 8f535e33-40b5-493c-a4b2-02ade631fe5e; ae907019-965d-5ddf-9959-8803fadc8401; c036a069-d9d9-44a6-b4e2-b691df19581c; d4183987-c4a2-4238-a600-cd3c38678af6; e7252ef5-0d45-4365-8a21-a9686cd099c5; TCGA-24-2293_treatment6; TCGA-24-2293_treatment4; TCGA-24-2293_treatment; TCGA-24-2293_treatment3; TCGA-24-2293_treatment5; TCGA-24-2293_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; 2025-01-06T21:05:44.128223-06:00; 2025-01-06T21:05:44.128223-06:00; NA; 2025-01-06T21:05:44.128223-06:00; 2025-01-06T21:05:44.128223-06:00; 2025-01-06T21:05:44.128223-06:00; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; Carboplatin; Carboplatin; Etoposide; Melphalan; Paclitaxel; NA; NA; 6; NA; NA; 6","Specified parts of peritoneum",17235,"Serous cystadenocarcinoma, NOS","primary",NA,"9b15e2a6-35c6-5b7c-a120-c89694cdd36a","Specified parts of peritoneum","No",TRUE,0,NA,"Not Reported","Right","not reported",1995,"Surgical Resection","C48.1","G3",NA,"white","female","not reported","Dead",47,-17235,"8d3d202d-b300-5de9-9226-3338350a13e7",FALSE,506,NA,"TCGA-24-2293-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2293-01"
"TCGA-20-1687-01A-01R-1566-13","TCGA-20-1687-01A-01R-1566-13","TCGA-20-1687","TCGA-20-1687-01A","TP","Primary solid Tumor","TCGA-20-1687-01A","01","Primary","bcd16bf3-0877-4e4b-b70b-7d6a497af7ac","Primary Tumor",NA,"released","Unknown",0.8,"e966d90f-0e5f-42e6-b487-1f10fbef204f","TCGA-20-1687",0.5,"Unknown",1.8,FALSE,"Tumor","8441/3","172; 172; NA; 42; 42; NA; Intravenous; Intravenous; d9afbb9d-5ca7-5a29-80ac-efbbff19f83b; f16fb3a7-13ce-42ce-af3c-91f112c5abcc; f6779b7d-a733-4537-b6e2-2337982271b4; TCGA-20-1687_treatment; TCGA-20-1687_treatment2; TCGA-20-1687_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; NA; Paclitaxel; Carboplatin; NA; yes; yes; no; NA; 2025-01-06T21:11:47.682650-06:00; 2025-01-06T21:11:47.682650-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released","Ovary",16961,"Serous cystadenocarcinoma, NOS","primary",NA,"9729bb87-a1cc-5e8d-9e77-b68ef5b45a33","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2008,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",46,-16961,"c5058873-7e86-55ab-83ec-68f37f816ab9",FALSE,NA,NA,"TCGA-20-1687-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-20-1687-01"
"TCGA-29-1699-01A-01R-1567-13","TCGA-29-1699-01A-01R-1567-13","TCGA-29-1699","TCGA-29-1699-01A","TP","Primary solid Tumor","TCGA-29-1699-01A","01","Primary","a0a9b124-82fa-4eff-a5df-38932e8ce44a","Primary Tumor",NA,"released","Unknown",0.8,"9e2cf2f9-c45c-4702-8b6f-565c59730036","TCGA-29-1699",0.6,"Unknown",1.5,FALSE,"Tumor","8441/3","","Ovary",21130,"Serous cystadenocarcinoma, NOS","primary",NA,"1bd094f3-6920-5234-b706-e5a90b2cdf6c","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",57,-21130,"5ee5fdf5-f33a-5bd5-81e5-568f5772b628",FALSE,1106,NA,"TCGA-29-1699-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1699-01"
"TCGA-59-2363-01A-01R-1569-13","TCGA-59-2363-01A-01R-1569-13","TCGA-59-2363","TCGA-59-2363-01A","TP","Primary solid Tumor","TCGA-59-2363-01A","01","Primary","faf406a4-d3d4-4ff5-8a3b-86ecbc6802ab","Primary Tumor","Not Reported","released","Unknown",1,"9b047485-eb2b-4fc1-a22a-d96046b63bf2","TCGA-59-2363",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0f0a6ccf-861a-43d3-8bbd-2c92bac2b952; 15958777-9f8e-50af-995d-a42f6d60595c; f67577e8-014a-4fc4-b59a-af125c84474e; TCGA-59-2363_treatment3; TCGA-59-2363_treatment; TCGA-59-2363_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:36:24.754978-06:00; NA; 2025-01-06T21:36:24.754978-06:00; NA; Carboplatin; Paclitaxel","Ovary",NA,"Serous cystadenocarcinoma, NOS","primary",NA,"219b42b0-2897-5644-adb6-0bd82706bdac","Ovary","No",TRUE,0,"Stage IIIA","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G3","R0","asian","female","not hispanic or latino","Alive",40,NA,"70e5088b-a97a-527d-8705-0671fabd9fdb",FALSE,NA,NA,"TCGA-59-2363-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-59-2363-01"
"TCGA-13-1411-01A-01R-1565-13","TCGA-13-1411-01A-01R-1565-13","TCGA-13-1411","TCGA-13-1411-01A","TP","Primary solid Tumor","TCGA-13-1411-01A","01","Primary","157062b7-9451-4a83-9047-294497df3b28","Primary Tumor","Not Reported","released","Unknown",1.5,"F73F2D6F-3FD9-4457-921A-9EE0E47A6470","TCGA-13-1411",0.3,"Unknown",1.7,FALSE,"Tumor","Unknown","","Not Reported",30112,"Unknown","Unknown","TCGA-13-1411_diagnosis","2f4833c6-0f31-4b29-b154-e8359b605de1","Not Reported","Yes",FALSE,238,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",81,-29874,"27139b74-ed7d-5c9a-a505-c3f8562efbce",FALSE,531,NA,"TCGA-13-1411-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1411-01"
"TCGA-25-2409-01A-01R-1569-13","TCGA-25-2409-01A-01R-1569-13","TCGA-25-2409","TCGA-25-2409-01A","TP","Primary solid Tumor","TCGA-25-2409-01A","01","Primary","3d0f2483-ae45-4b2f-bba3-76a0eaecff4f","Primary Tumor","Not Reported","released","Unknown",1.5,"89A631C6-5000-4A96-B752-879EAA7231CB","TCGA-25-2409",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 7df3b163-c263-4cec-ad78-54032c4b8d19; af661944-a9d6-4eb2-8006-dc15b02d309a; TCGA-25-2409_treatment6; TCGA-25-2409_treatment5; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:28:19.062946-06:00; 2025-01-06T20:28:19.062946-06:00; Recurrent Disease; Recurrent Disease","Not Reported",26571,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-25-2409_diagnosis","34c4ee2c-8725-4f00-b402-a071d821e8b8","Not Reported","Yes",FALSE,304,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",71,-26267,"5897f462-2f0f-5340-b4d1-bff091eb649b",FALSE,821,NA,"TCGA-25-2409-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-2409-01"
"TCGA-30-1714-01A-02R-1567-13","TCGA-30-1714-01A-02R-1567-13","TCGA-30-1714","TCGA-30-1714-01A","TP","Primary solid Tumor","TCGA-30-1714-01A","01","Primary","44b8b591-5dd6-4b93-bd8f-d1c3284af41f","Primary Tumor",NA,"released","Unknown",0.4,"7bec7160-e40c-4b47-b0d6-93652c5e27f2","TCGA-30-1714",0.3,"Unknown",0.6,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 9f6d0128-d129-4fe9-ae0a-941540c4e5d0; c3d71106-d773-4469-9ed4-09ae295c8ae7; TCGA-30-1714_treatment16; TCGA-30-1714_treatment15; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; yes; yes; 2025-01-06T20:31:59.690684-06:00; 2025-01-06T20:31:59.690684-06:00; Recurrent Disease; Recurrent Disease","Not Reported",25273,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-30-1714_diagnosis","829b4b09-c75f-4290-96a6-a51c5f2183ce","Not Reported","Yes",FALSE,241,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",68,-25032,"490023f5-f2f1-5600-b594-3718d8334148",FALSE,1158,"Ashkenazi Jew","TCGA-30-1714-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-30-1714-01"
"TCGA-OY-A56P-01A-12R-A406-31","TCGA-OY-A56P-01A-12R-A406-31","TCGA-OY-A56P","TCGA-OY-A56P-01A","TP","Primary solid Tumor","TCGA-OY-A56P-01A","01","Primary","38875e85-5516-4775-a4b1-9b2b7ef4d732","Primary Tumor",NA,"released","Unknown",NA,"D916ED58-54D5-43FC-A5B0-6E4844A7F677","TCGA-OY-A56P",NA,"Unknown",NA,FALSE,"Tumor","Unknown","2025-01-08T13:15:37.188206-06:00; 29970bc9-0f51-426e-aceb-2324ae1dcd88; TCGA-OY-A56P_treatment5; Pharmaceutical Therapy, NOS; released; yes; 2025-01-06T20:17:00.599114-06:00; Unknown","Not Reported",18374,"Unknown","Unknown","TCGA-OY-A56P_diagnosis","555f158b-eb4f-406f-a71f-c672e1eb7533","Not Reported","Yes",FALSE,794,NA,NA,NA,NA,NA,NA,NA,NA,NA,"black or african american","female","not hispanic or latino","Alive",48,-17580,"24bd713d-fde2-55f4-b722-af81e504bde1",FALSE,NA,NA,"TCGA-OY-A56P-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,796,390,"false",NA,NA,NA,NA,"United States",NA,NA,"TCGA-OY-A56P-01"
"TCGA-59-2351-01A-01R-1569-13","TCGA-59-2351-01A-01R-1569-13","TCGA-59-2351","TCGA-59-2351-01A","TP","Primary solid Tumor","TCGA-59-2351-01A","01","Primary","5de10a41-af67-4417-9152-54a184a37f68","Primary Tumor","Not Reported","released","Unknown",0.8,"6cec74e9-4ad7-4c6d-abdd-36ba1573d6ad","TCGA-59-2351",0.4,"Unknown",2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1cef88d6-6d5e-4254-b4d7-96cf877e851f; bc3954b7-71d9-4e64-a1e6-f968e8f450b2; d02ec9e0-fe45-4d2a-bce5-cb9d9c3c52ef; TCGA-59-2351_treatment4; TCGA-59-2351_treatment5; TCGA-59-2351_treatment3; Radiation Therapy, NOS; Surgery, NOS; Pharmaceutical Therapy, NOS; released; released; released; no; yes; yes; 2025-01-06T20:59:06.209059-06:00; 2025-01-06T20:59:06.209059-06:00; 2025-01-06T20:59:06.209059-06:00; Progressive Disease; Progressive Disease; Progressive Disease; NA; 2154; NA","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-59-2351_diagnosis","4f9b4679-7b00-49b3-ade3-73c7390015d6","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",51,NA,"3ba18647-da19-54a4-8a1c-be83eb7827d5",FALSE,NA,NA,"TCGA-59-2351-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-59-2351-01"
"TCGA-25-1320-01A-01R-1565-13","TCGA-25-1320-01A-01R-1565-13","TCGA-25-1320","TCGA-25-1320-01A","TP","Primary solid Tumor","TCGA-25-1320-01A","01","Primary","97a91868-8a8d-4b2d-bba2-8bd187f572ac","Primary Tumor","Not Reported","released","Unknown",3,"AF68EF8D-A31D-453B-8083-CF6B9EE4E838","TCGA-25-1320",1,"Unknown",3.4,FALSE,"Tumor","8441/3","181; 181; 181; NA; 607; 28; 28; 28; NA; 424; Intravenous; Intravenous; Intravenous; Intravenous; 1f604ffe-d0c1-4e05-b0f4-bb3f9b9443fa; 28bb59a9-214d-4e0d-ad4a-da5e3d8ee2f9; 5c815fd4-2587-570d-8b77-cdb0cac1612d; 8fc807bc-08c4-486a-8796-68fde0d08375; df449d18-0780-4ca8-b41a-22ba1c245f34; TCGA-25-1320_treatment3; TCGA-25-1320_treatment2; TCGA-25-1320_treatment; TCGA-25-1320_treatment5; TCGA-25-1320_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 8; 8; 8; NA; 7; Topotecan; Paclitaxel; Carboplatin; NA; Pegylated Liposomal Doxorubicin Hydrochloride; yes; yes; yes; no; yes; 2025-01-06T20:28:37.273148-06:00; 2025-01-06T20:28:37.273148-06:00; NA; 2025-01-06T20:28:37.273148-06:00; 2025-01-06T20:28:37.273148-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; NA; NA; NA; NA; Recurrent Disease","Ovary",24018,"Serous cystadenocarcinoma, NOS","primary",NA,"1786b36d-9344-51a7-bf6a-5abd3ce5549b","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2001,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",65,-24018,"1720ccc7-09c1-5f51-9513-6a8de9c133e6",FALSE,1155,NA,"TCGA-25-1320-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1320-01"
"TCGA-13-0893-01B-01R-1565-13","TCGA-13-0893-01B-01R-1565-13","TCGA-13-0893","TCGA-13-0893-01B","TP","Primary solid Tumor","TCGA-13-0893-01B","01","Primary","8f4f9492-0d28-4747-b4bb-25ddc99e4327","Primary Tumor","Not Reported","released","Unknown",1,"0648E74B-766C-4AB7-BEEE-D45895413E5E","TCGA-13-0893",0.3,"Unknown",1.2,FALSE,"Tumor","8441/3","284; 284; 566; NA; 175; NA; 3; NA; 80; 80; 340; NA; Intravenous; Intravenous; 186be6ea-fe78-538d-aeb7-be248980c0ae; a41514b9-da97-4b56-9145-3d1ebe1a1a54; c3be81cf-0b66-4d5f-b879-7c3096fdcafc; f54a6a19-ca16-4a2a-a31c-0825f3fe6aa5; TCGA-13-0893_treatment; TCGA-13-0893_treatment2; TCGA-13-0893_treatment3; TCGA-13-0893_treatment4; Chemotherapy; Chemotherapy; Hormone Therapy; Radiation Therapy, NOS; 8; 8; NA; NA; Paclitaxel; Carboplatin; Letrozole; NA; yes; yes; yes; no; NA; 2025-01-06T21:41:03.847324-06:00; 2025-01-06T21:41:03.847324-06:00; 2025-01-06T21:41:03.847324-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; NA; mg/m2; NA","Ovary",17573,"Serous cystadenocarcinoma, NOS","primary",NA,"74c32721-9793-5e47-9563-559b08a6f618","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2003,"Cytology","C56.9","G3",NA,"black or african american","female","not hispanic or latino","Dead",48,-17573,"6c86e5a1-4fa3-5421-8580-641c2765baa8",FALSE,1319,NA,"TCGA-13-0893-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0893-01"
"TCGA-31-1951-01A-01R-1568-13","TCGA-31-1951-01A-01R-1568-13","TCGA-31-1951","TCGA-31-1951-01A","TP","Primary solid Tumor","TCGA-31-1951-01A","01","Primary","cc6a73f6-9dee-4eeb-85c3-c81f02d1adef","Primary Tumor","Not Reported","released","Unknown",0.5,"b10efe75-1420-47d2-9c5b-202b09099357","TCGA-31-1951",0.3,"Unknown",0.7,FALSE,"Tumor","8441/3","146; 482; 482; NA; 146; 3600; 240; 3600; NA; 1260; 41; 328; 328; NA; 41; Intravenous; Intravenous; Intravenous; Intravenous; 0cc14ffb-50e9-4538-a1ba-a1bac0d63e8f; 26eb5580-5888-5b83-8256-0e83babb4ed7; 6eed5189-5fb1-40c3-91ce-93b632514031; 9d44da79-0ad1-46d2-b038-1f7ef881abcb; caa50005-4228-49cd-985e-5c6eb04d452b; TCGA-31-1951_treatment4; TCGA-31-1951_treatment; TCGA-31-1951_treatment3; TCGA-31-1951_treatment5; TCGA-31-1951_treatment2; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; 6; 6; NA; 6; Carboplatin; Pegylated Liposomal Doxorubicin Hydrochloride; Carboplatin; NA; Paclitaxel; yes; yes; yes; no; yes; 2025-01-06T20:18:12.163725-06:00; NA; 2025-01-06T20:18:12.163725-06:00; 2025-01-06T20:18:12.163725-06:00; 2025-01-06T20:18:12.163725-06:00; Adjuvant; NA; NA; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg; mg; mg; NA; mg; NA; Recurrent Disease; Recurrent Disease; NA; NA","Ovary",21352,"Serous cystadenocarcinoma, NOS","primary",NA,"201d89c4-e6e6-5f26-9ffc-249c94991d25","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2007,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",58,-21352,"1f9b5de4-e9f0-5e4d-8959-ccfe046d49a5",FALSE,NA,NA,"TCGA-31-1951-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-31-1951-01"
"TCGA-09-1673-01A-01R-1566-13","TCGA-09-1673-01A-01R-1566-13","TCGA-09-1673","TCGA-09-1673-01A","TP","Primary solid Tumor","TCGA-09-1673-01A","01","Primary","95522925-79b0-4ce7-8323-dce56cbf15cd","Primary Tumor",NA,"released","Unknown",1,"d4f7aa96-11e8-4d66-a1be-595ec22de450","TCGA-09-1673",0.6,"Unknown",3,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 25; 25; NA; Intravenous; Intravenous; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 21025756-0f6d-4b51-8fdb-fa54631dd241; 8a696dc3-800d-55d6-ad6e-a0a36d15bc7c; ffbe2df7-6b80-471a-975c-c6bce9ff1baf; TCGA-09-1673_treatment2; TCGA-09-1673_treatment; TCGA-09-1673_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; released; released; released; Unknown; Carboplatin; NA; yes; yes; no; 2025-01-06T20:07:52.241674-06:00; NA; 2025-01-06T20:07:52.241674-06:00","Ovary",18599,"Serous cystadenocarcinoma, NOS","primary",NA,"18cf8d27-34a1-592b-b795-f9dd1ad5ee52","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",50,-18599,"52ee8dcb-6b70-54da-9a9b-846e68a0b566",FALSE,NA,NA,"TCGA-09-1673-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-1673-01"
"TCGA-29-1769-01A-01R-1567-13","TCGA-29-1769-01A-01R-1567-13","TCGA-29-1769","TCGA-29-1769-01A","TP","Primary solid Tumor","TCGA-29-1769-01A","01","Primary","cbfe2502-c3d1-44a5-bd1a-4a775c86d27f","Primary Tumor",NA,"released","Unknown",0.5,"67f144b3-c10b-4f96-a70b-6794d817170f","TCGA-29-1769",0.4,"Unknown",1.1,FALSE,"Tumor","8441/3","150; 150; 20; 20; NA; NA; 300; 130; 870; 318; NA; 2; 42; 42; 20; 20; NA; 206; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intravenous; Intravenous; 11936ff0-0e52-5af1-a590-7c1e25af2352; 910ba2b0-dfcc-46af-b8dc-5603b1dc9218; 97f5198b-cc51-41b4-ab93-ad8d2d5de6d8; a375b584-9e4b-4c2e-8d2d-c5fdefc33e5a; e6215bfb-caa8-4697-a8e0-599a27bcbbd3; fdc977d7-73fe-4ecd-95d2-c6f56bbc6487; TCGA-29-1769_treatment; TCGA-29-1769_treatment3; TCGA-29-1769_treatment2; TCGA-29-1769_treatment4; TCGA-29-1769_treatment6; TCGA-29-1769_treatment5; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Immunotherapy (Including Vaccines); 6; 6; 1; 1; NA; NA; Paclitaxel; Cisplatin; Carboplatin; Paclitaxel; NA; Clinical Trial; yes; yes; yes; yes; no; yes; NA; 2025-01-06T21:01:21.080608-06:00; 2025-01-06T21:01:21.080608-06:00; 2025-01-06T21:01:21.080608-06:00; 2025-01-06T21:01:21.080608-06:00; 2025-01-06T21:01:21.080608-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; mg; mg; mg; mg; NA; mg; NA; NA; NA; NA; NA; Treatment Ongoing","Ovary",14754,"Serous cystadenocarcinoma, NOS","primary",NA,"4a6c3210-bd6e-5fed-aa66-cd78f1e21390","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",40,-14754,"c864bf04-f19e-53ae-98dc-29cf75ba37fe",FALSE,NA,NA,"TCGA-29-1769-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1769-01"
"TCGA-13-1404-01A-01R-1565-13","TCGA-13-1404-01A-01R-1565-13","TCGA-13-1404","TCGA-13-1404-01A","TP","Primary solid Tumor","TCGA-13-1404-01A","01","Primary","f3cea00c-bc4a-450f-ae7b-cd97ab7369be","Primary Tumor","Not Reported","released","Unknown",1,"39B73962-A374-4521-BFBB-F10D117979F9","TCGA-13-1404",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","274; 156; NA; 156; 75; NA; NA; 175; 232; 50; NA; 50; Intraperitoneal; Intravenous; Intravenous; 4997ac35-df51-529f-91be-802f4bedd7d2; 91fb2cdc-b02e-4d4f-9e60-f2a9a0bf1761; c408657e-3d52-48be-9acb-6b93d1410642; d3a0df2f-68ec-4550-a144-c6c7c4e05896; TCGA-13-1404_treatment; TCGA-13-1404_treatment2; TCGA-13-1404_treatment4; TCGA-13-1404_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 3; 6; NA; 6; Cisplatin; Carboplatin; NA; Paclitaxel; yes; yes; no; yes; NA; 2025-01-06T21:04:00.207007-06:00; 2025-01-06T21:04:00.207007-06:00; 2025-01-06T21:04:00.207007-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; NA; NA; mg/m2","Ovary",17784,"Serous cystadenocarcinoma, NOS","primary",NA,"7b7eb1ba-bb1d-57b4-89e6-1c838f2f540e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",48,-17784,"edf28ac0-2fef-5d14-9ecd-ff8a593fa717",FALSE,NA,NA,"TCGA-13-1404-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1404-01"
"TCGA-59-A5PD-01A-11R-A406-31","TCGA-59-A5PD-01A-11R-A406-31","TCGA-59-A5PD","TCGA-59-A5PD-01A","TP","Primary solid Tumor","TCGA-59-A5PD-01A","01","Primary","9609e049-77c8-46ea-884e-32e18d7a9602","Primary Tumor",NA,"released","Unknown",NA,"9A3CB382-654F-4DFD-BF41-7615710D2825","TCGA-59-A5PD",NA,"Unknown",NA,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0f531cca-34af-4b59-b04a-54de813753df; 6b80f06f-f159-44a9-89d6-c7ab78bc28db; 7b50f3f5-4146-4992-8431-67bf02afe8e8; TCGA-59-A5PD_treatment3; TCGA-59-A5PD_treatment5; TCGA-59-A5PD_treatment4; Pharmaceutical Therapy, NOS; Surgery, NOS; Radiation Therapy, NOS; released; released; released; no; yes; no; 2025-01-06T20:38:35.483301-06:00; 2025-01-06T20:38:35.483301-06:00; 2025-01-06T20:38:35.483301-06:00; Not Reported; NA; 0; NA","Ovary",20263,"Serous cystadenocarcinoma, NOS","Synchronous primary",NA,"0ec071ce-05ed-4755-815b-68662ad23d8c","Not Reported",NA,FALSE,0,NA,NA,"Left",NA,NA,NA,NA,NA,NA,"black or african american","female","not hispanic or latino","Dead",55,-20263,"84b549ae-9aa7-5dd3-aaef-b55ad5f6eb0d",FALSE,624,NA,"TCGA-59-A5PD-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,730,130,"false","T1c","N0","MX","7th","United States",NA,NA,"TCGA-59-A5PD-01"
"TCGA-13-0908-01B-01R-1565-13","TCGA-13-0908-01B-01R-1565-13","TCGA-13-0908","TCGA-13-0908-01B","TP","Primary solid Tumor","TCGA-13-0908-01B","01","Primary","b2f596ea-10ad-4a17-aea3-88756fb0b7f9","Primary Tumor","Not Reported","released","Unknown",1.3,"AE735D44-31EA-4345-9B3E-E92C7F236569","TCGA-13-0908",0.3,"Unknown",1.4,FALSE,"Tumor","Unknown","","Not Reported",21974,"Unknown","Unknown","TCGA-13-0908_diagnosis","481009f9-c3d0-4cc5-8dc9-ddf1a3ce0a9f","Not Reported","Yes",FALSE,552,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",58,-21422,"0efe3097-e953-59c4-8eb1-a4d8d5c68285",FALSE,1843,NA,"TCGA-13-0908-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0908-01"
"TCGA-04-1350-01A-01R-1565-13","TCGA-04-1350-01A-01R-1565-13","TCGA-04-1350","TCGA-04-1350-01A","TP","Primary solid Tumor","TCGA-04-1350-01A","01","Primary","c8a0c290-56de-4ebe-80d3-ca8fb2f85188","Primary Tumor","Not Reported","released","Unknown",1,"C4BB615C-ABBA-4136-AAB4-52EA1FE88D14","TCGA-04-1350",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","1726; 363; NA; 216; 1389; 216; 1580; 720; 1389; 1622; 1389; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 15fa95a9-3a11-46db-bfdc-704aadc8cedb; 1c4f0647-6ac5-4a0d-a320-d0be4eb63d23; 2db3341c-cb64-4be7-9714-5621a45b2583; 2f6c2643-4469-47c7-b6c7-4187e217ac47; 7ee9c0ed-86ec-4a5d-88b3-ae3007774b80; 9b6c967b-ef4d-48fa-a439-fe33059f0a20; be3ff3bd-d801-5b71-94ab-a9b321903f23; c2a9dfc0-e312-45a1-ab07-9110e01a3e83; ccb198ed-a5ed-4db9-9922-f67e4266f1e6; f53cbc4b-003e-4ec4-9627-a43d34f852ce; fbc23d5a-e44b-4e0f-8899-db61dee1cd8a; TCGA-04-1350_treatment4; TCGA-04-1350_treatment3; TCGA-04-1350_treatment11; TCGA-04-1350_treatment7; TCGA-04-1350_treatment10; TCGA-04-1350_treatment8; TCGA-04-1350_treatment; TCGA-04-1350_treatment2; TCGA-04-1350_treatment5; TCGA-04-1350_treatment6; TCGA-04-1350_treatment9; Targeted Molecular Therapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Immunotherapy (Including Vaccines); Chemotherapy; Targeted Molecular Therapy; Chemotherapy; Chemotherapy; Targeted Molecular Therapy; Chemotherapy; released; released; released; released; released; released; released; released; released; released; released; Fulvestrant; Cisplatin; NA; Paclitaxel; Bevacizumab; Carboplatin; Tamoxifen; Gemcitabine; Gemcitabine; Exemestane; Cisplatin; yes; yes; no; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T20:19:21.344848-06:00; 2025-01-06T20:19:21.344848-06:00; 2025-01-06T20:19:21.344848-06:00; 2025-01-06T20:19:21.344848-06:00; 2025-01-06T20:19:21.344848-06:00; 2025-01-06T20:19:21.344848-06:00; NA; 2025-01-06T20:19:21.344848-06:00; 2025-01-06T20:19:21.344848-06:00; 2025-01-06T20:19:21.344848-06:00; 2025-01-06T20:19:21.344848-06:00; Progressive Disease; Progressive Disease; NA; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; NA; Adjuvant; NA; NA; NA; NA; NA; NA; NA; NA","Ovary",16942,"Serous cystadenocarcinoma, NOS","primary",NA,"2755ddb9-4175-5754-a34d-883256cd0dc5","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2003,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",46,-16942,"a8d4c73c-f71c-5015-9cfe-d6499ca3919b",FALSE,1946,NA,"TCGA-04-1350-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1350-01"
"TCGA-61-1736-01B-01R-1568-13","TCGA-61-1736-01B-01R-1568-13","TCGA-61-1736","TCGA-61-1736-01B","TP","Primary solid Tumor","TCGA-61-1736-01B","01","Primary","8a5f3650-3bfa-48f9-80c3-270b05daa00c","Primary Tumor","Not Reported","released","Unknown",0.8,"c034e484-683b-463c-999d-eb1fd9741292","TCGA-61-1736",0.4,"Unknown",1,FALSE,"Tumor","8441/3","138; NA; 138; NA; NA; NA; 34; NA; 34; NA; 946; NA; Intravenous; Intravenous; 26cdbde5-ebec-5818-8d7a-29010209e452; 5cc20747-d14a-4a76-b448-e37ac91a6070; 95410298-1ce8-494d-8e95-9f10c6c0e860; aae02639-70cd-4a5b-8f89-032999ac473b; cb0d37d1-df4b-474b-845e-1f62091fd964; e642e5c4-6725-4287-b1ef-401a001bc3c7; TCGA-61-1736_treatment; TCGA-61-1736_treatment4; TCGA-61-1736_treatment2; TCGA-61-1736_treatment5; TCGA-61-1736_treatment3; TCGA-61-1736_treatment6; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; NA; 6; NA; NA; NA; Carboplatin; Gemcitabine Hydrochloride; Paclitaxel; Cisplatin; Pegylated Liposomal Doxorubicin Hydrochloride; NA; yes; yes; yes; yes; yes; no; NA; 2025-01-06T21:19:58.007183-06:00; 2025-01-06T21:19:58.007183-06:00; 2025-01-06T21:19:58.007183-06:00; 2025-01-06T21:19:58.007183-06:00; 2025-01-06T21:19:58.007183-06:00; Adjuvant; NA; Adjuvant; NA; NA; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; NA; Recurrent Disease; NA; Recurrent Disease; Progressive Disease; NA","Ovary",16613,"Serous cystadenocarcinoma, NOS","primary",NA,"06cbb2ff-f89f-5c49-a700-1241cb4fa9f8","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2005,"Excisional Biopsy","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",45,-16613,"939d1efe-bdfb-577a-94ee-c8c9e51b5fe6",FALSE,1484,NA,"TCGA-61-1736-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1736-01"
"TCGA-04-1338-01A-01R-1564-13","TCGA-04-1338-01A-01R-1564-13","TCGA-04-1338","TCGA-04-1338-01A","TP","Primary solid Tumor","TCGA-04-1338-01A","01","Primary","7b90d4ab-6c0a-4428-9ef1-20c7c09ff9e7","Primary Tumor",NA,"released","Unknown",1,"889AF2DB-7FF9-45B1-8FD4-28D57CF870A7","TCGA-04-1338",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","201; 510; 627; NA; NA; 201; Adjuvant; NA; NA; Adjuvant; NA; Adjuvant; 0; 415; 597; NA; 627; 0; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 281b59c3-bf65-5194-ae83-64187eba70fc; 54422771-5f2e-4183-b7d5-fb25a0533734; 5bbdf4ef-abc5-4695-b688-db3b92c1f3aa; 6bf283f9-f5fc-44d6-86fd-5a98cd84d9ab; 8d220e33-4b39-4244-982b-64a18d969683; b39b6eae-ba30-4905-9091-619a9fd685d4; TCGA-04-1338_treatment; TCGA-04-1338_treatment5; TCGA-04-1338_treatment2; TCGA-04-1338_treatment6; TCGA-04-1338_treatment3; TCGA-04-1338_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 8; 6; 1; NA; NA; 8; released; released; released; released; released; released; Carboplatin; Docetaxel; Gemcitabine; NA; Tamoxifen; Paclitaxel; yes; yes; yes; no; yes; yes; NA; 2025-01-06T21:26:29.741468-06:00; 2025-01-06T21:26:29.741468-06:00; 2025-01-06T21:26:29.741468-06:00; 2025-01-06T21:26:29.741468-06:00; 2025-01-06T21:26:29.741468-06:00; NA; 812; 800; NA; 10; NA; Intravenous; Intravenous; Intravenous; NA; Progressive Disease; Progressive Disease; NA; Progressive Disease; NA; NA; mg; mg; NA; mg; NA; NA; NA; NA; NA; Treatment Ongoing; NA","Ovary",28789,"Serous cystadenocarcinoma, NOS","primary",NA,"5a6c0be4-e300-56d1-85c2-bb11bf6409b8","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2005,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",78,-28789,"e8692f76-bc92-57a4-9d02-6ea94d74b7b9",FALSE,NA,NA,"TCGA-04-1338-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1338-01"
"TCGA-61-1737-01A-01R-1567-13","TCGA-61-1737-01A-01R-1567-13","TCGA-61-1737","TCGA-61-1737-01A","TP","Primary solid Tumor","TCGA-61-1737-01A","01","Primary","782164d9-0804-48f7-bb97-a35ebfb0c372","Primary Tumor",NA,"released","Unknown",0.3,"2fa09bf8-8be5-411c-a9cf-16c12ed1390f","TCGA-61-1737",0.2,"Unknown",0.7,FALSE,"Tumor","8441/3","176; NA; NA; 176; 106; 106; 176; 372; NA; 19000; 270; 2600; 480; 198; 127; NA; 582; 127; 43; 43; 127; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intravenous; Intravenous; Intravenous; 1125bf50-97a7-43e9-8297-c7863272df73; 1385a320-bfc5-4da4-914c-c682bb5c36cc; 440d0d89-80b4-41d3-84b7-5deb3cae6438; b0b08730-81d3-4e63-baee-f4210547ae89; b3e3a376-78cb-47a9-adb3-3e31e0a7ee90; bf28a79c-0327-5f7a-9371-c7dcce64526c; f3ba530c-7b74-4a48-b762-d05f3c3eb91a; TCGA-61-1737_treatment6; TCGA-61-1737_treatment7; TCGA-61-1737_treatment3; TCGA-61-1737_treatment2; TCGA-61-1737_treatment5; TCGA-61-1737_treatment; TCGA-61-1737_treatment4; Chemotherapy; Radiation Therapy, NOS; Hormone Therapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 3; NA; NA; 3; 4; 4; 3; Cisplatin; NA; Tamoxifen; Docetaxel; Carboplatin; Docetaxel; Paclitaxel; yes; no; yes; yes; yes; yes; yes; 2025-01-06T20:55:11.990857-06:00; 2025-01-06T20:55:11.990857-06:00; 2025-01-06T20:55:11.990857-06:00; 2025-01-06T20:55:11.990857-06:00; 2025-01-06T20:55:11.990857-06:00; NA; 2025-01-06T20:55:11.990857-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; mg; NA; mg/day; mg; mg; mg; mg; NA; NA; Treatment Ongoing; NA; NA; NA; NA","Ovary",15515,"Serous cystadenocarcinoma, NOS","primary",NA,"12f72a04-d096-517f-b4d6-c4369f4a1bf6","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2005,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",42,-15515,"7a541ca2-8c30-58c9-ad7e-ff1f0d75aa14",FALSE,NA,NA,"TCGA-61-1737-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1737-01"
"TCGA-24-1435-01A-01R-1566-13","TCGA-24-1435-01A-01R-1566-13","TCGA-24-1435","TCGA-24-1435-01A","TP","Primary solid Tumor","TCGA-24-1435-01A","01","Primary","a36ab3e1-b5fb-4557-af54-88d4ada2aaaf","Primary Tumor","Not Reported","released","Unknown",1.2,"d1574b6c-6cc1-45bc-86d0-97585d8a5c93","TCGA-24-1435",0.5,"Unknown",1.5,FALSE,"Tumor","8441/3","1189; 912; 149; NA; 771; 1126; 1266; 1028; 149; 1189; 263; 2350; 1848; NA; 136; 4500; 10; 286; 3590; 6952; 1140; 814; 27; NA; 511; 1058; 1259; 944; 27; 1140; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 16d57f7e-ca7d-43c5-9ef1-5b960266dbcd; 5b769cab-0807-42e9-bb6b-0b69e04b78e6; 77c9a497-741e-4700-86b2-6ed961da47ad; 7d4a01fb-5191-41d1-af8b-2dd8881b158c; 860856be-14fb-4f16-8f9d-7dd57beb3564; 9504fd23-5eba-5a30-b910-8975b0786281; 9e4c8b10-a60c-47fe-bb5a-daa07fc528c1; ed6f872f-33fe-4f89-bf8f-9fee4b97e635; fbf5915f-7650-4fbb-9927-88b519f9bf8f; fd723dd2-1e4b-46c2-97c9-8951ac58dda9; TCGA-24-1435_treatment5; TCGA-24-1435_treatment2; TCGA-24-1435_treatment9; TCGA-24-1435_treatment10; TCGA-24-1435_treatment6; TCGA-24-1435_treatment; TCGA-24-1435_treatment8; TCGA-24-1435_treatment4; TCGA-24-1435_treatment7; TCGA-24-1435_treatment3; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 3; 5; 6; NA; 13; 10; 1; 4; 6; 3; Cisplatin; Carboplatin; Paclitaxel; NA; Topotecan; Paclitaxel; Topotecan; Pegylated Liposomal Doxorubicin Hydrochloride; Carboplatin; Gemcitabine Hydrochloride; yes; yes; yes; no; yes; yes; yes; yes; yes; yes; 2025-01-06T20:26:30.794722-06:00; 2025-01-06T20:26:30.794722-06:00; 2025-01-06T20:26:30.794722-06:00; 2025-01-06T20:26:30.794722-06:00; 2025-01-06T20:26:30.794722-06:00; NA; 2025-01-06T20:26:30.794722-06:00; 2025-01-06T20:26:30.794722-06:00; 2025-01-06T20:26:30.794722-06:00; 2025-01-06T20:26:30.794722-06:00; Progressive Disease; Progressive Disease; NA; NA; Recurrent Disease; Progressive Disease; Progressive Disease; Progressive Disease; NA; Progressive Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; mg; mg; mg; NA; mg; mg; mg; mg; mg; mg; NA; NA; Adjuvant; Adjuvant; NA; NA; NA; NA; Adjuvant; NA","Ovary",21107,"Serous cystadenocarcinoma, NOS","primary",NA,"020510a4-78b5-5290-a377-54a07c066478","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1999,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",57,-21107,"1a799775-3d93-5950-9ea0-0ac519e37476",FALSE,1324,NA,"TCGA-24-1435-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1435-01"
"TCGA-61-1918-01A-01R-1568-13","TCGA-61-1918-01A-01R-1568-13","TCGA-61-1918","TCGA-61-1918-01A","TP","Primary solid Tumor","TCGA-61-1918-01A","01","Primary","f17ca1b8-f58c-4b17-bc4d-3bd33d9aec5f","Primary Tumor","Not Reported","released","Unknown",0.4,"6c95bd12-e871-4e4e-961f-09a64c1fe2de","TCGA-61-1918",0.4,"Unknown",1,FALSE,"Tumor","8441/3","146; 146; 146; NA; 4686; 2179; 15616; NA; 9; 9; 9; NA; Intravenous; Intravenous; Intravenous; 854ad469-98aa-47e9-944c-3b5c18a80cae; 913a1420-0d51-49c3-9f1c-c44985a6b80e; 92769dda-b04b-5014-a5a0-0fb807673dfe; 936ec02e-0b1c-44dd-a9b9-def34f1dde01; TCGA-61-1918_treatment3; TCGA-61-1918_treatment2; TCGA-61-1918_treatment; TCGA-61-1918_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; 6; NA; Carboplatin; Paclitaxel; Gemcitabine; NA; yes; yes; yes; no; 2025-01-06T21:19:25.997892-06:00; 2025-01-06T21:19:25.997892-06:00; NA; 2025-01-06T21:19:25.997892-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; Treatment Ongoing; NA; NA; NA; released; released; released; released; mg; mg; mg; NA","Ovary",16689,"Serous cystadenocarcinoma, NOS","primary",NA,"333c3c88-a293-5542-b167-ffd3a6a82a8d","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",45,-16689,"3e70c222-a83b-5da9-9917-afab5c944561",FALSE,479,NA,"TCGA-61-1918-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1918-01"
"TCGA-04-1536-01A-01R-1566-13","TCGA-04-1536-01A-01R-1566-13","TCGA-04-1536","TCGA-04-1536-01A","TP","Primary solid Tumor","TCGA-04-1536-01A","01","Primary","841bdebe-253d-4183-a3a1-e2780c859187","Primary Tumor",NA,"released","Unknown",1.5,"167826A1-0854-442E-8AF5-85294D1CB0B9","TCGA-04-1536",0.2,"Unknown",1.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; c07094ce-30f7-4661-91d8-5b43e081f9ab; f35bf032-0a76-493c-b708-db790885574d; TCGA-04-1536_treatment9; TCGA-04-1536_treatment8; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:19:49.526247-06:00; 2025-01-06T20:19:49.526247-06:00; Recurrent Disease; Recurrent Disease","Not Reported",22437,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-04-1536_diagnosis","bb0701cb-c8ea-4a48-9f6c-62c7dcde1aa4","Not Reported","Yes",FALSE,498,NA,NA,NA,NA,NA,NA,NA,NA,NA,"black or african american","female","not reported","Dead",60,-21939,"4075c35e-4315-55c2-8f7e-f4fccace1701",FALSE,885,NA,"TCGA-04-1536-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1536-01"
"TCGA-VG-A8LO-01A-11R-A406-31","TCGA-VG-A8LO-01A-11R-A406-31","TCGA-VG-A8LO","TCGA-VG-A8LO-01A","TP","Primary solid Tumor","TCGA-VG-A8LO-01A","01","Primary","ccd3903e-eee6-41f0-9a07-4351a00a7dc3","Primary Tumor",NA,"released","Unknown",NA,"6FF4C359-F127-44E6-A1A2-641D60A3665F","TCGA-VG-A8LO",NA,"Unknown",NA,FALSE,"Tumor","8460/3","8; NA; 8; No; NA; No; 8; NA; 8; 24e3a3e4-fea0-54a7-81de-f636e54333f7; 2a9eba0e-c481-4c95-bfa5-6a171a52e28e; f3226fa4-69d4-4744-8144-1414d436abbd; TCGA-VG-A8LO_treatment; TCGA-VG-A8LO_treatment3; TCGA-VG-A8LO_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Paclitaxel; NA; Carboplatin; yes; no; yes; NA; 2025-01-06T20:41:01.116551-06:00; 2025-01-06T20:41:01.116551-06:00; NA; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; Unknown; NA; Unknown; released; released; released","Ovary",20274,"Papillary serous cystadenocarcinoma","primary",NA,"aaaed386-e2f5-53c2-bdc4-6508fdec1123","Ovary","No",TRUE,0,"Stage IV","No","Right","no",2013,"Excisional Biopsy","C56.9","GB","R2","black or african american","female","not hispanic or latino","Dead",55,-20274,"bd84ae7e-b25d-59f9-9161-7cc10e02bf9f",FALSE,24,NA,"TCGA-VG-A8LO-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,122,260,"false",NA,NA,NA,NA,"Nigeria",0,NA,"TCGA-VG-A8LO-01"
"TCGA-31-1956-01A-01R-1568-13","TCGA-31-1956-01A-01R-1568-13","TCGA-31-1956","TCGA-31-1956-01A","TP","Primary solid Tumor","TCGA-31-1956-01A","01","Primary","3218e049-6d6a-471c-8453-d8ac52cf9d14","Primary Tumor","Not Reported","released","Unknown",0.9,"3646c24b-c4b7-400b-bc93-7ef485c6892c","TCGA-31-1956",0.2,"Unknown",1.3,FALSE,"Tumor","8441/3","119; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 48bc3ec7-6be9-4bb4-b2b3-b566a19dda78; dec21502-9d88-4a3d-83c3-4c075eef88e3; f0b3cc76-100f-43ee-a5b6-28f9ba37c7a3; TCGA-31-1956_treatment6; TCGA-31-1956_treatment4; TCGA-31-1956_treatment5; Surgery, NOS; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; released; yes; yes; no; 2025-01-06T20:08:39.334984-06:00; 2025-01-06T20:08:39.334984-06:00; 2025-01-06T20:08:39.334984-06:00; Unknown; Unknown; Unknown","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-31-1956_diagnosis","7321be07-41a7-4b72-b725-86fcf0f519ff","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",60,-22100,"567cb496-8b1d-54e3-bfa7-401b51d6b3fd",FALSE,NA,NA,"TCGA-31-1956-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-31-1956-01"
"TCGA-13-1477-01A-01R-1565-13","TCGA-13-1477-01A-01R-1565-13","TCGA-13-1477","TCGA-13-1477-01A","TP","Primary solid Tumor","TCGA-13-1477-01A","01","Primary","79908395-d442-44a3-8e91-97c3ae97ddd5","Primary Tumor","Not Reported","released","Unknown",1.3,"2507FA0F-9709-4B5D-9EC1-907637FB373A","TCGA-13-1477",0.3,"Unknown",1.3,FALSE,"Tumor","8441/3","206; 206; NA; 360; 175; NA; 57; 57; NA; Intravenous; Intravenous; bc902138-7d50-5a41-ba40-4935459f3eb9; e8b2cd10-1935-48dc-936f-7b59f4dc23e2; e928df47-6f55-4342-ba1f-a7781c5de4c0; TCGA-13-1477_treatment; TCGA-13-1477_treatment2; TCGA-13-1477_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 7; 7; NA; Carboplatin; Paclitaxel; NA; yes; yes; no; NA; 2025-01-06T20:23:43.350302-06:00; 2025-01-06T20:23:43.350302-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg/m2; mg/m2; NA","Ovary",18111,"Serous cystadenocarcinoma, NOS","primary",NA,"999ac7a5-2147-5a8f-afac-d62ded2f8f79","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2000,"Incisional Biopsy","C56.9","G2",NA,"white","female","not hispanic or latino","Dead",49,-18111,"b24d11cb-3d0e-5e1e-a82e-75025a577914",FALSE,1662,NA,"TCGA-13-1477-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1477-01"
"TCGA-25-1326-01A-01R-1565-13","TCGA-25-1326-01A-01R-1565-13","TCGA-25-1326","TCGA-25-1326-01A","TP","Primary solid Tumor","TCGA-25-1326-01A","01","Primary","655bee4a-887e-495e-9afe-586b75516e7d","Primary Tumor","Not Reported","released","Unknown",2.5,"B17E5B27-48DB-4E64-A1C3-CAE4921C14DF","TCGA-25-1326",1.2,"Unknown",3,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 107ef6a2-38d6-4714-84c2-16e28b8b0407; 9ab8ca43-4d1d-4e08-8347-456ce14545ee; TCGA-25-1326_treatment6; TCGA-25-1326_treatment7; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:14:19.167917-06:00; 2025-01-06T21:14:19.167917-06:00; Recurrent Disease; Recurrent Disease","Not Reported",22735,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-25-1326_diagnosis","9e71118d-7fb5-4f0b-b005-2a56cafa47d1","Not Reported","Yes",FALSE,396,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",61,-22339,"64e2c7b4-6061-5765-b200-5ae4c9836b78",FALSE,1249,NA,"TCGA-25-1326-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1326-01"
"TCGA-24-2267-01A-01R-1568-13","TCGA-24-2267-01A-01R-1568-13","TCGA-24-2267","TCGA-24-2267-01A","TP","Primary solid Tumor","TCGA-24-2267-01A","01","Primary","00be5ec1-3b0f-4b5a-b116-4efce25d2cc8","Primary Tumor","Not Reported","released","Unknown",1.3,"24844312-f32c-4366-945e-96d9a923f82a","TCGA-24-2267",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 3fcadb7a-715f-4433-9f82-aac5ee801aa9; 7afc0f1c-f514-4a92-a84e-076781fc7fe8; TCGA-24-2267_treatment14; TCGA-24-2267_treatment13; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:13:54.880377-06:00; 2025-01-06T21:13:54.880377-06:00; Recurrent Disease; Recurrent Disease","Not Reported",21805,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-2267_diagnosis","50af2a05-8c9b-465e-a3b3-8d7c2c8125e1","Not Reported","Yes",FALSE,512,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",58,-21293,"299c04b0-8890-5057-97b4-2e1177e03833",FALSE,1446,NA,"TCGA-24-2267-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2267-01"
"TCGA-25-1312-01A-01R-1565-13","TCGA-25-1312-01A-01R-1565-13","TCGA-25-1312","TCGA-25-1312-01A","TP","Primary solid Tumor","TCGA-25-1312-01A","01","Primary","ce884866-7563-44b2-a7b0-849512c66abf","Primary Tumor","Not Reported","released","Unknown",2.5,"9AD5ADDB-713E-4FF7-97F1-123FA771AC5B","TCGA-25-1312",1,"Unknown",3,FALSE,"Tumor","8441/3","Adjuvant; 2025-01-08T13:15:37.188206-06:00; 46926ff0-1c00-56ad-a1f3-e60215b191eb; TCGA-25-1312_treatment; Radiation Therapy, NOS; released; NA; no; NA","Ovary",25537,"Serous cystadenocarcinoma, NOS","primary",NA,"7c0d838a-d4ca-5f23-85c8-672a6ef301b9","Ovary","No",TRUE,0,"Stage IV","Not Reported","Left","not reported",2001,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",69,-25537,"3eec1dc1-4d6d-5b73-bbde-6688b95c256a",FALSE,31,NA,"TCGA-25-1312-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1312-01"
"TCGA-25-2392-01A-01R-1569-13","TCGA-25-2392-01A-01R-1569-13","TCGA-25-2392","TCGA-25-2392-01A","TP","Primary solid Tumor","TCGA-25-2392-01A","01","Primary","bbfeb712-4736-49c9-9cc6-74a94c6e8195","Primary Tumor","Not Reported","released","Unknown",1,"C520D0D6-F104-492C-A4C2-844390F55570","TCGA-25-2392",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 484210e4-fc40-40be-960b-93734ea5f051; f156e02a-a3e2-5333-8eb7-3ad870a73902; TCGA-25-2392_treatment2; TCGA-25-2392_treatment; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; no; 2025-01-06T20:08:07.427448-06:00; NA; NA; NA","Ovary",27667,"Serous cystadenocarcinoma, NOS","primary",NA,"99ca4e5c-3912-5835-8d01-9492e0b5074f","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2003,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",75,-27667,"0239e132-69ad-584f-a099-4a1b626fdc4d",FALSE,31,NA,"TCGA-25-2392-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-2392-01"
"TCGA-24-2035-01A-01R-1568-13","TCGA-24-2035-01A-01R-1568-13","TCGA-24-2035","TCGA-24-2035-01A","TP","Primary solid Tumor","TCGA-24-2035-01A","01","Primary","e4ccc95d-79ca-49e3-8cd0-c8452c5f9aa2","Primary Tumor","Not Reported","released","Unknown",0.7,"025d4b31-5832-451a-9f70-e0281f698aa6","TCGA-24-2035",0.3,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; NA; NA; NA; Adjuvant; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 052a1ab0-3690-46b0-93a9-5ec33b9e099b; 2c437e8c-ef7c-4307-808d-6a26d821976f; 5b0af149-7523-4f85-97a8-2eb00593caae; 7cab499b-45bd-4160-82a0-4531c6437cb2; 7f982705-4e3a-4708-8ef0-eb0625c051a4; 87ee65f0-37d3-4a36-8e82-bdf885d45b95; d183dbca-1016-5ed6-8e50-f554c32c5b76; e70859dd-6c5f-4eab-bf4a-41257869f24f; TCGA-24-2035_treatment8; TCGA-24-2035_treatment4; TCGA-24-2035_treatment7; TCGA-24-2035_treatment6; TCGA-24-2035_treatment3; TCGA-24-2035_treatment5; TCGA-24-2035_treatment; TCGA-24-2035_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T21:34:17.765288-06:00; 2025-01-06T21:34:17.765288-06:00; 2025-01-06T21:34:17.765288-06:00; 2025-01-06T21:34:17.765288-06:00; 2025-01-06T21:34:17.765288-06:00; 2025-01-06T21:34:17.765288-06:00; NA; 2025-01-06T21:34:17.765288-06:00; Intravenous; Oral; Intravenous; Intravenous; Intravenous; Oral; NA; 6; NA; NA; 2; 6; 2; NA; NA; Cisplatin; Etoposide; Topotecan; Valspodar; Paclitaxel; Paclitaxel; Ifosfamide; NA; NA; 688; 343; NA; NA; NA; 688; NA; NA; Progressive Disease; Progressive Disease; Recurrent Disease; NA; Recurrent Disease; Progressive Disease; NA; NA; NA; 679; NA; NA; NA; NA","Ovary",23855,"Serous cystadenocarcinoma, NOS","primary",NA,"0e6482de-13e4-5907-b7c0-18515ebd9c3d","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",1996,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",65,-23855,"07018a25-f50f-5622-ac08-b364ea38ff12",FALSE,857,NA,"TCGA-24-2035-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2035-01"
"TCGA-09-2053-01C-01R-1568-13","TCGA-09-2053-01C-01R-1568-13","TCGA-09-2053","TCGA-09-2053-01C","TP","Primary solid Tumor","TCGA-09-2053-01C","01","Primary","9236e7c0-7b03-4bed-9f19-e3cf805be49b","Primary Tumor","Not Reported","released","Unknown",0.4,"0d28e549-3ed0-4a22-bac7-9cbe24e44f53","TCGA-09-2053",0.3,"Unknown",0.7,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 436eb7e2-6c39-4450-9eed-5d5f6f2c2924; 727de4af-4e11-5739-930d-233dbc34ad1f; cb331bbc-43e2-4be5-82ab-fc5c62265858; TCGA-09-2053_treatment3; TCGA-09-2053_treatment; TCGA-09-2053_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:39:28.604284-06:00; NA; 2025-01-06T21:39:28.604284-06:00; NA; 138; 138; NA; 6; 175; NA; 34; 34; Intravenous; Intravenous; NA; 6; 6; NA; Carboplatin; Paclitaxel; NA; AUC; mg/m2","Ovary",26433,"Serous cystadenocarcinoma, NOS","primary",NA,"0517938d-2b87-5aae-a33c-e315635ccbe5","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2005,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",72,-26433,"bb80c4c4-c773-51f5-99e1-61f3b1610405",FALSE,NA,NA,"TCGA-09-2053-01C","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-2053-01"
"TCGA-29-1711-01A-01R-1567-13","TCGA-29-1711-01A-01R-1567-13","TCGA-29-1711","TCGA-29-1711-01A","TP","Primary solid Tumor","TCGA-29-1711-01A","01","Primary","f0f721b2-edab-49c9-b271-2204878c2ae5","Primary Tumor",NA,"released","Unknown",1.1,"e0e207a0-c3c2-4bfc-9d7d-d00c5c953d3d","TCGA-29-1711",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 039b1e9f-245c-445e-88cd-25ba82934dfc; 440d246c-0fd0-58e7-be8a-18e0015a9589; c3899088-1e6c-4d14-8f8c-6b07aaa0a052; f387fd70-16f3-4dd5-b0bb-54eb257fdd01; TCGA-29-1711_treatment4; TCGA-29-1711_treatment; TCGA-29-1711_treatment3; TCGA-29-1711_treatment2; Radiation Therapy, NOS; Targeted Molecular Therapy; Chemotherapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T20:30:55.550316-06:00; NA; 2025-01-06T20:30:55.550316-06:00; 2025-01-06T20:30:55.550316-06:00; NA; 234; 136; 136; NA; 1863; 150; 170; NA; 30; 30; 30; NA; Bevacizumab; Docetaxel; Oxaliplatin; NA; mg; mg; mg; Intravenous; Intravenous; NA; NA; 6; 6","Ovary",16485,"Serous cystadenocarcinoma, NOS","primary",NA,"eda2964c-ca2e-5949-a47e-bde81da98557","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2006,"Surgical Resection","C56.9","G2",NA,"black or african american","female","not reported","Alive",45,-16485,"8281281b-4e5e-598a-b5f4-68ff6e315138",FALSE,NA,NA,"TCGA-29-1711-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1711-01"
"TCGA-24-1923-01A-01R-1567-13","TCGA-24-1923-01A-01R-1567-13","TCGA-24-1923","TCGA-24-1923-01A","TP","Primary solid Tumor","TCGA-24-1923-01A","01","Primary","84d06f56-6611-4fa1-89fd-df8780f7f446","Primary Tumor","Not Reported","released","Unknown",0.6,"6ae8158a-e236-4cc0-88d2-50756216f0e7","TCGA-24-1923",0.6,"Unknown",1.3,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0a032f64-d73c-48fe-bb64-f0cd7ea8eb6c; 97c68816-da6a-4352-8ba6-a3f0e0619f04; TCGA-24-1923_treatment7; TCGA-24-1923_treatment8; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:35:00.861711-06:00; 2025-01-06T21:35:00.861711-06:00; Recurrent Disease; Recurrent Disease","Not Reported",18971,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1923_diagnosis","347a4fdb-c1fa-4a5c-8bff-612ce2d7ddb3","Not Reported","Yes",FALSE,343,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",51,-18628,"96d5e3f2-4a30-5a3a-ba6f-eecd943d1046",FALSE,690,NA,"TCGA-24-1923-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1923-01"
"TCGA-30-1718-01A-01R-1567-13","TCGA-30-1718-01A-01R-1567-13","TCGA-30-1718","TCGA-30-1718-01A","TP","Primary solid Tumor","TCGA-30-1718-01A","01","Primary","9ea630a2-1412-4f40-897a-38a52600a1cb","Primary Tumor",NA,"released","Unknown",0.6,"078da76a-b9f5-40d0-9a57-04c306ade36a","TCGA-30-1718",0.4,"Unknown",1.3,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 03b3b1bd-5e6f-47a5-8cee-448e77bc6e6f; 17cbc288-edde-54bb-a604-7b7421ba7b73; 1e1c9bb6-da2a-4575-a198-da9f1237e74f; 5e7bd0e0-d85b-49f8-9797-864460c78a36; b1a7fd43-8292-4a76-858f-b5d680287445; d0ab8730-72a3-4dee-980b-c610e4797fe7; fbce0faa-8d82-4f37-8b3e-9f01be7bdfaf; TCGA-30-1718_treatment7; TCGA-30-1718_treatment; TCGA-30-1718_treatment5; TCGA-30-1718_treatment2; TCGA-30-1718_treatment3; TCGA-30-1718_treatment4; TCGA-30-1718_treatment6; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Hormone Therapy; Chemotherapy; released; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; yes; 2025-01-06T20:47:34.295208-06:00; NA; 2025-01-06T20:47:34.295208-06:00; 2025-01-06T20:47:34.295208-06:00; 2025-01-06T20:47:34.295208-06:00; 2025-01-06T20:47:34.295208-06:00; 2025-01-06T20:47:34.295208-06:00; NA; 492; NA; NA; 178; 896; NA; NA; 206; NA; NA; 31; 865; NA; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; 11; NA; NA; 8; NA; NA; NA; Paclitaxel; Carboplatin; Altretamine; Carboplatin; Tamoxifen; Paclitaxel","Ovary",16400,"Serous cystadenocarcinoma, NOS","primary",NA,"a8f15bcc-2d2b-58da-adf9-fe2277971d9e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",44,-16400,"af0f012e-4f9b-5984-9ca8-278a4b50c0ce",FALSE,1579,NA,"TCGA-30-1718-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-30-1718-01"
"TCGA-13-0920-01A-01R-1564-13","TCGA-13-0920-01A-01R-1564-13","TCGA-13-0920","TCGA-13-0920-01A","TP","Primary solid Tumor","TCGA-13-0920-01A","01","Primary","a2530fac-9d42-4fbe-881b-e9bad5a2d793","Primary Tumor",NA,"released","Unknown",0.7,"6880B406-08B2-43CE-9274-5826B1BE9114","TCGA-13-0920",0.4,"Unknown",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; b7553d4f-8588-4842-8f9d-2f420a7ec1e9; c627b724-7601-4b26-8d2e-5d619c089f1b; TCGA-13-0920_treatment3; TCGA-13-0920_treatment4; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:30:33.687751-06:00; 2025-01-06T21:30:33.687751-06:00; Recurrent Disease; Recurrent Disease","Not Reported",24361,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-13-0920_diagnosis","9065505c-8b4d-4bd1-8c24-61efcec769f0","Not Reported","Yes",FALSE,297,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",65,-24064,"4d9e60db-29bf-55a5-b771-45b205a0536b",FALSE,1484,NA,"TCGA-13-0920-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0920-01"
"TCGA-13-1408-01A-01R-1565-13","TCGA-13-1408-01A-01R-1565-13","TCGA-13-1408","TCGA-13-1408-01A","TP","Primary solid Tumor","TCGA-13-1408-01A","01","Primary","1e5e8214-4132-461d-ae3e-bd1f87faa61d","Primary Tumor","Not Reported","released","Unknown",1.1,"39435FCB-699F-4A2F-9005-E67C9A41C766","TCGA-13-1408",0.3,"Unknown",1.8,FALSE,"Tumor","8441/3","201; 201; 91; NA; 201; 91; mg/m2; mg/m2; NA; NA; mg/m2; NA; 152; 152; 8; NA; 152; 8; Intraperitoneal; Intravenous; Intravenous; Intraperitoneal; Intravenous; 313de0f0-e7f6-42cf-b44b-b4e11c8a76ff; 3bef52d7-95c1-4eaa-9e49-7aa31a18d798; 8be8284b-3a48-4df2-ba42-f1a47f34e638; 91890577-a9c7-4c47-bfc4-bbea6a3f22d2; a2186591-a57e-43f8-afdf-cd00a181db9c; d62233c1-db6f-5c67-8080-81da1707a968; TCGA-13-1408_treatment5; TCGA-13-1408_treatment4; TCGA-13-1408_treatment2; TCGA-13-1408_treatment6; TCGA-13-1408_treatment3; TCGA-13-1408_treatment; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 3; 3; 5; NA; 3; 5; 75; 135; NA; NA; 60; NA; Cisplatin; Paclitaxel; Carboplatin; NA; Paclitaxel; Paclitaxel; yes; yes; yes; no; yes; yes; 2025-01-06T20:11:54.066474-06:00; 2025-01-06T20:11:54.066474-06:00; 2025-01-06T20:11:54.066474-06:00; 2025-01-06T20:11:54.066474-06:00; 2025-01-06T20:11:54.066474-06:00; NA; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; NA; NA; 5; NA; NA; 175; NA; NA; AUC; NA; NA; mg/m2","Ovary",21635,"Serous cystadenocarcinoma, NOS","primary",NA,"8ea974b6-785e-5566-a7c3-61fc6c0fd914","Ovary","No",TRUE,0,"Stage IIIC","Not Reported",NA,"not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",59,-21635,"45f8a427-8d1d-5aae-b1f3-7f698c460b17",FALSE,1680,"Ashkenazi Jew","TCGA-13-1408-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1408-01"
"TCGA-25-2042-01A-01R-1568-13","TCGA-25-2042-01A-01R-1568-13","TCGA-25-2042","TCGA-25-2042-01A","TP","Primary solid Tumor","TCGA-25-2042-01A","01","Primary","71484ed8-3496-48b2-81b8-888d04f10f0a","Primary Tumor","Not Reported","released","Unknown",0.6,"4D14A408-E3F6-47EB-A67C-0606450DB0C5","TCGA-25-2042",0.3,"Unknown",1.4,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 51c04297-1166-4597-9394-952ebf000670; a70e8014-1485-4c4c-8f56-9311082ed4a7; bc1a8fea-ed6a-49f8-b6d7-230b3b86ab56; TCGA-25-2042_treatment9; TCGA-25-2042_treatment11; TCGA-25-2042_treatment10; Pharmaceutical Therapy, NOS; Surgery, NOS; Radiation Therapy, NOS; released; released; released; yes; yes; no; 2025-01-06T20:15:32.176569-06:00; 2025-01-06T20:15:32.176569-06:00; 2025-01-06T20:15:32.176569-06:00; Progressive Disease; Progressive Disease; Progressive Disease; NA; 123; NA","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-25-2042_diagnosis","0359e54b-74dc-4817-a4ff-28f28482678b","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"american indian or alaska native","female","not hispanic or latino","Dead",60,-22127,"6b47a6c1-f0cd-5fa9-9205-69c8f3ec37e7",FALSE,396,NA,"TCGA-25-2042-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-2042-01"
"TCGA-13-1505-01A-01R-1565-13","TCGA-13-1505-01A-01R-1565-13","TCGA-13-1505","TCGA-13-1505-01A","TP","Primary solid Tumor","TCGA-13-1505-01A","01","Primary","4fb10554-1573-44d5-99dd-d7abef42e373","Primary Tumor","Not Reported","released","Unknown",1,"ACD1E3CC-53FC-4615-B31B-0AFDF4B259BF","TCGA-13-1505",0.3,"Unknown",1.2,FALSE,"Tumor","Unknown","","Not Reported",24799,"Unknown","Unknown","TCGA-13-1505_diagnosis","64dc1b15-7bae-4545-a667-bd90e4b2eeb2","Not Reported","Yes",FALSE,1561,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",63,-23238,"b7362858-0e48-5035-9da1-763716901ea0",FALSE,NA,NA,"TCGA-13-1505-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1505-01"
"TCGA-24-2033-01A-01R-1568-13","TCGA-24-2033-01A-01R-1568-13","TCGA-24-2033","TCGA-24-2033-01A","TP","Primary solid Tumor","TCGA-24-2033-01A","01","Primary","88152ab3-4bbc-4d80-9e1e-34c96de3d604","Primary Tumor","Not Reported","released","Unknown",0.7,"c804dedf-5495-4051-b87f-974afe4d5718","TCGA-24-2033",0.7,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1d33693e-72e5-4321-8b79-f22fc5f9af5e; 2b692939-01eb-5f0f-9fb5-c6bb2f44a78f; 4442f6de-d2a2-476c-b516-dbfaef3dbb42; 9a9ca7ba-fafe-465a-bcb5-0929ed6eb699; c7ca1018-1ad9-4219-8945-cb9fbc8e74f7; TCGA-24-2033_treatment5; TCGA-24-2033_treatment; TCGA-24-2033_treatment4; TCGA-24-2033_treatment2; TCGA-24-2033_treatment3; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; no; yes; yes; yes; yes; 2025-01-06T21:32:42.493636-06:00; NA; 2025-01-06T21:32:42.493636-06:00; 2025-01-06T21:32:42.493636-06:00; 2025-01-06T21:32:42.493636-06:00; NA; 232; 232; NA; 400; NA; 2940; 3020; NA; NA; NA; 38; 38; 471; 358; Intravenous; Intravenous; Oral; Intravenous; NA; 10; 10; NA; 3; NA; Paclitaxel; Carboplatin; Altretamine; Topotecan; NA; mg; mg; NA; NA; NA; NA; NA; Progressive Disease; Recurrent Disease","Ovary",31977,"Serous cystadenocarcinoma, NOS","primary",NA,"54f526da-dd2d-5ca2-ba04-32fa91ce3f46","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1995,"Surgical Resection","C56.9","G3","R1","white","female","not reported","Dead",87,-31977,"7726c9f9-3852-5bc5-99d6-00a44e1d0173",FALSE,562,NA,"TCGA-24-2033-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2033-01"
"TCGA-13-1512-01A-01R-1565-13","TCGA-13-1512-01A-01R-1565-13","TCGA-13-1512","TCGA-13-1512-01A","TP","Primary solid Tumor","TCGA-13-1512-01A","01","Primary","92baeb34-1fa4-4ee5-8c29-5596c4a29a29","Primary Tumor","Not Reported","released","Unknown",1.4,"66DC098E-9ADD-4446-AB6D-FEA35D5FD33B","TCGA-13-1512",0.4,"Unknown",2,FALSE,"Tumor","Unknown","","Not Reported",18561,"Unknown","Unknown","TCGA-13-1512_diagnosis","dd38c8ad-ee58-4619-8fd7-ac90964e1475","Not Reported","Yes",FALSE,427,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",49,-18134,"605e97f3-8618-5b7b-8c23-0e82f639a1f0",FALSE,NA,NA,"TCGA-13-1512-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1512-01"
"TCGA-25-1329-01A-01R-1565-13","TCGA-25-1329-01A-01R-1565-13","TCGA-25-1329","TCGA-25-1329-01A","TP","Primary solid Tumor","TCGA-25-1329-01A","01","Primary","d7ad6239-b56b-4762-9656-7653f308e01d","Primary Tumor","Not Reported","released","Unknown",2.6,"857409C6-75EC-4935-85BC-6D5F66AF4DB3","TCGA-25-1329",0.6,"Unknown",3,FALSE,"Tumor","8441/3","Adjuvant; 2025-01-08T13:15:37.188206-06:00; 94eb5635-bcdc-5024-98a0-919a48c5108e; TCGA-25-1329_treatment; Pharmaceutical Therapy, NOS; Not Reported; released; NA; yes; NA","Ovary",28093,"Serous cystadenocarcinoma, NOS","primary",NA,"728d06d8-6ccd-5a53-90a6-cb4107824d5a","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",76,-28093,"3300031e-8802-584a-9af4-d00c691a2330",FALSE,457,NA,"TCGA-25-1329-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1329-01"
"TCGA-24-1843-01A-01R-1567-13","TCGA-24-1843-01A-01R-1567-13","TCGA-24-1843","TCGA-24-1843-01A","TP","Primary solid Tumor","TCGA-24-1843-01A","01","Primary","737481f9-845a-4c7a-b12f-881d9da3998a","Primary Tumor",NA,"released","Unknown",1,"d2625c77-0f03-42ea-b5ea-df45769f0fbb","TCGA-24-1843",0.4,"Unknown",1.4,FALSE,"Tumor","8441/3","134; NA; 134; 134; 373; NA; 582; 2957; 20; NA; 20; 20; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; 25d0621f-3c4b-56a8-92c5-7b9192816479; 3cb0841b-5c0e-4ce1-b562-e617923b575b; 610cbd42-6486-403e-8725-6ac970e1ebda; 88f3fe49-26f6-49a9-a0db-f232670656d6; TCGA-24-1843_treatment; TCGA-24-1843_treatment4; TCGA-24-1843_treatment2; TCGA-24-1843_treatment3; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 5; NA; 5; 5; Paclitaxel; NA; Docetaxel; Carboplatin; yes; no; yes; yes; NA; 2025-01-06T20:14:09.841671-06:00; 2025-01-06T20:14:09.841671-06:00; 2025-01-06T20:14:09.841671-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; NA; mg; mg","Ovary",24469,"Serous cystadenocarcinoma, NOS","primary",NA,"59f8614c-8ad2-570a-9e9e-134adc1741a0","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",66,-24469,"63120061-1f2d-5054-ae2e-359fc077acae",FALSE,NA,NA,"TCGA-24-1843-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1843-01"
"TCGA-20-1683-01A-01R-1566-13","TCGA-20-1683-01A-01R-1566-13","TCGA-20-1683","TCGA-20-1683-01A","TP","Primary solid Tumor","TCGA-20-1683-01A","01","Primary","a0300830-9dd9-46bc-94c0-23b2e8703e25","Primary Tumor",NA,"released","Unknown",0.5,"5a83e4b3-8be2-4628-bd4b-93d040b43856","TCGA-20-1683",0.4,"Unknown",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 761fbadd-9d25-4cd6-a1ee-e6c05e5bdd4f; c49b2084-b9ac-4e13-af22-64a0b7cfb1ed; TCGA-20-1683_treatment6; TCGA-20-1683_treatment5; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:26:28.431400-06:00; 2025-01-06T20:26:28.431400-06:00; Recurrent Disease; Recurrent Disease","Not Reported",24624,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-20-1683_diagnosis","06542bee-6ecf-4857-855a-135a278c5a69","Not Reported","Yes",FALSE,618,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",65,-24006,"7ca939fc-90ab-59cf-bf58-f423d134465e",FALSE,NA,NA,"TCGA-20-1683-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-20-1683-01"
"TCGA-24-2254-01A-01R-1568-13","TCGA-24-2254-01A-01R-1568-13","TCGA-24-2254","TCGA-24-2254-01A","TP","Primary solid Tumor","TCGA-24-2254-01A","01","Primary","c2699551-32d9-46ad-9c41-04730ef6a8a4","Primary Tumor","Not Reported","released","Unknown",1,"3788629f-17da-4075-af61-cf124bdfb48e","TCGA-24-2254",0.4,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; NA; NA; Adjuvant; Adjuvant; Adjuvant; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 15219a22-a150-4453-bff0-e148dca1ede1; 4c61d397-260b-583f-bb65-98f9b8feb433; 666ebfe1-d2ac-4a6c-9fc6-506f28fa8944; afc21889-eb6a-44c5-9835-f91a19e2b74c; c34cb944-dbaa-43ba-92de-97dc684335c0; d018894e-b817-452c-abcd-21b4c912aca1; e736f1fd-a3fd-418b-9e29-6283ec1ba5c4; f9a7a3de-b48c-4f06-84d3-049d8ecf434e; TCGA-24-2254_treatment8; TCGA-24-2254_treatment; TCGA-24-2254_treatment6; TCGA-24-2254_treatment5; TCGA-24-2254_treatment3; TCGA-24-2254_treatment4; TCGA-24-2254_treatment7; TCGA-24-2254_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T21:00:06.289636-06:00; NA; 2025-01-06T21:00:06.289636-06:00; 2025-01-06T21:00:06.289636-06:00; 2025-01-06T21:00:06.289636-06:00; 2025-01-06T21:00:06.289636-06:00; 2025-01-06T21:00:06.289636-06:00; 2025-01-06T21:00:06.289636-06:00; NA; 1112; 718; 165; 165; 165; 1112; 718; NA; 16000; 780; 3000; 233; 2717; 4630; 2765; NA; 984; 615; 17; 17; 17; 984; 615; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; 6; 6; 8; 8; 8; 6; 6; NA; Gemcitabine Hydrochloride; Docetaxel; Carboplatin; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; Carboplatin; Carboplatin; NA; Recurrent Disease; Recurrent Disease; NA; NA; NA; Recurrent Disease; Recurrent Disease; NA; mg; mg; mg; mg; mg; mg; mg","Ovary",24407,"Serous cystadenocarcinoma, NOS","primary",NA,"a00f2045-a1f8-5198-8f98-26c7090ec6c5","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2003,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",66,-24407,"430d063a-f24e-5702-a4b9-2a5bef151ce1",FALSE,1736,NA,"TCGA-24-2254-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2254-01"
"TCGA-24-1845-01A-01R-1567-13","TCGA-24-1845-01A-01R-1567-13","TCGA-24-1845","TCGA-24-1845-01A","TP","Primary solid Tumor","TCGA-24-1845-01A","01","Primary","c6987abb-e8cb-4701-bee2-416627c1f970","Primary Tumor",NA,"released","Unknown",0.8,"1fda446a-e0d2-422a-a023-57ec5bfae62b","TCGA-24-1845",0.5,"Unknown",1.8,FALSE,"Tumor","8441/3","123; 123; 123; NA; 123; 118; 603; 469; NA; 1169; 72; 72; 72; NA; 72; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; 171e719a-d0c0-45df-8e69-ff043ec62acd; 7d9db0d7-056f-553a-9d8a-fbfb7f7b2e67; 97c8a850-f7dd-48a0-9bbe-22a5bef0e33f; 99b3ad36-8baa-49d4-b50f-08309a8bf85d; a7a5b490-017e-4229-aa9c-d3d97344df9a; TCGA-24-1845_treatment3; TCGA-24-1845_treatment; TCGA-24-1845_treatment4; TCGA-24-1845_treatment5; TCGA-24-1845_treatment2; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; 6; 6; NA; 6; Paclitaxel; Docetaxel; Cisplatin; NA; Carboplatin; yes; yes; yes; no; yes; 2025-01-06T21:21:08.900311-06:00; NA; 2025-01-06T21:21:08.900311-06:00; 2025-01-06T21:21:08.900311-06:00; 2025-01-06T21:21:08.900311-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg; mg; mg; NA; mg","Ovary",15599,"Serous cystadenocarcinoma, NOS","primary",NA,"77f2d86e-3e74-5e0b-a3b4-dc55a7d1702e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",42,-15599,"4992063f-c38e-540f-852c-da0c5b9e027b",FALSE,NA,NA,"TCGA-24-1845-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1845-01"
"TCGA-24-1560-01A-01R-1566-13","TCGA-24-1560-01A-01R-1566-13","TCGA-24-1560","TCGA-24-1560-01A","TP","Primary solid Tumor","TCGA-24-1560-01A","01","Primary","aeff4cbe-7abb-449a-a6f4-65e030548f4c","Primary Tumor",NA,"released","Unknown",1,"464e1a20-b2d1-49c4-8da5-11b8c0f96b4e","TCGA-24-1560",0.5,"Unknown",1.1,FALSE,"Tumor","8441/3","117; 614; 901; 1189; 481; 901; NA; 614; 1015; 614; 1258; 117; 726; 726; 4620; 1730; 2875; 2730; 48; 4650; NA; 7220; 210000; 3100; 1640; 1620; 200; 15000; 15; 509; 757; 1043; 398; 757; NA; 509; 931; 509; 1216; 15; 635; 635; Intravenous; Intravenous; Not Reported; Intravenous; Intravenous; Not Reported; Intravenous; Oral; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 147c1956-b0f6-443c-88d2-b9220796b32c; 258c3977-35a2-4c3e-a46a-6836d4fb5f36; 28274d8a-3646-4cfb-bf36-c5f6ea09b452; 2f93067d-da93-49f0-a125-913a84d25a8a; 433292e6-7678-56ee-8919-2c720079f7f2; 5a7f25f0-96b3-438e-9f91-7ea021ea8c07; 6cbaed26-25c3-4491-986e-98f995de09dd; 8006b3d6-2d47-4bd1-9c85-a78d2cd56d11; 8fecbaeb-6d47-4252-8162-40e7e37b5a40; acc910f1-b151-4c98-b826-a78c83d95558; af39e8d8-2656-4e2e-ba66-fd37b6d960d1; af46cb53-45cc-44da-a49f-8158f9485762; c8b62bf4-f8f4-4329-b0e5-3a5de042e292; e9e41016-05e3-4893-b17b-bfae048c99f9; TCGA-24-1560_treatment5; TCGA-24-1560_treatment6; TCGA-24-1560_treatment3; TCGA-24-1560_treatment13; TCGA-24-1560_treatment; TCGA-24-1560_treatment9; TCGA-24-1560_treatment14; TCGA-24-1560_treatment8; TCGA-24-1560_treatment12; TCGA-24-1560_treatment2; TCGA-24-1560_treatment7; TCGA-24-1560_treatment10; TCGA-24-1560_treatment11; TCGA-24-1560_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 6; 6; 6; 5; 5; 6; NA; 6; 5; 6; 3; 6; 3; 3; Carboplatin; Paclitaxel; Carboplatin; Paclitaxel; Topotecan; Etoposide; NA; Amifostine; Capecitabine; Carboplatin; Carboplatin; Paclitaxel; Pegylated Liposomal Doxorubicin Hydrochloride; Gemcitabine Hydrochloride; yes; yes; yes; yes; yes; yes; no; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T21:07:18.643370-06:00; 2025-01-06T21:07:18.643370-06:00; 2025-01-06T21:07:18.643370-06:00; 2025-01-06T21:07:18.643370-06:00; NA; 2025-01-06T21:07:18.643370-06:00; 2025-01-06T21:07:18.643370-06:00; 2025-01-06T21:07:18.643370-06:00; 2025-01-06T21:07:18.643370-06:00; 2025-01-06T21:07:18.643370-06:00; 2025-01-06T21:07:18.643370-06:00; 2025-01-06T21:07:18.643370-06:00; 2025-01-06T21:07:18.643370-06:00; 2025-01-06T21:07:18.643370-06:00; Adjuvant; NA; NA; NA; NA; NA; Adjuvant; NA; NA; NA; NA; Adjuvant; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; released; released; released; released; mg; mg; mg; mg; mg; mg; NA; mg; mg; mg; mg; mg; mg; mg; NA; Progressive Disease; Recurrent Disease; Progressive Disease; Recurrent Disease; Recurrent Disease; NA; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; NA; Recurrent Disease; Recurrent Disease","Ovary",18671,"Serous cystadenocarcinoma, NOS","primary",NA,"c81c054c-bd20-5c4f-b3bd-3d67dc613c2b","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",1999,"Surgical Resection","C56.9","G4",NA,"white","female","not reported","Dead",51,-18671,"78a963aa-07fe-526a-93c8-3f2bc9d8d317",FALSE,1341,NA,"TCGA-24-1560-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1560-01"
"TCGA-13-0799-01A-01R-1564-13","TCGA-13-0799-01A-01R-1564-13","TCGA-13-0799","TCGA-13-0799-01A","TP","Primary solid Tumor","TCGA-13-0799-01A","01","Primary","05315ef9-1103-4651-b8e9-a7eb7d71702d","Primary Tumor","Not Reported","released","Unknown",1.1,"CBB83CF3-9846-409B-858B-C8A7E74CDFF1","TCGA-13-0799",0.3,"Unknown",1.6,FALSE,"Tumor","8441/3","146; NA; 146; 146; 75; NA; 60; 135; 36; NA; 36; 36; Intraperitoneal; Intraperitoneal; Intravenous; 1197e425-e369-4998-8e07-beb27ef0ce11; 36ab23c0-ffed-4fa8-9d91-268b417e8b42; 4800630e-79c4-5b3f-a821-3b0ec51f16d5; 6b00f295-1259-46f3-a799-7daf5600dd22; TCGA-13-0799_treatment3; TCGA-13-0799_treatment4; TCGA-13-0799_treatment; TCGA-13-0799_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 6; NA; 6; 6; Cisplatin; NA; Paclitaxel; Paclitaxel; yes; no; yes; yes; 2025-01-06T20:23:40.566862-06:00; 2025-01-06T20:23:40.566862-06:00; NA; 2025-01-06T20:23:40.566862-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; NA; mg/m2; mg/m2","Ovary",16171,"Serous cystadenocarcinoma, NOS","primary",NA,"1216ba5e-1eb5-5540-9476-831e7434c39a","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"asian","female","not hispanic or latino","Alive",44,-16171,"7c7c62c8-4ef7-5df4-a00b-512a62df70bf",FALSE,NA,NA,"TCGA-13-0799-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0799-01"
"TCGA-13-0724-01A-01R-1564-13","TCGA-13-0724-01A-01R-1564-13","TCGA-13-0724","TCGA-13-0724-01A","TP","Primary solid Tumor","TCGA-13-0724-01A","01","Primary","30abe357-43d0-434c-99d1-affe0fd047d8","Primary Tumor","Not Reported","released","Unknown",0.7,"1EC7581B-E7B6-41B9-B96C-DCAF37912D3F","TCGA-13-0724",0.4,"Unknown",1.3,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 03f77fe9-683d-4831-bd0c-e50d96627987; eb88500c-daaa-42b5-965f-c02c9b802855; TCGA-13-0724_treatment4; TCGA-13-0724_treatment3; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:05:22.978374-06:00; 2025-01-06T20:05:22.978374-06:00; Progressive Disease; Progressive Disease","Not Reported",26425,"Serous cystadenocarcinoma, NOS","Progression","TCGA-13-0724_diagnosis","b4836b5f-972c-4098-b4a5-2fa16e79dacd","Not Reported","Yes",FALSE,83,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","hispanic or latino","Dead",72,-26342,"f7209024-2212-57c6-a911-814f868dded7",FALSE,83,NA,"TCGA-13-0724-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0724-01"
"TCGA-61-2094-01A-01R-1568-13","TCGA-61-2094-01A-01R-1568-13","TCGA-61-2094","TCGA-61-2094-01A","TP","Primary solid Tumor","TCGA-61-2094-01A","01","Primary","ae00d18f-7117-4cfb-a306-168f1f5d493a","Primary Tumor","Not Reported","released","Unknown",1.1,"205b0520-854c-480e-881d-89bc8cbcff75","TCGA-61-2094",0.3,"Unknown",2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 58dedc4b-d8c0-4b8a-b51c-7b92f4eb7f06; d0cf9ac5-8f1b-4a67-9753-6d31662bb1c8; e9c4d759-9318-57e7-ac69-8e7165a8bf5f; TCGA-61-2094_treatment3; TCGA-61-2094_treatment2; TCGA-61-2094_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:09:33.701178-06:00; 2025-01-06T21:09:33.701178-06:00; NA; NA; 166; 166; NA; 24; 24; NA; 6; 6; NA; Paclitaxel; Carboplatin","Ovary",23273,"Serous cystadenocarcinoma, NOS","primary",NA,"38e754fd-a254-5193-9f78-49239781ea56","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2003,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",63,-23273,"b5affed5-6e77-5623-b1a4-a0cdcef3b0d9",FALSE,NA,NA,"TCGA-61-2094-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2094-01"
"TCGA-23-1032-01A-02R-1564-13","TCGA-23-1032-01A-02R-1564-13","TCGA-23-1032","TCGA-23-1032-01A","TP","Primary solid Tumor","TCGA-23-1032-01A","01","Primary","a155cdf0-597c-4ddd-a184-10a29ff428e1","Primary Tumor",NA,"released","Unknown",0.8,"6E8A5413-EB7E-49D8-8E11-8CA6A912ED50","TCGA-23-1032",0.6,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 418a9bac-9b85-4c4c-9b29-a554b0af5674; ed7d9fbd-a8bd-50cc-acf7-b81fc834bc92; TCGA-23-1032_treatment2; TCGA-23-1032_treatment; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; no; 2025-01-06T20:06:28.909306-06:00; NA; NA; NA","Ovary",26715,"Serous cystadenocarcinoma, NOS","primary",NA,"ce95a788-c4a1-573a-bf27-259e0b06fc75","Ovary","No",TRUE,0,"Stage IV","Not Reported","Right","not reported",2002,"Surgical Resection","C56.9","G3",NA,"black or african american","female","not hispanic or latino","Dead",73,-26715,"11f19a38-9234-583d-bfa1-72d744906534",FALSE,84,NA,"TCGA-23-1032-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1032-01"
"TCGA-13-1410-01A-01R-1565-13","TCGA-13-1410-01A-01R-1565-13","TCGA-13-1410","TCGA-13-1410-01A","TP","Primary solid Tumor","TCGA-13-1410-01A","01","Primary","62812cb1-e25e-4a3f-9e8e-1993b138e1a6","Primary Tumor","Not Reported","released","Unknown",1.3,"0F641D88-673B-48C4-97F5-730DA3FD343C","TCGA-13-1410",0.5,"Unknown",1.9,FALSE,"Tumor","8441/3","83; 125; 83; NA; 125; 39; 103; 39; NA; 103; Intravenous; Intraperitoneal; Intravenous; Intravenous; Intraperitoneal; Intravenous; 2b230ef2-11da-4175-9171-30caca913d2c; 35b5209f-4450-58fe-87f6-96613c89f7fb; 7679adc6-2db2-4f4e-9f5d-f96dfc269e3a; 7fd0fe35-169f-4f40-8c86-cf4e7b50d8aa; f817e44e-f432-4d4b-b6b3-22322566d04f; TCGA-13-1410_treatment2; TCGA-13-1410_treatment; TCGA-13-1410_treatment3; TCGA-13-1410_treatment5; TCGA-13-1410_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 3; 2; 3; NA; 2; Carboplatin; Paclitaxel; Paclitaxel; NA; Cisplatin; yes; yes; yes; no; yes; 2025-01-06T20:12:15.632150-06:00; NA; 2025-01-06T20:12:15.632150-06:00; 2025-01-06T20:12:15.632150-06:00; 2025-01-06T20:12:15.632150-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; NA; 135; 175; NA; 75; NA; mg/m2; mg/m2; NA; mg/m2","Ovary",20950,"Serous cystadenocarcinoma, NOS","primary",NA,"5e13b45b-37a6-5228-8b30-a580f27d1c1a","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","GX",NA,"white","female","not hispanic or latino","Alive",57,-20950,"dddcc9ce-814f-57e6-88a2-e528d7447fbb",FALSE,NA,NA,"TCGA-13-1410-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1410-01"
"TCGA-29-1701-01A-01R-1567-13","TCGA-29-1701-01A-01R-1567-13","TCGA-29-1701","TCGA-29-1701-01A","TP","Primary solid Tumor","TCGA-29-1701-01A","01","Primary","eae870be-bbc8-4ffe-bffc-86d87414ff4b","Primary Tumor",NA,"released","Unknown",1.1,"f7568046-b77a-4654-9f94-8978bd3e22c4","TCGA-29-1701",0.6,"Unknown",1.3,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; NA; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 086b997f-2f87-4649-9e8f-94cb05dd8519; 0c5d1c6d-280f-418d-8a9e-1ef6f3528158; 1f0103b1-1924-432e-a491-d534988bf032; 2411538c-6d01-5b61-969d-ff4d50ed1969; 49783079-0370-4b51-9338-cf7433c8a909; TCGA-29-1701_treatment5; TCGA-29-1701_treatment2; TCGA-29-1701_treatment3; TCGA-29-1701_treatment; TCGA-29-1701_treatment4; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; no; yes; yes; yes; yes; 2025-01-06T20:50:19.222435-06:00; 2025-01-06T20:50:19.222435-06:00; 2025-01-06T20:50:19.222435-06:00; NA; 2025-01-06T20:50:19.222435-06:00; NA; 160; 381; 160; 472; NA; 1280; 75; 4505; 6; NA; 31; 318; 31; 409; Intravenous; Intravenous; Intravenous; Intravenous; NA; 5; 3; 5; 3; NA; Paclitaxel; Pegylated Liposomal Doxorubicin Hydrochloride; Carboplatin; Carboplatin; NA; mg; mg; mg; AUC; NA; NA; Recurrent Disease; NA; Progressive Disease","Ovary",20737,"Serous cystadenocarcinoma, NOS","primary",NA,"7970b8af-897d-58cd-9c10-f467a239f1d1","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",56,-20737,"5a7b3dcd-6dc2-5969-88a3-e6623cb00004",FALSE,515,NA,"TCGA-29-1701-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1701-01"
"TCGA-24-2280-01A-01R-1568-13","TCGA-24-2280-01A-01R-1568-13","TCGA-24-2280","TCGA-24-2280-01A","TP","Primary solid Tumor","TCGA-24-2280-01A","01","Primary","e24b153c-001b-43a3-b0d4-2b6eec615cfd","Primary Tumor","Not Reported","released","Unknown",1.3,"deb1a0d1-92a0-4c10-b491-a6a1ca5e3192","TCGA-24-2280",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","178; NA; 178; 178; 766; 1025; 1025; 1025; 4240; NA; 2248; 192; 478; 58; 2882; 599; 17; NA; 17; 17; 538; 906; 906; 906; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 00f18966-19bf-4f66-bd94-8a889b9f3e23; 12b0dc40-8c01-4beb-9c49-a3f43511c067; 317d070b-4f4b-58cf-a8e0-83c2f5517b93; 623239dc-8767-4b5a-bb24-4a7d2225be47; 77baa340-c0f0-47dc-aa58-6479d01a71c0; 92b795a0-2b7d-4952-a96c-59e08c6c170a; ccbc86b5-cfac-4cc5-b4f9-2b61302f750a; dc6c6634-72cb-4c81-a537-2c9f6e5ec355; TCGA-24-2280_treatment5; TCGA-24-2280_treatment8; TCGA-24-2280_treatment; TCGA-24-2280_treatment6; TCGA-24-2280_treatment2; TCGA-24-2280_treatment3; TCGA-24-2280_treatment4; TCGA-24-2280_treatment7; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Targeted Molecular Therapy; Chemotherapy; Chemotherapy; 8; NA; 8; 8; 8; NA; 6; 6; Carboplatin; NA; Paclitaxel; Pegylated Liposomal Doxorubicin Hydrochloride; Pegylated Liposomal Doxorubicin Hydrochloride; Bevacizumab; Carboplatin; Docetaxel; yes; no; yes; yes; yes; yes; yes; yes; 2025-01-06T20:13:14.245156-06:00; 2025-01-06T20:13:14.245156-06:00; NA; 2025-01-06T20:13:14.245156-06:00; 2025-01-06T20:13:14.245156-06:00; 2025-01-06T20:13:14.245156-06:00; 2025-01-06T20:13:14.245156-06:00; 2025-01-06T20:13:14.245156-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; NA; NA; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; mg; NA; mg; mg; mg; mg; mg; mg; NA; NA; NA; NA; Recurrent Disease; Progressive Disease; Progressive Disease; Progressive Disease","Ovary",27356,"Serous cystadenocarcinoma, NOS","primary",NA,"1d5b60d6-7bc9-56ad-8e82-0acd994fd1c7","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",74,-27356,"20c0c7cf-6af3-503b-bf45-29229f4e17cb",FALSE,NA,NA,"TCGA-24-2280-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2280-01"
"TCGA-29-1710-01A-02R-1567-13","TCGA-29-1710-01A-02R-1567-13","TCGA-29-1710","TCGA-29-1710-01A","TP","Primary solid Tumor","TCGA-29-1710-01A","01","Primary","61513da0-4eb3-4cae-bfff-7b05f3362488","Primary Tumor",NA,"released","Unknown",1.1,"52a0d2ae-7467-40f0-b8f3-59812cfac52a","TCGA-29-1710",0.4,"Unknown",1.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 9f3547b1-2a0e-44b1-9fb4-7f890e2e6a39; dac26356-c27c-4cb6-8e41-d62cdca87113; e5882412-3dc3-4e77-889b-00425c58f4ad; TCGA-29-1710_treatment15; TCGA-29-1710_treatment16; TCGA-29-1710_treatment17; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; Surgery, NOS; released; released; released; yes; no; yes; 2025-01-06T21:30:03.867012-06:00; 2025-01-06T21:30:03.867012-06:00; 2025-01-06T21:30:03.867012-06:00; Progressive Disease; Progressive Disease; Progressive Disease; NA; NA; 878","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-29-1710_diagnosis","73bfbaa5-616b-4dd8-b686-71d50d4919d1","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",54,-19969,"9a82b4e9-f427-5855-bbf0-dc8473c619e0",FALSE,951,NA,"TCGA-29-1710-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1710-01"
"TCGA-29-2425-01A-01R-1569-13","TCGA-29-2425-01A-01R-1569-13","TCGA-29-2425","TCGA-29-2425-01A","TP","Primary solid Tumor","TCGA-29-2425-01A","01","Primary","0a6d3bb3-512a-47bc-9b84-b6fa017da9c3","Primary Tumor","Not Reported","released","Unknown",0.8,"ec04e6ae-ae66-4fc2-b77b-485f77ce39bc","TCGA-29-2425",0.5,"Unknown",1,FALSE,"Tumor","8441/3","202; 97; NA; 1696; 202; 1696; 1696; 6; 1000; NA; 5; 175; 15; 175; 10; 10; NA; 1584; 119; 1584; 1584; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 0f9840d1-0c0d-47f0-b453-3f7b69096726; 3633f109-d50b-4166-988f-e5aed2104055; 68e6aad7-87f3-4c08-ae44-ef4276129042; afe76cb3-785a-5ba4-b647-a3aa0f8b49fb; b4caaa99-c67b-4c1f-a574-a72d1b58c271; c041fe4b-360e-4dd6-88b1-d822774db67f; f57e90a8-d355-4263-840d-19e5274db15b; TCGA-29-2425_treatment2; TCGA-29-2425_treatment3; TCGA-29-2425_treatment7; TCGA-29-2425_treatment; TCGA-29-2425_treatment6; TCGA-29-2425_treatment4; TCGA-29-2425_treatment5; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Targeted Molecular Therapy; Chemotherapy; 6; 4; NA; 6; 2; NA; 6; Carboplatin; Gemcitabine Hydrochloride; NA; Carboplatin; Paclitaxel; Bevacizumab; Paclitaxel; yes; yes; no; yes; yes; yes; yes; 2025-01-06T20:46:41.157973-06:00; 2025-01-06T20:46:41.157973-06:00; 2025-01-06T20:46:41.157973-06:00; NA; 2025-01-06T20:46:41.157973-06:00; 2025-01-06T20:46:41.157973-06:00; 2025-01-06T20:46:41.157973-06:00; Adjuvant; Adjuvant; Adjuvant; NA; Adjuvant; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; AUC; mg/m2; NA; AUC; mg/m2; mg/m2; mg/m2; NA; NA; NA; Progressive Disease; NA; Progressive Disease; Progressive Disease","Ovary",22089,"Serous cystadenocarcinoma, NOS","primary",NA,"0d0523a7-c86c-5ce8-a0ab-2cc6094af039","Ovary","No",TRUE,0,"Stage IIIC","Not Reported",NA,"not reported",2004,"Surgical Resection","C56.9","G2","R1","white","female","not reported","Alive",60,-22089,"90915e14-fbfa-56e5-8fcd-04df28f44be4",FALSE,NA,NA,"TCGA-29-2425-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-2425-01"
"TCGA-61-2095-01A-01R-1568-13","TCGA-61-2095-01A-01R-1568-13","TCGA-61-2095","TCGA-61-2095-01A","TP","Primary solid Tumor","TCGA-61-2095-01A","01","Primary","b2cde517-9404-45b2-bd39-3dedb4e129fc","Primary Tumor","Not Reported","released","Unknown",1,"3e08408b-b76a-4a32-b3f1-4590459f4af8","TCGA-61-2095",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1429dad6-9d92-4c8a-911b-17db81c46cb4; 61e1eae0-8540-4ee1-831e-52da42e864a7; 6c05915f-5976-41e7-9c02-3cfdd4ec3312; TCGA-61-2095_treatment11; TCGA-61-2095_treatment12; TCGA-61-2095_treatment13; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; Surgery, NOS; released; released; released; yes; no; yes; 2025-01-06T20:40:49.916987-06:00; 2025-01-06T20:40:49.916987-06:00; 2025-01-06T20:40:49.916987-06:00; Progressive Disease; Progressive Disease; Progressive Disease; NA; NA; 452","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-61-2095_diagnosis","5d2a39ed-a690-481a-884c-e1ce263f28a6","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",54,-19797,"f4e599b6-8cb0-5ad4-9f8a-a704e2149024",FALSE,1875,NA,"TCGA-61-2095-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2095-01"
"TCGA-13-1489-01A-01R-1565-13","TCGA-13-1489-01A-01R-1565-13","TCGA-13-1489","TCGA-13-1489-01A","TP","Primary solid Tumor","TCGA-13-1489-01A","01","Primary","4b2b6e5e-248c-46f6-938a-95571577e02d","Primary Tumor","Not Reported","released","Unknown",1,"C65BE57D-0015-49BB-A4BE-81D7B302F464","TCGA-13-1489",0.4,"Unknown",1.7,FALSE,"Tumor","8441/3","833; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 194bb7f1-f5a5-444a-8fc6-e2ef1b3e2397; 24623334-22f3-429b-ad25-6e485766f467; 63a1427d-732c-45b9-885c-24fe7162f353; TCGA-13-1489_treatment13; TCGA-13-1489_treatment12; TCGA-13-1489_treatment11; Surgery, NOS; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; released; yes; no; yes; 2025-01-06T20:06:02.619309-06:00; 2025-01-06T20:06:02.619309-06:00; 2025-01-06T20:06:02.619309-06:00; Unknown; Unknown; Unknown","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-13-1489_diagnosis","18019ed5-8e39-416a-9f1a-d82eab745478","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",70,-25768,"39bca6ab-f7fe-59fd-b376-b16f300c341d",FALSE,2553,NA,"TCGA-13-1489-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1489-01"
"TCGA-29-1691-01A-01R-1566-13","TCGA-29-1691-01A-01R-1566-13","TCGA-29-1691","TCGA-29-1691-01A","TP","Primary solid Tumor","TCGA-29-1691-01A","01","Primary","5dbb6c5e-be66-47ca-9bb4-1845b8004286","Primary Tumor",NA,"released","Unknown",0.4,"74e45220-b3ac-4404-8bb6-811f3d4ba611","TCGA-29-1691",0.05,"Unknown",0.5,FALSE,"Tumor","8441/3","137; 1353; 1353; NA; 868; 868; 137; NA; NA; NA; Adjuvant; NA; NA; NA; NA; NA; Adjuvant; NA; Adjuvant; NA; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intravenous; Oral; Intraperitoneal; Intravenous; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 19b3b873-f0c8-4043-a827-11da06f523b9; 21675d44-1a2b-4119-bebf-87315ce21123; 422134be-b175-48af-9f71-330e754e04aa; 807f244e-7c88-4767-a43c-cd3216e872da; a93d26be-fd01-447d-b0fc-663276156cfb; ab171b2b-788a-4081-ae4f-0772abcc0e25; ab9e8288-c148-5fc9-8502-54b6d560c9a5; cf846774-fdc5-405a-9588-3b4105652c67; e5572e60-116e-40e7-8580-0db6d6c662a4; eed38277-d0a0-4093-b8d3-4cff500fb40a; TCGA-29-1691_treatment2; TCGA-29-1691_treatment3; TCGA-29-1691_treatment6; TCGA-29-1691_treatment5; TCGA-29-1691_treatment4; TCGA-29-1691_treatment7; TCGA-29-1691_treatment; TCGA-29-1691_treatment8; TCGA-29-1691_treatment10; TCGA-29-1691_treatment9; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Hormone Therapy; Radiation Therapy, NOS; Chemotherapy; 6; NA; NA; NA; 6; 6; 6; NA; NA; NA; released; released; released; released; released; released; released; released; released; released; Cisplatin; Cyclophosphamide; Carboplatin; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; Carboplatin; Paclitaxel; Megestrol Acetate; NA; Topotecan; yes; yes; yes; yes; yes; yes; yes; yes; no; yes; 2025-01-06T20:49:49.092959-06:00; 2025-01-06T20:49:49.092959-06:00; 2025-01-06T20:49:49.092959-06:00; 2025-01-06T20:49:49.092959-06:00; 2025-01-06T20:49:49.092959-06:00; 2025-01-06T20:49:49.092959-06:00; NA; 2025-01-06T20:49:49.092959-06:00; 2025-01-06T20:49:49.092959-06:00; 2025-01-06T20:49:49.092959-06:00; NA; 1233; 1233; 988; 654; 654; NA; 988; NA; 868; NA; Progressive Disease; Progressive Disease; Progressive Disease; Recurrent Disease; Recurrent Disease; NA; Progressive Disease; NA; Progressive Disease; NA; NA; NA; NA; 175; 5; NA; NA; NA; NA; NA; NA; NA; NA; mg/m2; AUC; NA; NA; NA; NA","Ovary",18664,"Serous cystadenocarcinoma, NOS","primary",NA,"462c9b3c-1b04-5e25-bdd0-cb23c26c7256","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1995,"Surgical Resection","C56.9","G2",NA,"white","female","not reported","Dead",51,-18664,"3e0c0748-6430-57d2-81fa-e74f67bba190",FALSE,1470,NA,"TCGA-29-1691-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1691-01"
"TCGA-23-1116-01A-01R-1564-13","TCGA-23-1116-01A-01R-1564-13","TCGA-23-1116","TCGA-23-1116-01A","TP","Primary solid Tumor","TCGA-23-1116-01A","01","Primary","91fbc26e-c049-49af-8307-22c7980079df","Primary Tumor",NA,"released","Unknown",0.8,"d39c8f94-c4f0-4166-864b-912d7535f2b6","TCGA-23-1116",0.6,"Unknown",1,FALSE,"Tumor","Unknown","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 134306c5-e9d4-4e80-a108-dadd26d8de61; 968d130a-b182-417b-ae15-e2a791eace9d; TCGA-23-1116_treatment9; TCGA-23-1116_treatment8; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:32:20.331740-06:00; 2025-01-06T21:32:20.331740-06:00; Unknown; Unknown","Not Reported",30750,"Unknown","Unknown","TCGA-23-1116_diagnosis","02ff8b29-727c-4cb9-b974-9af95c0775ba","Not Reported","Yes",FALSE,286,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",83,-30464,"4b9f2013-cf47-571e-8a15-8f1207cd8a5a",FALSE,592,"Ashkenazi Jew","TCGA-23-1116-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1116-01"
"TCGA-29-1781-01A-01R-1567-13","TCGA-29-1781-01A-01R-1567-13","TCGA-29-1781","TCGA-29-1781-01A","TP","Primary solid Tumor","TCGA-29-1781-01A","01","Primary","b9a63363-bd0c-496f-a375-fce0d0a370d8","Primary Tumor",NA,"released","Unknown",1,"959c11fe-f170-49bc-a1fe-73b799741b93","TCGA-29-1781",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 140465ac-f47c-4869-b318-9c16fe9bd10c; 32792d93-6714-57b9-a3dc-5bc59a18a6f1; 65a5ee47-84fd-4688-b691-434b3daf00c5; TCGA-29-1781_treatment3; TCGA-29-1781_treatment; TCGA-29-1781_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:29:30.375935-06:00; NA; 2025-01-06T21:29:30.375935-06:00; NA; 255; 255; NA; 2970; 2322; NA; 52; 52; Intravenous; Intravenous; NA; 6; 6; NA; Carboplatin; Paclitaxel; NA; mg; mg","Ovary",25404,"Serous cystadenocarcinoma, NOS","primary",NA,"d76e4af6-34c3-5b30-9645-83c9a06479ea","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",69,-25404,"34cdc2c3-656e-598f-98cd-ba99fa210ff2",FALSE,NA,NA,"TCGA-29-1781-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1781-01"
"TCGA-31-1959-01A-01R-1568-13","TCGA-31-1959-01A-01R-1568-13","TCGA-31-1959","TCGA-31-1959-01A","TP","Primary solid Tumor","TCGA-31-1959-01A","01","Primary","dd8556f8-461a-468d-8604-c4f2366b1cd7","Primary Tumor","Not Reported","released","Unknown",0.7,"c78c6998-1f86-4dd2-bf41-78f12d43c33a","TCGA-31-1959",0.2,"Unknown",1.1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 13257195-47ed-4195-8d46-f1f6f8112e50; 8aca474d-6dba-5b4e-bd7d-3cbe12ceacf0; ede088a1-c130-424a-9656-de5d01e70ed1; TCGA-31-1959_treatment3; TCGA-31-1959_treatment; TCGA-31-1959_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T20:18:17.827386-06:00; NA; 2025-01-06T20:18:17.827386-06:00; NA; 26; 26; Intravenous; Intravenous; NA; Treatment Ongoing; Treatment Ongoing; NA; Carboplatin; Paclitaxel","Ovary",18247,"Serous cystadenocarcinoma, NOS","primary",NA,"121cc11a-b0d3-537e-ae08-106d193c7667","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2009,"Excisional Biopsy","C56.9","G2",NA,"white","female","not hispanic or latino","Alive",49,-18247,"f9c4143c-c920-522f-9333-0e259cb78801",FALSE,NA,NA,"TCGA-31-1959-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-31-1959-01"
"TCGA-WR-A838-01A-12R-A406-31","TCGA-WR-A838-01A-12R-A406-31","TCGA-WR-A838","TCGA-WR-A838-01A","TP","Primary solid Tumor","TCGA-WR-A838-01A","01","Primary","828b6893-62cd-4248-a31b-7da875d657f1","Primary Tumor",NA,"released","Unknown",NA,"8F364931-727D-4099-A1D2-E96C61461479","TCGA-WR-A838",NA,"Unknown",NA,FALSE,"Tumor","8441/3","","Not Reported",26663,"Serous cystadenocarcinoma, NOS","Progression","TCGA-WR-A838_diagnosis","4c207882-6cf0-4f0f-a759-abec3c65f99e","Not Reported","Yes",FALSE,245,NA,NA,NA,NA,NA,NA,NA,NA,NA,"black or african american","female","not hispanic or latino","Dead",72,-26418,"2e3f8de2-09c9-56c0-9615-ff7b01989992",FALSE,304,NA,"TCGA-WR-A838-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,110,200,"false",NA,NA,NA,NA,"United States",NA,NA,"TCGA-WR-A838-01"
"TCGA-13-1506-01A-01R-1565-13","TCGA-13-1506-01A-01R-1565-13","TCGA-13-1506","TCGA-13-1506-01A","TP","Primary solid Tumor","TCGA-13-1506-01A","01","Primary","4725c6d3-c67d-4ce8-a4c1-68c242183ce3","Primary Tumor","Not Reported","released","Unknown",0.6,"88E423FF-4070-4F01-A0B0-41B45443E762","TCGA-13-1506",0.2,"Unknown",1.1,FALSE,"Tumor","Unknown","","Not Reported",17400,"Unknown","Unknown","TCGA-13-1506_diagnosis","260569da-fe10-48c3-b85e-a8dbcb985bf9","Not Reported","Yes",FALSE,666,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",45,-16734,"75bc4385-e9df-5793-a283-7c3a014c1c85",FALSE,1039,NA,"TCGA-13-1506-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1506-01"
"TCGA-24-1850-01A-01R-1567-13","TCGA-24-1850-01A-01R-1567-13","TCGA-24-1850","TCGA-24-1850-01A","TP","Primary solid Tumor","TCGA-24-1850-01A","01","Primary","511be3b8-efdb-4e2e-8115-7b83e16471c1","Primary Tumor",NA,"released","Unknown",1.5,"a8c2f09f-6971-48e1-b890-f1d63611cdbd","TCGA-24-1850",0.5,"Unknown",2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 08a909a0-6ca2-47fb-87fd-7514445993ee; 294270d5-39c3-4bff-9e8d-6012f7b1ff73; b0328c0c-f7ff-526e-9535-360ebe7a5d00; TCGA-24-1850_treatment3; TCGA-24-1850_treatment2; TCGA-24-1850_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:33:18.568635-06:00; 2025-01-06T21:33:18.568635-06:00; NA; NA; 138; 138; NA; 706; 3138; NA; 34; 34; Intravenous; Intravenous; NA; 6; 6; NA; Docetaxel; Carboplatin; NA; mg; mg","Ovary",26369,"Serous cystadenocarcinoma, NOS","primary",NA,"f34214f1-17e6-51fa-a214-6826ccc10fd8","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",72,-26369,"d6afc291-5d82-5eb0-90e0-91d9933e5c0a",FALSE,NA,NA,"TCGA-24-1850-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1850-01"
"TCGA-23-1111-01A-01R-1567-13","TCGA-23-1111-01A-01R-1567-13","TCGA-23-1111","TCGA-23-1111-01A","TP","Primary solid Tumor","TCGA-23-1111-01A","01","Primary","2dc30180-9f69-4dd5-914c-1a27fcf170bd","Primary Tumor",NA,"released","Unknown",0.9,"ba3ae03c-74d4-4b5f-849f-71466bae7c0e","TCGA-23-1111",0.4,"Unknown",0.9,FALSE,"Tumor","8441/3","129; 129; 129; NA; 3389; 1860; 5850; NA; 24; 24; 45; NA; Intravenous; Intravenous; Intravenous; 71a3b9da-1e31-48e1-abb2-226f2078d43c; 7a566f90-5991-4211-b22b-e31ed5e0f6f9; a3567e3c-4b84-5146-9bd0-d18a0d6f2496; bd795e1b-9997-42d4-b908-b95dc992ad45; TCGA-23-1111_treatment2; TCGA-23-1111_treatment3; TCGA-23-1111_treatment; TCGA-23-1111_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; 5; NA; Carboplatin; Paclitaxel; Bevacizumab; NA; yes; yes; yes; no; 2025-01-06T21:12:17.613299-06:00; 2025-01-06T21:12:17.613299-06:00; NA; 2025-01-06T21:12:17.613299-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; mg; mg; NA","Ovary",23171,"Serous cystadenocarcinoma, NOS","primary",NA,"b706f41e-b852-562e-b355-bba9f964e38a","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",63,-23171,"c6a9c1d3-b55e-5ef9-a771-a2a379aa9539",FALSE,NA,NA,"TCGA-23-1111-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1111-01"
"TCGA-13-0916-01A-01R-1564-13","TCGA-13-0916-01A-01R-1564-13","TCGA-13-0916","TCGA-13-0916-01A","TP","Primary solid Tumor","TCGA-13-0916-01A","01","Primary","4a2528c7-eaba-46da-b1e5-431a17bff9c7","Primary Tumor",NA,"released","Unknown",1,"28A2A65C-70A2-40D2-A03A-F68884457C14","TCGA-13-0916",0.6,"Unknown",1.5,FALSE,"Tumor","8441/3","161; NA; 161; 182; 161; 60; NA; 75; 15; 135; 35; NA; 35; 70; 35; Intraperitoneal; Intraperitoneal; Intravenous; 0f6be681-a693-5dbc-88d9-01ab2afb79d0; 1cce68b8-c2d9-418e-b609-9ac7dc6ae527; 3e903888-7a29-4c70-9cb1-faec5d4d8d96; 49ef66b3-42a7-47b1-882a-a35d7254d359; dc53c6cd-56aa-4b72-91d0-db56fe0d5f64; TCGA-13-0916_treatment; TCGA-13-0916_treatment5; TCGA-13-0916_treatment2; TCGA-13-0916_treatment4; TCGA-13-0916_treatment3; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Targeted Molecular Therapy; Chemotherapy; 6; NA; 6; NA; 6; Paclitaxel; NA; Cisplatin; Bevacizumab; Paclitaxel; yes; no; yes; yes; yes; NA; 2025-01-06T21:40:26.929877-06:00; 2025-01-06T21:40:26.929877-06:00; 2025-01-06T21:40:26.929877-06:00; 2025-01-06T21:40:26.929877-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg/m2; NA; mg/m2; mg/m2; mg/m2","Ovary",18189,"Serous cystadenocarcinoma, NOS","primary",NA,"013ba4e2-f2d0-5a07-a02e-5293a1da0678","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2006,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",49,-18189,"eb66def4-8b14-5b5c-9c01-bd60707a8e18",FALSE,NA,NA,"TCGA-13-0916-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0916-01"
"TCGA-24-2019-01A-02R-1568-13","TCGA-24-2019-01A-02R-1568-13","TCGA-24-2019","TCGA-24-2019-01A","TP","Primary solid Tumor","TCGA-24-2019-01A","01","Primary","d2dd3d17-790f-4aa2-945d-db72df6ec8eb","Primary Tumor","Not Reported","released","Unknown",1,"15a77e5d-acfb-4013-81de-ef9d2f6398d1","TCGA-24-2019",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 02bd3368-a572-426a-8489-966260e79e34; a78e377d-5270-55e9-ba09-406e129ccc09; TCGA-24-2019_treatment2; TCGA-24-2019_treatment; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:00:27.322401-06:00; NA; NA; Not Reported; NA; NA","Ovary",17009,"Serous cystadenocarcinoma, NOS","primary",NA,"4422c00b-d710-52d1-b3c3-a3b6879dd792","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",46,-17009,"d1eab0fc-7b3b-562a-a9f8-771209dca14f",FALSE,NA,NA,"TCGA-24-2019-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2019-01"
"TCGA-24-2027-01A-01R-1567-13","TCGA-24-2027-01A-01R-1567-13","TCGA-24-2027","TCGA-24-2027-01A","TP","Primary solid Tumor","TCGA-24-2027-01A","01","Primary","d458ab44-bd23-410d-9ffa-4d469d16c62b","Primary Tumor","Not Reported","released","Unknown",0.8,"8a4d0373-9d57-4cf7-ac78-d8b558d43df6","TCGA-24-2027",0.6,"Unknown",1.6,FALSE,"Tumor","8441/3","3154; 258; 2540; NA; 784; 1985; 3273; 784; 2216; 2951; 784; 2745; 2591; 258; 2591; 67; 9838; 400; NA; 3411; 151; 1052; 1860; 1747; 1108; 88; 311; 1992; 3724; 83; 2982; 6; 2400; NA; 624; 1614; 3168; 624; 2048; 2759; 624; 2602; 2577; 6; 2577; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 069bf078-c3eb-448f-ae37-44eddd36443b; 16f2f158-bba0-4390-b197-cde5326ffa41; 213ba8f2-4ff7-41d0-80e1-2431fe1511d9; 326e6346-1a29-4fb9-b83c-177725f15488; 3f913450-7829-55de-a999-e5e30b983e2e; 49e84fba-4a17-4c29-81af-8c1d39f001f6; 62d8cd80-15ce-4a93-a867-bd73c33a3f4c; 744d79a0-9bb4-4802-ad69-130b537d90e3; 74b4b448-38df-44c8-b154-4ec4bc3cc77f; 7eb89c1f-5a24-4bc8-85cf-5d27e603aa52; c529f9f3-cbb7-4f9e-97a6-a21dbcd28e57; ca39274d-c6d7-44b6-820b-79593ad7a2ac; ed18fe32-696f-4920-aad2-95d064687528; fabdd2fb-6ad9-4e41-aac7-842b5254fa48; faea4e47-8c4e-4c45-8883-0a74835ce74a; TCGA-24-2027_treatment14; TCGA-24-2027_treatment11; TCGA-24-2027_treatment13; TCGA-24-2027_treatment15; TCGA-24-2027_treatment; TCGA-24-2027_treatment3; TCGA-24-2027_treatment8; TCGA-24-2027_treatment6; TCGA-24-2027_treatment4; TCGA-24-2027_treatment9; TCGA-24-2027_treatment10; TCGA-24-2027_treatment12; TCGA-24-2027_treatment2; TCGA-24-2027_treatment5; TCGA-24-2027_treatment7; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 6; 12; 6; NA; 7; 17; 6; 7; 20; 18; 7; 7; 1; 12; 1; Topotecan; Carboplatin; Pegylated Liposomal Doxorubicin Hydrochloride; NA; Carboplatin; Topotecan; Paclitaxel; Paclitaxel; Paclitaxel; Paclitaxel; Cisplatin; Vinorelbine Tartrate; Gemcitabine Hydrochloride; Paclitaxel; Cisplatin; yes; yes; yes; no; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T21:33:37.914690-06:00; 2025-01-06T21:33:37.914690-06:00; 2025-01-06T21:33:37.914690-06:00; 2025-01-06T21:33:37.914690-06:00; NA; 2025-01-06T21:33:37.914690-06:00; 2025-01-06T21:33:37.914690-06:00; 2025-01-06T21:33:37.914690-06:00; 2025-01-06T21:33:37.914690-06:00; 2025-01-06T21:33:37.914690-06:00; 2025-01-06T21:33:37.914690-06:00; 2025-01-06T21:33:37.914690-06:00; 2025-01-06T21:33:37.914690-06:00; 2025-01-06T21:33:37.914690-06:00; 2025-01-06T21:33:37.914690-06:00; Progressive Disease; NA; Recurrent Disease; NA; Recurrent Disease; Recurrent Disease; Progressive Disease; Recurrent Disease; Recurrent Disease; Progressive Disease; Recurrent Disease; Progressive Disease; Progressive Disease; NA; Progressive Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; released; released; released; released; released; mg; mg; mg; NA; mg; mg; mg; mg; mg; mg; mg; mg; mg; mg; mg; NA; Adjuvant; NA; Adjuvant; NA; NA; NA; NA; NA; NA; NA; NA; NA; Adjuvant; NA","Ovary",18835,"Serous cystadenocarcinoma, NOS","primary",NA,"7e4bfb50-f7b9-5a44-a69e-28e275a0517e","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",1995,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",51,-18835,"5baa23ff-1696-5388-a54c-c4fbd711013e",FALSE,3337,NA,"TCGA-24-2027-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2027-01"
"TCGA-04-1514-01A-01R-1566-13","TCGA-04-1514-01A-01R-1566-13","TCGA-04-1514","TCGA-04-1514-01A","TP","Primary solid Tumor","TCGA-04-1514-01A","01","Primary","18e0f4ed-43e2-451f-82bd-102260a30aaa","Primary Tumor",NA,"released","Unknown",0.5,"A0487B93-029F-48EB-AF5C-06A2F5A3FAAA","TCGA-04-1514",0.5,"Solid Tissue",1.1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 583f8f13-68fe-4363-84a9-845f71857dfd; b046b9c7-204d-43b6-8d90-fd8134b47310; TCGA-04-1514_treatment17; TCGA-04-1514_treatment16; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:22:24.547421-06:00; 2025-01-06T21:22:24.547421-06:00; Recurrent Disease; Recurrent Disease","Not Reported",17946,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-04-1514_diagnosis","05b21b27-5b8b-4cfc-9e24-c2adcd31a2ed","Not Reported","Yes",FALSE,1221,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",45,-16725,"487bc60d-e5db-52e4-88dc-f4f3e93f6695",FALSE,1720,NA,"TCGA-04-1514-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1514-01"
"TCGA-24-1463-01A-01R-1566-13","TCGA-24-1463-01A-01R-1566-13","TCGA-24-1463","TCGA-24-1463-01A","TP","Primary solid Tumor","TCGA-24-1463-01A","01","Primary","58b3222f-4ac0-4920-babc-e35b64cf90c6","Primary Tumor","Not Reported","released","Unknown",1.3,"864CB084-569A-47F0-A83D-F3FA649A6B00","TCGA-24-1463",0.5,"Unknown",2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 60deb3a5-41d0-47cc-949e-ba52a1ec88e2; b8cbd81e-5d43-45d5-b6bf-fa9fd53e2406; TCGA-24-1463_treatment14; TCGA-24-1463_treatment13; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:25:18.486869-06:00; 2025-01-06T20:25:18.486869-06:00; Recurrent Disease; Recurrent Disease","Not Reported",26705,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1463_diagnosis","3759142d-0cf6-4fc6-ae00-1e661971803e","Not Reported","Yes",FALSE,971,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",70,-25734,"9e8c9476-f74b-57c4-9fd8-5a3786d7c834",FALSE,2218,NA,"TCGA-24-1463-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1463-01"
"TCGA-24-1470-01A-01R-1566-13","TCGA-24-1470-01A-01R-1566-13","TCGA-24-1470","TCGA-24-1470-01A","TP","Primary solid Tumor","TCGA-24-1470-01A","01","Primary","5287e961-91f0-4fb0-a00a-d570377cee62","Primary Tumor",NA,"released","Unknown",1,"f47eefcf-f15d-42cb-8bd2-d0c252ecafb3","TCGA-24-1470",0.5,"Solid Tissue",1.2,FALSE,"Tumor","8441/3","83; NA; 83; 83; 593; NA; 110; 475; 17; NA; 17; 17; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; 445af3a9-3a77-4694-a572-8f67d16029e2; a9065bc0-02f2-4a7b-bacf-d4ce9fb1677f; b9ed5cd1-6ede-4be6-a986-6ac0ecc1cbc2; f4a5e8c4-7ce4-5a44-9abd-6942c0721e86; TCGA-24-1470_treatment2; TCGA-24-1470_treatment4; TCGA-24-1470_treatment3; TCGA-24-1470_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 4; NA; 4; 4; Cisplatin; NA; Paclitaxel; Docetaxel; yes; no; yes; yes; 2025-01-06T20:43:41.173430-06:00; 2025-01-06T20:43:41.173430-06:00; 2025-01-06T20:43:41.173430-06:00; NA; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; NA; mg; mg","Ovary",20007,"Serous cystadenocarcinoma, NOS","primary",NA,"7baca1af-8043-51b5-ab12-d87b025a8ded","Ovary","No",TRUE,0,"Stage IIIB","Not Reported","Bilateral","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",54,-20007,"db352bc7-95c7-59df-a9fe-4655e1c409df",FALSE,NA,NA,"TCGA-24-1470-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1470-01"
"TCGA-61-1725-01A-01R-1567-13","TCGA-61-1725-01A-01R-1567-13","TCGA-61-1725","TCGA-61-1725-01A","TP","Primary solid Tumor","TCGA-61-1725-01A","01","Primary","6ecade07-4c2f-4587-9c8b-589943f1c9e6","Primary Tumor",NA,"released","Unknown",0.8,"8bcf7f73-abe7-43d0-a7da-ede3f5c2bb04","TCGA-61-1725",0.4,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; NA; Adjuvant; Adjuvant; Adjuvant; NA; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0115e5ce-b8f6-48b6-a3ee-5550206448d6; 136687be-739e-47f7-829c-0096da4c451f; 39ca8e1b-2ec6-4294-b097-905aa24edef8; 856b5273-652c-4b8e-84df-7529b2d86e81; d5198be0-1414-55b3-98ae-cbb0ea820f6a; e50b8113-d861-4305-a132-86de2f88448b; f9a88eeb-6162-4af1-b5ae-67fee8ff36b0; fbe5a8cf-bc1f-4ffe-aaf3-e22b95442b42; TCGA-61-1725_treatment8; TCGA-61-1725_treatment5; TCGA-61-1725_treatment2; TCGA-61-1725_treatment3; TCGA-61-1725_treatment; TCGA-61-1725_treatment4; TCGA-61-1725_treatment7; TCGA-61-1725_treatment6; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T21:20:06.113548-06:00; 2025-01-06T21:20:06.113548-06:00; 2025-01-06T21:20:06.113548-06:00; 2025-01-06T21:20:06.113548-06:00; NA; 2025-01-06T21:20:06.113548-06:00; 2025-01-06T21:20:06.113548-06:00; 2025-01-06T21:20:06.113548-06:00; NA; 4368; 585; 456; 1548; 8550; 3204; 2400; NA; 908; 45; 45; 45; 908; 235; 908; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intravenous; Intravenous; Intravenous; NA; 6; 6; 6; 6; 6; 12; 6; NA; Carboplatin; Cisplatin; Paclitaxel; Paclitaxel; Bevacizumab; Paclitaxel; Gemcitabine Hydrochloride; NA; Recurrent Disease; NA; NA; NA; Recurrent Disease; NA; Recurrent Disease; NA; Treatment Ongoing; NA; NA; NA; Treatment Ongoing; NA; Treatment Ongoing; NA; mg; mg; mg; mg; mg; mg; mg; NA; NA; 158; 158; 158; NA; 577; NA","Ovary",14782,"Serous cystadenocarcinoma, NOS","primary",NA,"9ff03257-e85c-5449-95be-ea2f7d51e27d","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",40,-14782,"1567ed8d-6ce0-5fab-b6a3-901c244c2235",FALSE,NA,NA,"TCGA-61-1725-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1725-01"
"TCGA-24-1544-01A-01R-1566-13","TCGA-24-1544-01A-01R-1566-13","TCGA-24-1544","TCGA-24-1544-01A","TP","Primary solid Tumor","TCGA-24-1544-01A","01","Primary","cf7b9151-6479-41af-986c-d9db10e33ca6","Primary Tumor",NA,"released","Unknown",0.8,"2fd78a14-cc3f-4920-9c50-6051579b6ad4","TCGA-24-1544",0.5,"Unknown",1.4,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; a1dcc9b0-eaa8-4a7a-94ba-db6cfc54fead; b094e09a-e098-4800-8ca5-82f137e46f0d; TCGA-24-1544_treatment9; TCGA-24-1544_treatment8; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:27:05.651669-06:00; 2025-01-06T20:27:05.651669-06:00; Progressive Disease; Progressive Disease","Not Reported",26784,"Serous cystadenocarcinoma, NOS","Progression","TCGA-24-1544_diagnosis","4dc9a70e-5f7a-45b1-972e-aa5821eae909","Not Reported","Yes",FALSE,643,NA,NA,NA,NA,NA,NA,NA,NA,NA,"black or african american","female","not reported","Dead",71,-26141,"d6576dc5-1505-5552-85bd-65620144f49e",FALSE,820,NA,"TCGA-24-1544-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1544-01"
"TCGA-25-2399-01A-01R-1569-13","TCGA-25-2399-01A-01R-1569-13","TCGA-25-2399","TCGA-25-2399-01A","TP","Primary solid Tumor","TCGA-25-2399-01A","01","Primary","c9aa6cf0-f536-4640-8290-3e745ae2a36b","Primary Tumor","Not Reported","released","Unknown",0.8,"38AEA3BF-A853-4719-B308-63884A6F8F13","TCGA-25-2399",0.4,"Unknown",1.6,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 52f8e534-1554-40bb-93a1-9d5a3c3b1d7f; aecf5c12-5640-46ed-882a-a61da24eeedb; TCGA-25-2399_treatment5; TCGA-25-2399_treatment6; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:49:09.892770-06:00; 2025-01-06T20:49:09.892770-06:00; Recurrent Disease; Recurrent Disease","Not Reported",29616,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-25-2399_diagnosis","0f66c4fd-6a3e-4604-aef9-48f9726eb7d6","Not Reported","Yes",FALSE,243,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",80,-29373,"bf26361b-e6d4-5693-b15f-d91ed2a71b5f",FALSE,608,NA,"TCGA-25-2399-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-2399-01"
"TCGA-59-2348-01A-01R-1569-13","TCGA-59-2348-01A-01R-1569-13","TCGA-59-2348","TCGA-59-2348-01A","TP","Primary solid Tumor","TCGA-59-2348-01A","01","Primary","cbdafa49-7dd7-4a42-b0a5-891aad11a802","Primary Tumor","Not Reported","released","Unknown",1,"ffb300e9-cb06-4162-a751-f079fec57153","TCGA-59-2348",0.4,"Unknown",2,FALSE,"Tumor","8441/3","","Ovary",NA,"Serous cystadenocarcinoma, NOS","primary",NA,"7fbc9ad4-d3ae-5f9c-bb13-bdfa201dec51","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1994,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",59,NA,"6a7ef2cd-8b8c-57fc-af3d-74c34a357885",FALSE,NA,NA,"TCGA-59-2348-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-59-2348-01"
"TCGA-30-1857-01A-02R-1569-13","TCGA-30-1857-01A-02R-1569-13","TCGA-30-1857","TCGA-30-1857-01A","TP","Primary solid Tumor","TCGA-30-1857-01A","01","Primary","9aae154c-ffe9-4e86-9111-903b55de9228","Primary Tumor",NA,"released","Unknown",0.7,"e3d84909-0149-4691-a398-1a6b272dde60","TCGA-30-1857",0.4,"Unknown",0.8,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 45ef6db4-4afa-48ed-a7f3-a4b2e7fe900c; eda9659e-b534-500a-957b-cc01c9763139; TCGA-30-1857_treatment2; TCGA-30-1857_treatment; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; no; 2025-01-06T20:15:45.922024-06:00; NA; NA; NA","Ovary",23689,"Serous cystadenocarcinoma, NOS","primary",NA,"d43fe037-2d6d-5cea-b640-8656fb0ccd5c","Ovary","No",TRUE,0,"Stage IV","Not Reported","Right","not reported",2001,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",64,-23689,"053eda72-806d-5ada-932d-fc4e667f34f0",FALSE,8,NA,"TCGA-30-1857-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-30-1857-01"
"TCGA-13-0765-01A-01R-1564-13","TCGA-13-0765-01A-01R-1564-13","TCGA-13-0765","TCGA-13-0765-01A","TP","Primary solid Tumor","TCGA-13-0765-01A","01","Primary","1fa2d0a4-26a3-4b7b-818b-e20cc200a0ed","Primary Tumor","Not Reported","released","Unknown",0.6,"96588189-C273-4095-88C5-9E22368813C0","TCGA-13-0765",0.3,"Unknown",1.2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 55840c75-65af-4aea-85e8-2d04fba942ff; 7afd731f-e97c-4c12-a543-19ceb2a13f6a; 7b096bb7-3d19-410b-a137-7650bd54baf8; 893778bb-7b11-4052-b7d3-b9a8ded3a78d; bdcd4c6c-3ede-41a7-8f6a-0fcb99881cb2; e488c716-cfcb-4459-b9e4-b73156b73dfe; e85c2b74-e4ec-55fd-b9e6-2edf90f5a946; TCGA-13-0765_treatment7; TCGA-13-0765_treatment2; TCGA-13-0765_treatment3; TCGA-13-0765_treatment5; TCGA-13-0765_treatment4; TCGA-13-0765_treatment6; TCGA-13-0765_treatment; Radiation Therapy, NOS; Hormone Therapy; Targeted Molecular Therapy; Chemotherapy; Targeted Molecular Therapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; yes; 2025-01-06T21:23:54.272558-06:00; 2025-01-06T21:23:54.272558-06:00; 2025-01-06T21:23:54.272558-06:00; 2025-01-06T21:23:54.272558-06:00; 2025-01-06T21:23:54.272558-06:00; 2025-01-06T21:23:54.272558-06:00; NA; NA; 654; 519; 163; 155; 163; 163; NA; 20; 15; 60; 15; 75; 135; NA; 589; 176; 50; 71; 50; 50; NA; Tamoxifen; Bevacizumab; Paclitaxel; Bevacizumab; Cisplatin; Paclitaxel; NA; mg; mg/kg; mg/m2; mg/m2; mg/m2; mg/m2; Intraperitoneal; Intraperitoneal; Intravenous; NA; NA; NA; 6; NA; 6; 6","Ovary",18574,"Serous cystadenocarcinoma, NOS","primary",NA,"15b1a19f-09af-5637-a630-135ff926fb81","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2006,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",50,-18574,"7d9699a9-4ea0-5b30-bcda-46dac07eac0a",FALSE,1389,NA,"TCGA-13-0765-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0765-01"
"TCGA-24-1469-01A-01R-1566-13","TCGA-24-1469-01A-01R-1566-13","TCGA-24-1469","TCGA-24-1469-01A","TP","Primary solid Tumor","TCGA-24-1469-01A","01","Primary","389c632d-45cf-447e-9069-11b2fcb543f5","Primary Tumor",NA,"released","Unknown",0.7,"8f0b80d0-cf56-477c-898b-bb92934f64d4","TCGA-24-1469",0.3,"Solid Tissue",1.5,FALSE,"Tumor","8441/3","135; 135; NA; Adjuvant; Adjuvant; Adjuvant; Intravenous; Intravenous; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; a3e878cc-484a-5420-bdbf-c28781031d39; aeca23ed-c058-4181-b00c-d8962c26890a; ce19525e-a81a-4d67-bd4f-ef1892d660b4; TCGA-24-1469_treatment; TCGA-24-1469_treatment2; TCGA-24-1469_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; NA; released; released; released; Paclitaxel; Carboplatin; NA; yes; yes; no; NA; 2025-01-06T20:13:18.798950-06:00; 2025-01-06T20:13:18.798950-06:00","Ovary",25937,"Serous cystadenocarcinoma, NOS","primary",NA,"c35644a3-29fa-58ef-96eb-39833b3fd41f","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",71,-25937,"a68ea48a-8b0a-554f-a2a7-29d4474fe9e5",FALSE,NA,NA,"TCGA-24-1469-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1469-01"
"TCGA-09-1667-01C-01R-1566-13","TCGA-09-1667-01C-01R-1566-13","TCGA-09-1667","TCGA-09-1667-01C","TP","Primary solid Tumor","TCGA-09-1667-01C","01","Primary","111f607f-5b87-4595-9aa7-df9381717bee","Primary Tumor",NA,"released","Unknown",0.7,"0f3fbc34-6dce-467f-a837-442815ebc159","TCGA-09-1667",0.4,"Unknown",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 14e45dee-699b-4fda-89cd-b253cffa75f5; b3ddcf31-561e-494e-bf1d-0f6e82322383; TCGA-09-1667_treatment8; TCGA-09-1667_treatment7; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; yes; yes; 2025-01-06T20:10:54.084661-06:00; 2025-01-06T20:10:54.084661-06:00; Recurrent Disease; Recurrent Disease","Not Reported",22766,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-09-1667_diagnosis","84ba6cba-36d9-43bc-b567-0898cfb29516","Not Reported","Yes",FALSE,460,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",61,-22306,"74bea85c-1cac-5272-9bd3-f20fe9ca3b0d",FALSE,NA,NA,"TCGA-09-1667-01C","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-1667-01"
"TCGA-24-1474-01A-01R-1566-13","TCGA-24-1474-01A-01R-1566-13","TCGA-24-1474","TCGA-24-1474-01A","TP","Primary solid Tumor","TCGA-24-1474-01A","01","Primary","216c9136-673a-4e87-8537-daf1e4fbf394","Primary Tumor",NA,"released","Unknown",1,"c4d49a95-0478-4399-a5eb-224ca6d16cd7","TCGA-24-1474",0.7,"Solid Tissue",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2400da21-e14c-4bcd-b792-bb4003e8ebbb; bfd3390d-341a-4fc4-b025-402d4c49ecf4; TCGA-24-1474_treatment7; TCGA-24-1474_treatment8; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:27:58.416608-06:00; 2025-01-06T20:27:58.416608-06:00; Recurrent Disease; Recurrent Disease","Not Reported",21234,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1474_diagnosis","b25cd618-4a70-4b9a-a75d-227666c21295","Not Reported","Yes",FALSE,332,NA,NA,NA,NA,NA,NA,NA,NA,NA,"black or african american","female","not reported","Dead",57,-20902,"4812aee4-fa81-5936-a941-fc0d01dba26d",FALSE,676,NA,"TCGA-24-1474-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1474-01"
"TCGA-24-2036-01A-01R-1568-13","TCGA-24-2036-01A-01R-1568-13","TCGA-24-2036","TCGA-24-2036-01A","TP","Primary solid Tumor","TCGA-24-2036-01A","01","Primary","389cd452-fcf0-498b-9e65-7e28dbe8d5a4","Primary Tumor","Not Reported","released","Unknown",0.8,"3c1ecc69-a121-4c32-b15a-1e5bbf2f8d7e","TCGA-24-2036",0.4,"Unknown",1.1,FALSE,"Tumor","8441/3","579; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0ec49ace-90f6-4079-b084-de76c23cf912; 65592d8c-8757-47c6-be67-619856bb7d9b; 73560574-2111-4d58-b5d6-e73a05637de8; TCGA-24-2036_treatment16; TCGA-24-2036_treatment14; TCGA-24-2036_treatment15; Surgery, NOS; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; released; yes; yes; yes; 2025-01-06T20:15:05.183520-06:00; 2025-01-06T20:15:05.183520-06:00; 2025-01-06T20:15:05.183520-06:00; Unknown; Unknown; Unknown","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-24-2036_diagnosis","69d25ae5-5d99-4ab9-ad5c-7499e42c04a9","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",50,-18582,"8d1986bb-40dd-57cb-9ca9-33b4a9651882",FALSE,1947,NA,"TCGA-24-2036-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2036-01"
"TCGA-24-1553-01A-01R-1566-13","TCGA-24-1553-01A-01R-1566-13","TCGA-24-1553","TCGA-24-1553-01A","TP","Primary solid Tumor","TCGA-24-1553-01A","01","Primary","aefe6c18-3891-4c17-99d3-16931151d96e","Primary Tumor",NA,"released","Unknown",0.8,"5abe7782-ca53-4add-9a9a-01955859420b","TCGA-24-1553",0.4,"Solid Tissue",1.3,FALSE,"Tumor","8441/3","1283; 1691; 1293; 1735; 1623; 1224; 1224; 735; 154; 154; NA; 1623; 735; 70; 6000; 20; 63; 3800; 29746; 448; 1740; 2715; 1732; NA; 3360; 3360; 864; 1659; 1243; 1735; 1309; 944; 944; 566; 17; 17; NA; 1309; 566; Intravenous; Oral; Oral; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 131b477e-dcc0-44d6-be1b-145a8512206b; 1cf6111d-abb6-47fa-9acb-583cfb52940a; 2013ed67-c225-52e5-91aa-e926eaa05f58; 24202c42-3f55-4d47-b66b-ef5950862010; 317af912-2313-4000-ba8a-e5b16d6b73c0; 33034fe3-cff7-43be-95cc-4deeca965302; 399217ff-15dc-49ab-81a1-83d8c69ecedf; 8b1bd283-3b31-448e-938e-d456a7371ad1; 8b3d425a-5ec8-46f9-aea6-694f29ac43d0; 9984b132-5bb0-4bee-9597-a2c2d900ee10; a1d09b82-b9a9-4b7d-a1ce-5bae251f8397; c98cdc9f-6df6-468d-9946-02530b2787f5; ca153da3-c183-4212-939c-29d64d9f954b; TCGA-24-1553_treatment9; TCGA-24-1553_treatment6; TCGA-24-1553_treatment; TCGA-24-1553_treatment12; TCGA-24-1553_treatment4; TCGA-24-1553_treatment5; TCGA-24-1553_treatment8; TCGA-24-1553_treatment3; TCGA-24-1553_treatment11; TCGA-24-1553_treatment2; TCGA-24-1553_treatment13; TCGA-24-1553_treatment10; TCGA-24-1553_treatment7; Chemotherapy; Chemotherapy; Hormone Therapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 3; 2; NA; 1; 12; 9; 9; 6; 6; 6; NA; 12; 6; Topotecan; Capecitabine; Tamoxifen; Pegylated Liposomal Doxorubicin Hydrochloride; Carboplatin; Gemcitabine Hydrochloride; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; Carboplatin; Paclitaxel; NA; Paclitaxel; Carboplatin; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; no; yes; yes; 2025-01-06T20:14:35.987625-06:00; 2025-01-06T20:14:35.987625-06:00; NA; 2025-01-06T20:14:35.987625-06:00; 2025-01-06T20:14:35.987625-06:00; 2025-01-06T20:14:35.987625-06:00; 2025-01-06T20:14:35.987625-06:00; 2025-01-06T20:14:35.987625-06:00; 2025-01-06T20:14:35.987625-06:00; 2025-01-06T20:14:35.987625-06:00; 2025-01-06T20:14:35.987625-06:00; 2025-01-06T20:14:35.987625-06:00; 2025-01-06T20:14:35.987625-06:00; Recurrent Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Recurrent Disease; NA; NA; NA; Progressive Disease; Recurrent Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; released; released; released; mg; mg; mg; mg; mg; mg; mg; mg; mg; mg; NA; mg; mg; NA; NA; NA; NA; NA; NA; NA; NA; Adjuvant; Adjuvant; Adjuvant; NA; NA","Ovary",19393,"Serous cystadenocarcinoma, NOS","primary",NA,"0f6394e0-ad6b-55a6-bb34-cb34cbc020ef","Ovary","No",TRUE,0,"Stage IIIB","Not Reported","Bilateral","not reported",1997,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",53,-19393,"f6ba61ac-3f98-557c-ac57-f0a30a3dc22b",FALSE,1767,NA,"TCGA-24-1553-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1553-01"
"TCGA-24-1550-01A-01R-1566-13","TCGA-24-1550-01A-01R-1566-13","TCGA-24-1550","TCGA-24-1550-01A","TP","Primary solid Tumor","TCGA-24-1550-01A","01","Primary","2726ed05-ac38-41d6-85f3-35ab0bcbc47a","Primary Tumor",NA,"released","Unknown",1,"7ebd8d19-0a81-4623-8127-f225ad650d46","TCGA-24-1550",0.7,"Solid Tissue",1.5,FALSE,"Tumor","8441/3","965; 1233; 174; 1211; 174; 1107; NA; 1211; 405; 64; 165; 837; 2070; 4200; NA; 1950; 902; 1233; 8; 1164; 8; 986; NA; 1164; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 4a777e8f-38d3-5b9a-9567-7ece5a98878f; 6cb177b2-84ee-4a45-a5dd-bf2f2a3476eb; 77b0a730-c557-4b57-a1bf-e18d1d69c30b; 87d74113-d7c6-4fa5-bfcf-3388ddc5e022; bf6c4cf4-333a-467e-8cb0-770862f7c41c; c45f1f87-0594-4968-bdc9-c1267177a129; c8432b5f-3fa6-4935-938a-cf055d0a34f8; f1a9f26b-2d54-4883-9f67-fa027cb348cd; TCGA-24-1550_treatment; TCGA-24-1550_treatment7; TCGA-24-1550_treatment5; TCGA-24-1550_treatment6; TCGA-24-1550_treatment3; TCGA-24-1550_treatment2; TCGA-24-1550_treatment8; TCGA-24-1550_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 4; 1; 7; 3; 7; 6; NA; 3; Topotecan; Pegylated Liposomal Doxorubicin Hydrochloride; Cisplatin; Paclitaxel; Paclitaxel; Carboplatin; NA; Carboplatin; yes; yes; yes; yes; yes; yes; no; yes; NA; 2025-01-06T20:41:56.039885-06:00; 2025-01-06T20:41:56.039885-06:00; 2025-01-06T20:41:56.039885-06:00; 2025-01-06T20:41:56.039885-06:00; 2025-01-06T20:41:56.039885-06:00; 2025-01-06T20:41:56.039885-06:00; 2025-01-06T20:41:56.039885-06:00; Recurrent Disease; Progressive Disease; NA; Progressive Disease; NA; Progressive Disease; NA; Progressive Disease; NA; NA; Adjuvant; NA; Adjuvant; NA; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; mg; mg; mg; mg; mg; mg; NA; mg","Ovary",18049,"Serous cystadenocarcinoma, NOS","primary",NA,"128ce7b5-2666-568d-8370-bd8ce225cb6a","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",1997,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",49,-18049,"398a8019-dc37-529c-a1ed-c9dd8bc38628",FALSE,1249,NA,"TCGA-24-1550-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1550-01"
"TCGA-23-1123-01A-01R-1565-13","TCGA-23-1123-01A-01R-1565-13","TCGA-23-1123","TCGA-23-1123-01A","TP","Primary solid Tumor","TCGA-23-1123-01A","01","Primary","ed537d83-388b-4125-8c8c-204a0bcbcde8","Primary Tumor",NA,"released","Unknown",0.8,"28f9189b-24eb-4540-8551-4eaacc296c20","TCGA-23-1123",0.6,"Unknown",0.8,FALSE,"Tumor","8441/3","Adjuvant; Not Reported; Adjuvant; Not Reported; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1f0188f3-b8a7-4edf-a8bc-cecf07957327; 2c6020bf-b59a-41d4-9c03-b473eae12ce2; 3dab401e-37f6-4d3c-9130-a7e57b8942e2; bd510df9-8aa0-482a-a620-f943fe9ef3f5; fdde878a-f1e1-5022-90a0-86319fee955a; TCGA-23-1123_treatment5; TCGA-23-1123_treatment2; TCGA-23-1123_treatment4; TCGA-23-1123_treatment3; TCGA-23-1123_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; no; yes; yes; yes; yes; 2025-01-06T21:13:07.499788-06:00; 2025-01-06T21:13:07.499788-06:00; 2025-01-06T21:13:07.499788-06:00; 2025-01-06T21:13:07.499788-06:00; NA; NA; 894; 250; 599; 250; NA; 40; 4800; 456; 2000; NA; 812; 7; 452; 7; Not Reported; Not Reported; Not Reported; NA; 3; 8; 6; 8; NA; Topotecan; Carboplatin; Doxorubicin; Paclitaxel; NA; Persistent Disease; NA; Persistent Disease; NA; NA; mg; mg; mg; mg","Ovary",21552,"Serous cystadenocarcinoma, NOS","primary",NA,"394df501-4b80-527f-91ba-621c945330b6","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",1998,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",59,-21552,"ce764708-fee9-5782-b207-acbf274a2c5e",FALSE,1018,NA,"TCGA-23-1123-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1123-01"
"TCGA-23-1119-01A-02R-1565-13","TCGA-23-1119-01A-02R-1565-13","TCGA-23-1119","TCGA-23-1119-01A","TP","Primary solid Tumor","TCGA-23-1119-01A","01","Primary","072ba366-b5ad-46bd-ad87-e85057ca6bf7","Primary Tumor",NA,"released","Unknown",0.8,"86389912-6945-49e6-9255-e7a41fde197a","TCGA-23-1119",0.6,"Unknown",0.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; b2881a0c-3a68-4de9-b874-155ebd1cc5be; b7e73882-3cd1-4d88-9be2-1206e8b8442c; TCGA-23-1119_treatment5; TCGA-23-1119_treatment4; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:12:52.638934-06:00; 2025-01-06T21:12:52.638934-06:00; Recurrent Disease; Recurrent Disease","Not Reported",27064,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-23-1119_diagnosis","8f1e3f64-95d0-4d3a-9658-049e35597ae6","Not Reported","Yes",FALSE,3378,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",64,-23686,"f3da4ea8-cbc9-5519-9037-d701e149a8f6",FALSE,NA,NA,"TCGA-23-1119-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1119-01"
"TCGA-25-2398-01A-01R-1569-13","TCGA-25-2398-01A-01R-1569-13","TCGA-25-2398","TCGA-25-2398-01A","TP","Primary solid Tumor","TCGA-25-2398-01A","01","Primary","a5ad2377-7f60-4c8a-8343-4589b01dc4c5","Primary Tumor","Not Reported","released","Unknown",1.3,"CFF4E9E3-AC10-4A50-BE90-5A12822FEF42","TCGA-25-2398",0.5,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 008f743b-1fcf-4a1b-84c7-0a49b29ae784; 771ed1df-5ba6-484e-a768-6d8dd3e380d3; TCGA-25-2398_treatment7; TCGA-25-2398_treatment6; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:37:37.898503-06:00; 2025-01-06T21:37:37.898503-06:00; Recurrent Disease; Recurrent Disease","Not Reported",26844,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-25-2398_diagnosis","3dcb35de-69ee-4f99-9f32-038132c3e383","Not Reported","Yes",FALSE,577,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",71,-26267,"f3608d2c-1467-5436-8977-622ae51edd70",FALSE,1369,NA,"TCGA-25-2398-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-2398-01"
"TCGA-25-1315-01A-01R-1565-13","TCGA-25-1315-01A-01R-1565-13","TCGA-25-1315","TCGA-25-1315-01A","TP","Primary solid Tumor","TCGA-25-1315-01A","01","Primary","d1a2fb08-a7b9-4920-af5a-33118478a429","Primary Tumor","Not Reported","released","Unknown",2,"486E22A0-A224-4471-BA52-9F52E021B131","TCGA-25-1315",0.9,"Unknown",3.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; f1c0091f-937c-4e74-94ea-d8bc737cfba0; fc90eab3-63b2-4273-aab4-b629bf09671c; TCGA-25-1315_treatment8; TCGA-25-1315_treatment7; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:16:41.324353-06:00; 2025-01-06T21:16:41.324353-06:00; Progressive Disease; Progressive Disease","Not Reported",18416,"Serous cystadenocarcinoma, NOS","Progression","TCGA-25-1315_diagnosis","75df72c7-b68d-422d-a9b9-3279740d361d","Not Reported","Yes",FALSE,153,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",50,-18263,"37be6983-075c-55d9-a482-fc41dcc71bb0",FALSE,1583,NA,"TCGA-25-1315-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1315-01"
"TCGA-61-2104-01A-01R-1568-13","TCGA-61-2104-01A-01R-1568-13","TCGA-61-2104","TCGA-61-2104-01A","TP","Primary solid Tumor","TCGA-61-2104-01A","01","Primary","87b7ed22-4fe1-4539-8c37-ab085e2cb9c1","Primary Tumor","Not Reported","released","Unknown",0.6,"38d2e115-ec9a-40e5-bfa0-30fb1db60691","TCGA-61-2104",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0a2cceca-690f-4031-9e9b-3aacf2ac6f31; 610fa5b3-2954-48e0-8acf-96a934869db6; e3c8b210-cd81-4aff-9094-a943c3fbcfa7; TCGA-61-2104_treatment11; TCGA-61-2104_treatment10; TCGA-61-2104_treatment12; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; Surgery, NOS; released; released; released; no; yes; yes; 2025-01-06T20:39:35.439197-06:00; 2025-01-06T20:39:35.439197-06:00; 2025-01-06T20:39:35.439197-06:00; Progressive Disease; Progressive Disease; Progressive Disease; NA; NA; 1680","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-61-2104_diagnosis","0db77645-2e1d-4d38-bc54-320f5e465b27","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Alive",53,-19432,"f30ef53b-8af1-5eac-93f1-59318e77e83b",FALSE,NA,NA,"TCGA-61-2104-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2104-01"
"TCGA-31-1944-01A-01R-1568-13","TCGA-31-1944-01A-01R-1568-13","TCGA-31-1944","TCGA-31-1944-01A","TP","Primary solid Tumor","TCGA-31-1944-01A","01","Primary","69617aa2-3b7b-47b5-9f34-2051339dfd34","Primary Tumor","Not Reported","released","Unknown",0.5,"bd7361f7-07c1-4be8-92c6-4f0a3dea99b2","TCGA-31-1944",0.3,"Unknown",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 428a0372-28cf-4300-bb59-c773796a7408; 5903f4f0-8bdb-465f-8d3e-a71667101674; TCGA-31-1944_treatment11; TCGA-31-1944_treatment12; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:33:04.936436-06:00; 2025-01-06T20:33:04.936436-06:00; Recurrent Disease; Recurrent Disease","Not Reported",17885,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-31-1944_diagnosis","7ee5a686-dc85-4bf8-8561-7fe214f21100","Not Reported","Yes",FALSE,678,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",47,-17207,"1846915b-b3b0-5629-bb73-f78bf2081edf",FALSE,NA,NA,"TCGA-31-1944-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-31-1944-01"
"TCGA-04-1530-01A-02R-1569-13","TCGA-04-1530-01A-02R-1569-13","TCGA-04-1530","TCGA-04-1530-01A","TP","Primary solid Tumor","TCGA-04-1530-01A","01","Primary","2b89e52a-a064-4151-87e1-20fec4eed015","Primary Tumor",NA,"released","Unknown",1,"6CB3AECE-ADBB-4AED-A036-2E2D28D68369","TCGA-04-1530",0.4,"Solid Tissue",1.4,FALSE,"Tumor","8441/3","153; 550; 550; NA; 153; 1218; 2490; 1200; NA; 678; 43; 382; 382; NA; 43; Intravenous; Intravenous; Intravenous; Intravenous; 153f2aef-ee14-5507-8a67-d42e561f5ace; 2c740855-2322-47dc-a9a2-2208805ddc01; bfaa57b9-4981-4a10-863c-7663e568160b; ccc617ec-f106-4b76-ab01-434402640ba7; dcea6857-fbd5-45cc-ad9b-c9afeb8aba2f; TCGA-04-1530_treatment; TCGA-04-1530_treatment4; TCGA-04-1530_treatment2; TCGA-04-1530_treatment5; TCGA-04-1530_treatment3; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; 6; 6; NA; 6; Paclitaxel; Carboplatin; Paclitaxel; NA; Cisplatin; yes; yes; yes; no; yes; NA; 2025-01-06T20:52:56.171421-06:00; 2025-01-06T20:52:56.171421-06:00; 2025-01-06T20:52:56.171421-06:00; 2025-01-06T20:52:56.171421-06:00; Adjuvant; NA; NA; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg; mg; mg; NA; mg; NA; Recurrent Disease; Recurrent Disease; NA; NA","Ovary",25013,"Serous cystadenocarcinoma, NOS","primary",NA,"3f5e6198-cbee-5262-a733-ce32d75b7057","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1995,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",68,-25013,"1403a8ca-ec97-5425-bb3c-49e4dc50322c",FALSE,3622,NA,"TCGA-04-1530-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1530-01"
"TCGA-59-2355-01A-01R-1569-13","TCGA-59-2355-01A-01R-1569-13","TCGA-59-2355","TCGA-59-2355-01A","TP","Primary solid Tumor","TCGA-59-2355-01A","01","Primary","fc1a6b07-e91e-47c5-bf00-80be3c167605","Primary Tumor","Not Reported","released","Unknown",0.4,"322bedf6-e6b5-4275-a186-0075a2ec271e","TCGA-59-2355",0.2,"Unknown",0.6,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 53746f06-6b6e-4fe2-b720-ebe5c21ae792; c74b03d1-9ee4-5d0f-a5d0-39b066358ffd; TCGA-59-2355_treatment2; TCGA-59-2355_treatment; Chemotherapy; Chemotherapy; released; released; Paclitaxel; Carboplatin; yes; yes; 2025-01-06T21:36:20.744738-06:00; NA","Ovary",NA,"Serous cystadenocarcinoma, NOS","primary",NA,"399bd74f-6959-50b6-9977-29d7ab3b4588","Ovary","No",TRUE,0,"Stage IV","Not Reported","Right","not reported",2006,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",58,NA,"ea0a2db7-aa6f-51d6-b99f-2e20666781ef",FALSE,65,NA,"TCGA-59-2355-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-59-2355-01"
"TCGA-36-1575-01A-01R-1566-13","TCGA-36-1575-01A-01R-1566-13","TCGA-36-1575","TCGA-36-1575-01A","TP","Primary solid Tumor","TCGA-36-1575-01A","01","Primary","e53c2985-f410-43f1-8fde-7181112b9c14","Primary Tumor",NA,"released","Unknown",0.8,"44cf8eee-71b1-4499-815a-7d1c3092dbe3","TCGA-36-1575",0.4,"Unknown",1.6,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 31d18e73-e380-478d-bccd-f36e8952b0c3; d67ba0e7-920f-53a6-a76e-c8a76ed42d7e; TCGA-36-1575_treatment2; TCGA-36-1575_treatment; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:29:54.909914-06:00; NA; NA; Not Reported; NA; NA","Ovary",30592,"Serous cystadenocarcinoma, NOS","primary",NA,"e7428b28-df7a-5573-8867-a864e51c6a92","Ovary","No",TRUE,0,"Stage IIIB","Not Reported",NA,"not reported",2006,"Surgical Resection","C56.9","G3",NA,"not reported","female","not reported","Alive",83,-30592,"dd3e8198-e1e2-5976-a248-79485941dd2d",FALSE,NA,NA,"TCGA-36-1575-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-36-1575-01"
"TCGA-04-1356-01A-01R-1569-13","TCGA-04-1356-01A-01R-1569-13","TCGA-04-1356","TCGA-04-1356-01A","TP","Primary solid Tumor","TCGA-04-1356-01A","01","Primary","3d1f80f8-1033-48d9-9b97-36f025486b0a","Primary Tumor","Not Reported","released","Unknown",1,"7D26B212-1DE7-43CC-A0DC-A9071C3A534F","TCGA-04-1356",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 51ecdd4d-ccb3-4819-bba4-9999d3cf23a0; b16ea8e8-a1ef-4373-8d40-7097babe520d; TCGA-04-1356_treatment5; TCGA-04-1356_treatment4; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:25:57.346267-06:00; 2025-01-06T21:25:57.346267-06:00; Recurrent Disease; Recurrent Disease","Not Reported",23011,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-04-1356_diagnosis","0376f311-efe5-41f3-b975-4104015c228e","Not Reported","Yes",FALSE,156,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","hispanic or latino","Dead",62,-22855,"6f4e3146-4cfe-55b8-8427-ff6397b2269e",FALSE,1499,NA,"TCGA-04-1356-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1356-01"
"TCGA-25-1877-01A-01R-1567-13","TCGA-25-1877-01A-01R-1567-13","TCGA-25-1877","TCGA-25-1877-01A","TP","Primary solid Tumor","TCGA-25-1877-01A","01","Primary","95bc63bd-436a-4ee4-91dd-95c5188fe261","Primary Tumor","Not Reported","released","Unknown",0.4,"D98B5A1F-DF34-43E7-826F-BCB45DEC582D","TCGA-25-1877",0.4,"Unknown",0.7,FALSE,"Tumor","8441/3","Intravenous; Intravenous; Intravenous; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0236fb9f-5b83-493f-bd81-622d93ec11a2; 1b1923a4-ea51-47ea-ac3d-c332529058a4; db1814cc-564c-5d6c-b21d-ce6dc60a5b57; f45810bf-0df7-49e5-89a5-12ad17252585; TCGA-25-1877_treatment2; TCGA-25-1877_treatment4; TCGA-25-1877_treatment; TCGA-25-1877_treatment3; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; released; Paclitaxel; NA; Cyclophosphamide; Carboplatin; yes; no; yes; yes; 2025-01-06T21:37:41.030296-06:00; 2025-01-06T21:37:41.030296-06:00; NA; 2025-01-06T21:37:41.030296-06:00; Recurrent Disease; NA; NA; NA; NA; Adjuvant; Adjuvant; Adjuvant; NA; NA; 31; 31","Ovary",29615,"Serous cystadenocarcinoma, NOS","primary",NA,"96598802-b58e-538b-a149-13802533384c","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",1993,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",81,-29615,"b10665a5-1955-5d79-92f4-5917a33bfa22",FALSE,730,NA,"TCGA-25-1877-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1877-01"
"TCGA-29-1776-01A-01R-1567-13","TCGA-29-1776-01A-01R-1567-13","TCGA-29-1776","TCGA-29-1776-01A","TP","Primary solid Tumor","TCGA-29-1776-01A","01","Primary","5b6791a5-2fec-41c8-87fb-9d83a3bed4bc","Primary Tumor",NA,"released","Unknown",0.7,"eb6df66e-c6ee-4c63-889d-9f4b6ca170c7","TCGA-29-1776",0.4,"Unknown",0.9,FALSE,"Tumor","8441/3","592; 592; 154; NA; 154; 2184; 88; 6; NA; 175; 522; 522; 32; NA; 32; 1528564f-24c2-4211-a96b-1334159f4534; 731d2b98-8572-43c4-baf1-4e226761729f; cccdf89e-7a68-5630-b208-ecb71e11900a; cd7c02c6-f2d7-46f7-af40-b1dc5ec47f1e; e26498e9-5f55-4e26-a040-f8c50b9d0930; TCGA-29-1776_treatment2; TCGA-29-1776_treatment3; TCGA-29-1776_treatment; TCGA-29-1776_treatment5; TCGA-29-1776_treatment4; Targeted Molecular Therapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Bevacizumab; Docetaxel; Carboplatin; NA; Paclitaxel; yes; yes; yes; no; yes; 2025-01-06T21:17:41.513248-06:00; 2025-01-06T21:17:41.513248-06:00; NA; 2025-01-06T21:17:41.513248-06:00; 2025-01-06T21:17:41.513248-06:00; Progressive Disease; Progressive Disease; NA; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; Treatment Ongoing; Treatment Ongoing; NA; NA; NA; released; released; released; released; released; mg; mg; AUC; NA; mg/m2; Intravenous; Intravenous; Intravenous; NA; 3; 6; NA; 6; NA; NA; Adjuvant; Adjuvant; Adjuvant","Ovary",23016,"Serous cystadenocarcinoma, NOS","primary",NA,"0716ed12-2ffb-546f-a3c1-8a2cefdfaab5","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"black or african american","female","not reported","Alive",63,-23016,"ab7de0f2-baa5-58ec-bd27-60f24523a32a",FALSE,NA,NA,"TCGA-29-1776-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1776-01"
"TCGA-24-2289-01A-01R-1568-13","TCGA-24-2289-01A-01R-1568-13","TCGA-24-2289","TCGA-24-2289-01A","TP","Primary solid Tumor","TCGA-24-2289-01A","01","Primary","f39ab685-fda1-43e8-aa70-fa3ed1566061","Primary Tumor","Not Reported","released","Unknown",1,"3c9bb67a-702f-4e9b-bd0f-c0ef8a5d237d","TCGA-24-2289",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","183; 183; 708; NA; 645; 1735; 957; NA; 4; 4; 598; NA; Intravenous; Intravenous; Intravenous; 029f7aa0-151f-44ec-9551-8c7c98234723; 13ec1c2a-b48f-5fce-a7c0-e091a367564f; 685d1a50-2c1d-4c4d-b9d1-897db586953f; ff29b456-ee5e-4902-b2cf-8579e4b5c94c; TCGA-24-2289_treatment2; TCGA-24-2289_treatment; TCGA-24-2289_treatment3; TCGA-24-2289_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 8; 8; 6; NA; Cisplatin; Paclitaxel; Docetaxel; NA; yes; yes; yes; no; 2025-01-06T21:06:09.172400-06:00; NA; 2025-01-06T21:06:09.172400-06:00; 2025-01-06T21:06:09.172400-06:00; Adjuvant; Adjuvant; NA; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; mg; mg; NA; NA; NA; Recurrent Disease; NA","Ovary",25191,"Serous cystadenocarcinoma, NOS","primary",NA,"566061b0-53fa-5c9b-aba1-fe01ff343b32","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",1997,"Cytology","C56.9","G3",NA,"white","female","not reported","Dead",68,-25191,"c9b134f1-5648-5775-8531-9769fbda3073",FALSE,2049,NA,"TCGA-24-2289-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2289-01"
"TCGA-25-1623-01A-01R-1566-13","TCGA-25-1623-01A-01R-1566-13","TCGA-25-1623","TCGA-25-1623-01A","TP","Primary solid Tumor","TCGA-25-1623-01A","01","Primary","09f0e0d8-1f35-4781-8c71-5b0843483cd7","Primary Tumor",NA,"released","Unknown",1,"A57CB221-076A-4EE5-8C77-D1E33070597C","TCGA-25-1623",0.3,"Unknown",1.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0f1d6b7a-e5bc-47b0-b54a-e0e026d95dc3; 43d72dca-7006-4ce9-a406-468853b1b977; TCGA-25-1623_treatment6; TCGA-25-1623_treatment5; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:45:38.147350-06:00; 2025-01-06T20:45:38.147350-06:00; Recurrent Disease; Recurrent Disease","Not Reported",26402,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-25-1623_diagnosis","8ecf1562-42dc-4403-bd2e-0f2ec8be6394","Not Reported","Yes",FALSE,342,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",71,-26060,"23ac0f67-276c-5d57-b52e-1764a643b863",FALSE,565,NA,"TCGA-25-1623-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1623-01"
"TCGA-13-1409-01A-01R-1565-13","TCGA-13-1409-01A-01R-1565-13","TCGA-13-1409","TCGA-13-1409-01A","TP","Primary solid Tumor","TCGA-13-1409-01A","01","Primary","930c3552-f960-4a57-aa35-b504807a9676","Primary Tumor","Not Reported","released","Unknown",1,"3F18B612-EE50-4459-8CAF-61A12157DD8A","TCGA-13-1409",0.6,"Unknown",1.6,FALSE,"Tumor","8441/3","175; NA; NA; 94; NA; 94; Intravenous; Intravenous; 3a194d10-0034-4360-af0b-0220f04faacb; 6f43a717-fff1-4073-9a7f-1f1fc810c2d3; c9c78335-6d3f-52a5-92a9-c41ccbd8d4d8; TCGA-13-1409_treatment2; TCGA-13-1409_treatment3; TCGA-13-1409_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; NA; 6; Paclitaxel; NA; Carboplatin; yes; no; yes; 2025-01-06T21:40:48.236707-06:00; 2025-01-06T21:40:48.236707-06:00; NA; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; Treatment Ongoing; NA; Treatment Ongoing; released; released; released; mg/m2; NA; NA","Ovary",26836,"Serous cystadenocarcinoma, NOS","primary",NA,"6b0f33e6-884d-5a93-8335-9f55569790a7","Ovary","No",TRUE,0,"Stage IIIC","Not Reported",NA,"not reported",2008,"Incisional Biopsy","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",73,-26836,"cf0eeee1-5dd7-5bef-ad40-5d881bf9d762",FALSE,1742,NA,"TCGA-13-1409-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1409-01"
"TCGA-24-1556-01A-01R-1566-13","TCGA-24-1556-01A-01R-1566-13","TCGA-24-1556","TCGA-24-1556-01A","TP","Primary solid Tumor","TCGA-24-1556-01A","01","Primary","ba4d22b5-f97a-413f-9cc7-30d1e5c91f7e","Primary Tumor",NA,"released","Unknown",1,"75c91323-45a7-4629-b014-f7eda2f1075e","TCGA-24-1556",0.6,"Unknown",1.9,FALSE,"Tumor","8441/3","1832; NA; NA; 628; 1832; NA; NA; NA; 1724; NA; NA; 539; 1724; NA; NA; 1298; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 2e361170-37ac-4712-8d75-c89d4bf5aeca; 35c981f6-005c-4d50-937c-c5b3bdb959d8; 3856ad30-2cf9-4121-aa6c-bca6402a01eb; 5b53dc68-f599-4ca8-8156-f512e0e68ce5; ae790b5a-fccc-4645-986f-296cc0711535; ddd91f37-694f-45eb-a840-0f0fb2dff9a9; ec057975-9541-47de-b43f-71a556baf349; fc7d1943-885f-55f8-8dc6-fbc6b5f3f66d; TCGA-24-1556_treatment7; TCGA-24-1556_treatment6; TCGA-24-1556_treatment4; TCGA-24-1556_treatment8; TCGA-24-1556_treatment5; TCGA-24-1556_treatment2; TCGA-24-1556_treatment3; TCGA-24-1556_treatment; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 5; 2; 6; 7; 5; 4; 6; NA; Docetaxel; Paclitaxel; Carboplatin; Topotecan; Carboplatin; Cyclophosphamide; Cisplatin; NA; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T20:41:35.681499-06:00; 2025-01-06T20:41:35.681499-06:00; 2025-01-06T20:41:35.681499-06:00; 2025-01-06T20:41:35.681499-06:00; 2025-01-06T20:41:35.681499-06:00; 2025-01-06T20:41:35.681499-06:00; 2025-01-06T20:41:35.681499-06:00; NA; Progressive Disease; NA; NA; Recurrent Disease; Progressive Disease; NA; Progressive Disease; Progressive Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; NA; Adjuvant; Adjuvant; NA; NA; Adjuvant; NA; NA; Locoregional Site","Ovary",18517,"Serous cystadenocarcinoma, NOS","primary",NA,"21fca019-acce-5868-9629-eaf16a9567a7","Ovary","No",TRUE,0,"Stage IIB","Not Reported","Left","not reported",2000,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",50,-18517,"2dcec934-ec62-5a81-9bbc-8582f8129183",FALSE,2148,NA,"TCGA-24-1556-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1556-01"
"TCGA-24-1471-01A-01R-1566-13","TCGA-24-1471-01A-01R-1566-13","TCGA-24-1471","TCGA-24-1471-01A","TP","Primary solid Tumor","TCGA-24-1471-01A","01","Primary","43d7d5cf-e988-4b6b-925e-2b7bbd67e4fc","Primary Tumor",NA,"released","Unknown",1,"d20b8ed1-c74e-4ee8-9ae2-5512429810bc","TCGA-24-1471",0.5,"Solid Tissue",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 261f42c9-fc10-44a9-b754-6fcaa8932e3a; 6d58e60c-c601-41b9-ba19-0683bec01fad; fc984d64-8a86-5f39-ae93-f96f0a16b7c6; TCGA-24-1471_treatment3; TCGA-24-1471_treatment2; TCGA-24-1471_treatment; Radiation Therapy, NOS; Targeted Molecular Therapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T20:13:57.521428-06:00; 2025-01-06T20:13:57.521428-06:00; NA; NA; Clinical Trial; NA","Ovary",22081,"Serous cystadenocarcinoma, NOS","primary",NA,"43f6535a-4e53-5545-8cb3-311a4901f939","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",60,-22081,"2cc27fab-a108-5748-aefe-0bef861bc009",FALSE,NA,NA,"TCGA-24-1471-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1471-01"
"TCGA-57-1583-01A-01R-1566-13","TCGA-57-1583-01A-01R-1566-13","TCGA-57-1583","TCGA-57-1583-01A","TP","Primary solid Tumor","TCGA-57-1583-01A","01","Primary","04b379ac-220b-4582-84c8-be370d5ad619","Primary Tumor",NA,"released","Unknown",1,"b899b485-621f-46df-8bda-97b0fbe10b6d","TCGA-57-1583",0.4,"Unknown",1.4,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 37; 37; NA; Intravenous; Intravenous; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 34e4a5f6-22af-59c9-9dd1-e4c91dff74c6; 6886f7d0-619c-469b-9871-96b61b228619; e11a92f7-cc6f-4e0b-90cd-d33b89ed985c; TCGA-57-1583_treatment; TCGA-57-1583_treatment2; TCGA-57-1583_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Treatment Ongoing; NA; NA; released; released; released; Carboplatin; Paclitaxel; NA; yes; yes; no; NA; 2025-01-06T20:38:18.432558-06:00; 2025-01-06T20:38:18.432558-06:00","Ovary",21167,"Serous cystadenocarcinoma, NOS","primary",NA,"03a569c0-4d70-554f-9b61-b414ecfffa8e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2006,"Surgical Resection","C56.9","G3",NA,"black or african american","female","not reported","Dead",57,-21167,"65d45d68-52f7-5bf9-83b6-a053ab03eef7",FALSE,346,NA,"TCGA-57-1583-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-57-1583-01"
"TCGA-09-1669-01A-01R-1566-13","TCGA-09-1669-01A-01R-1566-13","TCGA-09-1669","TCGA-09-1669-01A","TP","Primary solid Tumor","TCGA-09-1669-01A","01","Primary","646165d1-4eb0-4dbd-8e05-90cdb30e1d22","Primary Tumor",NA,"released","Unknown",0.5,"7870b5a7-a96c-4e55-b56f-8eca45918251","TCGA-09-1669",0.3,"Unknown",0.9,FALSE,"Tumor","8441/3","132; NA; 132; 175; NA; NA; 27; NA; 27; Intravenous; Intravenous; 15a724f5-1a73-51fb-83ad-81dbf48cc564; 5c233f57-7dd3-4fbc-9923-41f17b5a7c00; cce89418-ea58-415e-8feb-7c7a3991b863; TCGA-09-1669_treatment; TCGA-09-1669_treatment3; TCGA-09-1669_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; NA; 6; Paclitaxel; NA; Carboplatin; yes; no; yes; NA; 2025-01-06T20:53:19.251220-06:00; 2025-01-06T20:53:19.251220-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg/m2; NA; NA","Ovary",20052,"Serous cystadenocarcinoma, NOS","primary",NA,"a5bcf80f-e5db-5ab5-8c04-57c2093acb89","Ovary","No",TRUE,0,"Stage IIIA","Not Reported","Right","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",54,-20052,"85394400-da7b-574f-8346-6d5fc26b3df5",FALSE,NA,NA,"TCGA-09-1669-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-1669-01"
"TCGA-25-1628-01A-01R-1566-13","TCGA-25-1628-01A-01R-1566-13","TCGA-25-1628","TCGA-25-1628-01A","TP","Primary solid Tumor","TCGA-25-1628-01A","01","Primary","efe5ae48-c145-4b24-a1df-ba485d355dfa","Primary Tumor",NA,"released","Unknown",0.5,"790D6E48-15D0-45F9-B6DD-182787298EBA","TCGA-25-1628",0.4,"Unknown",2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 6a082f2a-692d-41aa-8285-66e9aab926c9; b708d9ba-a812-4b35-a46e-30f0aaafbb1a; b82985d8-ddbc-423c-994c-7a8b7a240476; TCGA-25-1628_treatment8; TCGA-25-1628_treatment7; TCGA-25-1628_treatment9; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; Surgery, NOS; released; released; released; no; yes; yes; 2025-01-06T20:45:58.742607-06:00; 2025-01-06T20:45:58.742607-06:00; 2025-01-06T20:45:58.742607-06:00; Progressive Disease; Progressive Disease; Progressive Disease; NA; NA; 483","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-25-1628_diagnosis","32e96cae-7bf2-487e-97b5-dd2bb49ea751","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",67,-24488,"6e2d232b-ab2e-50d6-bfae-ee839c5600ad",FALSE,627,NA,"TCGA-25-1628-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1628-01"
"TCGA-24-1423-01A-01R-1565-13","TCGA-24-1423-01A-01R-1565-13","TCGA-24-1423","TCGA-24-1423-01A","TP","Primary solid Tumor","TCGA-24-1423-01A","01","Primary","eaf742ea-5bdc-4f44-a390-77cba766d260","Primary Tumor","Not Reported","released","Unknown",1,"47331163-68e9-44fd-8b80-b9f70058957f","TCGA-24-1423",0.6,"Unknown",1.8,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1b8f7954-3135-441b-bad3-64223712c36e; 4c58edb9-2eb9-4477-8d86-89464d0da3bd; daf9c3a2-fdd8-55fa-aeed-0b37b8fd4d57; ef12c30b-8bb0-4b39-826a-307687066c02; TCGA-24-1423_treatment4; TCGA-24-1423_treatment3; TCGA-24-1423_treatment; TCGA-24-1423_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T20:57:27.340834-06:00; 2025-01-06T20:57:27.340834-06:00; NA; 2025-01-06T20:57:27.340834-06:00; NA; 151; 151; 151; NA; 532; 1703; 477; NA; 21; 21; 21; Intravenous; Intravenous; Intravenous; NA; 7; 7; 7; NA; Cisplatin; Paclitaxel; Doxorubicin; NA; mg; mg; mg","Ovary",22281,"Serous cystadenocarcinoma, NOS","primary",NA,"4b898782-211b-5014-b4fc-29731d9e4489","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",61,-22281,"a4ae248f-d90b-5ced-a3c7-bf5619b4bffd",FALSE,NA,NA,"TCGA-24-1423-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1423-01"
"TCGA-24-2024-01A-02R-1568-13","TCGA-24-2024-01A-02R-1568-13","TCGA-24-2024","TCGA-24-2024-01A","TP","Primary solid Tumor","TCGA-24-2024-01A","01","Primary","a3f8dcad-c42a-4070-80c4-782627bbaca2","Primary Tumor","Not Reported","released","Unknown",1,"4189cfa0-00c3-42fb-91b9-d2f4b4887061","TCGA-24-2024",0.5,"Unknown",1.1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0bd5424e-fc61-4cb2-922e-d6a21649d954; a671333f-6470-48d6-8534-e23336721bf8; TCGA-24-2024_treatment7; TCGA-24-2024_treatment6; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:13:47.241136-06:00; 2025-01-06T21:13:47.241136-06:00; Recurrent Disease; Recurrent Disease","Not Reported",26897,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-2024_diagnosis","d5ea7a05-cb2b-491d-abcd-c7daa8cce177","Not Reported","Yes",FALSE,421,NA,NA,NA,NA,NA,NA,NA,NA,NA,"black or african american","female","not reported","Dead",72,-26476,"7d734828-adb9-5d7e-966d-8e0043300194",FALSE,1769,NA,"TCGA-24-2024-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2024-01"
"TCGA-24-0979-01A-01R-1565-13","TCGA-24-0979-01A-01R-1565-13","TCGA-24-0979","TCGA-24-0979-01A","TP","Primary solid Tumor","TCGA-24-0979-01A","01","Primary","9b072344-31cf-471a-af4f-23ae73a98c93","Primary Tumor",NA,"released","Unknown",0.6,"3385E5B4-EBD4-4317-8805-EE6EA47A2E4A","TCGA-24-0979",0.5,"Unknown",0.8,FALSE,"Tumor","8441/3","187; 357; 187; 15; 338; 15; Intravenous; Intravenous; 6e1068a3-cbd6-4e5d-8275-7d4f3fdc7613; a25fada3-32e0-5ee1-99b3-944dedf07040; fb6fd474-6ac1-480d-8506-abbb96cfd429; TCGA-24-0979_treatment2; TCGA-24-0979_treatment; TCGA-24-0979_treatment3; Chemotherapy; Radiation, External Beam; Chemotherapy; 8; NA; 8; Paclitaxel; NA; Carboplatin; yes; yes; yes; 2025-01-06T21:43:20.368739-06:00; NA; 2025-01-06T21:43:20.368739-06:00; Adjuvant; NA; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; NA; 3500; NA; NA; 14; NA; NA; Recurrent Disease; NA; Distant Site; NA; cGy; NA","Ovary",19595,"Serous cystadenocarcinoma, NOS","primary",NA,"600bf167-5408-5802-8f4b-f20f53e15337","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2003,"Cytology","C56.9","G3",NA,"white","female","not reported","Dead",53,-19595,"267cae75-6ddd-5309-979e-1fa1196aa5e1",FALSE,1264,NA,"TCGA-24-0979-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-0979-01"
"TCGA-61-1740-01A-01R-1567-13","TCGA-61-1740-01A-01R-1567-13","TCGA-61-1740","TCGA-61-1740-01A","TP","Primary solid Tumor","TCGA-61-1740-01A","01","Primary","ac9c5b5e-8e14-4a76-a68d-78a8349c40f7","Primary Tumor",NA,"released","Unknown",0.4,"b87690ba-0cd2-458e-938f-553cd5ab6d84","TCGA-61-1740",0.3,"Unknown",0.6,FALSE,"Tumor","8441/3","74; NA; 1020; NA; 23; NA; cb2dc0c4-bd49-58f3-aa30-fc5f15c8fd08; e458f367-1154-49ad-9075-b5ab3b8393f7; TCGA-61-1740_treatment; TCGA-61-1740_treatment2; Hormone Therapy; Radiation Therapy, NOS; Tamoxifen; NA; yes; no; NA; 2025-01-06T21:35:19.822934-06:00; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; mg; NA","Ovary",26169,"Serous cystadenocarcinoma, NOS","primary",NA,"6bce9673-5223-59f5-b869-2366b5e46652","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2005,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",71,-26169,"e5fbcd98-33f9-575e-880d-cb5bb82420cb",FALSE,74,NA,"TCGA-61-1740-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1740-01"
"TCGA-24-1427-01A-01R-1565-13","TCGA-24-1427-01A-01R-1565-13","TCGA-24-1427","TCGA-24-1427-01A","TP","Primary solid Tumor","TCGA-24-1427-01A","01","Primary","93827307-1efa-43b5-aea5-380c6ce5feed","Primary Tumor","Not Reported","released","Unknown",1,"af63c4e2-2f77-4311-bfe2-ee45cfd200bb","TCGA-24-1427",0.7,"Unknown",1.7,FALSE,"Tumor","8441/3","147; 147; NA; 1996; 3848; NA; 14; 14; NA; Intravenous; Intravenous; 38d34d79-35b6-4cd5-8661-9c7d686a9b5f; 61d7052b-b5bb-5959-991d-9fab45e4ff79; 82cc6d34-c9cc-45df-9a04-7b6ce8fa5edf; TCGA-24-1427_treatment2; TCGA-24-1427_treatment; TCGA-24-1427_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; NA; Paclitaxel; Carboplatin; NA; yes; yes; no; 2025-01-06T20:13:35.839382-06:00; NA; 2025-01-06T20:13:35.839382-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; mg; NA","Ovary",21423,"Serous cystadenocarcinoma, NOS","primary",NA,"6adf251d-ef48-5413-8547-40f40921f744","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"not reported","female","not reported","Alive",58,-21423,"ec306cf2-62ba-5e6a-b350-fab228fd3b76",FALSE,NA,NA,"TCGA-24-1427-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1427-01"
"TCGA-13-0720-01A-01R-1564-13","TCGA-13-0720-01A-01R-1564-13","TCGA-13-0720","TCGA-13-0720-01A","TP","Primary solid Tumor","TCGA-13-0720-01A","01","Primary","5c315f82-d4ac-40fd-9cc2-c4bc61286f8e","Primary Tumor","Not Reported","released","Unknown",1.2,"0A196866-A083-40AC-90E3-5ECA3B141645","TCGA-13-0720",0.5,"Unknown",8,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0f5122e9-1454-4ed6-8f15-06a74b7d89fd; 52c3f16b-43d6-5f3b-b00b-54f81ff2d588; 9d88b2bb-bc92-412f-98de-989a4818e932; f8880274-08b2-41d8-86da-bf1d1b4a4ef3; TCGA-13-0720_treatment4; TCGA-13-0720_treatment; TCGA-13-0720_treatment3; TCGA-13-0720_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T20:59:46.396442-06:00; NA; 2025-01-06T20:59:46.396442-06:00; 2025-01-06T20:59:46.396442-06:00; NA; 180; 292; 180; NA; 7; 239; 7; Intravenous; Intravenous; Intravenous; NA; 8; 7; 8; NA; Carboplatin; Paclitaxel; Paclitaxel; NA; NA; 560; 175; NA; NA; mg/m2; mg/m2","Ovary",17799,"Serous cystadenocarcinoma, NOS","primary",NA,"2946e499-dcfb-57a8-8e37-07c35d2228f7","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2001,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",48,-17799,"4361c0b6-dffe-5928-aabe-49e87f1a9447",FALSE,1355,NA,"TCGA-13-0720-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0720-01"
"TCGA-13-1403-01A-01R-1565-13","TCGA-13-1403-01A-01R-1565-13","TCGA-13-1403","TCGA-13-1403-01A","TP","Primary solid Tumor","TCGA-13-1403-01A","01","Primary","62043d1b-2c38-4c45-abd0-97ff2f77176b","Primary Tumor","Not Reported","released","Unknown",0.9,"435619AB-01F5-4AC3-8D28-A8CC0054699F","TCGA-13-1403",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","142; 142; NA; 142; 60; 75; NA; 135; 27; 27; NA; 27; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; 0809387c-642c-42e0-81d7-d3679368a7ce; 71a4ee5b-ad87-5777-a700-f569bd948d39; c32d0c82-c4b7-4300-b1a8-578a75b821e3; f75c0b46-f64d-4ea1-a26b-42768cc90fb1; TCGA-13-1403_treatment3; TCGA-13-1403_treatment; TCGA-13-1403_treatment4; TCGA-13-1403_treatment2; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; 6; NA; 6; Paclitaxel; Cisplatin; NA; Paclitaxel; yes; yes; no; yes; 2025-01-06T21:24:10.784012-06:00; NA; 2025-01-06T21:24:10.784012-06:00; 2025-01-06T21:24:10.784012-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; mg/m2; NA; mg/m2","Ovary",17697,"Serous cystadenocarcinoma, NOS","primary",NA,"2bb5937a-3659-5c77-a650-35e461810f1f","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2008,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",48,-17697,"cd835f8d-6b5c-5b52-b9f3-6392a04c6f1e",FALSE,2345,NA,"TCGA-13-1403-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1403-01"
"TCGA-61-1733-01A-01R-1567-13","TCGA-61-1733-01A-01R-1567-13","TCGA-61-1733","TCGA-61-1733-01A","TP","Primary solid Tumor","TCGA-61-1733-01A","01","Primary","a047a512-409f-4293-9585-9933f1503f9d","Primary Tumor",NA,"released","Unknown",0.6,"bc4e6e92-d716-4ab3-8459-4f339caecffd","TCGA-61-1733",0.2,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 67fef56c-df5e-4080-ad7e-2ccaa439b467; 985fd474-a1d4-4b3f-bf43-fcd1827c059b; 99f9377c-c928-45cf-9f53-1fed7b60a0a7; TCGA-61-1733_treatment10; TCGA-61-1733_treatment12; TCGA-61-1733_treatment11; Pharmaceutical Therapy, NOS; Surgery, NOS; Radiation Therapy, NOS; released; released; released; yes; yes; no; 2025-01-06T21:38:34.927680-06:00; 2025-01-06T21:38:34.927680-06:00; 2025-01-06T21:38:34.927680-06:00; Progressive Disease; Progressive Disease; Progressive Disease; NA; 175; NA","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-61-1733_diagnosis","63c1e491-a690-4a13-a158-4cf3ab1ec63b","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Alive",71,-26180,"84a893c5-e066-5859-b953-0c02021e7041",FALSE,NA,NA,"TCGA-61-1733-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1733-01"
"TCGA-13-0797-01A-01R-1564-13","TCGA-13-0797-01A-01R-1564-13","TCGA-13-0797","TCGA-13-0797-01A","TP","Primary solid Tumor","TCGA-13-0797-01A","01","Primary","52f8884e-c99a-44ae-8d74-6b219070902e","Primary Tumor","Not Reported","released","Unknown",1.2,"84ED21CA-E018-44C5-86E4-57927ABBCC9A","TCGA-13-0797",0.3,"Unknown",1.6,FALSE,"Tumor","8441/3","146; NA; 146; 135; NA; 599; 42; NA; 42; Intravenous; Intravenous; 2987e269-6b99-4fa3-a726-e6c26f410e21; 8931d609-610b-4514-ad22-95ba578e55b7; a8e3feee-1dca-5f8c-845b-80182d750816; TCGA-13-0797_treatment2; TCGA-13-0797_treatment3; TCGA-13-0797_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; NA; 6; Paclitaxel; NA; Carboplatin; yes; no; yes; 2025-01-06T20:04:49.626816-06:00; 2025-01-06T20:04:49.626816-06:00; NA; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg/m2; NA; mg","Ovary",18051,"Serous cystadenocarcinoma, NOS","primary",NA,"1721bac4-b2e8-508d-8b99-aed22fef7600","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",49,-18051,"000181a9-73a5-5da4-9bf0-5e025cfce047",FALSE,NA,NA,"TCGA-13-0797-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0797-01"
"TCGA-25-1318-01A-01R-1565-13","TCGA-25-1318-01A-01R-1565-13","TCGA-25-1318","TCGA-25-1318-01A","TP","Primary solid Tumor","TCGA-25-1318-01A","01","Primary","ced18b90-cbcc-4593-9eaf-2d91daa9d756","Primary Tumor","Not Reported","released","Unknown",2,"D9B9F69A-265C-42F4-BCD2-4B136A7FE935","TCGA-25-1318",0.8,"Unknown",4.5,FALSE,"Tumor","8441/3","Adjuvant; NA; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 3f3fef64-d0bb-4765-88df-2441307961eb; a70c7b2b-68d3-4271-ba0f-4762131ed24a; a8dead29-cdfb-544f-a4fd-7ffb3c12f56b; b3e812a4-c2f2-4c65-a75b-47d3c14c4ad8; TCGA-25-1318_treatment4; TCGA-25-1318_treatment3; TCGA-25-1318_treatment; TCGA-25-1318_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T21:16:19.362479-06:00; 2025-01-06T21:16:19.362479-06:00; NA; 2025-01-06T21:16:19.362479-06:00; NA; 273; 122; 122; NA; 212; 30; 30; Intravenous; Intravenous; Intravenous; NA; 4; 6; 6; NA; Topotecan; Paclitaxel; Carboplatin; NA; Progressive Disease; NA; NA","Ovary",19755,"Serous cystadenocarcinoma, NOS","primary",NA,"2e841bcd-46c2-5c16-95cc-6d40414476b3","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2000,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",54,-19755,"f25e1764-8f69-5eb1-824e-789ac5a8ff24",FALSE,1064,NA,"TCGA-25-1318-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1318-01"
"TCGA-13-0887-01A-01R-1564-13","TCGA-13-0887-01A-01R-1564-13","TCGA-13-0887","TCGA-13-0887-01A","TP","Primary solid Tumor","TCGA-13-0887-01A","01","Primary","1713ce6c-f182-41df-a356-b073002ca1f7","Primary Tumor",NA,"released","Unknown",1.2,"AAEBFF3C-EA12-4D58-A424-2463307484A3","TCGA-13-0887",0.4,"Unknown",1.3,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 07d14647-9b4b-402e-895e-0a91bca8c431; 5f565541-3828-4a2f-b534-f4cbff7986be; a96bd863-5a58-5e3b-a71d-a2cf736e0240; e777ee76-35a2-4783-8351-03a428a1b35e; TCGA-13-0887_treatment4; TCGA-13-0887_treatment2; TCGA-13-0887_treatment; TCGA-13-0887_treatment3; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T20:43:19.954797-06:00; 2025-01-06T20:43:19.954797-06:00; NA; 2025-01-06T20:43:19.954797-06:00; NA; 268; 114; 114; NA; 184; 7; 7; Intraperitoneal; Intravenous; Intravenous; NA; 4; 6; 6; NA; Cisplatin; Carboplatin; Paclitaxel","Ovary",15669,"Serous cystadenocarcinoma, NOS","primary",NA,"5e9e3f81-ce0d-57fd-824c-1c7d28ccdbfe","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",42,-15669,"05ddf2a8-4ba3-5158-ad54-369b93b80bf4",FALSE,2028,"Ashkenazi Jew","TCGA-13-0887-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0887-01"
"TCGA-25-1630-01A-01R-1566-13","TCGA-25-1630-01A-01R-1566-13","TCGA-25-1630","TCGA-25-1630-01A","TP","Primary solid Tumor","TCGA-25-1630-01A","01","Primary","899b4fa3-95cb-4f8e-930c-bc29e20b5144","Primary Tumor",NA,"released","Unknown",1,"0BF406EC-B97B-4A05-9EBB-F40CF96233E9","TCGA-25-1630",0.4,"Unknown",1.4,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 6434071f-6e27-411d-bc75-bcb73e980431; 79b18290-a7b8-5b0c-9922-a85b4d5adcc6; acfcfa22-f818-4fc3-98f2-59d5a8b4b33d; TCGA-25-1630_treatment3; TCGA-25-1630_treatment; TCGA-25-1630_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T20:30:19.906162-06:00; NA; 2025-01-06T20:30:19.906162-06:00; NA; 33; 33; Intravenous; Intravenous; NA; 6; 6; NA; Paclitaxel; Carboplatin","Ovary",27006,"Serous cystadenocarcinoma, NOS","primary",NA,"3c66f500-b2a5-5482-af5d-a85b32db3b8f","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",73,-27006,"8731f7e7-074d-5810-ae94-e09b25cf790d",FALSE,1162,NA,"TCGA-25-1630-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1630-01"
"TCGA-10-0928-01A-02R-1564-13","TCGA-10-0928-01A-02R-1564-13","TCGA-10-0928","TCGA-10-0928-01A","TP","Primary solid Tumor","TCGA-10-0928-01A","01","Primary","4416312b-c64f-4fb2-9819-6ccf9b8ab219","Primary Tumor",NA,"released","Unknown",0.8,"859b2662-493a-4ead-9ac7-0aa8d0a7a3d8","TCGA-10-0928",0.4,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 8e5cb970-4c0d-59ae-bbb8-b542474096f1; c8d10e50-b189-4b47-a960-d6e85ba07625; TCGA-10-0928_treatment; TCGA-10-0928_treatment2; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; Not Reported; NA; released; released; NA; NA; yes; no; NA; 2025-01-06T21:26:50.088753-06:00","Ovary",26066,"Serous cystadenocarcinoma, NOS","primary",NA,"b513bda1-4ea9-5a15-be5c-afdf0225f33f","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2000,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",71,-26066,"86af060d-7656-5dea-bef2-06252f78bea5",FALSE,563,NA,"TCGA-10-0928-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-10-0928-01"
"TCGA-29-1695-01A-01R-1567-13","TCGA-29-1695-01A-01R-1567-13","TCGA-29-1695","TCGA-29-1695-01A","TP","Primary solid Tumor","TCGA-29-1695-01A","01","Primary","7a1db005-662a-4df4-886a-ec3319bde99a","Primary Tumor",NA,"released","Unknown",1,"136a4380-2a2a-489f-8675-886e876f17f7","TCGA-29-1695",0.4,"Unknown",1.1,FALSE,"Tumor","8441/3","Adjuvant; 2025-01-08T13:15:37.188206-06:00; 5e98915f-9215-5b0f-a8d2-af86dff4b291; TCGA-29-1695_treatment; Radiation Therapy, NOS; released; NA; no; NA","Ovary",22895,"Serous cystadenocarcinoma, NOS","primary",NA,"545dae36-7e9c-574c-81a8-71ad91172902","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2003,"Surgical Resection","C56.9","G2",NA,"white","female","not reported","Dead",62,-22895,"dce94daf-399a-5bdc-9190-563469a5a908",FALSE,1229,NA,"TCGA-29-1695-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1695-01"
"TCGA-24-1467-01A-01R-1566-13","TCGA-24-1467-01A-01R-1566-13","TCGA-24-1467","TCGA-24-1467-01A","TP","Primary solid Tumor","TCGA-24-1467-01A","01","Primary","b0b13b63-cf9d-4cb9-a3fa-217d499763f8","Primary Tumor","Not Reported","released","Unknown",1.2,"6949EFBE-C2EA-4767-B194-2343254F2752","TCGA-24-1467",0.7,"Unknown",1.3,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0b278c6d-2c93-4a92-94fc-ad1ca312deaa; ba463a42-e9bf-4379-bc26-6d9404f5fa1e; ca037d5d-8892-4cd7-bbb6-2a442f143f0e; TCGA-24-1467_treatment23; TCGA-24-1467_treatment24; TCGA-24-1467_treatment25; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; Surgery, NOS; released; released; released; yes; no; yes; 2025-01-06T20:57:10.963298-06:00; 2025-01-06T20:57:10.963298-06:00; 2025-01-06T20:57:10.963298-06:00; Progressive Disease; Progressive Disease; Progressive Disease; NA; NA; 1253","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-24-1467_diagnosis","5fefd09f-e6da-4962-b32c-38b35b442491","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",51,-18652,"6a7e579e-29e7-5428-ae75-1909d32d4438",FALSE,3224,NA,"TCGA-24-1467-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1467-01"
"TCGA-29-1778-01A-01R-1567-13","TCGA-29-1778-01A-01R-1567-13","TCGA-29-1778","TCGA-29-1778-01A","TP","Primary solid Tumor","TCGA-29-1778-01A","01","Primary","be6771b3-dc5e-46fb-998a-a66a6fd63c85","Primary Tumor",NA,"released","Unknown",1,"439a81dd-dc54-49e5-942c-4aa8d0be8701","TCGA-29-1778",0.5,"Unknown",1.1,FALSE,"Tumor","8441/3","80; 125; NA; 125; 80; 500; 410; NA; 110; 325; 17; 101; NA; 101; 17; Intravenous; Intravenous; Intravenous; Intravenous; 0cad2edd-2f81-4bbb-bb99-953f27c75ef5; 5f208d34-5ee4-4d51-8e5e-7bea411ca0d0; 8969e8ec-68aa-4c1f-a8e6-2002058a1999; dd84cb40-8d12-49e3-a665-5546ab870857; fb421159-b9d1-5a4c-8cbd-1e1b8de351f6; TCGA-29-1778_treatment3; TCGA-29-1778_treatment4; TCGA-29-1778_treatment5; TCGA-29-1778_treatment2; TCGA-29-1778_treatment; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 4; 2; NA; 2; 4; Carboplatin; Carboplatin; NA; Docetaxel; Paclitaxel; yes; yes; no; yes; yes; 2025-01-06T20:35:48.696954-06:00; 2025-01-06T20:35:48.696954-06:00; 2025-01-06T20:35:48.696954-06:00; 2025-01-06T20:35:48.696954-06:00; NA; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg; mg; NA; mg; mg","Ovary",28147,"Serous cystadenocarcinoma, NOS","primary",NA,"64f96092-ae3e-556c-9c0c-cbba2bdef290","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",77,-28147,"c85be1b6-1039-536e-988b-2c193dd334e2",FALSE,NA,NA,"TCGA-29-1778-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1778-01"
"TCGA-20-0991-01A-01R-1564-13","TCGA-20-0991-01A-01R-1564-13","TCGA-20-0991","TCGA-20-0991-01A","TP","Primary solid Tumor","TCGA-20-0991-01A","01","Primary","62af5b99-db7f-4c92-97f1-92e825c15729","Primary Tumor",NA,"released","Unknown",0.6,"8FB04F5F-B278-4E3C-A88B-9597F7B93F6E","TCGA-20-0991",0.4,"Unknown",0.8,FALSE,"Tumor","8441/3","425; NA; 71; NA; Intravenous; 0bac6761-7a5f-5ace-8dca-80cefb181dc5; e3b1ad43-dc0d-4647-b564-ef94d2f52512; TCGA-20-0991_treatment; TCGA-20-0991_treatment2; Chemotherapy; Radiation Therapy, NOS; 3; NA; Carboplatin; NA; yes; no; NA; 2025-01-06T20:26:48.192792-06:00; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; mg/m2; NA","Ovary",28694,"Serous cystadenocarcinoma, NOS","primary",NA,"b12547de-b3e3-59fe-a426-d67e9bb05533","Ovary","No",TRUE,0,"Stage IIB","Not Reported","Right","not reported",2006,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",78,-28694,"36753d6c-f821-5dbf-a8b3-662cb2430bed",FALSE,NA,NA,"TCGA-20-0991-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-20-0991-01"
"TCGA-13-1485-01A-02R-1565-13","TCGA-13-1485-01A-02R-1565-13","TCGA-13-1485","TCGA-13-1485-01A","TP","Primary solid Tumor","TCGA-13-1485-01A","01","Primary","558827de-87a0-4041-89b2-fe439ac820a2","Primary Tumor","Not Reported","released","Unknown",1.1,"5ABB28A5-1BF3-4E90-AD3B-3692893C8686","TCGA-13-1485",0.3,"Unknown",1.6,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 6ae01c7c-3498-4d04-9cce-726cf212fd13; 9f90dfdf-73f7-46ed-9a12-b0fda052c09b; TCGA-13-1485_treatment4; TCGA-13-1485_treatment5; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:23:25.269311-06:00; 2025-01-06T20:23:25.269311-06:00; Progressive Disease; Progressive Disease","Not Reported",17812,"Serous cystadenocarcinoma, NOS","Progression","TCGA-13-1485_diagnosis","b162e4e9-2127-49e0-8928-d4bdd875d883","Not Reported","Yes",FALSE,170,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",48,-17642,"4ad24e85-b885-58a1-a2c0-f1278fae3a4a",FALSE,629,NA,"TCGA-13-1485-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1485-01"
"TCGA-61-2016-01A-01R-1568-13","TCGA-61-2016-01A-01R-1568-13","TCGA-61-2016","TCGA-61-2016-01A","TP","Primary solid Tumor","TCGA-61-2016-01A","01","Primary","b15d7b36-c394-4ba4-a896-3e8beb2f8db0","Primary Tumor","Not Reported","released","Unknown",0.6,"1bb87fde-9ff0-4c33-a388-b655f9647407","TCGA-61-2016",0.1,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 70c37684-9f15-5798-9b71-4dcfe6f95f9c; e0ab3ec4-ba52-4e73-a25a-7cf964ef338f; TCGA-61-2016_treatment; TCGA-61-2016_treatment2; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; Progressive Disease; NA; released; released; NA; NA; yes; no; NA; 2025-01-06T21:38:18.815258-06:00","Ovary",18788,"Serous cystadenocarcinoma, NOS","primary",NA,"ff9cb7c9-66ac-5907-9329-78183e6e5040","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2006,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",51,-18788,"29e38624-fecd-5f04-b88e-09db2f1de386",FALSE,36,NA,"TCGA-61-2016-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2016-01"
"TCGA-24-1464-01A-01R-1566-13","TCGA-24-1464-01A-01R-1566-13","TCGA-24-1464","TCGA-24-1464-01A","TP","Primary solid Tumor","TCGA-24-1464-01A","01","Primary","cd43784d-8829-4cac-819f-d2960c5409cb","Primary Tumor","Not Reported","released","Unknown",1.2,"242047B0-E0E3-4BA3-A0DF-95887392602E","TCGA-24-1464",0.7,"Unknown",1.5,FALSE,"Tumor","8441/3","343; 163; NA; 163; 8; 1937; NA; 5555; 342; 28; 353; 28; Intravenous; Intravenous; Intravenous; 088cbc72-80b4-46da-b3b6-9440676b6861; 730c9e55-5213-4968-b058-f4af56e25db1; ab42f598-17c8-5847-ae16-a068190bd6f0; f8cea108-0048-4719-bacf-3d63febd19a5; TCGA-24-1464_treatment4; TCGA-24-1464_treatment2; TCGA-24-1464_treatment; TCGA-24-1464_treatment3; Chemotherapy; Chemotherapy; Radiation, External Beam; Chemotherapy; 1; 7; NA; 7; Topotecan; Paclitaxel; NA; Carboplatin; yes; yes; yes; yes; 2025-01-06T21:05:19.741494-06:00; 2025-01-06T21:05:19.741494-06:00; NA; 2025-01-06T21:05:19.741494-06:00; Recurrent Disease; NA; Recurrent Disease; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; mg; NA; mg; NA; Adjuvant; NA; Adjuvant; Primary Tumor Field","Ovary",25874,"Serous cystadenocarcinoma, NOS","primary",NA,"3092467a-bee4-5eb1-bd74-5efa87d5836e","Ovary","No",TRUE,0,"Stage IIIC","No","Left","no",1998,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",70,-25874,"12069954-6818-59be-9f0a-bea245e7b149",FALSE,379,NA,"TCGA-24-1464-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1464-01"
"TCGA-24-2281-01A-01R-1568-13","TCGA-24-2281-01A-01R-1568-13","TCGA-24-2281","TCGA-24-2281-01A","TP","Primary solid Tumor","TCGA-24-2281-01A","01","Primary","fcd83e7f-2210-465d-8362-3b5e2c368625","Primary Tumor","Not Reported","released","Unknown",0.9,"363dc00f-480d-4a3f-8950-80a6bc0b7dd8","TCGA-24-2281",0.2,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Intravenous; Intravenous; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1b582411-3b41-47a3-bd49-86596e895f74; 7f1743f0-eb08-56bc-88cc-14c67bb223f5; a5b5f1d7-c84c-4818-ad7b-6c2bcac46f7c; TCGA-24-2281_treatment2; TCGA-24-2281_treatment; TCGA-24-2281_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; NA; released; released; released; Paclitaxel; Carboplatin; NA; yes; yes; no; 2025-01-06T20:58:08.030135-06:00; NA; 2025-01-06T20:58:08.030135-06:00","Ovary",25019,"Serous cystadenocarcinoma, NOS","primary",NA,"c9b6188c-636e-5f19-9261-7b9a70e42044","Ovary","No",TRUE,0,"Stage IIA","Not Reported","Bilateral","not reported",2006,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",68,-25019,"31c47fb8-f9c9-5bd3-a2e0-1416b999df2b",FALSE,NA,NA,"TCGA-24-2281-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2281-01"
"TCGA-24-1434-01A-01R-1566-13","TCGA-24-1434-01A-01R-1566-13","TCGA-24-1434","TCGA-24-1434-01A","TP","Primary solid Tumor","TCGA-24-1434-01A","01","Primary","e6751f11-2f24-426c-a34f-c03cddc999cc","Primary Tumor","Not Reported","released","Unknown",1.5,"0a5fd2a4-560b-4769-ba4e-868854471961","TCGA-24-1434",0.6,"Unknown",1.5,FALSE,"Tumor","8441/3","371; 228; 228; 535; 314; 426; 228; NA; 160; 1890; 284; 756; 24; 4200; 16000; NA; 343; 45; 45; 496; 281; 395; 45; NA; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Oral; Intravenous; 0d0e3b8a-69b9-4db8-abe8-fd8fd118a0d9; 13a8470e-e4f4-417a-b653-8de9aefa8092; 4e4f41fc-5ade-4d91-9eeb-e7bea60a2ee5; 8c1f4723-4bcf-5383-a19d-9c115b44b9cd; b36476c4-9d80-461b-8fe4-8dafb55c6f97; bb80675e-b313-4c5c-a4df-3ff8a176f78c; db9fca23-8a89-4724-afbe-d833ee38fdf5; fb42c0c8-2823-4675-b205-9a59dbcf6fa5; TCGA-24-1434_treatment3; TCGA-24-1434_treatment2; TCGA-24-1434_treatment5; TCGA-24-1434_treatment; TCGA-24-1434_treatment6; TCGA-24-1434_treatment7; TCGA-24-1434_treatment4; TCGA-24-1434_treatment8; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 2; 8; 8; 2; 2; 2; 8; NA; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; Carboplatin; Paclitaxel; Topotecan; Etoposide; Gemcitabine Hydrochloride; NA; yes; yes; yes; yes; yes; yes; yes; no; 2025-01-06T21:33:17.432593-06:00; 2025-01-06T21:33:17.432593-06:00; 2025-01-06T21:33:17.432593-06:00; NA; 2025-01-06T21:33:17.432593-06:00; 2025-01-06T21:33:17.432593-06:00; 2025-01-06T21:33:17.432593-06:00; 2025-01-06T21:33:17.432593-06:00; Progressive Disease; NA; NA; Progressive Disease; Recurrent Disease; Progressive Disease; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; mg; mg; mg; mg; mg; mg; mg; NA; NA; Adjuvant; Adjuvant; NA; NA; NA; Adjuvant; Adjuvant","Ovary",21810,"Serous cystadenocarcinoma, NOS","primary",NA,"13f08258-6176-5a27-8f77-a01958a576b2","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1999,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",59,-21810,"c792a067-b1c0-5367-8655-db6c055fbd87",FALSE,568,NA,"TCGA-24-1434-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1434-01"
"TCGA-24-1555-01A-01R-1566-13","TCGA-24-1555-01A-01R-1566-13","TCGA-24-1555","TCGA-24-1555-01A","TP","Primary solid Tumor","TCGA-24-1555-01A","01","Primary","b359856a-959f-4b31-9e92-ef33c591c17a","Primary Tumor",NA,"released","Unknown",1,"b7b2f370-207a-4849-b7a0-528789363a02","TCGA-24-1555",0.4,"Solid Tissue",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2bbbfc29-2f2d-4216-9cf1-494ccb8323d5; ec0246d9-0792-4dbf-ad96-7f2199a15abb; TCGA-24-1555_treatment14; TCGA-24-1555_treatment13; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:27:08.533737-06:00; 2025-01-06T20:27:08.533737-06:00; Recurrent Disease; Recurrent Disease","Not Reported",19981,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1555_diagnosis","6abd2c15-7ecd-4384-9a78-51e401ec5db1","Not Reported","Yes",FALSE,1577,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",50,-18404,"c78d7d69-2916-5e30-85d8-5d59a1e088d4",FALSE,2692,NA,"TCGA-24-1555-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1555-01"
"TCGA-23-1113-01A-01R-1564-13","TCGA-23-1113-01A-01R-1564-13","TCGA-23-1113","TCGA-23-1113-01A","TP","Primary solid Tumor","TCGA-23-1113-01A","01","Primary","9552886e-881b-4bed-842c-596fcc8d87c3","Primary Tumor",NA,"released","Unknown",0.8,"a7fa848e-2492-4802-9cb2-58ec66fc3dd4","TCGA-23-1113",0.8,"Unknown",1,FALSE,"Tumor","8441/3","253; NA; 187; 187; 74; 873; 74; 816; NA; 528; 11282; 870; 910; 1650; 225; NA; 102; 102; 27; 253; 27; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 32f898c8-4620-435a-b7ff-97ec6d428a7c; 35a39fc8-8c5b-4d17-85e9-48723b75e55b; 363c63d0-9f36-44e3-8e72-c7e9161507be; 52839a35-4a29-4765-a394-d03fbd764e08; 69678175-b7f5-4f79-aa5a-254bb7760144; f57886e0-cdf6-41bc-aca9-b0874f64d401; f9bad516-36e1-5939-aae3-a947ec9eb0b2; TCGA-23-1113_treatment6; TCGA-23-1113_treatment7; TCGA-23-1113_treatment2; TCGA-23-1113_treatment5; TCGA-23-1113_treatment4; TCGA-23-1113_treatment3; TCGA-23-1113_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 12; NA; 4; 4; 3; 9; 3; Doxorubicin; NA; Cisplatin; Gemcitabine; Paclitaxel; Docetaxel; Carboplatin; yes; no; yes; yes; yes; yes; yes; 2025-01-06T21:24:55.253824-06:00; 2025-01-06T21:24:55.253824-06:00; 2025-01-06T21:24:55.253824-06:00; 2025-01-06T21:24:55.253824-06:00; 2025-01-06T21:24:55.253824-06:00; 2025-01-06T21:24:55.253824-06:00; NA; Progressive Disease; NA; NA; NA; NA; Progressive Disease; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; mg; NA; mg; mg; mg; mg; mg; NA; Adjuvant; Adjuvant; Adjuvant; Adjuvant; NA; Adjuvant","Ovary",17791,"Serous cystadenocarcinoma, NOS","primary",NA,"b23cc40b-3cda-5ccc-9089-804096c70d8b","Ovary","No",TRUE,0,"Stage IV","Not Reported","Left","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",48,-17791,"5a2431ef-c08f-54a7-8154-48b049a5370f",FALSE,949,NA,"TCGA-23-1113-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1113-01"
"TCGA-61-1998-01A-01R-1568-13","TCGA-61-1998-01A-01R-1568-13","TCGA-61-1998","TCGA-61-1998-01A","TP","Primary solid Tumor","TCGA-61-1998-01A","01","Primary","981e7677-6bde-4617-8c24-732d606b81e4","Primary Tumor","Not Reported","released","Unknown",0.5,"788d25c6-75c4-4c85-be93-98dec021219a","TCGA-61-1998",0.1,"Unknown",1,FALSE,"Tumor","8441/3","175; 6; NA; 188; 52; 52; NA; 10; Intravenous; Intravenous; Intravenous; 62001908-9063-4d71-9d13-79ca02ffce76; 911145e7-d12b-4215-824f-7cc4eec3c18d; dcb56e2e-758f-42b3-9f0c-6d34e4cbacb5; e3fafe10-5118-51b1-8db6-d84c45daec73; TCGA-61-1998_treatment3; TCGA-61-1998_treatment2; TCGA-61-1998_treatment4; TCGA-61-1998_treatment; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; 6; NA; 2; Paclitaxel; Carboplatin; NA; Cisplatin; yes; yes; no; yes; 2025-01-06T20:59:25.007484-06:00; 2025-01-06T20:59:25.007484-06:00; 2025-01-06T20:59:25.007484-06:00; NA; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; Treatment Ongoing; Treatment Ongoing; NA; NA; released; released; released; released; mg/m2; AUC; NA; mg; NA; NA; NA; 77","Ovary",17855,"Serous cystadenocarcinoma, NOS","primary",NA,"720e8667-af0a-5909-9705-68bab71ed9f5","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",48,-17855,"dcf3372c-5c88-5b4b-96fe-6f38ca251168",FALSE,NA,NA,"TCGA-61-1998-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1998-01"
"TCGA-24-1616-01A-01R-1566-13","TCGA-24-1616-01A-01R-1566-13","TCGA-24-1616","TCGA-24-1616-01A","TP","Primary solid Tumor","TCGA-24-1616-01A","01","Primary","20d8a43d-e1a7-4e85-8da2-2e9b5f1d3a9a","Primary Tumor",NA,"released","Unknown",0.7,"d8c764d9-0fe8-488e-8aa1-da73a8c10b01","TCGA-24-1616",0.4,"Solid Tissue",0.9,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 6bce0348-131c-4741-91d0-905eb5ca8720; 6c1aaf2a-e72c-4953-8b2c-84c1cd64354b; TCGA-24-1616_treatment11; TCGA-24-1616_treatment10; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:44:00.276514-06:00; 2025-01-06T20:44:00.276514-06:00; Recurrent Disease; Recurrent Disease","Not Reported",21190,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1616_diagnosis","13aea83e-f432-4e05-be35-60d24a3228a9","Not Reported","Yes",FALSE,405,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",56,-20785,"b5a2d23a-7e9e-5ce2-bf23-c98e8e04a0a6",FALSE,1163,NA,"TCGA-24-1616-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1616-01"
"TCGA-24-1552-01A-01R-1566-13","TCGA-24-1552-01A-01R-1566-13","TCGA-24-1552","TCGA-24-1552-01A","TP","Primary solid Tumor","TCGA-24-1552-01A","01","Primary","411b4c26-fcc4-438a-8731-d0cf5dd6c74f","Primary Tumor",NA,"released","Unknown",0.8,"FF7B6D0B-D13B-473E-A924-C63CB0B46511","TCGA-24-1552",0.8,"Solid Tissue",0.9,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 622ae3e2-fa6d-4034-8758-79fb89f621ad; 8099f11a-0bdf-4c18-8633-f594065d0364; TCGA-24-1552_treatment9; TCGA-24-1552_treatment10; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:05:24.544159-06:00; 2025-01-06T21:05:24.544159-06:00; Recurrent Disease; Recurrent Disease","Not Reported",28532,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1552_diagnosis","1e8560cd-2985-47f8-85ba-8e9dfba445ac","Not Reported","Yes",FALSE,403,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",77,-28129,"74a423cc-a9ec-5dd0-b5aa-5054a39621ef",FALSE,1259,NA,"TCGA-24-1552-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1552-01"
"TCGA-24-1548-01A-01R-1566-13","TCGA-24-1548-01A-01R-1566-13","TCGA-24-1548","TCGA-24-1548-01A","TP","Primary solid Tumor","TCGA-24-1548-01A","01","Primary","5d4e65aa-d7d0-43ec-b395-df2f01b1a203","Primary Tumor",NA,"released","Unknown",0.7,"d7b9bc71-e243-478f-a116-7e9371b87327","TCGA-24-1548",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","Adjuvant; NA; Adjuvant; NA; NA; NA; NA; NA; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 28750eb4-dddc-4994-9b08-6180fa9c787e; 403b5c7f-9192-4e1a-a3c1-3d20f097bb65; 43227535-0173-536d-954d-34a51afbada3; 60d6e3ae-23cc-4d79-ae90-19d9d311d5bf; 6d3db560-8702-40b9-826f-0e74c892312d; ac6b0094-3ff4-40f3-a266-ee041eadfc94; c6c03b97-e1bf-4445-963f-86cfab17b1e3; c8e5dc72-654f-4193-a720-b283edff1a36; d1109875-6874-4dfc-9a91-96352c62acd5; TCGA-24-1548_treatment9; TCGA-24-1548_treatment8; TCGA-24-1548_treatment; TCGA-24-1548_treatment7; TCGA-24-1548_treatment3; TCGA-24-1548_treatment4; TCGA-24-1548_treatment5; TCGA-24-1548_treatment2; TCGA-24-1548_treatment6; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T21:13:34.795203-06:00; 2025-01-06T21:13:34.795203-06:00; NA; 2025-01-06T21:13:34.795203-06:00; 2025-01-06T21:13:34.795203-06:00; 2025-01-06T21:13:34.795203-06:00; 2025-01-06T21:13:34.795203-06:00; 2025-01-06T21:13:34.795203-06:00; 2025-01-06T21:13:34.795203-06:00; NA; 488; 123; 242; 327; 242; 443; 443; 123; NA; 360; 4790; 250; 197; 10; NA; NA; 1750; NA; 475; 6; 221; 272; 221; 351; 351; 6; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; 3; 6; 2; 3; 2; NA; NA; 6; NA; Paclitaxel; Carboplatin; Cisplatin; Pegylated Liposomal Doxorubicin Hydrochloride; Topotecan; Gemcitabine; Vinorelbine Tartrate; Paclitaxel; NA; Progressive Disease; NA; Recurrent Disease; Progressive Disease; Recurrent Disease; Progressive Disease; Progressive Disease; NA; NA; mg; mg; mg; mg; mg; NA; NA; mg","Ovary",20945,"Serous cystadenocarcinoma, NOS","primary",NA,"8eaff24a-deb4-59b6-9bec-4fdf16ac70bf","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1997,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",57,-20945,"31a687e4-6949-5697-b241-1ff704021006",FALSE,493,NA,"TCGA-24-1548-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1548-01"
"TCGA-24-1930-01A-01R-1567-13","TCGA-24-1930-01A-01R-1567-13","TCGA-24-1930","TCGA-24-1930-01A","TP","Primary solid Tumor","TCGA-24-1930-01A","01","Primary","b9e08539-3921-490e-9f35-013f9704d516","Primary Tumor","Not Reported","released","Unknown",1,"746ac85a-ea6d-4d60-859f-69bf580a707c","TCGA-24-1930",0.6,"Unknown",1,FALSE,"Tumor","8441/3","274; 1083; 1475; 707; 2144; 2325; 1112; 2325; 1389; 274; 631; 1112; 1275; 1684; 2144; 274; 274; 2286; 95; 11435; 3750; 448; 23008; 450; 896; 218; 518; NA; 305; 3170; NA; 45; 4020; 1960; 14; 726; 1422; 684; 2052; 2164; 1112; 2164; 1331; 14; 547; 1112; 1135; 1492; 2052; 14; 14; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Oral; Intravenous; Intravenous; Intravenous; 047eebda-6513-4237-a7a2-f8a73d3d1941; 12cad609-75b0-40b4-8fe1-54ef2403e049; 1ff4bd51-5307-49e4-a256-e8d1af716974; 2262a9a9-e859-55d3-90bd-5074c52ee546; 51b8d087-6924-4272-a876-17977be5a577; 5a6a2113-df3a-4475-8dcf-67516caaba59; 66abb5e3-a94e-467a-8a2b-8463fa4ba9cd; aa9d2944-ee13-45b6-8312-57271561c014; c4fa067f-625e-47cc-9e25-b4a138145fcd; c6990d1d-f680-4ffe-83b7-4d5b1365fcc8; c8705249-ffde-4560-8e26-ef12d33efb67; d74be33b-dd21-48c9-bc7b-bbd6f720ca9b; dcb95037-b962-4a8e-9bb1-3f36ed1b8db5; e294c6a1-52e2-4cac-982c-4d74e3bdb60e; edd33c7f-ce6d-4608-ac0d-303f996ba61e; fe4f72c0-e2b6-4fc4-af3a-0b475a6035db; ff93a496-efcd-4185-a8b2-7f91e3832360; TCGA-24-1930_treatment15; TCGA-24-1930_treatment13; TCGA-24-1930_treatment4; TCGA-24-1930_treatment; TCGA-24-1930_treatment16; TCGA-24-1930_treatment14; TCGA-24-1930_treatment5; TCGA-24-1930_treatment10; TCGA-24-1930_treatment11; TCGA-24-1930_treatment8; TCGA-24-1930_treatment2; TCGA-24-1930_treatment9; TCGA-24-1930_treatment6; TCGA-24-1930_treatment17; TCGA-24-1930_treatment12; TCGA-24-1930_treatment7; TCGA-24-1930_treatment3; Chemotherapy; Chemotherapy; Chemotherapy; Radiation, External Beam; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 13; 12; 3; NA; 5; 8; 1; 8; 3; 13; 5; 1; 7; 7; 5; 13; 13; Paclitaxel; Topotecan; Gemcitabine; NA; Vinorelbine Tartrate; Gemcitabine Hydrochloride; Carboplatin; Cisplatin; Pegylated Liposomal Doxorubicin Hydrochloride; Cisplatin; Clinical Trial; Paclitaxel; Carboplatin; Altretamine; Topotecan; Carboplatin; Amifostine; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; NA; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; 2025-01-06T20:58:19.467294-06:00; Adjuvant; NA; NA; NA; NA; NA; NA; NA; NA; Adjuvant; NA; NA; NA; NA; NA; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; released; released; released; released; released; released; released; mg; mg; mg; cGy; mg; mg; mg; mg; mg; mg; NA; mg; mg; NA; mg; mg; mg; NA; Progressive Disease; Progressive Disease; Recurrent Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; NA; Recurrent Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; NA; NA; Distant Site","Ovary",19387,"Serous cystadenocarcinoma, NOS","primary",NA,"2cd199cc-198a-518f-b3da-a3f3640b2ba7","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1998,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",53,-19387,"54ce0094-e7b7-5ac4-b909-215939d4d01e",FALSE,2467,NA,"TCGA-24-1930-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1930-01"
"TCGA-24-1846-01A-01R-1567-13","TCGA-24-1846-01A-01R-1567-13","TCGA-24-1846","TCGA-24-1846-01A","TP","Primary solid Tumor","TCGA-24-1846-01A","01","Primary","046c032f-69e8-4815-b7ab-28858392d6b0","Primary Tumor",NA,"released","Unknown",0.7,"fb12e5b3-1529-4873-90fd-7ba0a78dd9f4","TCGA-24-1846",0.6,"Unknown",1.1,FALSE,"Tumor","8441/3","175; NA; 175; 1173; NA; 3800; 43; NA; 43; Intravenous; Intravenous; 0e907242-92a0-4153-ae95-35984d0ea412; 52341a90-92d3-4fb3-a4ba-f39dbce25a49; d13984a8-7135-5021-a2f0-7bc08c643fbe; TCGA-24-1846_treatment2; TCGA-24-1846_treatment3; TCGA-24-1846_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 5; NA; 5; Paclitaxel; NA; Carboplatin; yes; no; yes; 2025-01-06T21:08:15.187228-06:00; 2025-01-06T21:08:15.187228-06:00; NA; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; NA; mg","Ovary",16534,"Serous cystadenocarcinoma, NOS","primary",NA,"cc622c11-e77b-5fd6-b673-baeb226d3ce6","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2009,"Surgical Resection","C56.9","G3",NA,"not reported","female","not reported","Alive",45,-16534,"c265a8c5-231d-5f56-bea9-1444d77aeceb",FALSE,NA,NA,"TCGA-24-1846-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1846-01"
"TCGA-24-1604-01A-01R-1566-13","TCGA-24-1604-01A-01R-1566-13","TCGA-24-1604","TCGA-24-1604-01A","TP","Primary solid Tumor","TCGA-24-1604-01A","01","Primary","b3909bea-c426-4dad-94a9-15577e9f0c09","Primary Tumor",NA,"released","Unknown",1.3,"de978a3d-92f9-4bd8-98f4-f8a3ec09b362","TCGA-24-1604",0.6,"Solid Tissue",1.4,FALSE,"Tumor","8441/3","Adjuvant; NA; NA; Adjuvant; NA; Intravenous; Intravenous; Intravenous; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 19bd2972-6bee-46f5-a7b5-98745db2e70a; 2ea30412-aa92-4501-bad6-4ab289609af3; 7678f010-6e8d-582c-8bf7-40cdc871a1f8; e6801996-f389-4d5d-9c6e-5537b1324d06; ff4cb4dd-55e9-4a2e-92bf-62ea15e2d006; TCGA-24-1604_treatment4; TCGA-24-1604_treatment3; TCGA-24-1604_treatment; TCGA-24-1604_treatment2; TCGA-24-1604_treatment5; Chemotherapy; Chemotherapy; Radiation, External Beam; Chemotherapy; Chemotherapy; released; released; released; released; released; Carboplatin; NA; NA; Paclitaxel; Pegylated Liposomal Doxorubicin Hydrochloride; yes; yes; yes; yes; yes; 2025-01-06T21:33:35.679543-06:00; 2025-01-06T21:33:35.679543-06:00; NA; 2025-01-06T21:33:35.679543-06:00; 2025-01-06T21:33:35.679543-06:00; NA; Recurrent Disease; Recurrent Disease; NA; Recurrent Disease; Distant Site","Ovary",24471,"Serous cystadenocarcinoma, NOS","primary",NA,"d92abbe4-d3f0-57cb-84bb-a07a6746bd3f","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1996,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",66,-24471,"88b4acdd-e3e8-5e2a-9820-0fd2ed174d45",FALSE,2688,NA,"TCGA-24-1604-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1604-01"
"TCGA-25-1321-01A-01R-1565-13","TCGA-25-1321-01A-01R-1565-13","TCGA-25-1321","TCGA-25-1321-01A","TP","Primary solid Tumor","TCGA-25-1321-01A","01","Primary","57f7a91d-c569-433f-ae21-8a22e5d187bf","Primary Tumor","Not Reported","released","Unknown",1.6,"5D309784-AED1-4946-817D-37AC8969315C","TCGA-25-1321",0.8,"Unknown",3,FALSE,"Tumor","8441/3","181; 181; 498; 181; NA; 28; 28; 454; 28; NA; Intravenous; Intravenous; Intravenous; 0210d1cd-b459-5acf-95bd-bd0e38b825be; 48dbd078-85b5-4c38-8e87-e2d79721a694; 7604a6ef-1ef0-4804-bd19-401a9501276f; b342ccc0-64a0-45e3-922d-8b72ec012c0f; e8f1e952-9bdf-4af7-9bae-e9811eded30f; TCGA-25-1321_treatment; TCGA-25-1321_treatment4; TCGA-25-1321_treatment2; TCGA-25-1321_treatment3; TCGA-25-1321_treatment5; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 8; 8; 2; 8; NA; Gemcitabine Hydrochloride; Paclitaxel; Topotecan; Carboplatin; NA; yes; yes; yes; yes; no; NA; 2025-01-06T20:14:12.855808-06:00; 2025-01-06T20:14:12.855808-06:00; 2025-01-06T20:14:12.855808-06:00; 2025-01-06T20:14:12.855808-06:00; Adjuvant; Adjuvant; NA; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; NA; NA; Recurrent Disease; NA; NA","Ovary",23987,"Serous cystadenocarcinoma, NOS","primary",NA,"75f56478-bab2-51ee-821d-9db5567f6b98","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2001,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",65,-23987,"90f4c061-f159-5a33-9711-19ed94507147",FALSE,1033,NA,"TCGA-25-1321-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1321-01"
"TCGA-59-2352-01A-01R-1569-13","TCGA-59-2352-01A-01R-1569-13","TCGA-59-2352","TCGA-59-2352-01A","TP","Primary solid Tumor","TCGA-59-2352-01A","01","Primary","2892b681-6001-4124-ae86-3363be75463b","Primary Tumor","Not Reported","released","Unknown",1.2,"15f65643-b84c-4239-bc14-0ddacdfe0425","TCGA-59-2352",0.4,"Unknown",2,FALSE,"Tumor","8441/3","","Ovary",NA,"Serous cystadenocarcinoma, NOS","primary",NA,"ea0ad7ed-ad39-564d-80bc-d7365bdeeff0","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2002,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",78,NA,"ea4eb7f5-e69a-5300-8b57-2b53ea2b245f",FALSE,286,NA,"TCGA-59-2352-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-59-2352-01"
"TCGA-10-0938-01A-02R-1564-13","TCGA-10-0938-01A-02R-1564-13","TCGA-10-0938","TCGA-10-0938-01A","TP","Primary solid Tumor","TCGA-10-0938-01A","01","Primary","c11664e8-8883-4a0f-87c3-6fdc903860d5","Primary Tumor",NA,"released","Unknown",0.6,"faa8920a-3b4a-4767-bdb1-5d086e51fe92","TCGA-10-0938",0.6,"Unknown",1,FALSE,"Tumor","8441/3","362; 2025-01-08T13:15:37.188206-06:00; b33c1221-87f7-48d9-9f28-e0acf23f1dab; TCGA-10-0938_treatment6; Surgery, NOS; released; yes; 2025-01-06T20:55:11.123846-06:00; Progressive Disease","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-10-0938_diagnosis","0484e57b-65bb-41b1-ae50-fae60efec2b2","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",80,-29558,"6b9e14b1-a534-5fd8-9147-5a6e1b068be7",FALSE,636,NA,"TCGA-10-0938-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-10-0938-01"
"TCGA-04-1331-01A-01R-1569-13","TCGA-04-1331-01A-01R-1569-13","TCGA-04-1331","TCGA-04-1331-01A","TP","Primary solid Tumor","TCGA-04-1331-01A","01","Primary","a1ec9279-c1a6-4e58-97ed-9ec1f36187c5","Primary Tumor",NA,"released","Unknown",0.4,"2CF541C5-B56A-4946-A5C4-DBB4D71D7908","TCGA-04-1331",0.4,"Unknown",0.5,FALSE,"Tumor","8441/3","169; NA; 169; 498; 455; NA; 1650; 4; 36; NA; 36; 481; Intravenous; Intravenous; 605bf3f2-5b65-4de8-bdd2-613d7bf919ec; 6bda952f-8c70-4f44-9d25-89fff9523805; ccb64579-fa43-532e-9f4f-97223d2e70ff; e7f109b0-3fea-4980-9373-3ca05967daec; TCGA-04-1331_treatment3; TCGA-04-1331_treatment4; TCGA-04-1331_treatment; TCGA-04-1331_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Targeted Molecular Therapy; 6; NA; 6; NA; Carboplatin; NA; Paclitaxel; Bortezomib; yes; no; yes; yes; 2025-01-06T20:20:28.047357-06:00; 2025-01-06T20:20:28.047357-06:00; NA; 2025-01-06T20:20:28.047357-06:00; Adjuvant; Adjuvant; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; NA; mg; mg; NA; NA; NA; Recurrent Disease","Ovary",28848,"Serous cystadenocarcinoma, NOS","primary",NA,"a5055ee4-957a-58aa-9f8d-4ee8c627de20","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",78,-28848,"484bfbce-553b-5967-b6b1-2db46d395d5d",FALSE,1336,NA,"TCGA-04-1331-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1331-01"
"TCGA-13-0804-01A-01R-1564-13","TCGA-13-0804-01A-01R-1564-13","TCGA-13-0804","TCGA-13-0804-01A","TP","Primary solid Tumor","TCGA-13-0804-01A","01","Primary","7432f954-a16f-4053-bedd-aa776f939f71","Primary Tumor","Not Reported","released","Unknown",1.3,"34870541-DEE9-4B39-A292-117E443B1CBF","TCGA-13-0804",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; deec39ca-0e24-47b9-8101-142d5f7955e0; ebcc39e8-f757-42ca-b49c-0a9354db5558; TCGA-13-0804_treatment6; TCGA-13-0804_treatment5; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:27:19.991294-06:00; 2025-01-06T21:27:19.991294-06:00; Recurrent Disease; Recurrent Disease","Not Reported",27350,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-13-0804_diagnosis","e8754a9c-733b-40f4-a5e7-26e59825d876","Not Reported","Yes",FALSE,329,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",73,-27021,"8b22ed63-d399-5745-b49d-e471cc2b44b8",FALSE,1073,NA,"TCGA-13-0804-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0804-01"
"TCGA-09-1662-01A-01R-1566-13","TCGA-09-1662-01A-01R-1566-13","TCGA-09-1662","TCGA-09-1662-01A","TP","Primary solid Tumor","TCGA-09-1662-01A","01","Primary","510f8684-3686-4192-b2a3-dd2499365f78","Primary Tumor",NA,"released","Unknown",0.7,"8e2676a4-2ac3-42af-be7d-cf74b6d82f2f","TCGA-09-1662",0.5,"Unknown",1.5,FALSE,"Tumor","8441/3","1081; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 59871f55-feb1-445e-83d2-ad238863078e; af1c79bb-9e9b-497d-bda9-785e82476a4a; c5b86b57-46c2-41ec-8cb3-bb9c7d2217f8; TCGA-09-1662_treatment29; TCGA-09-1662_treatment27; TCGA-09-1662_treatment28; Surgery, NOS; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; released; yes; yes; no; 2025-01-06T21:23:00.849111-06:00; 2025-01-06T21:23:00.849111-06:00; 2025-01-06T21:23:00.849111-06:00; Progressive Disease; Progressive Disease; Progressive Disease","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-09-1662_diagnosis","25388e78-4b52-4fe3-8399-ffc15b9a9ceb","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",58,-21246,"b1157df0-4b67-57c6-a41d-2425cbc0a707",FALSE,2717,NA,"TCGA-09-1662-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-1662-01"
"TCGA-24-1428-01A-01R-1564-13","TCGA-24-1428-01A-01R-1564-13","TCGA-24-1428","TCGA-24-1428-01A","TP","Primary solid Tumor","TCGA-24-1428-01A","01","Primary","b0dfa5b0-79fc-4f28-bca7-d47f54c05775","Primary Tumor","Not Reported","released","Unknown",1.2,"9fcdd584-25e6-4a5a-ae15-f2956de32822","TCGA-24-1428",0.5,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 5a4e96a5-73a5-4a8c-bf4a-fd231bd34e49; 9604a3fb-6338-4596-a936-9e273190cfd5; TCGA-24-1428_treatment6; TCGA-24-1428_treatment7; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:44:21.580958-06:00; 2025-01-06T20:44:21.580958-06:00; Recurrent Disease; Recurrent Disease","Not Reported",18754,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1428_diagnosis","8d9d0acb-49e2-4246-b893-8f0f68b65e42","Not Reported","Yes",FALSE,448,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Alive",50,-18306,"cc02ff8d-6eff-5479-acd0-8b3230bcfafa",FALSE,NA,NA,"TCGA-24-1428-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1428-01"
"TCGA-61-2110-01A-01R-1568-13","TCGA-61-2110-01A-01R-1568-13","TCGA-61-2110","TCGA-61-2110-01A","TP","Primary solid Tumor","TCGA-61-2110-01A","01","Primary","6ae6b10a-fc2b-4c6e-a30e-0299c22ac042","Primary Tumor","Not Reported","released","Unknown",0.4,"d7a597dc-d607-4e20-90a9-a181d6c11d17","TCGA-61-2110",0.1,"Unknown",0.4,FALSE,"Tumor","8441/3","1354; 1239; 930; NA; 1089; 161; 161; 356; 770; 10; 12640; 3900; 600; 315; 2970; 1620; NA; 28; 459; 1089; 774; 1263; 979; 20; 20; 244; 661; Oral; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intraperitoneal; Intravenous; 0460dc35-1b84-43db-a153-535a25b1c396; 061c1c33-8156-4b61-b3f5-a53bba4bcddc; 3d8f4d7d-d041-404a-90d8-584913dc75c3; 40938b97-fc11-528c-8a13-07959e393c9c; 7f9aa3a3-16d8-4c88-9fc0-ce039d934fc9; 97dce764-9904-4d7b-97fb-c879f8e0b90e; a4816b18-2c87-4f70-9ab1-237148862c98; c5760c5e-850e-41f9-9a95-df45bab256e2; c74541b4-3e28-4a22-a505-46a3b339a937; TCGA-61-2110_treatment6; TCGA-61-2110_treatment5; TCGA-61-2110_treatment7; TCGA-61-2110_treatment; TCGA-61-2110_treatment8; TCGA-61-2110_treatment3; TCGA-61-2110_treatment4; TCGA-61-2110_treatment9; TCGA-61-2110_treatment2; Hormone Therapy; Chemotherapy; Chemotherapy; Radiation, External Beam; Chemotherapy; Chemotherapy; Chemotherapy; Immunotherapy (Including Vaccines); Chemotherapy; Tamoxifen; Gemcitabine Hydrochloride; Carboplatin; NA; Pegylated Liposomal Doxorubicin Hydrochloride; Carboplatin; Paclitaxel; Recombinant Interleukin-2; Topotecan; yes; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T20:08:57.268792-06:00; 2025-01-06T20:08:57.268792-06:00; 2025-01-06T20:08:57.268792-06:00; NA; 2025-01-06T20:08:57.268792-06:00; 2025-01-06T20:08:57.268792-06:00; 2025-01-06T20:08:57.268792-06:00; 2025-01-06T20:08:57.268792-06:00; 2025-01-06T20:08:57.268792-06:00; Progressive Disease; Recurrent Disease; Recurrent Disease; Recurrent Disease; Recurrent Disease; NA; NA; Progressive Disease; Recurrent Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; mg; mg; mg; cGy; mg; mg; mg; NA; mg; NA; 5; 6; NA; 5; 6; 6; NA; 5; NA; NA; NA; 2; NA; NA; NA; NA; NA; Locoregional Site; NA; NA; NA; NA; NA; Adjuvant; Adjuvant; NA; NA","Ovary",20718,"Serous cystadenocarcinoma, NOS","primary",NA,"1e51ebe2-c57d-5a2a-8421-1f6cbdf4003b","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1998,"Surgical Resection","C56.9",NA,NA,"white","female","not hispanic or latino","Dead",56,-20718,"f60176dd-6543-512c-8308-244afc979cf1",FALSE,1354,NA,"TCGA-61-2110-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2110-01"
"TCGA-29-1696-01A-01R-1567-13","TCGA-29-1696-01A-01R-1567-13","TCGA-29-1696","TCGA-29-1696-01A","TP","Primary solid Tumor","TCGA-29-1696-01A","01","Primary","75d36397-75e8-4925-bf1e-6f73bd9293ba","Primary Tumor",NA,"released","Unknown",0.8,"5e817943-3108-4838-bf8c-85c4507eb873","TCGA-29-1696",0.3,"Unknown",0.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; b9570236-582d-4d42-8cd5-47d5c9117e2c; bafcfc13-228b-4e5a-bf7f-b824665c1d3e; TCGA-29-1696_treatment10; TCGA-29-1696_treatment11; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:46:20.756698-06:00; 2025-01-06T20:46:20.756698-06:00; Recurrent Disease; Recurrent Disease","Not Reported",16160,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-29-1696_diagnosis","10c051ad-bab9-4c85-9865-8a7b74b60f7d","Not Reported","Yes",FALSE,342,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",43,-15818,"c51e54e0-2edf-5cdc-8ca8-6d6d57b1a6fc",FALSE,1032,NA,"TCGA-29-1696-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1696-01"
"TCGA-10-0937-01A-02R-1564-13","TCGA-10-0937-01A-02R-1564-13","TCGA-10-0937","TCGA-10-0937-01A","TP","Primary solid Tumor","TCGA-10-0937-01A","01","Primary","8585d596-4d6b-4f6c-bb46-a2661f9ca05a","Primary Tumor",NA,"released","Unknown",0.4,"2a86dcb5-1af7-447d-b20f-eef4972048a0","TCGA-10-0937",0.4,"Unknown",0.6,FALSE,"Tumor","8441/3","146; 146; NA; 296; 451; NA; 1980; 3990; 21; 140; 4176; NA; 33; 33; 346; 244; NA; NA; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 08f4f458-fb4d-4cc7-9ef3-972d8477d64b; 237d5a37-b0e1-50be-a0bc-5e78e355e012; 3a8f222f-66a0-4098-81af-bb66d5cf41df; 79325dbf-42ac-4935-b9f6-3a106ecce47c; 800072eb-0169-47d8-b08f-3dddbb9ca38c; 88ef0764-8762-49e6-9c10-08c5cf1448ef; TCGA-10-0937_treatment3; TCGA-10-0937_treatment; TCGA-10-0937_treatment4; TCGA-10-0937_treatment5; TCGA-10-0937_treatment2; TCGA-10-0937_treatment6; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; 1; 6; 3; NA; Paclitaxel; Carboplatin; Topotecan; Pegylated Liposomal Doxorubicin Hydrochloride; Gemcitabine; NA; yes; yes; yes; yes; yes; no; 2025-01-06T21:39:38.001734-06:00; NA; 2025-01-06T21:39:38.001734-06:00; 2025-01-06T21:39:38.001734-06:00; 2025-01-06T21:39:38.001734-06:00; 2025-01-06T21:39:38.001734-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; mg/m2; mg/m2; mg/m2; mg/m2; mg/m2; NA","Ovary",16222,"Serous cystadenocarcinoma, NOS","primary",NA,"4a6e1e14-2751-5cb3-b3b1-b559944ace34","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2005,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",44,-16222,"ec4793f1-4af3-5052-bc55-d865c8d8a000",FALSE,608,NA,"TCGA-10-0937-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-10-0937-01"
"TCGA-5X-AA5U-01A-11R-A406-31","TCGA-5X-AA5U-01A-11R-A406-31","TCGA-5X-AA5U","TCGA-5X-AA5U-01A","TP","Primary solid Tumor","TCGA-5X-AA5U-01A","01","Primary","e2d8b59b-b044-4aad-9e1b-f88c3208df3a","Primary Tumor",NA,"released","OCT",NA,"28F20F49-20C6-4B93-957D-8DAEF04657AE","TCGA-5X-AA5U",NA,"Unknown",NA,FALSE,"Tumor","8460/3","Adjuvant; NA; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 146393dd-59e3-405c-bc0a-54fc24c4deeb; 2fec166a-281f-55ed-97e9-c3513e22fb44; 83850744-4f0c-42a9-a897-27fc30f54c5b; cc1856bd-72ea-4852-8546-d7a8b91583f2; TCGA-5X-AA5U_treatment4; TCGA-5X-AA5U_treatment; TCGA-5X-AA5U_treatment2; TCGA-5X-AA5U_treatment3; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T21:02:43.290637-06:00; NA; 2025-01-06T21:02:43.290637-06:00; 2025-01-06T21:02:43.290637-06:00; NA; 178; 178; 178; NA; No; No; No; NA; 66; 63; 63; NA; Docetaxel; Cisplatin; Carboplatin; NA; Complete Response; Complete Response; Complete Response","Ovary",22438,"Papillary serous cystadenocarcinoma","primary",NA,"14b248c8-51a1-5f37-9c1f-5b310254bd02","Ovary","No",TRUE,0,"Stage IIC","Yes","Right","no",2013,"Surgical Resection","C56.9","GX","R0","black or african american","female","not reported","Alive",61,-22438,"168d1029-2d5f-5f1c-8258-18c881e52862",FALSE,NA,NA,"TCGA-5X-AA5U-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,11,230,"true",NA,NA,NA,NA,"United States",NA,NA,"TCGA-5X-AA5U-01"
"TCGA-09-2056-01B-01R-1568-13","TCGA-09-2056-01B-01R-1568-13","TCGA-09-2056","TCGA-09-2056-01B","TP","Primary solid Tumor","TCGA-09-2056-01B","01","Primary","c6045243-4072-4342-8fb1-f2bbea55fe7b","Primary Tumor","Not Reported","released","Unknown",0.7,"67bdb457-cfb8-4052-bd33-bff86c736910","TCGA-09-2056",0.4,"Unknown",1.6,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 27b20fb0-2d59-4b6f-9090-999dd23150d8; 58e398e1-041f-5ea9-b2bc-71395883c72d; 5b53e0df-2de7-48f1-83bc-8d30304dd3ad; TCGA-09-2056_treatment3; TCGA-09-2056_treatment; TCGA-09-2056_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:10:01.034160-06:00; NA; 2025-01-06T21:10:01.034160-06:00; NA; 147; 147; NA; 25; 25; Intravenous; Intravenous; NA; 6; 6; NA; Paclitaxel; Carboplatin","Ovary",22864,"Serous cystadenocarcinoma, NOS","primary",NA,"70e65ccc-6f17-52fe-a1e7-1f828967cdaf","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","hispanic or latino","Alive",62,-22864,"639a1216-bb98-5a39-8290-2bc82db55e29",FALSE,NA,NA,"TCGA-09-2056-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-2056-01"
"TCGA-23-1023-01A-02R-1564-13","TCGA-23-1023-01A-02R-1564-13","TCGA-23-1023","TCGA-23-1023-01A","TP","Primary solid Tumor","TCGA-23-1023-01A","01","Primary","a6fdfc35-a178-4d5a-8e07-346b55dd936d","Primary Tumor",NA,"released","Unknown",0.6,"98EBC356-C54E-4C1E-9726-BA61397DDA38","TCGA-23-1023",0.4,"Unknown",0.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 8f52fe8b-401b-444e-a5d9-6a48d380faa8; bf246123-0716-4de3-8225-66ca6ac21a83; cd577fe3-9a4f-44b9-9a7c-b5a412e69f4c; TCGA-23-1023_treatment18; TCGA-23-1023_treatment19; TCGA-23-1023_treatment20; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; Surgery, NOS; released; released; released; yes; no; yes; 2025-01-06T21:12:25.530396-06:00; 2025-01-06T21:12:25.530396-06:00; 2025-01-06T21:12:25.530396-06:00; Unknown; Unknown; Unknown; NA; NA; 1209","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-23-1023_diagnosis","70c1f438-89c0-4ce7-a69e-1c03d515f76a","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",65,-23826,"5401c2e3-25c5-547a-a9df-fce704e3b3f4",FALSE,NA,NA,"TCGA-23-1023-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1023-01"
"TCGA-13-0913-02A-01R-1564-13","TCGA-13-0913-02A-01R-1564-13","TCGA-13-0913","TCGA-13-0913-02A","TR","Recurrent Solid Tumor","TCGA-13-0913-02A","02","Recurrence","bbe91b44-cb43-4763-8783-169c458c5c3c","Recurrent Tumor",NA,"released","Unknown",1,"61FBF10C-A508-4D83-971D-5A48BA81F08A","TCGA-13-0913",0.3,"Unknown",1.4,FALSE,"Tumor","Unknown","","Not Reported",20444,"Unknown","Unknown","TCGA-13-0913_diagnosis","2614be00-e0af-4ade-8eea-b9f54a1490d8","Not Reported","Yes",FALSE,871,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",53,-19573,"7566af4a-1027-5501-b6dd-0c2b437a7790",FALSE,NA,NA,"TCGA-13-0913-02A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0913-02"
"TCGA-29-1707-02A-01R-1567-13","TCGA-29-1707-02A-01R-1567-13","TCGA-29-1707","TCGA-29-1707-02A","TR","Recurrent Solid Tumor","TCGA-29-1707-02A","02","Recurrence","f2a14f3d-6181-48d6-8f44-48b36ab1f246","Recurrent Tumor",NA,"released","Unknown",0.6,"264DFD3E-7413-4DEA-A115-14887718139D","TCGA-29-1707",0.5,"Unknown",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; bb8fb14b-9ce5-4850-902d-fa8725b41fb6; eb151d49-880d-4578-adf4-431c00ddad19; TCGA-29-1707_treatment7; TCGA-29-1707_treatment6; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:33:18.844492-06:00; 2025-01-06T20:33:18.844492-06:00; Recurrent Disease; Recurrent Disease","Not Reported",16218,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-29-1707_diagnosis","22aa2e60-6af6-41ef-9b2d-7590ce932c9a","Not Reported","Yes",FALSE,1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Alive",41,-15017,"fe01d20e-05e0-5be5-89e4-ddd1074b6831",FALSE,NA,NA,"TCGA-29-1707-02A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1707-02"
"TCGA-29-1770-01A-01R-1567-13","TCGA-29-1770-01A-01R-1567-13","TCGA-29-1770","TCGA-29-1770-01A","TP","Primary solid Tumor","TCGA-29-1770-01A","01","Primary","e14eecdb-9843-4549-917b-ee1e3d77025d","Primary Tumor",NA,"released","Unknown",0.6,"05816aac-55d2-4604-9300-e268f73338fe","TCGA-29-1770",0.5,"Unknown",1.2,FALSE,"Tumor","8441/3","546; 68; 546; NA; 136; 762; 762; 68; 136; 1370; 630; 650; NA; 100; NA; NA; 300; 690; 384; 19; 384; NA; 87; 741; 741; 19; 87; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 443b5df5-23e8-4a13-9de9-278eb64b37dc; 6cfc5a11-51df-4ddd-88bc-9632e13ce305; 908b1b35-18d5-4630-96e8-309fc9d1b285; a5231e45-8b6c-41c2-8228-5baa5e0d666f; bafb4da9-41ca-51be-92f7-f757fdb708d4; e9df8ae6-2b65-47a5-8db6-51fe58ecaf17; f20b6495-e469-49db-82c2-cc0718135776; f65e27f0-1b37-4c30-b82e-82cbcdb4488e; fe359b27-3817-4434-9e27-8c5b669746bd; TCGA-29-1770_treatment6; TCGA-29-1770_treatment8; TCGA-29-1770_treatment4; TCGA-29-1770_treatment9; TCGA-29-1770_treatment; TCGA-29-1770_treatment2; TCGA-29-1770_treatment7; TCGA-29-1770_treatment5; TCGA-29-1770_treatment3; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Targeted Molecular Therapy; Chemotherapy; Chemotherapy; 6; 3; 6; NA; 3; 2; NA; 3; 3; Gemcitabine; Carboplatin; Carboplatin; NA; Docetaxel; Docetaxel; Bevacizumab; Paclitaxel; Carboplatin; yes; yes; yes; no; yes; yes; yes; yes; yes; 2025-01-06T20:29:12.763683-06:00; 2025-01-06T20:29:12.763683-06:00; 2025-01-06T20:29:12.763683-06:00; 2025-01-06T20:29:12.763683-06:00; NA; 2025-01-06T20:29:12.763683-06:00; 2025-01-06T20:29:12.763683-06:00; 2025-01-06T20:29:12.763683-06:00; 2025-01-06T20:29:12.763683-06:00; Recurrent Disease; NA; Recurrent Disease; NA; NA; Recurrent Disease; Recurrent Disease; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; mg; mg; mg; NA; mg; NA; NA; mg; mg; NA; Adjuvant; NA; Adjuvant; Adjuvant; NA; NA; Adjuvant; Adjuvant","Ovary",20015,"Serous cystadenocarcinoma, NOS","primary",NA,"05b7bdb6-00fc-573b-88b0-3985a0a97199","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G2",NA,"white","female","not reported","Alive",54,-20015,"08af8cb4-296c-5a4f-b5fc-951011920166",FALSE,NA,NA,"TCGA-29-1770-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1770-01"
"TCGA-61-2008-01A-02R-1568-13","TCGA-61-2008-01A-02R-1568-13","TCGA-61-2008","TCGA-61-2008-01A","TP","Primary solid Tumor","TCGA-61-2008-01A","01","Primary","69d76e7a-e0cb-4a8d-b6cd-67d8702d2af9","Primary Tumor","Not Reported","released","Unknown",0.7,"25448427-9a2c-4c36-bc9d-40a82d6e3710","TCGA-61-2008",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","979; 149; 149; 979; 979; NA; 1260; 690; 3600; 372; 702; NA; 861; 29; 29; 861; 861; NA; Intravenous; Intravenous; Intravenous; Intraperitoneal; Intraperitoneal; Intravenous; 250be9cb-0748-4ce8-9b12-4bde630732da; 272bb86f-8af0-4e53-b5bf-85c34c32cdfa; 58c61cf2-ff51-4029-9532-35c2f6340c86; 8e378e12-53e5-58b2-b236-5632aa905b06; be98b2ae-dfc0-4117-8634-22a7a747aa22; dfe28ad7-c53d-4c03-bc34-9e1c1235e2f3; TCGA-61-2008_treatment4; TCGA-61-2008_treatment2; TCGA-61-2008_treatment5; TCGA-61-2008_treatment; TCGA-61-2008_treatment3; TCGA-61-2008_treatment6; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; 6; 6; 6; NA; Paclitaxel; Docetaxel; Carboplatin; Paclitaxel; Cisplatin; NA; yes; yes; yes; yes; yes; no; 2025-01-06T20:51:08.044808-06:00; 2025-01-06T20:51:08.044808-06:00; 2025-01-06T20:51:08.044808-06:00; NA; 2025-01-06T20:51:08.044808-06:00; 2025-01-06T20:51:08.044808-06:00; Recurrent Disease; NA; NA; Recurrent Disease; Recurrent Disease; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; mg; mg; mg; mg; mg; NA; NA; Adjuvant; Adjuvant; NA; NA; Adjuvant","Ovary",14791,"Serous cystadenocarcinoma, NOS","primary",NA,"4233e6db-8d18-5461-b504-3aa62d11e73f","Ovary","No",TRUE,0,"Stage IIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G2",NA,"asian","female","not hispanic or latino","Alive",40,-14791,"32601890-a62f-5eac-821d-10d86af7637f",FALSE,NA,NA,"TCGA-61-2008-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2008-01"
"TCGA-29-2414-01A-02R-1569-13","TCGA-29-2414-01A-02R-1569-13","TCGA-29-2414","TCGA-29-2414-01A","TP","Primary solid Tumor","TCGA-29-2414-01A","01","Primary","c8de9eaf-cda6-4680-a710-93fd9e9a8903","Primary Tumor","Not Reported","released","Unknown",0.7,"c480ee08-d996-40e6-bd86-3e614625d98b","TCGA-29-2414",0.5,"Unknown",1,FALSE,"Tumor","8441/3","6600; 40; 20; 3; NA; NA; 75; 5; 1705; 2256; 3; 2315; 996; 996; 3; 2042; 6a5666f9-cc38-5f1c-a8b6-ec1953ac9ff2; 75d501e6-b6c7-488b-b187-d41a5916f2e6; 7db96c0f-cdf3-4194-8473-0e2e9f4263b0; 9b9cecbe-337f-4881-9df3-6ffa3727ce1f; e16a10a3-1f11-44e1-b272-8e0ce38afb3e; efcc1bfd-9911-4bd3-b3bf-a6e186083ee9; f0de6949-55f2-4189-9854-7df5a2396471; f2a0ab99-98a6-4d7a-ab28-292080b27d7d; TCGA-29-2414_treatment; TCGA-29-2414_treatment5; TCGA-29-2414_treatment3; TCGA-29-2414_treatment6; TCGA-29-2414_treatment7; TCGA-29-2414_treatment8; TCGA-29-2414_treatment2; TCGA-29-2414_treatment4; Radiation, External Beam; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; NA; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; Topotecan; Carboplatin; Paclitaxel; Cisplatin; Carboplatin; yes; yes; yes; yes; yes; yes; yes; yes; NA; 2025-01-06T20:16:13.039296-06:00; 2025-01-06T20:16:13.039296-06:00; 2025-01-06T20:16:13.039296-06:00; 2025-01-06T20:16:13.039296-06:00; 2025-01-06T20:16:13.039296-06:00; 2025-01-06T20:16:13.039296-06:00; 2025-01-06T20:16:13.039296-06:00; Progressive Disease; Progressive Disease; NA; Progressive Disease; Progressive Disease; Progressive Disease; NA; Progressive Disease; Distant Site; NA; NA; Adjuvant; NA; NA; NA; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; cGy; mg/m2; mg/m2; mg/m2; NA; NA; mg/m2; AUC; NA; 2287; 131; 2424; 1171; 1171; 131; 2151; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; 2; 6; 3; NA; NA; 6; 6","Ovary",27417,"Serous cystadenocarcinoma, NOS","primary",NA,"1911c0e4-d523-5681-9cc6-332707c4c25e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",1998,"Surgical Resection","C56.9","G2","R1","white","female","not reported","Dead",75,-27417,"7b9aeb08-3b4c-5661-bec0-b3b74dc9ec8a",FALSE,2621,NA,"TCGA-29-2414-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-2414-01"
"TCGA-24-1928-01A-01R-1567-13","TCGA-24-1928-01A-01R-1567-13","TCGA-24-1928","TCGA-24-1928-01A","TP","Primary solid Tumor","TCGA-24-1928-01A","01","Primary","595af317-cf8b-4f25-b005-426b078ffc4a","Primary Tumor","Not Reported","released","Unknown",0.5,"dc4407fb-d15b-44d5-9c3b-129cca67d8f1","TCGA-24-1928",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","126; 282; NA; 226; 126; NA; 537; 138; 1200; 560; 1130; NA; 14; 254; 327; 156; 14; NA; Intravenous; Intravenous; Oral; Intravenous; Intravenous; 1faabed2-3b8b-49ba-b0b6-f5e3327d28cf; 206c6379-6da7-4e1b-b997-eb7472e9f959; 45dfb6ee-1b16-4b3b-9965-592c263730a1; 60b47769-537d-536e-bfc4-e058ffe51a16; d0516061-9e84-47ca-a334-53a84a5eea0e; f5a5f9f8-0965-448d-83f6-a351acb22075; TCGA-24-1928_treatment5; TCGA-24-1928_treatment4; TCGA-24-1928_treatment2; TCGA-24-1928_treatment; TCGA-24-1928_treatment3; TCGA-24-1928_treatment6; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 2; 1; 4; 6; NA; Cisplatin; Pegylated Liposomal Doxorubicin Hydrochloride; Etoposide; Docetaxel; Paclitaxel; NA; yes; yes; yes; yes; yes; no; 2025-01-06T21:32:01.452913-06:00; 2025-01-06T21:32:01.452913-06:00; 2025-01-06T21:32:01.452913-06:00; NA; 2025-01-06T21:32:01.452913-06:00; 2025-01-06T21:32:01.452913-06:00; Adjuvant; NA; NA; NA; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; mg; mg; mg; mg; mg; NA; NA; Progressive Disease; Progressive Disease; Recurrent Disease; NA; NA","Ovary",28126,"Serous cystadenocarcinoma, NOS","primary",NA,"20d832c5-76d1-5895-aa49-3794d469aede","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1998,"Cytology","C56.9","G3",NA,"white","female","not reported","Dead",77,-28126,"e160398a-2b94-5d6a-88dc-1950614fd97d",FALSE,336,NA,"TCGA-24-1928-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1928-01"
"TCGA-29-1770-02A-01R-1567-13","TCGA-29-1770-02A-01R-1567-13","TCGA-29-1770","TCGA-29-1770-02A","TR","Recurrent Solid Tumor","TCGA-29-1770-02A","02","Recurrence","a22ee89e-b248-496c-bd1c-90d09d4433e1","Recurrent Tumor",NA,"released","Unknown",0.4,"49220236-FBFE-44AA-89BC-FC4E7CBC94FA","TCGA-29-1770",0.2,"Unknown",0.4,FALSE,"Tumor","8441/3","546; 68; 546; NA; 136; 762; 762; 68; 136; 1370; 630; 650; NA; 100; NA; NA; 300; 690; 384; 19; 384; NA; 87; 741; 741; 19; 87; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 443b5df5-23e8-4a13-9de9-278eb64b37dc; 6cfc5a11-51df-4ddd-88bc-9632e13ce305; 908b1b35-18d5-4630-96e8-309fc9d1b285; a5231e45-8b6c-41c2-8228-5baa5e0d666f; bafb4da9-41ca-51be-92f7-f757fdb708d4; e9df8ae6-2b65-47a5-8db6-51fe58ecaf17; f20b6495-e469-49db-82c2-cc0718135776; f65e27f0-1b37-4c30-b82e-82cbcdb4488e; fe359b27-3817-4434-9e27-8c5b669746bd; TCGA-29-1770_treatment6; TCGA-29-1770_treatment8; TCGA-29-1770_treatment4; TCGA-29-1770_treatment9; TCGA-29-1770_treatment; TCGA-29-1770_treatment2; TCGA-29-1770_treatment7; TCGA-29-1770_treatment5; TCGA-29-1770_treatment3; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Targeted Molecular Therapy; Chemotherapy; Chemotherapy; 6; 3; 6; NA; 3; 2; NA; 3; 3; Gemcitabine; Carboplatin; Carboplatin; NA; Docetaxel; Docetaxel; Bevacizumab; Paclitaxel; Carboplatin; yes; yes; yes; no; yes; yes; yes; yes; yes; 2025-01-06T20:29:12.763683-06:00; 2025-01-06T20:29:12.763683-06:00; 2025-01-06T20:29:12.763683-06:00; 2025-01-06T20:29:12.763683-06:00; NA; 2025-01-06T20:29:12.763683-06:00; 2025-01-06T20:29:12.763683-06:00; 2025-01-06T20:29:12.763683-06:00; 2025-01-06T20:29:12.763683-06:00; Recurrent Disease; NA; Recurrent Disease; NA; NA; Recurrent Disease; Recurrent Disease; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; mg; mg; mg; NA; mg; NA; NA; mg; mg; NA; Adjuvant; NA; Adjuvant; Adjuvant; NA; NA; Adjuvant; Adjuvant","Ovary",20015,"Serous cystadenocarcinoma, NOS","primary",NA,"05b7bdb6-00fc-573b-88b0-3985a0a97199","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G2",NA,"white","female","not reported","Alive",54,-20015,"08af8cb4-296c-5a4f-b5fc-951011920166",FALSE,NA,NA,"TCGA-29-1770-02A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1770-02"
"TCGA-29-2428-01A-01R-1569-13","TCGA-29-2428-01A-01R-1569-13","TCGA-29-2428","TCGA-29-2428-01A","TP","Primary solid Tumor","TCGA-29-2428-01A","01","Primary","15d26f43-0581-4cdd-aa2f-a04ad6901fd8","Primary Tumor","Not Reported","released","Unknown",1.2,"45a6c74c-045b-4fdd-a93d-9e1a8d36e4cb","TCGA-29-2428",0.4,"Unknown",1.7,FALSE,"Tumor","8441/3","141; 141; NA; 670; 280; NA; 18; 18; NA; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; 1137f07e-391a-5b5f-a537-bd03d22f3f20; 507449cc-22bc-4ae1-994d-d63856401014; 94f21461-8b39-4754-89df-146bda38ef64; TCGA-29-2428_treatment; TCGA-29-2428_treatment2; TCGA-29-2428_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; NA; Carboplatin; Paclitaxel; NA; yes; yes; no; NA; 2025-01-06T20:35:37.453397-06:00; 2025-01-06T20:35:37.453397-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; mg; NA","Ovary",21392,"Serous cystadenocarcinoma, NOS","primary",NA,"e20d29d9-559f-572a-8639-75c5d0f20e06","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2005,"Surgical Resection","C56.9","G3","R1","white","female","not reported","Alive",58,-21392,"f49495f3-6a81-572b-b92a-f1ffdb45a55d",FALSE,NA,NA,"TCGA-29-2428-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-2428-01"
"TCGA-25-2396-01A-01R-1569-13","TCGA-25-2396-01A-01R-1569-13","TCGA-25-2396","TCGA-25-2396-01A","TP","Primary solid Tumor","TCGA-25-2396-01A","01","Primary","96d1655d-0a5e-4e2e-b9eb-f422ced79483","Primary Tumor","Not Reported","released","Unknown",1,"5AD36576-BDCD-4DE8-9D8C-CD8BE71E4FCF","TCGA-25-2396",1,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; 2025-01-08T13:15:37.188206-06:00; 8f8e49d6-d0fd-5c94-8001-0861b70d6517; TCGA-25-2396_treatment; Radiation Therapy, NOS; released; NA; no; NA","Ovary",26145,"Serous cystadenocarcinoma, NOS","primary",NA,"962f2f69-2e79-50fc-ba72-03bf96cc0d4b","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",71,-26145,"abae41c1-1b5e-5262-b644-b8d7fc00fabd",FALSE,92,NA,"TCGA-25-2396-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-2396-01"
"TCGA-04-1364-01A-01R-1565-13","TCGA-04-1364-01A-01R-1565-13","TCGA-04-1364","TCGA-04-1364-01A","TP","Primary solid Tumor","TCGA-04-1364-01A","01","Primary","c8f56f7e-6b69-4276-ba97-7a70c4fa5071","Primary Tumor","Not Reported","released","Unknown",0.6,"CA87C9DF-D4ED-41BD-AEC9-B41C4FEC54A4","TCGA-04-1364",0.3,"Unknown",1.2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; bb170bda-9299-4fc4-b4d1-79ecaf73fdb8; dc44c5a3-f410-406c-94fb-a61feda36160; TCGA-04-1364_treatment18; TCGA-04-1364_treatment17; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:08:31.907990-06:00; 2025-01-06T21:08:31.907990-06:00; Recurrent Disease; Recurrent Disease","Not Reported",22582,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-04-1364_diagnosis","32b347a2-bbe0-4853-9425-2b47d066f293","Not Reported","Yes",FALSE,288,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",61,-22294,"fca74eca-e5f7-5dfb-8b16-08f9b4d83590",FALSE,1024,NA,"TCGA-04-1364-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1364-01"
"TCGA-61-2098-01A-01R-1568-13","TCGA-61-2098-01A-01R-1568-13","TCGA-61-2098","TCGA-61-2098-01A","TP","Primary solid Tumor","TCGA-61-2098-01A","01","Primary","60b275ef-91db-4572-a187-74fea2507bb8","Primary Tumor","Not Reported","released","Unknown",0.7,"d1c8ab49-5ba0-46c3-8205-53b4e39808b3","TCGA-61-2098",0.5,"Unknown",2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 07c803a9-f6fe-420c-8d6c-421e9267dd79; 2988bc18-b975-53a3-b1b9-338cb73f5f51; 859b65b1-3911-417b-bf10-5e751aef53a5; TCGA-61-2098_treatment3; TCGA-61-2098_treatment; TCGA-61-2098_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:18:03.030798-06:00; NA; 2025-01-06T21:18:03.030798-06:00; NA; 145; 145; NA; 14; 14; Intravenous; Intravenous; NA; 6; 5; NA; Paclitaxel; Carboplatin","Ovary",22876,"Serous cystadenocarcinoma, NOS","primary",NA,"00f8ee1c-618f-530e-8d64-954aff8478aa","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2003,"Surgical Resection","C56.9","G2",NA,"white","female","not reported","Alive",62,-22876,"cf4091c2-42a1-5de2-ae37-e74fa4824373",FALSE,NA,NA,"TCGA-61-2098-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2098-01"
"TCGA-29-1697-01A-01R-1567-13","TCGA-29-1697-01A-01R-1567-13","TCGA-29-1697","TCGA-29-1697-01A","TP","Primary solid Tumor","TCGA-29-1697-01A","01","Primary","3669f3bd-dffe-4737-bf81-07f38deceb2e","Primary Tumor",NA,"released","Unknown",0.8,"294ba09f-347a-4129-847d-211cdf73ca99","TCGA-29-1697",0.4,"Unknown",1.9,FALSE,"Tumor","8441/3","Adjuvant; NA; Adjuvant; NA; NA; Adjuvant; NA; NA; NA; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0093c11b-312f-4836-b4c3-9c3e300dad45; 3638e3ea-a207-4bd8-ae99-eef94c600687; 4580a2a1-9488-4e7d-b484-60f4e74dc30a; 5ec4bb66-ee00-4634-a262-59921e81c2f3; 6090ef0d-fa17-419b-a228-033f242776bb; acc4fc59-718a-462e-a20d-b3d66a2bc38b; e7859140-0f37-40cd-9c88-604bd98fc386; ea6096d3-702c-48a8-8a87-de53c8e2c7d8; f33119dc-404b-4298-8405-5cf8fcbe0b46; f79e3788-db4d-56a4-994a-eb405d6fccc4; TCGA-29-1697_treatment10; TCGA-29-1697_treatment5; TCGA-29-1697_treatment2; TCGA-29-1697_treatment8; TCGA-29-1697_treatment9; TCGA-29-1697_treatment3; TCGA-29-1697_treatment6; TCGA-29-1697_treatment7; TCGA-29-1697_treatment4; TCGA-29-1697_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Targeted Molecular Therapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T20:34:23.880190-06:00; 2025-01-06T20:34:23.880190-06:00; 2025-01-06T20:34:23.880190-06:00; 2025-01-06T20:34:23.880190-06:00; 2025-01-06T20:34:23.880190-06:00; 2025-01-06T20:34:23.880190-06:00; 2025-01-06T20:34:23.880190-06:00; 2025-01-06T20:34:23.880190-06:00; 2025-01-06T20:34:23.880190-06:00; NA; NA; 934; 182; 927; 843; 182; 664; 535; 899; 91; NA; 5; 4512; 650; 70; 1246; 574; 54; 574; 11184; NA; 927; 28; 927; 780; 111; 552; 510; 878; 28; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; 2; 7; NA; 3; 4; 6; 4; 2; 4; NA; Topotecan Hydrochloride; Carboplatin; Bevacizumab; Doxorubicin; Paclitaxel; Carboplatin; Docetaxel; Carboplatin; Gemcitabine; NA; Progressive Disease; NA; Progressive Disease; Recurrent Disease; NA; Progressive Disease; Recurrent Disease; Progressive Disease; NA; NA; mg; mg; mg; mg; mg; mg; mg; mg; mg","Ovary",22933,"Serous cystadenocarcinoma, NOS","primary",NA,"0be1c54a-5169-5542-894c-fa5257137496","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2003,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",62,-22933,"c1569def-c3d1-50c7-89d8-2a3decd38865",FALSE,949,NA,"TCGA-29-1697-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1697-01"
"TCGA-09-1659-01B-01R-1564-13","TCGA-09-1659-01B-01R-1564-13","TCGA-09-1659","TCGA-09-1659-01B","TP","Primary solid Tumor","TCGA-09-1659-01B","01","Primary","01a6f7cd-10cc-4f33-aa75-b29abd6c2edb","Primary Tumor",NA,"released","Unknown",0.6,"f10b2e12-02b2-42e0-a5b2-a02c1daabbdf","TCGA-09-1659",0.4,"Unknown",1,FALSE,"Tumor","8441/3","137; 137; 137; 176; NA; 75; NA; 110; 50; NA; 16; 16; 37; 176; NA; Intravenous; Intravenous; Intravenous; Oral; 24f276db-8ea8-48d9-8d9d-47238cc5c9c1; 41d0d5a4-19a7-54b1-8a5b-6025e3d5dc59; 538e914e-4a2a-45c2-8d54-406156ac5fb8; 6f346a32-693e-4558-91fb-e42b7a0875b8; e725f4a0-480c-48d1-b91f-f69221a5777d; TCGA-09-1659_treatment2; TCGA-09-1659_treatment; TCGA-09-1659_treatment3; TCGA-09-1659_treatment4; TCGA-09-1659_treatment5; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; 6; 1; NA; Cisplatin; Paclitaxel; Paclitaxel; Altretamine; NA; yes; yes; yes; yes; no; 2025-01-06T20:10:15.979896-06:00; NA; 2025-01-06T20:10:15.979896-06:00; 2025-01-06T20:10:15.979896-06:00; 2025-01-06T20:10:15.979896-06:00; Adjuvant; Adjuvant; Adjuvant; NA; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg/m2; NA; mg/m2; mg/m2; NA","Ovary",18733,"Serous cystadenocarcinoma, NOS","primary",NA,"0f558703-06e8-564a-b36a-1cec509b1429","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1997,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",51,-18733,"a5962b77-641c-5dd7-8efa-361ca8a34954",FALSE,304,NA,"TCGA-09-1659-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-1659-01"
"TCGA-09-0366-01A-01R-1564-13","TCGA-09-0366-01A-01R-1564-13","TCGA-09-0366","TCGA-09-0366-01A","TP","Primary solid Tumor","TCGA-09-0366-01A","01","Primary","f2e6f90f-6117-406d-8106-2ef4b37e19d2","Primary Tumor","Not Reported","released","Unknown",NA,"6C254448-2CF7-4283-9026-988273C712A1","TCGA-09-0366",NA,"Unknown",NA,FALSE,"Tumor","8441/3","288; 113; NA; 113; 2; 135; NA; NA; 225; 5; NA; 5; Intravenous; Intravenous; Intravenous; 4b0e57ae-1b82-4ff2-b6c0-9af318db90e1; 5ada961d-9f41-50bd-a6c4-ec939f27eb85; 6e8a80c5-0252-4c21-afa2-38a1c8cbe572; c0102571-7763-4de3-9a72-398bb10e7960; TCGA-09-0366_treatment3; TCGA-09-0366_treatment; TCGA-09-0366_treatment4; TCGA-09-0366_treatment2; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 4; 6; NA; 6; Topotecan; Paclitaxel; NA; Carboplatin; yes; yes; no; yes; 2025-01-06T20:53:56.116334-06:00; NA; 2025-01-06T20:53:56.116334-06:00; 2025-01-06T20:53:56.116334-06:00; Recurrent Disease; NA; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; mg/m2; NA; NA; NA; Adjuvant; Adjuvant; Adjuvant","Specified parts of peritoneum",20440,"Serous cystadenocarcinoma, NOS","primary",NA,"8e24dabb-8325-5099-846c-4f4bf21d7515","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1999,"Surgical Resection","C48.1","G3",NA,"white","female","not reported","Dead",55,-20440,"4168d972-f335-5e36-8145-ad9b8ef7441c",FALSE,1757,NA,"TCGA-09-0366-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-0366-01"
"TCGA-24-1431-01A-01R-1566-13","TCGA-24-1431-01A-01R-1566-13","TCGA-24-1431","TCGA-24-1431-01A","TP","Primary solid Tumor","TCGA-24-1431-01A","01","Primary","44f5f2b7-94ac-4bbd-8ca8-bb5be4b0fbdb","Primary Tumor","Not Reported","released","Unknown",1,"862aa4a2-d399-4aa0-998e-40b331c198ca","TCGA-24-1431",0.6,"Unknown",1.5,FALSE,"Tumor","8441/3","Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 414ba74f-851b-4655-9ba4-772aefb4fc88; 59c0259d-6e2a-5736-ace6-f9f0cb199276; 5ac8bf4d-5099-4ba1-b24b-67d17b8069cc; cc78ac0f-bd88-48b9-8aba-62eecb17f0ae; d1837a45-20b1-4c9b-86ef-e6ce13004e00; fad950d5-82f9-4283-9f91-44c40036d29e; TCGA-24-1431_treatment4; TCGA-24-1431_treatment; TCGA-24-1431_treatment6; TCGA-24-1431_treatment2; TCGA-24-1431_treatment5; TCGA-24-1431_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; Docetaxel; Carboplatin; NA; Paclitaxel; Pegylated Liposomal Doxorubicin Hydrochloride; Topotecan; yes; yes; no; yes; yes; yes; 2025-01-06T20:25:01.305436-06:00; NA; 2025-01-06T20:25:01.305436-06:00; 2025-01-06T20:25:01.305436-06:00; 2025-01-06T20:25:01.305436-06:00; 2025-01-06T20:25:01.305436-06:00; Progressive Disease; NA; NA; NA; Progressive Disease; Recurrent Disease; NA; 147; NA; 147; NA; 308; NA; 42; NA; 42; 329; 262; NA; 6; NA; 6; NA; 3; NA; Adjuvant; Adjuvant; Adjuvant; NA; NA","Ovary",24758,"Serous cystadenocarcinoma, NOS","primary",NA,"4ea91113-9bc3-52d6-92be-98286edfdb2e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1999,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",67,-24758,"60cbb98e-688e-507e-8f47-5429ab9d40b4",FALSE,567,NA,"TCGA-24-1431-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1431-01"
"TCGA-61-1743-01A-01R-1568-13","TCGA-61-1743-01A-01R-1568-13","TCGA-61-1743","TCGA-61-1743-01A","TP","Primary solid Tumor","TCGA-61-1743-01A","01","Primary","4090084e-e95a-4112-b87f-bddafc13b333","Primary Tumor","Not Reported","released","Unknown",1,"190b258b-d756-4872-b5f4-53c2d10e86b1","TCGA-61-1743",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 4034e908-860e-40e6-b928-f91460cf2c74; TCGA-61-1743_treatment4; Radiation Therapy, NOS; released; no; 2025-01-06T20:52:22.123729-06:00; Recurrent Disease","Not Reported",20174,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-61-1743_diagnosis","12e7d086-8b4e-4830-9ca6-ce8255dc2510","Not Reported","Yes",FALSE,809,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",53,-19365,"af7506f4-ac24-5171-bb5d-09f46567ea39",FALSE,1329,NA,"TCGA-61-1743-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1743-01"
"TCGA-24-2290-01A-01R-1568-13","TCGA-24-2290-01A-01R-1568-13","TCGA-24-2290","TCGA-24-2290-01A","TP","Primary solid Tumor","TCGA-24-2290-01A","01","Primary","bbfed693-79e1-4dc7-896e-15b98fc7dbac","Primary Tumor","Not Reported","released","Unknown",1,"71036f77-0d99-427a-883c-75624453890d","TCGA-24-2290",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","599; NA; 550; 705; 412; 119; 119; 939; 412; 614; 705; NA; 823; 1055; 600; NA; 707; 279; 3000; 1800; 4620; 2250; 1270; 7060; 780; NA; 60; NA; 578; NA; 439; 663; 349; 7; 7; 855; 349; 607; 663; NA; 727; 1005; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 12e46247-3efe-4ffe-9dbd-d9e0e7c737d9; 295f7e77-4e75-4e7b-9df6-6ec3119d8a89; 6e6045b5-9397-4534-b9d5-49bb88e1d1f2; 7b90f23d-284d-45fc-a2ab-b544f2282394; 7c1f47ac-8699-46c5-b756-b4f8ae265219; 85bbe000-218f-5fdd-a9e9-3873e195ba2f; 8cebc746-9293-4016-aea0-81c434956d1d; b52a70a6-1e98-4bca-834c-5a05f9bd447a; bdecf77d-5da5-4245-8991-e3d7653cf139; cc68dcaf-16b0-4686-b3ad-58f32ad1ba2d; e549ba53-b726-4b5b-a2f3-204af3a83220; f2b3d5c8-05cd-4722-b195-7840c2cf4b11; f3ccc4fb-b6cb-4a90-9462-0b602e2718ac; fc324269-3f30-4fc3-b6d3-49248afdc1f6; TCGA-24-2290_treatment3; TCGA-24-2290_treatment14; TCGA-24-2290_treatment13; TCGA-24-2290_treatment4; TCGA-24-2290_treatment6; TCGA-24-2290_treatment; TCGA-24-2290_treatment5; TCGA-24-2290_treatment11; TCGA-24-2290_treatment12; TCGA-24-2290_treatment9; TCGA-24-2290_treatment7; TCGA-24-2290_treatment8; TCGA-24-2290_treatment10; TCGA-24-2290_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Hormone Therapy; 4; NA; 6; 3; 4; 6; 6; 5; 4; 2; 3; NA; 5; NA; Paclitaxel; NA; Topotecan; Cisplatin; Carboplatin; Paclitaxel; Carboplatin; Plevitrexed; Paclitaxel; Gemcitabine Hydrochloride; Paclitaxel; NA; Topotecan; Tamoxifen; yes; no; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T21:06:27.140714-06:00; 2025-01-06T21:06:27.140714-06:00; 2025-01-06T21:06:27.140714-06:00; 2025-01-06T21:06:27.140714-06:00; 2025-01-06T21:06:27.140714-06:00; NA; 2025-01-06T21:06:27.140714-06:00; 2025-01-06T21:06:27.140714-06:00; 2025-01-06T21:06:27.140714-06:00; 2025-01-06T21:06:27.140714-06:00; 2025-01-06T21:06:27.140714-06:00; 2025-01-06T21:06:27.140714-06:00; 2025-01-06T21:06:27.140714-06:00; 2025-01-06T21:06:27.140714-06:00; Progressive Disease; NA; Progressive Disease; Progressive Disease; Recurrent Disease; NA; NA; Progressive Disease; Recurrent Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; released; released; released; released; mg; NA; mg; mg; mg; mg; mg; mg; mg; mg; mg; NA; mg; NA; NA; Adjuvant; NA; NA; NA; Adjuvant; Adjuvant; NA; NA; NA; NA; NA; NA; NA","Specified parts of peritoneum",20530,"Serous cystadenocarcinoma, NOS","primary",NA,"608d39b1-f3d7-5c83-a83a-61248eacbd74","Specified parts of peritoneum","No",TRUE,0,"Stage IIIC","Not Reported",NA,"not reported",1997,"Surgical Resection","C48.1","G3",NA,"white","female","not reported","Dead",56,-20530,"c59bc65d-24b8-5f31-a7bf-24ec7a57a5c3",FALSE,1102,NA,"TCGA-24-2290-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2290-01"
"TCGA-25-1313-01A-01R-1565-13","TCGA-25-1313-01A-01R-1565-13","TCGA-25-1313","TCGA-25-1313-01A","TP","Primary solid Tumor","TCGA-25-1313-01A","01","Primary","2e142ad3-0560-4e09-b5ce-ba9df578963d","Primary Tumor","Not Reported","released","Unknown",1.5,"3F5AAE21-3694-4AC2-8A18-4970090A08F4","TCGA-25-1313",1.5,"Unknown",2,FALSE,"Tumor","8441/3","547; 151; 151; 394; 29; 29; Intravenous; Intravenous; Intravenous; c9c7bc22-468c-48d9-8507-e8e8d742e8d7; e9515711-ffd8-53a5-b970-1a4ff3a601d2; f2107365-4254-473e-a355-aeaa149453c6; TCGA-25-1313_treatment3; TCGA-25-1313_treatment; TCGA-25-1313_treatment2; Chemotherapy; Chemotherapy; Chemotherapy; 5; 6; 6; Topotecan; Paclitaxel; Carboplatin; yes; yes; yes; 2025-01-06T21:11:12.862520-06:00; NA; 2025-01-06T21:11:12.862520-06:00; Recurrent Disease; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; NA; Adjuvant; Adjuvant","Ovary",22982,"Serous cystadenocarcinoma, NOS","primary",NA,"1ad23243-90b7-58dd-a896-f3a3432ad5f2","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2000,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",62,-22982,"eb34da9e-5cca-54f5-8a3b-7a4745c1edb5",FALSE,820,NA,"TCGA-25-1313-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1313-01"
"TCGA-09-2054-01A-01R-1568-13","TCGA-09-2054-01A-01R-1568-13","TCGA-09-2054","TCGA-09-2054-01A","TP","Primary solid Tumor","TCGA-09-2054-01A","01","Primary","e2a7621d-3c1d-4b7c-9494-0c02df363ecb","Primary Tumor","Not Reported","released","Unknown",0.8,"4f0eb2a1-996c-4816-a956-835ce5085438","TCGA-09-2054",0.4,"Unknown",2,FALSE,"Tumor","8441/3","161; 513; 421; NA; 300; 161; 6; NA; NA; NA; 50; 175; 37; 428; 329; NA; 244; 37; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 0d318cfb-b4dd-5b02-aac5-d0e3fe6aa09d; 893e8433-a421-44d1-bfc9-57ff8e61e401; 922f5dd7-63d0-4b63-ac69-9ffa83becf70; b01cdacb-54fd-46d1-9b7a-61f52867217b; e25c7aa7-a2c4-4bea-82a3-37bb321f0c7a; fcf55172-4912-4acd-8f36-5f5318d4c28d; TCGA-09-2054_treatment; TCGA-09-2054_treatment3; TCGA-09-2054_treatment5; TCGA-09-2054_treatment6; TCGA-09-2054_treatment2; TCGA-09-2054_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 6; 3; 3; NA; 3; 6; Carboplatin; Gemcitabine Hydrochloride; Topotecan; NA; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; yes; yes; yes; no; yes; yes; NA; 2025-01-06T20:11:30.664422-06:00; 2025-01-06T20:11:30.664422-06:00; 2025-01-06T20:11:30.664422-06:00; 2025-01-06T20:11:30.664422-06:00; 2025-01-06T20:11:30.664422-06:00; Adjuvant; NA; NA; Adjuvant; NA; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; AUC; NA; NA; NA; mg/m2; mg/m2; NA; Progressive Disease; Progressive Disease; NA; Progressive Disease; NA","Ovary",21285,"Serous cystadenocarcinoma, NOS","primary",NA,"90364ee6-2b18-5172-a7f4-b50c4343e0f4","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2005,"Surgical Resection","C56.9","G3",NA,"black or african american","female","not hispanic or latino","Dead",58,-21285,"8be5e1f5-91eb-53cd-9cfe-8cc67176093b",FALSE,637,NA,"TCGA-09-2054-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-2054-01"
"TCGA-36-1580-01A-01R-1566-13","TCGA-36-1580-01A-01R-1566-13","TCGA-36-1580","TCGA-36-1580-01A","TP","Primary solid Tumor","TCGA-36-1580-01A","01","Primary","e134063e-745d-4c97-8d48-6f3e238daefc","Primary Tumor",NA,"released","Unknown",1,"a647e4da-8579-4848-b545-bc857db85d98","TCGA-36-1580",0.4,"Unknown",2,FALSE,"Tumor","8441/3","553; NA; 348; 222; NA; 4796; 454; NA; 18; Intravenous; Intravenous; 17deb49e-ee6d-4fce-a88d-9c01c5d63a53; 5bd90d18-71b8-4c2e-83bf-5130ae149beb; 66904e0f-853e-5754-88cb-e9402250bd98; TCGA-36-1580_treatment2; TCGA-36-1580_treatment3; TCGA-36-1580_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 4; NA; 11; Pegylated Liposomal Doxorubicin Hydrochloride; NA; Carboplatin; yes; no; yes; 2025-01-06T21:09:14.408090-06:00; 2025-01-06T21:09:14.408090-06:00; NA; Progressive Disease; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; NA; mg; NA; Adjuvant; Adjuvant","Ovary",29992,"Serous cystadenocarcinoma, NOS","primary",NA,"b6c3e3e6-e354-5dd8-a77d-95a47bd63099","Ovary","No",TRUE,0,"Stage IIIC","Not Reported",NA,"not reported",2007,"Cytology","C56.9","G3",NA,"not reported","female","not reported","Dead",82,-29992,"8a7b50d7-9032-55a0-b9b9-293f589052cc",FALSE,737,NA,"TCGA-36-1580-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-36-1580-01"
"TCGA-61-1911-01A-01R-1567-13","TCGA-61-1911-01A-01R-1567-13","TCGA-61-1911","TCGA-61-1911-01A","TP","Primary solid Tumor","TCGA-61-1911-01A","01","Primary","7f7b442a-3985-4f4a-98b1-da82670c957c","Primary Tumor",NA,"released","Unknown",0.7,"ba6325b4-af61-42cc-b84c-aacee9d7ecc8","TCGA-61-1911",0.4,"Unknown",2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0afdf7f3-e918-453e-a1ce-f15b84d870c9; 52d3122a-c4c7-44ba-8745-8391360e018e; TCGA-61-1911_treatment9; TCGA-61-1911_treatment10; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:59:08.376851-06:00; 2025-01-06T20:59:08.376851-06:00; Recurrent Disease; Recurrent Disease","Not Reported",20988,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-61-1911_diagnosis","0bdff29a-883c-4ffc-9bf5-fa92962c59b7","Not Reported","Yes",FALSE,844,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",55,-20144,"da682e41-52c5-5a4f-b12c-62a7252a9929",FALSE,NA,NA,"TCGA-61-1911-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1911-01"
"TCGA-23-1030-01A-02R-1564-13","TCGA-23-1030-01A-02R-1564-13","TCGA-23-1030","TCGA-23-1030-01A","TP","Primary solid Tumor","TCGA-23-1030-01A","01","Primary","b3716b9c-af9c-41cd-9ceb-f45fcda4a2d5","Primary Tumor",NA,"released","Unknown",0.8,"E44D825F-89EE-4FF7-B6D6-B0B17E305B2C","TCGA-23-1030",0.5,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; cbe72d2a-a9ef-4b82-a211-a1cc6709b077; e91e3101-d39d-45dc-9cac-fad15ec80cc5; TCGA-23-1030_treatment6; TCGA-23-1030_treatment7; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:24:51.966760-06:00; 2025-01-06T21:24:51.966760-06:00; Recurrent Disease; Recurrent Disease","Not Reported",23960,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-23-1030_diagnosis","411da102-2939-45e2-972a-96369daee5ce","Not Reported","Yes",FALSE,544,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",64,-23416,"e8dc4dd7-3263-5e49-bcf9-65c4e263a04f",FALSE,NA,NA,"TCGA-23-1030-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1030-01"
"TCGA-24-1426-01A-01R-1565-13","TCGA-24-1426-01A-01R-1565-13","TCGA-24-1426","TCGA-24-1426-01A","TP","Primary solid Tumor","TCGA-24-1426-01A","01","Primary","4a4ec9eb-d594-449b-adfb-703ac1f25bb5","Primary Tumor","Not Reported","released","Unknown",0.4,"72914511-b2f7-484f-a7ab-3f4f1868f2cb","TCGA-24-1426",0.3,"Unknown",1.2,FALSE,"Tumor","8441/3","142; NA; 142; 142; 900; NA; 720; 780; -8; NA; -8; -8; Intravenous; Intravenous; Intravenous; 4e62a9f2-3ff9-53b6-bc81-449ddbcee8a9; 62c57493-d8f6-481b-81ec-e66ce354b1dd; a1b61240-4ef4-4c49-8ed1-a27e42b5f6bc; ad86990f-6dc2-414a-b937-1bb92e36ea74; TCGA-24-1426_treatment; TCGA-24-1426_treatment4; TCGA-24-1426_treatment3; TCGA-24-1426_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 6; NA; 6; 6; Cisplatin; NA; Paclitaxel; Docetaxel; yes; no; yes; yes; NA; 2025-01-06T21:02:18.903440-06:00; 2025-01-06T21:02:18.903440-06:00; 2025-01-06T21:02:18.903440-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; NA; mg; mg","Ovary",15949,"Serous cystadenocarcinoma, NOS","primary",NA,"73d04d1d-d04a-5882-9b7c-26f5a22bf03e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",43,-15949,"13753562-152d-554c-9562-f22a3fcf89f7",FALSE,NA,NA,"TCGA-24-1426-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1426-01"
"TCGA-24-2038-01A-01R-1568-13","TCGA-24-2038-01A-01R-1568-13","TCGA-24-2038","TCGA-24-2038-01A","TP","Primary solid Tumor","TCGA-24-2038-01A","01","Primary","cb5c8591-15ab-46b3-a819-57cbf71c6bce","Primary Tumor","Not Reported","released","Unknown",0.6,"82958234-9de0-429f-8e63-3e8891f1df81","TCGA-24-2038",0.4,"Unknown",1,FALSE,"Tumor","8441/3","1254; 1352; 1352; NA; 35; 2345; 1407; NA; 1212; 1268; 1268; NA; Intravenous; Intravenous; Intravenous; 3db13011-a4d2-48a0-bf8a-c90103a4b11d; 69152569-be83-508b-94fb-050e944616a9; 6be2a491-bdb0-4aeb-b616-225d6e80c21a; c80c597c-05e3-4085-a10e-4dbcfb2d8f14; TCGA-24-2038_treatment3; TCGA-24-2038_treatment; TCGA-24-2038_treatment2; TCGA-24-2038_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 2; 5; 5; NA; Topotecan; Carboplatin; Paclitaxel; NA; yes; yes; yes; no; 2025-01-06T20:44:41.845690-06:00; NA; 2025-01-06T20:44:41.845690-06:00; 2025-01-06T20:44:41.845690-06:00; Recurrent Disease; Progressive Disease; Progressive Disease; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; mg; mg; NA; NA; NA; NA; Adjuvant","Ovary",24957,"Serous cystadenocarcinoma, NOS","primary",NA,"82ae2a62-aea4-5d85-9136-e3403b28b06c","Ovary","No",TRUE,0,"Stage IIIA","Not Reported","Right","not reported",2000,"Surgical Resection","C56.9","GB",NA,"white","female","not reported","Dead",68,-24957,"3ea04b59-4837-5855-9da9-a7e5b46b7e10",FALSE,1354,NA,"TCGA-24-2038-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2038-01"
"TCGA-29-A5NZ-01A-11R-A406-31","TCGA-29-A5NZ-01A-11R-A406-31","TCGA-29-A5NZ","TCGA-29-A5NZ-01A","TP","Primary solid Tumor","TCGA-29-A5NZ-01A","01","Primary","cfa92815-5221-46e2-b7a2-958c556bb390","Primary Tumor",NA,"released","OCT",NA,"B7F69EE0-E844-434B-A76B-390590C85864","TCGA-29-A5NZ",NA,"Unknown",NA,FALSE,"Tumor","8460/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 577e7983-773a-46f6-aa04-d343a7221ba7; 937245fe-caf2-49a1-87af-55432805df9e; TCGA-29-A5NZ_treatment12; TCGA-29-A5NZ_treatment13; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:49:45.864679-06:00; 2025-01-06T20:49:45.864679-06:00; Progressive Disease; Progressive Disease","Not Reported",25040,"Papillary serous cystadenocarcinoma","Progression","TCGA-29-A5NZ_diagnosis","127d62d7-2eca-4add-a0d1-23e5566022c0","Not Reported","Yes",FALSE,879,NA,NA,NA,NA,NA,NA,NA,NA,NA,"black or african american","female","not reported","Dead",66,-24161,"5fcf9981-1d44-5962-8284-883451d2d003",FALSE,1088,NA,"TCGA-29-A5NZ-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,515,1040,"true",NA,NA,NA,NA,"United States",NA,NA,"TCGA-29-A5NZ-01"
"TCGA-24-1424-01A-01R-1565-13","TCGA-24-1424-01A-01R-1565-13","TCGA-24-1424","TCGA-24-1424-01A","TP","Primary solid Tumor","TCGA-24-1424-01A","01","Primary","9f88d3b0-edc0-4fca-a4a9-4d8aacedf9a7","Primary Tumor","Not Reported","released","Unknown",0.6,"2b1dfcc6-e4ee-4443-9472-171569244648","TCGA-24-1424",0.6,"Unknown",1.2,FALSE,"Tumor","8441/3","120; NA; 120; 120; 1441; NA; 429; 972; 8; NA; 8; 8; Intravenous; Intravenous; Intravenous; 0abda174-3602-5b21-9c07-80eb17808870; 7e58fd31-8b1f-4eae-80aa-4c5a4d850a71; a5120aaa-833a-472e-bd7f-4e3ff3cb8eaf; b9c16de8-5e53-41c7-806f-ab2fd1a2f602; TCGA-24-1424_treatment; TCGA-24-1424_treatment4; TCGA-24-1424_treatment3; TCGA-24-1424_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 6; NA; 6; 6; Carboplatin; NA; Docetaxel; Paclitaxel; yes; no; yes; yes; NA; 2025-01-06T21:02:03.827384-06:00; 2025-01-06T21:02:03.827384-06:00; 2025-01-06T21:02:03.827384-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; NA; mg; mg","Ovary",24545,"Serous cystadenocarcinoma, NOS","primary",NA,"51ca0e22-1a4d-5b23-a0bb-f197df114dfe","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",67,-24545,"63997bed-da2a-57ae-81e4-53468e3d556a",FALSE,NA,NA,"TCGA-24-1424-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1424-01"
"TCGA-23-1114-01B-01R-1566-13","TCGA-23-1114-01B-01R-1566-13","TCGA-23-1114","TCGA-23-1114-01B","TP","Primary solid Tumor","TCGA-23-1114-01B","01","Primary","424254f5-1bdf-43ed-b867-33a73a3c919f","Primary Tumor",NA,"released","Unknown",0.6,"d5c00586-d7e4-4909-be2b-ffc4f9ef2e82","TCGA-23-1114",0.4,"Unknown",1,FALSE,"Tumor","8441/3","1918; NA; 182; 907; 182; 747; 1222; 747; 1425; 1425; 2026; 1350; 1350; 475; NA; NA; 1305; NA; 1400; 520; 2100; 1190; 9625; 20; 5500; 260; 1741; NA; 43; 865; 43; 663; 1159; 663; 1357; 1348; 1985; 1324; 1324; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 217a7e5b-2644-4622-b6df-e0de8ec63e34; 260cad42-2a86-4d9d-a65d-5a0f4f4dc962; 3dc9ae85-15bc-4e2b-aa27-6a6366cacb81; 4ce7f4c7-428f-5c90-85c3-de43de186e0c; 53ed84a0-5e50-4f25-8fee-89b2f705a28e; 5ff2f676-16fc-4f39-85b8-16bdb77046fe; 75ef0e20-b37b-49f0-bb47-45de5d650e5a; 8a0adf52-6226-4724-a475-ddb5c691788c; 93c56564-9055-40f6-8c36-c19116986251; b024cf14-1247-46c3-b80d-e40f5c9fc1bb; be918966-a95d-4a87-97ad-c4a4c18979f8; e9e3f762-6e37-4613-8b3f-4e556f91e96c; f2e65017-3d5c-4b25-a8f0-29dd7f80be74; TCGA-23-1114_treatment3; TCGA-23-1114_treatment13; TCGA-23-1114_treatment7; TCGA-23-1114_treatment; TCGA-23-1114_treatment5; TCGA-23-1114_treatment4; TCGA-23-1114_treatment10; TCGA-23-1114_treatment9; TCGA-23-1114_treatment6; TCGA-23-1114_treatment11; TCGA-23-1114_treatment2; TCGA-23-1114_treatment8; TCGA-23-1114_treatment12; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 7; NA; 6; 3; 6; 5; 4; 5; 3; 3; 6; 2; 2; Pegylated Liposomal Doxorubicin Hydrochloride; NA; Carboplatin; Carboplatin; Paclitaxel; Paclitaxel; Docetaxel; Carboplatin; Carboplatin; Gemcitabine Hydrochloride; Topotecan; Gemcitabine Hydrochloride; Cisplatin; yes; no; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T20:44:56.788102-06:00; 2025-01-06T20:44:56.788102-06:00; 2025-01-06T20:44:56.788102-06:00; NA; 2025-01-06T20:44:56.788102-06:00; 2025-01-06T20:44:56.788102-06:00; 2025-01-06T20:44:56.788102-06:00; 2025-01-06T20:44:56.788102-06:00; 2025-01-06T20:44:56.788102-06:00; 2025-01-06T20:44:56.788102-06:00; 2025-01-06T20:44:56.788102-06:00; 2025-01-06T20:44:56.788102-06:00; 2025-01-06T20:44:56.788102-06:00; Recurrent Disease; NA; NA; Not Reported; NA; Recurrent Disease; Recurrent Disease; Recurrent Disease; Persistent Disease; Persistent Disease; Progressive Disease; Persistent Disease; Persistent Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; released; released; released; mg; NA; NA; mg; NA; mg; mg; mg; mg; mg; mg; mg; mg; NA; Adjuvant; Adjuvant; Consolidation Therapy; Adjuvant; NA; NA; NA; Not Reported; Not Reported; NA; Not Reported; Not Reported","Ovary",20409,"Serous cystadenocarcinoma, NOS","primary",NA,"2f26a07c-893d-5252-be5b-5dcb2902113a","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2000,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",55,-20409,"53467ffb-93bb-5572-b01e-19602c063a44",FALSE,2089,NA,"TCGA-23-1114-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1114-01"
"TCGA-24-0982-01A-01R-1565-13","TCGA-24-0982-01A-01R-1565-13","TCGA-24-0982","TCGA-24-0982-01A","TP","Primary solid Tumor","TCGA-24-0982-01A","01","Primary","7fec33cd-6f46-44c7-8204-e0f42b543abe","Primary Tumor",NA,"released","Unknown",0.8,"75BE9FE6-5606-4F29-A08F-69E3F50912D0","TCGA-24-0982",0.8,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; NA; NA; NA; NA; Adjuvant; Adjuvant; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1547ca03-0619-4f37-b17e-1789dde00839; 238a2a9a-2218-4fed-bbef-1466e53c3199; 54e94e17-9baf-4c2a-b5ad-a0581216c903; 75df1c59-9ee0-448f-9a88-787b76983a42; bc95f6b5-0673-4810-adfd-2b6ef4f7c161; bea58a28-e1e0-4c96-bd85-d5ab1f077b52; c873a01f-9b1c-4c50-9272-524734405d4f; d81ea43b-389a-5133-a0dd-61f3ff1b9e3b; f2dfa1cc-3eb9-4356-9bf5-c062afb8347b; TCGA-24-0982_treatment9; TCGA-24-0982_treatment5; TCGA-24-0982_treatment4; TCGA-24-0982_treatment7; TCGA-24-0982_treatment6; TCGA-24-0982_treatment2; TCGA-24-0982_treatment3; TCGA-24-0982_treatment; TCGA-24-0982_treatment8; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T21:15:28.681296-06:00; 2025-01-06T21:15:28.681296-06:00; 2025-01-06T21:15:28.681296-06:00; 2025-01-06T21:15:28.681296-06:00; 2025-01-06T21:15:28.681296-06:00; 2025-01-06T21:15:28.681296-06:00; 2025-01-06T21:15:28.681296-06:00; NA; 2025-01-06T21:15:28.681296-06:00; NA; 321; 474; 615; 321; 125; 125; 474; 615; NA; 390; 388; 2276; 39; 1966; 4090; 24798; 3800; NA; 251; 341; 488; 251; 13; 13; 341; 488; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; 4; 5; 7; 4; 6; 6; 5; 7; NA; Vinorelbine Tartrate; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; Topotecan; Paclitaxel; Carboplatin; Gemcitabine Hydrochloride; Carboplatin; NA; Recurrent Disease; Progressive Disease; Progressive Disease; Recurrent Disease; NA; NA; Progressive Disease; Progressive Disease; NA; mg; mg; mg; mg; mg; mg; mg; mg","Ovary",28201,"Serous cystadenocarcinoma, NOS","primary",NA,"39a59ccd-64aa-5441-84ae-81793fbe9199","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2003,"Cytology","C56.9","G3",NA,"white","female","not reported","Dead",77,-28201,"849e1718-c71c-5361-b7d6-b8cc306d138e",FALSE,679,NA,"TCGA-24-0982-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-0982-01"
"TCGA-57-1582-01A-01R-1566-13","TCGA-57-1582-01A-01R-1566-13","TCGA-57-1582","TCGA-57-1582-01A","TP","Primary solid Tumor","TCGA-57-1582-01A","01","Primary","84ee744e-ee7f-46e4-b1bd-40524ffcc902","Primary Tumor",NA,"released","Unknown",0.6,"0ed35510-c6ad-416b-8b57-e97005471dc1","TCGA-57-1582",0.6,"Unknown",2,FALSE,"Tumor","8441/3","718; 597; NA; 718; 170; 170; NA; 505; 597; 505; NA; 597; 17; 17; 260; 444; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 176080a4-c282-4285-8ad5-004315036ccc; 2012c078-f776-54bd-9420-efc9f564bc6f; 24b7aaec-18ce-4780-a941-5ae4ed36a271; 55334b85-51e8-4675-8e0e-4335cf6f92d2; 56bde0e7-c055-43c0-ba18-27faf7390fd8; 61f4692a-7268-4461-a871-1b5e02e8c8a8; 9b795355-3b64-4525-bd3e-43069f9c2791; a7588e5f-b988-4bf6-a886-c9d7fc49cb93; TCGA-57-1582_treatment2; TCGA-57-1582_treatment; TCGA-57-1582_treatment8; TCGA-57-1582_treatment3; TCGA-57-1582_treatment5; TCGA-57-1582_treatment4; TCGA-57-1582_treatment7; TCGA-57-1582_treatment6; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; released; released; Carboplatin; Topotecan; NA; Gemcitabine Hydrochloride; Carboplatin; Docetaxel; Patupilone; Pegylated Liposomal Doxorubicin Hydrochloride; yes; yes; no; yes; yes; yes; yes; yes; 2025-01-06T20:38:19.670694-06:00; NA; 2025-01-06T20:38:19.670694-06:00; 2025-01-06T20:38:19.670694-06:00; 2025-01-06T20:38:19.670694-06:00; 2025-01-06T20:38:19.670694-06:00; 2025-01-06T20:38:19.670694-06:00; 2025-01-06T20:38:19.670694-06:00; Progressive Disease; Progressive Disease; NA; Progressive Disease; NA; NA; Progressive Disease; Progressive Disease; NA; NA; Adjuvant; NA; Adjuvant; Adjuvant; NA; NA; Intravenous; Intravenous; Intravenous; NA; NA; NA; NA; 6; 6; NA; NA","Ovary",NA,"Serous cystadenocarcinoma, NOS","primary",NA,"46a3eb27-df60-59e2-9770-f710ce3057a5","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2006,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",50,NA,"cabdf363-332d-5055-8622-1a81a9a566fc",FALSE,731,NA,"TCGA-57-1582-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-57-1582-01"
"TCGA-36-1570-01A-01R-1566-13","TCGA-36-1570-01A-01R-1566-13","TCGA-36-1570","TCGA-36-1570-01A","TP","Primary solid Tumor","TCGA-36-1570-01A","01","Primary","22b7e0e2-334c-419c-a243-358ba22e479a","Primary Tumor",NA,"released","Unknown",1,"f83833f4-a820-4fb9-a040-c238084976c3","TCGA-36-1570",0.7,"Unknown",1.3,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; NA; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 32e51ce2-2665-4f37-b8bb-e3a4ca36d7ae; 4cdec97d-42bf-5508-a2e3-f9c2755ab3ed; 5633540b-88ab-4e50-8c9c-4385b4ace691; eea8be95-ab17-4812-9ca0-105e1d87be5d; TCGA-36-1570_treatment4; TCGA-36-1570_treatment; TCGA-36-1570_treatment2; TCGA-36-1570_treatment3; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T20:35:17.887345-06:00; NA; 2025-01-06T20:35:17.887345-06:00; 2025-01-06T20:35:17.887345-06:00; NA; 133; 432; 133; NA; 2808; 1200; 1330; NA; 23; 432; 23; Intravenous; Intravenous; Intravenous; NA; 5; 1; 5; NA; Carboplatin; Gemcitabine; Paclitaxel; NA; mg; mg; mg; NA; NA; Recurrent Disease; NA","Ovary",17956,"Serous cystadenocarcinoma, NOS","primary",NA,"2a9bd40c-59be-5757-894c-c0b7f1100b5f","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",49,-17956,"8bf011e8-2516-55b4-b40b-332a899f5710",FALSE,NA,NA,"TCGA-36-1570-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-36-1570-01"
"TCGA-29-1763-01A-02R-1567-13","TCGA-29-1763-01A-02R-1567-13","TCGA-29-1763","TCGA-29-1763-01A","TP","Primary solid Tumor","TCGA-29-1763-01A","01","Primary","3231d01a-e80c-46a1-8c9c-3492dca9f250","Primary Tumor",NA,"released","Unknown",0.7,"f90e0db8-f656-411c-be72-8e0774d2336b","TCGA-29-1763",0.5,"Unknown",1.3,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 28a92c4b-58d5-481c-899f-b02be1b78d98; d7b2cada-4c1a-4cdc-9fc5-89d504d4610d; TCGA-29-1763_treatment13; TCGA-29-1763_treatment12; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; yes; yes; 2025-01-06T20:31:33.593563-06:00; 2025-01-06T20:31:33.593563-06:00; Recurrent Disease; Recurrent Disease","Not Reported",16449,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-29-1763_diagnosis","98c9de89-8261-469c-9c72-ca953537f4c7","Not Reported","Yes",FALSE,428,NA,NA,NA,NA,NA,NA,NA,NA,NA,"black or african american","female","not reported","Alive",43,-16021,"8ae2cac3-bc30-5b1f-969f-cad425be9356",FALSE,NA,NA,"TCGA-29-1763-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1763-01"
"TCGA-61-2000-01A-01R-1568-13","TCGA-61-2000-01A-01R-1568-13","TCGA-61-2000","TCGA-61-2000-01A","TP","Primary solid Tumor","TCGA-61-2000-01A","01","Primary","fdb8966d-55c9-49be-80dd-369246604aad","Primary Tumor","Not Reported","released","Unknown",1,"4e13b897-c34a-4422-9c66-7ca8b2734ef2","TCGA-61-2000",0.4,"Unknown",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1bf10f84-13a7-4f39-aa84-f638f68c2645; cbf1f459-7a96-4ad6-b8f6-0c0dbac6cb65; TCGA-61-2000_treatment11; TCGA-61-2000_treatment10; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:02:50.565440-06:00; 2025-01-06T21:02:50.565440-06:00; Recurrent Disease; Recurrent Disease","Not Reported",25062,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-61-2000_diagnosis","36d85764-2bb9-4de7-b006-82408a0f5aef","Not Reported","Yes",FALSE,339,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",67,-24723,"2281e96f-9ac0-5e8c-9510-0876507277a1",FALSE,NA,NA,"TCGA-61-2000-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2000-01"
"TCGA-23-1122-01A-01R-1565-13","TCGA-23-1122-01A-01R-1565-13","TCGA-23-1122","TCGA-23-1122-01A","TP","Primary solid Tumor","TCGA-23-1122-01A","01","Primary","ff14c071-ccce-4d44-8d0b-c4cbdfb59c8c","Primary Tumor",NA,"released","Unknown",0.8,"9507d553-b1c7-4b71-90c1-064fd8ef15ba","TCGA-23-1122",0.5,"Unknown",1.1,FALSE,"Tumor","8441/3","244; 1031; 686; 859; 754; 1089; 1089; 4200; 72; 15900; 5900; 3500; 14290; 240; 27; 921; 501; 775; 707; 1054; 1054; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 10571b3f-0223-4817-aa51-f0fb0e6301cf; 167ee7a8-51da-4383-9f9b-ddaeb59c1f74; 38fb62c6-526b-4ac3-a117-8595ddb580c9; 696b1bf9-db47-48ca-b491-bc75ece1615c; 7fc5ab77-a14a-4d63-a56b-2e90d91ec211; 9d7b0051-95b8-5e5f-850a-505f56d62842; dfd3da5b-71a1-48f8-aea0-21a1c4905e18; TCGA-23-1122_treatment5; TCGA-23-1122_treatment2; TCGA-23-1122_treatment4; TCGA-23-1122_treatment7; TCGA-23-1122_treatment6; TCGA-23-1122_treatment; TCGA-23-1122_treatment3; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation, External Beam; Chemotherapy; 8; 6; 20; 9; 5; NA; 6; Carboplatin; Ifosfamide; Gemcitabine; Gemcitabine; Gemcitabine Hydrochloride; NA; Cisplatin; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T20:13:34.862358-06:00; 2025-01-06T20:13:34.862358-06:00; 2025-01-06T20:13:34.862358-06:00; 2025-01-06T20:13:34.862358-06:00; 2025-01-06T20:13:34.862358-06:00; NA; 2025-01-06T20:13:34.862358-06:00; Adjuvant; Not Reported; NA; Not Reported; NA; NA; Not Reported; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; mg; mg; mg; mg; mg; cGy; mg; NA; Persistent Disease; Recurrent Disease; Persistent Disease; Recurrent Disease; Progressive Disease; Persistent Disease; NA; NA; NA; NA; NA; 29; NA; Distant Site","Ovary",19537,"Serous cystadenocarcinoma, NOS","primary",NA,"0bf0b7d6-59fd-5d2e-b753-857c4b618889","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",1998,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",53,-19537,"35fba336-e795-5600-a892-a3899a3d9fe3",FALSE,1189,NA,"TCGA-23-1122-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1122-01"
"TCGA-24-0975-01A-02R-1565-13","TCGA-24-0975-01A-02R-1565-13","TCGA-24-0975","TCGA-24-0975-01A","TP","Primary solid Tumor","TCGA-24-0975-01A","01","Primary","b28f3b6f-8224-41e1-8777-23688e0155d1","Primary Tumor",NA,"released","Unknown",1,"8AA65DCA-E057-486F-AEFA-D8A3485416EC","TCGA-24-0975",0.7,"Unknown",1.5,FALSE,"Tumor","8441/3","22; NA; 22; 564; 22; NA; 22; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 02188573-ad8c-4a2d-b87c-40d7bb0862ff; 0246d614-352a-48c4-995f-6f0c05ce1dee; 0be86bba-9865-4aff-8b2c-cb70beafe532; 2c412943-9ae2-58df-8030-170df09b3888; 3c7b0072-f24b-4189-ab8c-092881f4afe4; 8d7c1b3a-4aaa-4289-b07e-9b41abcbc0bb; 94791315-dbd3-43b1-b19d-0c36d7bd3de6; TCGA-24-0975_treatment2; TCGA-24-0975_treatment5; TCGA-24-0975_treatment7; TCGA-24-0975_treatment; TCGA-24-0975_treatment6; TCGA-24-0975_treatment3; TCGA-24-0975_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation, External Beam; Chemotherapy; Chemotherapy; Chemotherapy; 2; 3; 2; NA; 8; 3; 8; released; released; released; released; released; released; released; Pegylated Liposomal Doxorubicin Hydrochloride; Vinorelbine Tartrate; Gemcitabine; NA; Carboplatin; Topotecan; Paclitaxel; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T20:14:59.610713-06:00; 2025-01-06T20:14:59.610713-06:00; 2025-01-06T20:14:59.610713-06:00; NA; 2025-01-06T20:14:59.610713-06:00; 2025-01-06T20:14:59.610713-06:00; 2025-01-06T20:14:59.610713-06:00; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; NA; Progressive Disease; NA; NA; 611; NA; 576; NA; 611; NA; NA; NA; NA; 3000; NA; NA; NA; NA; NA; NA; 10; NA; NA; NA; Distant Site; NA; NA; NA; NA; Adjuvant; NA; Adjuvant; NA; NA; NA; cGy; NA; NA; NA","Ovary",21417,"Serous cystadenocarcinoma, NOS","primary",NA,"76d84c00-0eb7-5a28-bb2c-e6fb683fecb8","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2004,"Cytology","C56.9","G3",NA,"white","female","not reported","Dead",58,-21417,"7ce08a4a-f076-5e4d-bbe0-a5ed3392d0a2",FALSE,663,NA,"TCGA-24-0975-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-0975-01"
"TCGA-23-1021-01B-01R-1564-13","TCGA-23-1021-01B-01R-1564-13","TCGA-23-1021","TCGA-23-1021-01B","TP","Primary solid Tumor","TCGA-23-1021-01B","01","Primary","36c901d8-885d-4fc0-8cd2-69229fddc566","Primary Tumor",NA,"released","Unknown",0.9,"4339A934-71A0-4E92-91D6-BEB0207939ED","TCGA-23-1021",0.5,"Unknown",1,FALSE,"Tumor","8441/3","1181; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 5eaf9dc2-d162-492f-b786-6abc79a6cfe6; 658276ed-fd28-49a5-866b-49e7ef2b0872; 79797abf-14fd-42c6-afb1-be88409bd7f9; TCGA-23-1021_treatment11; TCGA-23-1021_treatment9; TCGA-23-1021_treatment10; Surgery, NOS; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; released; yes; yes; no; 2025-01-06T21:32:15.105460-06:00; 2025-01-06T21:32:15.105460-06:00; 2025-01-06T21:32:15.105460-06:00; Unknown; Unknown; Unknown","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-23-1021_diagnosis","8ab9fe04-df2e-45b9-9304-b32a5a6d17f4","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",45,-16484,"5bf4dbf9-9ad3-56b4-a16a-b891ca34a898",FALSE,1446,NA,"TCGA-23-1021-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1021-01"
"TCGA-29-1762-01A-01R-1567-13","TCGA-29-1762-01A-01R-1567-13","TCGA-29-1762","TCGA-29-1762-01A","TP","Primary solid Tumor","TCGA-29-1762-01A","01","Primary","5df514e7-6e12-474a-92f2-067898b351ac","Primary Tumor",NA,"released","Unknown",0.9,"f94712a1-78da-4341-9ac9-6ea41c11610e","TCGA-29-1762",0.4,"Unknown",0.9,FALSE,"Tumor","8441/3","2488; 2555; 140; NA; 140; 2229; 1513; 2418; 60; 150; NA; NA; NA; 80; NA; 400; 2439; 2509; 7; NA; 7; 2167; 1387; 2255; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 166b8b13-30ac-58cb-b940-cfae6060fb58; 1b7f47b2-c73d-487e-a20d-8f7e706bbd7c; 3fc0ea83-55c4-4a69-999b-5bac0043263b; 75ab93d6-46eb-4629-ad7d-9f4df5a8893b; 96e784b6-5f0c-4171-8a78-71972f06cf6a; a01ccccd-a453-4e1f-89b2-65dd6936059f; a6adc36c-930e-4959-990a-bfd700765a1c; a7d6e11e-28a9-4e88-91ec-098175ede13a; TCGA-29-1762_treatment; TCGA-29-1762_treatment2; TCGA-29-1762_treatment7; TCGA-29-1762_treatment8; TCGA-29-1762_treatment4; TCGA-29-1762_treatment3; TCGA-29-1762_treatment5; TCGA-29-1762_treatment6; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 6; 3; NA; NA; NA; 3; 6; 8; Topotecan Hydrochloride; Docetaxel; Carboplatin; NA; Paclitaxel; Pegylated Liposomal Doxorubicin Hydrochloride; Carboplatin; Carboplatin; yes; yes; yes; no; yes; yes; yes; yes; NA; 2025-01-06T20:32:54.094473-06:00; 2025-01-06T20:32:54.094473-06:00; 2025-01-06T20:32:54.094473-06:00; 2025-01-06T20:32:54.094473-06:00; 2025-01-06T20:32:54.094473-06:00; 2025-01-06T20:32:54.094473-06:00; 2025-01-06T20:32:54.094473-06:00; Recurrent Disease; Recurrent Disease; NA; NA; NA; Recurrent Disease; Recurrent Disease; Recurrent Disease; NA; NA; Adjuvant; Adjuvant; Adjuvant; NA; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; mg; mg; NA; NA; NA; mg; NA; mg","Ovary",21879,"Serous cystadenocarcinoma, NOS","primary",NA,"0516c666-98fd-5556-b9f5-084913c790dc","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",1998,"Surgical Resection","C56.9","G2",NA,"white","female","not reported","Dead",59,-21879,"5670d6e7-a5d0-5321-9e29-1b6c44e7d0d4",FALSE,2634,NA,"TCGA-29-1762-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1762-01"
"TCGA-30-1861-01A-01R-1568-13","TCGA-30-1861-01A-01R-1568-13","TCGA-30-1861","TCGA-30-1861-01A","TP","Primary solid Tumor","TCGA-30-1861-01A","01","Primary","2642249c-adc7-48e2-8493-1597e269c2c9","Primary Tumor","Not Reported","released","Unknown",0.4,"446be880-d1d8-4b63-b4d5-5aa0468ccafe","TCGA-30-1861",0.4,"Unknown",0.8,FALSE,"Tumor","8441/3","","Ovary",27103,"Serous cystadenocarcinoma, NOS","primary",NA,"4df9c324-0ddb-5e04-beb7-a6c37bf5e8a8","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",74,-27103,"306e3132-57a0-51fc-87e4-1d00bf8466d0",FALSE,1058,NA,"TCGA-30-1861-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-30-1861-01"
"TCGA-20-1682-01A-01R-1564-13","TCGA-20-1682-01A-01R-1564-13","TCGA-20-1682","TCGA-20-1682-01A","TP","Primary solid Tumor","TCGA-20-1682-01A","01","Primary","3c3da068-a62f-43c9-91c7-41ead1ca7f75","Primary Tumor",NA,"released","Unknown",0.4,"cf49ea4d-478c-469d-ace2-7ef52b66a332","TCGA-20-1682",0.3,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 057e42e5-4576-46fd-8318-5d78b6e5c7a6; 95b68bc0-4a89-4341-9f78-e02db9e2d625; fae81cac-35fa-5817-832b-5b69dac21bfc; TCGA-20-1682_treatment3; TCGA-20-1682_treatment2; TCGA-20-1682_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:20:50.812034-06:00; 2025-01-06T21:20:50.812034-06:00; NA; NA; 145; 145; NA; 40; 40; Intravenous; Intravenous; NA; 6; 6; NA; Carboplatin; Paclitaxel; NA; NA; 175; NA; NA; mg/m2","Ovary",20583,"Serous cystadenocarcinoma, NOS","primary",NA,"72df9e88-9c14-5df0-820e-182c1459f906","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","GX",NA,"white","female","not hispanic or latino","Alive",56,-20583,"785a428f-fce0-5477-84d9-dc65a0af2908",FALSE,NA,NA,"TCGA-20-1682-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-20-1682-01"
"TCGA-04-1542-01A-01R-1566-13","TCGA-04-1542-01A-01R-1566-13","TCGA-04-1542","TCGA-04-1542-01A","TP","Primary solid Tumor","TCGA-04-1542-01A","01","Primary","d33fd264-13db-4642-afca-37125751cc28","Primary Tumor",NA,"released","Unknown",0.8,"E3103C8A-50CB-43FE-9670-2BFB5D1DC318","TCGA-04-1542",0.3,"Solid Tissue",1,FALSE,"Tumor","8441/3","167; 2268; 2176; 1781; 1781; 167; 1294; 2512; NA; 1487; 2512; 2176; 2328; 167; 2106; 1529; 1294; 17378; 5; 124; 32496; 11300; 2534; 4004; 28756; NA; 122; 2870; 4875; 343; 5; 7398; 159; 5; 2; 2207; 2115; 1564; 1564; 2; 1051; 2328; NA; 1322; 2328; 2115; 2268; 2; 1993; 1501; 1051; Intravenous; Intravenous; Intravenous; 08899f5f-8c88-4218-9cf9-1a02f4975a11; 275064ed-db5f-4c96-97f3-2abf24c1602a; 2d88345d-ffe6-48f8-a643-0e0a5f3dda1f; 2e4f1a88-6118-4af5-a3d0-beab5ffdba2e; 2f8b229d-8290-4f81-ac9e-f1a19fc15a75; 38e25d4e-a949-58c6-a84d-461f854c58fc; 407aa31a-0ff4-4833-9577-a197409e732f; 54a99eac-b72d-4877-8a8d-ea23a0c9812b; 58d4b26a-a818-4463-9534-b3c6e34f844a; 662b7067-7c7e-4751-a7a7-dfae159dd469; 7145fdd2-6c7e-4076-b2be-2ab7a347fc56; 78fd13bd-ec0b-4474-a8b0-0a158ee58c89; 861d72c4-2fff-4597-a940-d1538d2f89be; a9cdaff0-4b9d-48bb-bc5c-0e8cb1939eb9; bbb5175d-b4b5-49a4-8360-f4474c270d77; c76084a3-5478-471d-8ba0-2931fb65a3c7; e4568f8b-e61a-4d62-b392-2de7d43fcf66; TCGA-04-1542_treatment9; TCGA-04-1542_treatment8; TCGA-04-1542_treatment10; TCGA-04-1542_treatment2; TCGA-04-1542_treatment11; TCGA-04-1542_treatment; TCGA-04-1542_treatment15; TCGA-04-1542_treatment5; TCGA-04-1542_treatment17; TCGA-04-1542_treatment4; TCGA-04-1542_treatment13; TCGA-04-1542_treatment7; TCGA-04-1542_treatment14; TCGA-04-1542_treatment3; TCGA-04-1542_treatment12; TCGA-04-1542_treatment16; TCGA-04-1542_treatment6; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 8; 3; 4; 11; 11; 8; 12; 9; NA; 6; 9; 4; 3; 8; 6; 2; 12; Gemcitabine; Carboplatin; Docetaxel; Gemcitabine; Cisplatin; Paclitaxel; Paclitaxel; Gemcitabine; NA; Paclitaxel; Bevacizumab; Bevacizumab; Doxorubicin; Carboplatin; Bevacizumab; Pegylated Liposomal Doxorubicin Hydrochloride; Carboplatin; yes; yes; yes; yes; yes; yes; yes; yes; no; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; NA; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; 2025-01-06T21:09:50.414762-06:00; Adjuvant; NA; NA; NA; NA; Adjuvant; NA; NA; Adjuvant; NA; NA; NA; NA; Adjuvant; NA; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; released; released; released; released; released; released; released; mg; AUC; mg; mg; mg; mg; mg; mg; NA; mg; mg; mg; mg; AUC; mg; mg; AUC; NA; Recurrent Disease; Recurrent Disease; Recurrent Disease; Recurrent Disease; NA; Recurrent Disease; Recurrent Disease; NA; Recurrent Disease; Recurrent Disease; Recurrent Disease; Recurrent Disease; NA; Recurrent Disease; Recurrent Disease; Recurrent Disease","Ovary",19263,"Serous cystadenocarcinoma, NOS","primary",NA,"5c54e4c7-4168-5896-9e70-26530bcbb200","Ovary","No",TRUE,0,"Stage IIIB","Not Reported","Bilateral","not reported",2001,"Surgical Resection","C56.9","G2",NA,"white","female","not reported","Dead",52,-19263,"fb7f748c-1e48-553a-aa93-63181a69f871",FALSE,2561,NA,"TCGA-04-1542-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1542-01"
"TCGA-23-1109-01A-01R-1564-13","TCGA-23-1109-01A-01R-1564-13","TCGA-23-1109","TCGA-23-1109-01A","TP","Primary solid Tumor","TCGA-23-1109-01A","01","Primary","146f9463-de59-4418-9099-2425a6f86a0f","Primary Tumor",NA,"released","Unknown",0.9,"d70d81ca-5eb2-426c-afc7-4d52bc36bfb2","TCGA-23-1109",0.8,"Unknown",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0561e859-c9f3-47fd-92f3-60c66a782ea4; 6656f489-4e40-4f2d-a371-06d759f165c5; cf32e575-aed9-4c88-b1b5-7892c18eb053; TCGA-23-1109_treatment5; TCGA-23-1109_treatment7; TCGA-23-1109_treatment6; Pharmaceutical Therapy, NOS; Surgery, NOS; Radiation Therapy, NOS; released; released; released; yes; yes; yes; 2025-01-06T21:12:33.485420-06:00; 2025-01-06T21:12:33.485420-06:00; 2025-01-06T21:12:33.485420-06:00; Unknown; Unknown; Unknown; NA; 987; NA","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-23-1109_diagnosis","17b3c06c-0835-45e9-9a03-f2cccb955abe","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",62,-23002,"51854744-93b7-5026-a52b-398fdc2b8ec0",FALSE,1562,NA,"TCGA-23-1109-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1109-01"
"TCGA-30-1860-01A-01R-1568-13","TCGA-30-1860-01A-01R-1568-13","TCGA-30-1860","TCGA-30-1860-01A","TP","Primary solid Tumor","TCGA-30-1860-01A","01","Primary","5ae1ae22-b891-472a-b737-e48c73b91798","Primary Tumor","Not Reported","released","Unknown",0.4,"d5b8e59f-1ae5-4e22-b933-48e48a364788","TCGA-30-1860",0.3,"Unknown",0.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 407b0aa0-9eeb-48a5-986d-da6b5732f78a; 89e9969d-7fb7-4ba3-8972-da40f8b7c8a7; e48f98d3-7483-4fb6-b1c6-df8a1f0731c6; TCGA-30-1860_treatment13; TCGA-30-1860_treatment15; TCGA-30-1860_treatment14; Pharmaceutical Therapy, NOS; Surgery, NOS; Radiation Therapy, NOS; released; released; released; yes; yes; yes; 2025-01-06T20:48:08.521537-06:00; 2025-01-06T20:48:08.521537-06:00; 2025-01-06T20:48:08.521537-06:00; Unknown; Unknown; Unknown; NA; 974; NA","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-30-1860_diagnosis","24bd1d15-e2f6-40c4-a942-61e7a9532177","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","hispanic or latino","Dead",58,-21406,"e6e91e72-6dca-5afc-a512-914d653d4a4f",FALSE,1366,NA,"TCGA-30-1860-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-30-1860-01"
"TCGA-25-1319-01A-01R-1565-13","TCGA-25-1319-01A-01R-1565-13","TCGA-25-1319","TCGA-25-1319-01A","TP","Primary solid Tumor","TCGA-25-1319-01A","01","Primary","c063d066-9073-4f05-8a38-601aa65dc5bf","Primary Tumor","Not Reported","released","Unknown",2.5,"62BFD64E-1C60-49A8-BAD0-B173DD22C951","TCGA-25-1319",1,"Unknown",3,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 7b186a2a-391e-4607-870a-6f7ad041b5d6; f5cc86d7-c0ac-4599-a62c-91081ee10c5d; TCGA-25-1319_treatment4; TCGA-25-1319_treatment5; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:45:57.480639-06:00; 2025-01-06T20:45:57.480639-06:00; Recurrent Disease; Recurrent Disease","Not Reported",27516,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-25-1319_diagnosis","9001f454-36ca-4f3b-a6ae-08560aa67cd9","Not Reported","Yes",FALSE,730,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",73,-26786,"87285b0c-753a-5853-a163-2d40aeeb0262",FALSE,1977,NA,"TCGA-25-1319-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1319-01"
"TCGA-24-2297-01A-01R-1568-13","TCGA-24-2297-01A-01R-1568-13","TCGA-24-2297","TCGA-24-2297-01A","TP","Primary solid Tumor","TCGA-24-2297-01A","01","Primary","e1855137-b479-4d9c-b729-ff84263abd89","Primary Tumor","Not Reported","released","Unknown",0.6,"12b02227-4050-4d02-bdb8-939d348a4c19","TCGA-24-2297",0.3,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; d15a8c62-719a-4992-93c9-a7fd9ecfeab0; dc3124f9-3068-5934-890b-d005d0885181; ef3c0bca-e79a-4925-a9d0-14c6105c333c; TCGA-24-2297_treatment3; TCGA-24-2297_treatment; TCGA-24-2297_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:21:20.455110-06:00; NA; 2025-01-06T21:21:20.455110-06:00; NA; 153; 153; NA; 5530; 3981; NA; 19; 19; Intravenous; Intravenous; NA; 6; 6; NA; Cyclophosphamide; Carboplatin; NA; mg; mg","Ovary",20487,"Serous cystadenocarcinoma, NOS","primary",NA,"036f498f-caec-57c3-8ca1-8d83d027149d","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1993,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",56,-20487,"5e77a0b3-6cd4-5602-bdb2-874b275291f9",FALSE,1699,NA,"TCGA-24-2297-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2297-01"
"TCGA-OY-A56Q-01A-11R-A406-31","TCGA-OY-A56Q-01A-11R-A406-31","TCGA-OY-A56Q","TCGA-OY-A56Q-01A","TP","Primary solid Tumor","TCGA-OY-A56Q-01A","01","Primary","d5cad767-265f-480f-a3bf-185bd4a75d5e","Primary Tumor",NA,"released","Unknown",NA,"3EF6F66B-8B6E-48E6-9CF4-F8A6B236856D","TCGA-OY-A56Q",NA,"Unknown",NA,FALSE,"Tumor","8441/3","Adjuvant; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 77a61c99-b15a-47d5-8fcf-aa0f0a0f9432; aed9933d-25e1-49ce-9f7b-3fdcbc48cb27; af64e246-f0f8-51c9-8cc0-473354478c58; TCGA-OY-A56Q_treatment3; TCGA-OY-A56Q_treatment2; TCGA-OY-A56Q_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T20:16:45.346993-06:00; 2025-01-06T20:16:45.346993-06:00; NA; NA; 128; 128; NA; No; No; NA; 23; 23; NA; Complete Response; Complete Response; NA; Carboplatin; Paclitaxel","Ovary",28623,"Serous cystadenocarcinoma, NOS","primary",NA,"e64f78a3-2512-50f4-8b0c-34493a440422","Ovary","No",TRUE,0,"Stage IIA","No","Left","no",2012,"Surgical Resection","C56.9","G3","RX","black or african american","female","not hispanic or latino","Alive",78,-28623,"d29528b8-bba5-5033-8fed-7dc94e0f4764",FALSE,NA,NA,"TCGA-OY-A56Q-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,120,370,"false",NA,NA,NA,NA,"United States",NA,NA,"TCGA-OY-A56Q-01"
"TCGA-36-1568-01A-01R-1566-13","TCGA-36-1568-01A-01R-1566-13","TCGA-36-1568","TCGA-36-1568-01A","TP","Primary solid Tumor","TCGA-36-1568-01A","01","Primary","0c2b931b-813b-450f-a911-d25fd7465e18","Primary Tumor",NA,"released","Unknown",0.5,"dad4bbdc-0156-48c2-a975-27ccfb9152a3","TCGA-36-1568",0.3,"Unknown",1.6,FALSE,"Tumor","8441/3","737; 123; NA; 123; 286; 1257; NA; 2610; 624; 10; NA; 10; Intravenous; Intravenous; Intravenous; 2a0802da-d09e-5156-bca8-f7f3f8d78cb7; 487170b3-8753-45ab-9bb3-67e1e2bc9bff; 77e10bbe-63a9-456c-8668-43aab839981c; 8a4c0d5f-6264-4df9-b0a3-6db46d6f0876; TCGA-36-1568_treatment; TCGA-36-1568_treatment2; TCGA-36-1568_treatment4; TCGA-36-1568_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 5; 5; NA; 5; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; NA; Carboplatin; yes; yes; no; yes; NA; 2025-01-06T20:33:41.555861-06:00; 2025-01-06T20:33:41.555861-06:00; 2025-01-06T20:33:41.555861-06:00; Progressive Disease; NA; NA; NA; NA; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; mg; NA; mg","Ovary",19311,"Serous cystadenocarcinoma, NOS","primary",NA,"f0ac6623-6d2a-5f87-a515-fe563d907b98","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G3",NA,"not reported","female","not reported","Alive",52,-19311,"357b0c19-bb6c-588d-a652-1d4bf67cc0c4",FALSE,NA,NA,"TCGA-36-1568-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-36-1568-01"
"TCGA-29-1777-01A-01R-1567-13","TCGA-29-1777-01A-01R-1567-13","TCGA-29-1777","TCGA-29-1777-01A","TP","Primary solid Tumor","TCGA-29-1777-01A","01","Primary","afb43292-69c2-4d84-84f5-0bde9a6e9ea5","Primary Tumor",NA,"released","Unknown",0.6,"bfd59906-509b-4ca3-9282-c881f9962e15","TCGA-29-1777",0.5,"Unknown",1.3,FALSE,"Tumor","8441/3","346; 303; NA; 325; 70; 740; NA; 660; 346; 87; NA; 325; Intravenous; Intravenous; Intravenous; 1926b00e-c834-5070-8fe4-063f9171cb7f; 336bd139-0954-497b-a453-c6c528b1a12c; 3a540b46-fef9-46e4-93f2-39d11faf817a; d6e3536c-05db-4c39-a217-2c9587ca1367; TCGA-29-1777_treatment; TCGA-29-1777_treatment2; TCGA-29-1777_treatment4; TCGA-29-1777_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 1; 6; NA; 1; Doxorubicin Hydrochloride; Carboplatin; NA; Carboplatin; yes; yes; no; yes; NA; 2025-01-06T20:41:58.996331-06:00; 2025-01-06T20:41:58.996331-06:00; 2025-01-06T20:41:58.996331-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; mg; NA; mg","Ovary",17356,"Serous cystadenocarcinoma, NOS","primary",NA,"06faab0f-085d-5399-a16e-833cb5d7e9d7","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G2",NA,"white","female","not reported","Alive",47,-17356,"76f43d25-03dd-5e87-a305-baf33d049fbf",FALSE,NA,NA,"TCGA-29-1777-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1777-01"
"TCGA-24-2271-01A-01R-1568-13","TCGA-24-2271-01A-01R-1568-13","TCGA-24-2271","TCGA-24-2271-01A","TP","Primary solid Tumor","TCGA-24-2271-01A","01","Primary","de9d08f5-24f5-4cdc-8f30-d05a2bea5301","Primary Tumor","Not Reported","released","Unknown",0.8,"87d64a93-9b08-48a5-a26e-1cc4b5ac8bde","TCGA-24-2271",0.5,"Unknown",1.6,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 5ce9a5a0-145c-40d7-99ec-d96af0868739; 5e66868a-e1ff-4554-931c-3c971c223c93; 870b4b25-54da-4479-92d8-f172adf8d81a; TCGA-24-2271_treatment6; TCGA-24-2271_treatment7; TCGA-24-2271_treatment8; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; Surgery, NOS; released; released; released; yes; no; yes; 2025-01-06T21:14:48.518953-06:00; 2025-01-06T21:14:48.518953-06:00; 2025-01-06T21:14:48.518953-06:00; Progressive Disease; Progressive Disease; Progressive Disease; NA; NA; 22","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-24-2271_diagnosis","01d0842c-eaa0-4aaf-a557-6a482c619c8e","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"asian","female","not reported","Dead",55,-20399,"ade57b50-0f6f-525d-b4d9-895575ae7a36",FALSE,962,NA,"TCGA-24-2271-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2271-01"
"TCGA-61-2092-01A-01R-1568-13","TCGA-61-2092-01A-01R-1568-13","TCGA-61-2092","TCGA-61-2092-01A","TP","Primary solid Tumor","TCGA-61-2092-01A","01","Primary","962bb8fd-018e-49d0-b1df-dc0192e1b2a6","Primary Tumor","Not Reported","released","Unknown",1.2,"35b4bfa3-e6a5-4b55-a7f1-bc39953422c0","TCGA-61-2092",0.4,"Unknown",1.3,FALSE,"Tumor","8441/3","160; NA; 160; 41; NA; 41; Intravenous; Intravenous; 2d8c1dcf-b0a7-4630-82c2-8054ac8b7052; ac21f76e-5537-42ee-b868-8831478c5150; e69ef619-a6ae-5941-a261-0a6ee83ea47a; TCGA-61-2092_treatment2; TCGA-61-2092_treatment3; TCGA-61-2092_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; NA; 6; Paclitaxel; NA; Carboplatin; yes; no; yes; 2025-01-06T20:39:16.828273-06:00; 2025-01-06T20:39:16.828273-06:00; NA; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released","Ovary",21072,"Serous cystadenocarcinoma, NOS","primary",NA,"8fd8c018-04a7-549f-a3a6-ac8e9b87c065","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",57,-21072,"53de236f-819a-54ee-9111-6556f3647385",FALSE,NA,NA,"TCGA-61-2092-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2092-01"
"TCGA-24-1924-01A-01R-1567-13","TCGA-24-1924-01A-01R-1567-13","TCGA-24-1924","TCGA-24-1924-01A","TP","Primary solid Tumor","TCGA-24-1924-01A","01","Primary","525471c8-0249-45ed-a443-db52ca6c04d9","Primary Tumor","Not Reported","released","Unknown",0.5,"4199b57a-81f5-4d5f-9f4c-1e514dcd26dc","TCGA-24-1924",0.5,"Unknown",1,FALSE,"Tumor","8441/3","743; 681; 525; 681; 583; NA; 161; 161; 583; 12600; 441; 576; 7914; 18; NA; 1621; 2595; 184; 706; 597; 329; 597; 553; NA; 21; 21; 553; Oral; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 540e1de8-6626-46ea-b212-5915c2072f56; 56c7c373-092e-4317-bd86-e5e16fc232bc; 991d649e-fae8-468f-9dbf-89734c29201a; a33a3246-fb6d-4410-8e04-ad0b49adce09; ba91a268-44c4-5348-b906-56556ec299ff; c16ec088-4a40-4afd-8abf-5ef4a85f2fe5; ee827b1e-fb59-4f78-8714-71dcd8e358ee; f8f6bfaf-014d-478c-ac59-6649843c1f4e; fe3a611b-1d63-4de3-ae27-247b916bde09; TCGA-24-1924_treatment6; TCGA-24-1924_treatment4; TCGA-24-1924_treatment7; TCGA-24-1924_treatment2; TCGA-24-1924_treatment; TCGA-24-1924_treatment9; TCGA-24-1924_treatment5; TCGA-24-1924_treatment3; TCGA-24-1924_treatment8; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; 2; 5; 8; 5; 2; NA; 6; 6; 2; Altretamine; Cisplatin; Pegylated Liposomal Doxorubicin Hydrochloride; Gemcitabine Hydrochloride; Topotecan; NA; Paclitaxel; Carboplatin; Vinorelbine Tartrate; yes; yes; yes; yes; yes; no; yes; yes; yes; 2025-01-06T20:38:56.431936-06:00; 2025-01-06T20:38:56.431936-06:00; 2025-01-06T20:38:56.431936-06:00; 2025-01-06T20:38:56.431936-06:00; NA; 2025-01-06T20:38:56.431936-06:00; 2025-01-06T20:38:56.431936-06:00; 2025-01-06T20:38:56.431936-06:00; 2025-01-06T20:38:56.431936-06:00; Progressive Disease; Progressive Disease; Recurrent Disease; Progressive Disease; Progressive Disease; NA; NA; NA; Progressive Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; mg; mg; mg; mg; mg; NA; mg; mg; mg; NA; NA; NA; NA; NA; Adjuvant; Adjuvant; Adjuvant; NA","Ovary",23801,"Serous cystadenocarcinoma, NOS","primary",NA,"2d0eccd4-29ce-5014-9267-b0c39ebbf933","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2001,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",65,-23801,"ebc2ba2c-fc56-5869-b71c-e4f8b4479474",FALSE,919,NA,"TCGA-24-1924-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1924-01"
"TCGA-13-1405-01A-01R-1565-13","TCGA-13-1405-01A-01R-1565-13","TCGA-13-1405","TCGA-13-1405-01A","TP","Primary solid Tumor","TCGA-13-1405-01A","01","Primary","d900cebf-8795-4385-8f57-77209178ff43","Primary Tumor","Not Reported","released","Unknown",1.3,"DFB9F8B2-986C-4963-B2D2-837E54174CF0","TCGA-13-1405",0.5,"Unknown",1.3,FALSE,"Tumor","Unknown","","Not Reported",18446,"Unknown","Unknown","TCGA-13-1405_diagnosis","802a2497-9dfe-4433-9166-6272d2c9cb74","Not Reported","Yes",FALSE,228,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",49,-18218,"baec593a-b625-575d-9c78-53c435b457e4",FALSE,868,NA,"TCGA-13-1405-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1405-01"
"TCGA-09-2045-01A-01R-1568-13","TCGA-09-2045-01A-01R-1568-13","TCGA-09-2045","TCGA-09-2045-01A","TP","Primary solid Tumor","TCGA-09-2045-01A","01","Primary","4d5aaf12-a500-4709-9c99-5b9fef2c79b1","Primary Tumor","Not Reported","released","Unknown",0.7,"6c826e9d-b1aa-4c84-b294-c8fb41818da1","TCGA-09-2045",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","895; 239; 11; 808; 11; 939; 808; NA; 939; 94; 94; 239; 875; 121; 11; 678; 11; 933; 678; NA; 933; 64; 64; 121; Oral; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 00384dae-a28f-47e3-a395-36bdecd58af0; 07c51cb8-37a0-48c8-9324-57207fde0293; 1b2c6cef-ba81-4958-938d-225000f554be; 35aab97a-27d7-48df-a26e-68963cecaebb; 3fddf00d-d655-4ee4-b10a-0252399d9e26; 49e9ebeb-2801-4180-a82a-7c71790182ca; 7d4be807-5188-482b-b262-cb1f3829207c; c2b741f0-9882-4483-b1ea-6742c0846fd4; c7a499ad-5696-4fd4-80fb-5e3509451f5a; d6c5532c-b73c-4446-99aa-9b24d9c6ba22; e31e9778-3847-42eb-a80b-d9e469c14dea; fbf4c9d9-7fcc-5779-8624-88535dfac6a3; TCGA-09-2045_treatment6; TCGA-09-2045_treatment8; TCGA-09-2045_treatment2; TCGA-09-2045_treatment3; TCGA-09-2045_treatment7; TCGA-09-2045_treatment9; TCGA-09-2045_treatment10; TCGA-09-2045_treatment12; TCGA-09-2045_treatment11; TCGA-09-2045_treatment4; TCGA-09-2045_treatment5; TCGA-09-2045_treatment; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 2; 5; 1; 6; 1; 2; 6; NA; 2; 2; 2; 5; Etoposide; Paclitaxel; Paclitaxel; Docetaxel; Carboplatin; Gemcitabine; Topotecan; NA; Carboplatin; Cisplatin; Paclitaxel; Cisplatin; yes; yes; yes; yes; yes; yes; yes; no; yes; yes; yes; yes; 2025-01-06T20:22:04.777680-06:00; 2025-01-06T20:22:04.777680-06:00; 2025-01-06T20:22:04.777680-06:00; 2025-01-06T20:22:04.777680-06:00; 2025-01-06T20:22:04.777680-06:00; 2025-01-06T20:22:04.777680-06:00; 2025-01-06T20:22:04.777680-06:00; 2025-01-06T20:22:04.777680-06:00; 2025-01-06T20:22:04.777680-06:00; 2025-01-06T20:22:04.777680-06:00; 2025-01-06T20:22:04.777680-06:00; NA; Progressive Disease; NA; NA; Progressive Disease; NA; Progressive Disease; Progressive Disease; NA; Progressive Disease; NA; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; released; released; NA; 135; 135; 70; 810; 1600; 1; NA; 560; 50; 100; 50; NA; Adjuvant; Adjuvant; Not Reported; Adjuvant; NA; Not Reported; Adjuvant; NA; Adjuvant; Adjuvant; Adjuvant; NA; mg/m2; mg/m2; mg/m2; mg; mg; mg/m2; NA; mg; mg/m2; mg/m2; mg/m2","Ovary",18285,"Serous cystadenocarcinoma, NOS","primary",NA,"0ffcd742-a709-52d5-b7ac-ea8a72376fdf","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",1996,"Surgical Resection","C56.9","G2",NA,"asian","female","not hispanic or latino","Dead",50,-18285,"6ca6b1db-10fc-590d-a441-127763862ffa",FALSE,1069,NA,"TCGA-09-2045-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-2045-01"
"TCGA-24-1422-01A-01R-1565-13","TCGA-24-1422-01A-01R-1565-13","TCGA-24-1422","TCGA-24-1422-01A","TP","Primary solid Tumor","TCGA-24-1422-01A","01","Primary","b6568556-a2fb-4eec-a953-b8b81d2fd6dd","Primary Tumor","Not Reported","released","Unknown",1.2,"8bcb6cf4-84ea-41a1-9113-061a7523c19f","TCGA-24-1422",0.5,"Unknown",1.8,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 8a06f721-acc6-4f57-b56a-60f8f3987d3f; a9ea5705-2622-5dc2-b25c-5610263acf81; TCGA-24-1422_treatment2; TCGA-24-1422_treatment; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; no; 2025-01-06T20:38:03.901456-06:00; NA; NA; NA","Ovary",30234,"Serous cystadenocarcinoma, NOS","primary",NA,"f2ffb8cb-705b-5752-84dd-53e3f9fab12b","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"black or african american","female","not reported","Dead",82,-30234,"838591b6-cdae-547d-adfe-1dfcc60db703",FALSE,23,NA,"TCGA-24-1422-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1422-01"
"TCGA-61-1728-01A-01R-1568-13","TCGA-61-1728-01A-01R-1568-13","TCGA-61-1728","TCGA-61-1728-01A","TP","Primary solid Tumor","TCGA-61-1728-01A","01","Primary","9c3d5caf-78e2-4a1c-9e08-1ca5aa1c5625","Primary Tumor","Not Reported","released","Unknown",0.6,"7611c4d4-f58b-404e-93f1-949c865c9e12","TCGA-61-1728",0.2,"Unknown",1.1,FALSE,"Tumor","8441/3","204; 848; NA; 204; 2000; 1920; NA; 5280; 43; 246; NA; 43; Intravenous; Intravenous; Intravenous; 01845e5b-e916-474f-beec-3539158a4453; b04063f1-386e-4ed4-8e9d-32ef5ccf0fb2; c3b52cb2-dbed-4760-bf4a-62a0c6168485; f656a5c5-3c82-5dc0-b931-b7ca5d849549; TCGA-61-1728_treatment3; TCGA-61-1728_treatment2; TCGA-61-1728_treatment4; TCGA-61-1728_treatment; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 8; 20; NA; 8; Paclitaxel; Vosaroxin; NA; Carboplatin; yes; yes; no; yes; 2025-01-06T21:19:11.782473-06:00; 2025-01-06T21:19:11.782473-06:00; 2025-01-06T21:19:11.782473-06:00; NA; Adjuvant; NA; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; mg; NA; mg; NA; Recurrent Disease; NA; NA","Ovary",21582,"Serous cystadenocarcinoma, NOS","primary",NA,"947ce4f7-c76d-587a-af7d-533e4eeb9b1f","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",59,-21582,"3a226523-d211-5c33-ab72-74b052e22634",FALSE,NA,NA,"TCGA-61-1728-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1728-01"
"TCGA-25-1314-01A-01R-1565-13","TCGA-25-1314-01A-01R-1565-13","TCGA-25-1314","TCGA-25-1314-01A","TP","Primary solid Tumor","TCGA-25-1314-01A","01","Primary","a3d8fe02-63fa-40ff-9563-38e8d2bf04bb","Primary Tumor","Not Reported","released","Unknown",2,"B208F8AC-5F06-4DAD-A410-5D65D36674D6","TCGA-25-1314",0.8,"Unknown",4.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 93609a03-5c16-4a58-be54-7cf798c41beb; fedfc2d5-ba54-4568-a286-7f34a9deac26; TCGA-25-1314_treatment6; TCGA-25-1314_treatment7; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:28:07.789094-06:00; 2025-01-06T20:28:07.789094-06:00; Progressive Disease; Progressive Disease","Not Reported",15736,"Serous cystadenocarcinoma, NOS","Progression","TCGA-25-1314_diagnosis","21d8ec03-5fae-439d-83c1-94488c75f843","Not Reported","Yes",FALSE,274,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",42,-15462,"e600b6c2-88c6-5447-835f-a71c482c6c16",FALSE,1004,NA,"TCGA-25-1314-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1314-01"
"TCGA-09-1668-01B-01R-1566-13","TCGA-09-1668-01B-01R-1566-13","TCGA-09-1668","TCGA-09-1668-01B","TP","Primary solid Tumor","TCGA-09-1668-01B","01","Primary","3db1f968-6db6-40c7-aacd-44921f0bf709","Primary Tumor",NA,"released","Unknown",0.6,"7740b3ec-1d81-4408-be9e-45ccd7e91b3a","TCGA-09-1668",0.3,"Unknown",0.7,FALSE,"Tumor","8441/3","Adjuvant; NA; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 217a4531-e4c7-4a78-b385-6bce29396e31; 552490ce-3dd5-4b2c-ac73-4898de99932c; 5ab929e6-f83f-4c44-9475-df029560e687; a2ef7309-4ade-5a6a-949f-d52fe5347193; TCGA-09-1668_treatment4; TCGA-09-1668_treatment2; TCGA-09-1668_treatment3; TCGA-09-1668_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T20:21:02.983919-06:00; 2025-01-06T20:21:02.983919-06:00; 2025-01-06T20:21:02.983919-06:00; NA; NA; 320; 135; 135; NA; 60; 480; 120; NA; 151; 31; 31; Intravenous; Intravenous; Intravenous; NA; 9; 6; 6; NA; Docetaxel; Carboplatin; Docetaxel; NA; mg/m2; mg; mg","Ovary",20972,"Serous cystadenocarcinoma, NOS","primary",NA,"0fbdc72e-a36b-5c66-9042-67e6732464ab","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",57,-20972,"750dae51-7957-57e9-9cf2-2054e1f5840a",FALSE,NA,NA,"TCGA-09-1668-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-1668-01"
"TCGA-61-1741-01A-02R-1567-13","TCGA-61-1741-01A-02R-1567-13","TCGA-61-1741","TCGA-61-1741-01A","TP","Primary solid Tumor","TCGA-61-1741-01A","01","Primary","e5e22755-8759-4349-a6ba-87fff441183c","Primary Tumor",NA,"released","Unknown",1,"e2d0ec41-559c-48d4-8c4d-59e0f9d48823","TCGA-61-1741",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","605; 605; 717; 180; NA; 180; 838; 1750; 20; 2240; NA; 3799; 522; 522; 711; 12; NA; 12; Intravenous; Intravenous; Intravenous; Oral; Intravenous; 19c4806c-15ed-46ec-a97a-1d7913aa212a; 3a5a378f-30e8-48e8-b268-f7bf68429821; 56160cfd-0619-58a1-bbb8-d6d31502c502; 7006c1a0-45f5-4eb5-8d8b-2b9fbfa7bba9; 7d9a49ce-8c0f-4d5f-a189-2d582aa2d68a; c5402745-e4d8-4bac-8bd0-41a0a767118e; TCGA-61-1741_treatment6; TCGA-61-1741_treatment4; TCGA-61-1741_treatment; TCGA-61-1741_treatment2; TCGA-61-1741_treatment3; TCGA-61-1741_treatment5; Chemotherapy; Chemotherapy; Radiation, External Beam; Chemotherapy; Hormone Therapy; Chemotherapy; 3; 3; NA; 8; NA; 8; Paclitaxel; Carboplatin; NA; Paclitaxel; Tamoxifen; Carboplatin; yes; yes; yes; yes; yes; yes; 2025-01-06T20:51:24.473450-06:00; 2025-01-06T20:51:24.473450-06:00; NA; 2025-01-06T20:51:24.473450-06:00; 2025-01-06T20:51:24.473450-06:00; 2025-01-06T20:51:24.473450-06:00; Recurrent Disease; Recurrent Disease; NA; NA; Recurrent Disease; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; mg; mg; cGy; mg; NA; mg; NA; NA; 5; NA; NA; NA; Locoregional Site; NA; NA; Palliative; Adjuvant; NA; Adjuvant","Ovary",27762,"Serous cystadenocarcinoma, NOS","primary",NA,"4338074a-9988-5342-ae53-3406d24b6758","Ovary","No",TRUE,0,"Stage IIIB","Not Reported","Bilateral","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",76,-27762,"058fb30f-2085-5770-b4f2-6a6cf64072f7",FALSE,1024,NA,"TCGA-61-1741-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1741-01"
"TCGA-09-2048-01A-01R-1568-13","TCGA-09-2048-01A-01R-1568-13","TCGA-09-2048","TCGA-09-2048-01A","TP","Primary solid Tumor","TCGA-09-2048-01A","01","Primary","fe693f25-efb5-46d5-8bab-de5b87eef1ad","Primary Tumor","Not Reported","released","Unknown",0.7,"0755D708-ADF5-4219-ABC6-BCD9C2BCA089","TCGA-09-2048",0.2,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 60; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 6742f88d-c93f-565f-8b51-0f565f6845e8; ef8dbed5-5e21-4f99-aba0-81ec234681e2; TCGA-09-2048_treatment; TCGA-09-2048_treatment2; Chemotherapy; Radiation Therapy, NOS; released; released; NA; NA; yes; no; NA; 2025-01-06T20:41:12.240603-06:00","Ovary",23043,"Serous cystadenocarcinoma, NOS","primary",NA,"e84e8a2c-231c-56f6-97e2-983b9bb2e049","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1999,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",63,-23043,"43dd4513-5e1d-57ed-8b5a-5bf9175bb209",FALSE,138,NA,"TCGA-09-2048-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-2048-01"
"TCGA-29-1694-01A-01R-1567-13","TCGA-29-1694-01A-01R-1567-13","TCGA-29-1694","TCGA-29-1694-01A","TP","Primary solid Tumor","TCGA-29-1694-01A","01","Primary","4d74ff85-24e2-4e93-aa23-94d58efd22e4","Primary Tumor",NA,"released","Unknown",1,"ccfb9f1d-1779-4fae-a34f-c46a19d4b095","TCGA-29-1694",0.3,"Unknown",1.2,FALSE,"Tumor","8441/3","206; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1d19f824-ae61-4185-a505-5fb36c67d9d1; 8ce456ae-5071-44ef-b110-ada0d0674b08; f3e1630f-2a21-4fe8-be19-4d4300b6d18f; TCGA-29-1694_treatment13; TCGA-29-1694_treatment12; TCGA-29-1694_treatment11; Surgery, NOS; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; released; yes; yes; yes; 2025-01-06T21:00:50.460822-06:00; 2025-01-06T21:00:50.460822-06:00; 2025-01-06T21:00:50.460822-06:00; Unknown; Unknown; Unknown","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-29-1694_diagnosis","23e1151c-8ade-4fd6-a9ac-5368e0e52d28","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",45,-16523,"109ece40-b218-5b70-83d3-e21fe429076f",FALSE,1187,NA,"TCGA-29-1694-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1694-01"
"TCGA-13-0714-01A-01R-1564-13","TCGA-13-0714-01A-01R-1564-13","TCGA-13-0714","TCGA-13-0714-01A","TP","Primary solid Tumor","TCGA-13-0714-01A","01","Primary","7cb799d4-b69f-4cac-b975-1df91396250a","Primary Tumor","Not Reported","released","Unknown",0.6,"96EB4BD1-CE3B-44D8-8095-076712A3E082","TCGA-13-0714",0.5,"Unknown",1.2,FALSE,"Tumor","8441/3","175; NA; NA; NA; 12; NA; 12; 12; Intravenous; Intravenous; Oral; 04a61e9c-f15e-4b06-aeac-f44bb78a91e5; 97546469-eff3-4b64-a472-a95e494aa5d5; be736da6-b59e-5da9-b184-ad682b358041; c96e6636-2200-422d-b084-4b794107c461; TCGA-13-0714_treatment3; TCGA-13-0714_treatment4; TCGA-13-0714_treatment; TCGA-13-0714_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 4; NA; 4; 4; Paclitaxel; NA; Gemcitabine; Carboplatin; yes; no; yes; yes; 2025-01-06T21:04:44.153463-06:00; 2025-01-06T21:04:44.153463-06:00; NA; 2025-01-06T21:04:44.153463-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; NA; NA; NA","Ovary",20109,"Serous cystadenocarcinoma, NOS","primary",NA,"a2212176-e116-5cb8-adee-defab8d379bf","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2000,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",55,-20109,"228a6c55-1ab5-5019-bd8f-387fb592df71",FALSE,189,NA,"TCGA-13-0714-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0714-01"
"TCGA-61-2088-01A-01R-1568-13","TCGA-61-2088-01A-01R-1568-13","TCGA-61-2088","TCGA-61-2088-01A","TP","Primary solid Tumor","TCGA-61-2088-01A","01","Primary","29d36fc7-e849-42aa-bcc8-2fd9f7c9e24e","Primary Tumor","Not Reported","released","Unknown",1,"62624308-45b6-46f3-85a0-5a4639b44bf3","TCGA-61-2088",0.4,"Unknown",1.4,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0620c19a-1e05-4d55-a864-ef3c568c63b5; afebd551-2446-4f52-9a2a-b41485f9aafe; ef2a5e93-9f0f-53c1-96d5-da124011ce36; TCGA-61-2088_treatment3; TCGA-61-2088_treatment2; TCGA-61-2088_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T20:40:34.155664-06:00; 2025-01-06T20:40:34.155664-06:00; NA; NA; 145; 145; NA; 3900; 900; NA; 34; 34; Intravenous; Intravenous; NA; 6; 6; NA; Carboplatin; Docetaxel; NA; mg; mg","Ovary",18770,"Serous cystadenocarcinoma, NOS","primary",NA,"6e4a13d0-dffc-5780-9f24-ee952362f22d","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",51,-18770,"f10f87ea-db88-50ac-8b62-e269aa16ba67",FALSE,NA,NA,"TCGA-61-2088-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2088-01"
"TCGA-13-0901-01B-01R-1565-13","TCGA-13-0901-01B-01R-1565-13","TCGA-13-0901","TCGA-13-0901-01B","TP","Primary solid Tumor","TCGA-13-0901-01B","01","Primary","04cc5fca-1b0e-408b-bc12-b0987c561d53","Primary Tumor","Not Reported","released","Unknown",1.3,"5613318C-D3D4-436D-B22F-BE8FC36D9686","TCGA-13-0901",0.4,"Unknown",1.3,FALSE,"Tumor","8441/3","88; 165; 165; NA; 250; NA; 175; NA; 44; 44; 44; NA; 469999a3-4b66-5c0e-a9df-78a39a510a99; d08674eb-a73f-46ed-ba7d-36185905b210; d0a4d8cf-f3d9-4c77-ab5a-bfdbc66e4fdd; f90eec4a-0af2-4c55-9744-eea930803e37; TCGA-13-0901_treatment; TCGA-13-0901_treatment3; TCGA-13-0901_treatment2; TCGA-13-0901_treatment4; Targeted Molecular Therapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Cetuximab; Cisplatin; Paclitaxel; NA; yes; yes; yes; no; NA; 2025-01-06T20:43:39.734374-06:00; 2025-01-06T20:43:39.734374-06:00; 2025-01-06T20:43:39.734374-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; NA; mg/m2; NA; Intravenous; Intravenous; NA; 6; 6; NA","Ovary",15333,"Serous cystadenocarcinoma, NOS","primary",NA,"8285c0fe-f59c-574b-87d7-0bb866d8ac59","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2004,"Surgical Resection","C56.9","G3",NA,"asian","female","not hispanic or latino","Alive",41,-15333,"039bb7cc-4731-57bd-bbe7-dfce13b11b2e",FALSE,NA,NA,"TCGA-13-0901-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0901-01"
"TCGA-13-0885-01A-02R-1569-13","TCGA-13-0885-01A-02R-1569-13","TCGA-13-0885","TCGA-13-0885-01A","TP","Primary solid Tumor","TCGA-13-0885-01A","01","Primary","8486f0d0-2bb2-41a0-8b21-308407ce4aba","Primary Tumor",NA,"released","Unknown",0.6,"81DFFD49-45F0-4A20-AC27-B8316B2E0289","TCGA-13-0885",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 131907d6-7838-4b60-98ae-48369a37cf62; 3c9fc7f5-2aed-50e8-b25b-9b2f60e6e352; 64e62513-8668-47d0-84d3-86d7e2674f2d; 9ecbe30b-5c66-4e4c-97f6-6294b1f9ad0a; TCGA-13-0885_treatment4; TCGA-13-0885_treatment; TCGA-13-0885_treatment2; TCGA-13-0885_treatment3; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T21:40:44.898516-06:00; NA; 2025-01-06T21:40:44.898516-06:00; 2025-01-06T21:40:44.898516-06:00; NA; 208; 110; 110; Intraperitoneal; Intravenous; Intravenous; NA; 3; 6; 6; NA; Cisplatin; Paclitaxel; Carboplatin; NA; NA; 175; 5; NA; NA; 6; 6; NA; NA; mg/m2; AUC","Ovary",25763,"Serous cystadenocarcinoma, NOS","primary",NA,"65552a39-e03f-5986-9476-19628f3e6d7e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2000,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",70,-25763,"83bbd790-7f3e-5f1e-91be-9aaf019078bd",FALSE,NA,NA,"TCGA-13-0885-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0885-01"
"TCGA-25-1633-01A-01R-1566-13","TCGA-25-1633-01A-01R-1566-13","TCGA-25-1633","TCGA-25-1633-01A","TP","Primary solid Tumor","TCGA-25-1633-01A","01","Primary","170514dc-2d77-48f3-b9d0-42c216211e5b","Primary Tumor",NA,"released","Unknown",1,"B3B45EA2-B154-45DC-B49D-422500EA1D9C","TCGA-25-1633",0.2,"Unknown",1.3,FALSE,"Tumor","8441/3","184; 740; 740; NA; 184; 184; 26; 617; 617; NA; 26; 26; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 2253f219-7f50-5701-aef6-ab41b0a2129b; 32760cdf-4012-4ce1-a5cf-5454e56668b2; 4c2299d0-04a8-4509-bac0-f069996d21a3; b40d4f39-c075-40b4-a524-aa96354af3fc; d4639cdf-13f9-42e0-a85d-27b8642750f5; eacbc6ef-4dd5-4d5e-975f-0b48f3b5e7bb; TCGA-25-1633_treatment; TCGA-25-1633_treatment3; TCGA-25-1633_treatment2; TCGA-25-1633_treatment6; TCGA-25-1633_treatment4; TCGA-25-1633_treatment5; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 8; 8; 8; NA; 8; 8; Paclitaxel; Paclitaxel; Carboplatin; NA; Gemcitabine Hydrochloride; Carboplatin; yes; yes; yes; no; yes; yes; NA; 2025-01-06T21:17:39.512418-06:00; 2025-01-06T21:17:39.512418-06:00; 2025-01-06T21:17:39.512418-06:00; 2025-01-06T21:17:39.512418-06:00; 2025-01-06T21:17:39.512418-06:00; Adjuvant; NA; NA; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; NA; Recurrent Disease; Recurrent Disease; NA; NA; NA","Ovary",23407,"Serous cystadenocarcinoma, NOS","primary",NA,"a2f9c05f-49fc-5fcf-8f44-9a62df7e890e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",64,-23407,"e394758b-5b02-5855-a821-a660650ab989",FALSE,1891,NA,"TCGA-25-1633-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1633-01"
"TCGA-24-2288-01A-01R-1568-13","TCGA-24-2288-01A-01R-1568-13","TCGA-24-2288","TCGA-24-2288-01A","TP","Primary solid Tumor","TCGA-24-2288-01A","01","Primary","8f515078-38de-44c1-81ce-e40d8a942fc7","Primary Tumor","Not Reported","released","Unknown",0.6,"a8d48a3e-3f22-44ec-8cbd-2ad8bb43bb45","TCGA-24-2288",0.5,"Unknown",1.2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1ecfc1fe-7051-451e-9fb3-8c4c281efda9; a514274f-a2ac-5f8f-9a8b-c8b32dec1aee; ad4ef2d9-253b-46d0-ab87-adee25c798ac; TCGA-24-2288_treatment3; TCGA-24-2288_treatment; TCGA-24-2288_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:33:01.936118-06:00; NA; 2025-01-06T21:33:01.936118-06:00; NA; 21; 21; NA; 350; 600; NA; 21; 21; Intravenous; Intravenous; NA; 1; 1; NA; Paclitaxel; Carboplatin; NA; mg; mg","Ovary",25831,"Serous cystadenocarcinoma, NOS","primary",NA,"54c4860f-11d8-5cff-be3e-d4405cc30f73","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1999,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",70,-25831,"04990ab9-c2a6-52e5-be59-8e9024d7e18c",FALSE,25,NA,"TCGA-24-2288-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2288-01"
"TCGA-23-2084-01A-02R-1568-13","TCGA-23-2084-01A-02R-1568-13","TCGA-23-2084","TCGA-23-2084-01A","TP","Primary solid Tumor","TCGA-23-2084-01A","01","Primary","6ea4f0e4-f241-4d14-af35-a9bbcb8f4a9d","Primary Tumor","Not Reported","released","Unknown",1.1,"00fd3d04-b48e-434e-8d25-0f0949e796cc","TCGA-23-2084",0.5,"Unknown",1.4,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 15a71c6e-1b95-4919-8ad5-e6d7345c2c64; e55e269c-4a75-4129-a4dc-97f74ea6c6c1; f7d8c710-b6eb-4fa8-bdaa-c86fd008bd72; TCGA-23-2084_treatment17; TCGA-23-2084_treatment18; TCGA-23-2084_treatment19; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; Surgery, NOS; released; released; released; yes; no; yes; 2025-01-06T20:45:04.527308-06:00; 2025-01-06T20:45:04.527308-06:00; 2025-01-06T20:45:04.527308-06:00; Unknown; Unknown; Unknown; NA; NA; 627","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-23-2084_diagnosis","249b85e7-5021-4131-90a7-1a13987a70d2","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",45,-16493,"0344269b-0441-5bd3-9846-3c0415320ab6",FALSE,1516,"Ashkenazi Jew","TCGA-23-2084-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-2084-01"
"TCGA-13-0730-01A-01R-1564-13","TCGA-13-0730-01A-01R-1564-13","TCGA-13-0730","TCGA-13-0730-01A","TP","Primary solid Tumor","TCGA-13-0730-01A","01","Primary","bbe4ea81-6f31-4589-8797-b140bcb35d2b","Primary Tumor","Not Reported","released","Unknown",0.6,"2AF2844E-F1DC-4938-85D3-08B07BB9DCFF","TCGA-13-0730",0.4,"Unknown",1.1,FALSE,"Tumor","8441/3","Adjuvant; 2025-01-08T13:15:37.188206-06:00; e37bbf48-7ace-5775-9bee-668d8cd94a3a; TCGA-13-0730_treatment; Radiation Therapy, NOS; released; NA; unknown; NA","Ovary",26086,"Serous cystadenocarcinoma, NOS","primary",NA,"fc0019a4-0e6b-5e7d-b8f7-e7a1d85c90e6","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2003,"Fine Needle Aspiration","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",71,-26086,"1049f24d-d521-549d-bda2-361501386994",FALSE,542,NA,"TCGA-13-0730-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0730-01"
"TCGA-24-1549-01A-01R-1566-13","TCGA-24-1549-01A-01R-1566-13","TCGA-24-1549","TCGA-24-1549-01A","TP","Primary solid Tumor","TCGA-24-1549-01A","01","Primary","cd81e8c8-2526-4427-a1db-6ce6bff105e6","Primary Tumor",NA,"released","Unknown",0.6,"6431416b-d089-442d-9db8-32118eed41de","TCGA-24-1549",0.4,"Solid Tissue",0.6,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1c2e0a4e-5586-4c53-bf4a-1e1645a6aeb4; d62ef05a-9b24-4811-a209-eb38bed371fb; TCGA-24-1549_treatment17; TCGA-24-1549_treatment16; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:07:20.020292-06:00; 2025-01-06T20:07:20.020292-06:00; Recurrent Disease; Recurrent Disease","Not Reported",22474,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1549_diagnosis","4260a528-be39-47a7-8ba7-50172f482ceb","Not Reported","Yes",FALSE,1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",58,-21432,"c55541b5-4687-5f7e-ad06-df8ce619bf84",FALSE,1721,NA,"TCGA-24-1549-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1549-01"
"TCGA-13-0923-01A-01R-1564-13","TCGA-13-0923-01A-01R-1564-13","TCGA-13-0923","TCGA-13-0923-01A","TP","Primary solid Tumor","TCGA-13-0923-01A","01","Primary","38e5fc32-615e-435d-ae6e-b79701aba593","Primary Tumor",NA,"released","Unknown",NA,"06AB5B8C-7B57-43B0-8376-7A05C58AFC1A","TCGA-13-0923",NA,"Unknown",NA,FALSE,"Tumor","8441/3","151; 151; NA; 151; 135; 75; NA; 60; 39; 39; NA; 39; Intravenous; Intraperitoneal; Intraperitoneal; 0df3a888-7ae2-4c44-9297-eb7e07254fbc; 4c9c8bc1-8450-5812-85a2-9263e7d23512; 78666a7c-f6aa-4601-8f08-2ab035e611a6; 9dbbd0d7-4336-4f54-b61c-4d34c1de458c; TCGA-13-0923_treatment3; TCGA-13-0923_treatment; TCGA-13-0923_treatment4; TCGA-13-0923_treatment2; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; 6; NA; 6; Paclitaxel; Cisplatin; NA; Paclitaxel; yes; yes; no; yes; 2025-01-06T21:31:34.428502-06:00; NA; 2025-01-06T21:31:34.428502-06:00; 2025-01-06T21:31:34.428502-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; mg/m2; NA; mg/m2","Ovary",27081,"Serous cystadenocarcinoma, NOS","primary",NA,"47744210-bad0-50d1-a104-be4181e7ed85","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",74,-27081,"b8d6ce63-c7cb-5f82-a118-f49f9fc7cb75",FALSE,NA,NA,"TCGA-13-0923-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0923-01"
"TCGA-13-1507-01A-01R-1565-13","TCGA-13-1507-01A-01R-1565-13","TCGA-13-1507","TCGA-13-1507-01A","TP","Primary solid Tumor","TCGA-13-1507-01A","01","Primary","fce7a055-f6ea-4dc3-a42f-51b8ed236ca7","Primary Tumor","Not Reported","released","Unknown",1.1,"0B6D1513-8119-459C-8D5A-8942B8C31179","TCGA-13-1507",0.4,"Unknown",2,FALSE,"Tumor","8441/3","166; NA; 166; 166; mg/m2; NA; mg/m2; mg/m2; 54; NA; 54; 54; Intraperitoneal; Intraperitoneal; Intravenous; 6341084e-dd54-4eca-a294-1a01f2a73bdc; 669fb723-5f51-4ed4-8e65-b040bad08e27; 96b1ed58-d60c-4261-ba7b-540dcd8b7cf3; ba370601-81b6-599a-b4bb-9ae81c595161; TCGA-13-1507_treatment3; TCGA-13-1507_treatment4; TCGA-13-1507_treatment2; TCGA-13-1507_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 6; NA; 6; 6; 37.5; NA; 60; 135; Cisplatin; NA; Paclitaxel; Paclitaxel; yes; no; yes; yes; 2025-01-06T20:24:02.986641-06:00; 2025-01-06T20:24:02.986641-06:00; 2025-01-06T20:24:02.986641-06:00; NA; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released","Ovary",28445,"Serous cystadenocarcinoma, NOS","primary",NA,"3b1937d2-acf2-5a70-ac4c-0df7f5e295f7","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",77,-28445,"4b3ee618-9be0-5230-9ca5-33cab6e8a02f",FALSE,1993,NA,"TCGA-13-1507-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1507-01"
"TCGA-23-2081-01A-01R-1568-13","TCGA-23-2081-01A-01R-1568-13","TCGA-23-2081","TCGA-23-2081-01A","TP","Primary solid Tumor","TCGA-23-2081-01A","01","Primary","48b84b42-0a80-4429-9d6f-1a51b8aaae2e","Primary Tumor","Not Reported","released","Unknown",0.7,"05dc597f-052a-461e-a67c-27dac0d10972","TCGA-23-2081",0.5,"Unknown",0.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 07baba5d-3edf-4896-88a7-1b8ee0d20320; 1200a710-9586-41bd-aa61-289cb3912a41; c81b9935-5a94-4fcc-a0e9-8ed80ea45c26; TCGA-23-2081_treatment15; TCGA-23-2081_treatment16; TCGA-23-2081_treatment14; Radiation Therapy, NOS; Surgery, NOS; Pharmaceutical Therapy, NOS; released; released; released; no; yes; yes; 2025-01-06T21:42:57.632200-06:00; 2025-01-06T21:42:57.632200-06:00; 2025-01-06T21:42:57.632200-06:00; Unknown; Unknown; Unknown; NA; 250; NA","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-23-2081_diagnosis","222ce34a-9038-42ea-ab8c-819ceb2c5ab8","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",49,-18162,"dff24d73-a1fd-59fb-a913-7e99897a2a11",FALSE,2342,"Ashkenazi Jew","TCGA-23-2081-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-2081-01"
"TCGA-30-1862-01A-02R-1568-13","TCGA-30-1862-01A-02R-1568-13","TCGA-30-1862","TCGA-30-1862-01A","TP","Primary solid Tumor","TCGA-30-1862-01A","01","Primary","6211110a-552c-492f-b066-c3b41db7fbad","Primary Tumor","Not Reported","released","Unknown",NA,"a6b7b0c1-5954-487b-b27d-73850a08a194","TCGA-30-1862",NA,"Unknown",NA,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; e901e62d-705b-53c7-8bfa-c10e4797f089; efdcf2b9-b539-432b-baad-bd550adc0fd9; TCGA-30-1862_treatment; TCGA-30-1862_treatment2; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; NA; NA; no; no; NA; 2025-01-06T20:15:52.764915-06:00","Ovary",23895,"Serous cystadenocarcinoma, NOS","primary",NA,"43530a4f-d2b9-5c4b-b4a5-1450b2fa35a4","Ovary","No",TRUE,0,"Stage IV","Not Reported",NA,"not reported",2003,"Surgical Resection","C56.9","G2",NA,"white","female","not hispanic or latino","Dead",65,-23895,"bf047813-e305-5aa3-a47a-6582e28a88c3",FALSE,186,NA,"TCGA-30-1862-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-30-1862-01"
"TCGA-25-1631-01A-01R-1569-13","TCGA-25-1631-01A-01R-1569-13","TCGA-25-1631","TCGA-25-1631-01A","TP","Primary solid Tumor","TCGA-25-1631-01A","01","Primary","6b4aff1a-568e-453f-9679-55b3442c491d","Primary Tumor",NA,"released","Unknown",2,"1C74F61E-1131-4782-8117-20C59B86D845","TCGA-25-1631",0.4,"Unknown",2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; c93a722b-2a1e-412c-b725-2232968dc6c1; d5a84b53-ef3f-574a-b25e-9ca3b214e0c4; TCGA-25-1631_treatment2; TCGA-25-1631_treatment; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; no; 2025-01-06T20:49:29.847843-06:00; NA; NA; NA","Ovary",26687,"Serous cystadenocarcinoma, NOS","primary",NA,"407c0da4-f263-5ceb-abd5-c62004aaf0b5","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",73,-26687,"add82ac4-19b9-5d45-a879-a9ca0d73962b",FALSE,9,NA,"TCGA-25-1631-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1631-01"
"TCGA-10-0936-01A-01R-1564-13","TCGA-10-0936-01A-01R-1564-13","TCGA-10-0936","TCGA-10-0936-01A","TP","Primary solid Tumor","TCGA-10-0936-01A","01","Primary","88c24748-3aee-4a05-8730-9a802f1876d2","Primary Tumor",NA,"released","Unknown",0.6,"6b9a13e4-760e-476f-a0a7-fb42ab7c63c5","TCGA-10-0936",0.5,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; NA; NA; NA; NA; Adjuvant; Adjuvant; NA; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 21b448ee-c075-4f27-a05e-bbf65290d152; 4187d75a-cf75-466e-8290-9b30ae1bd317; 49df81ca-e27f-46e0-9bb7-dd46346681e9; 5b25cd96-198d-4a30-9b20-1a649cd44343; 7402965a-bc8e-5082-b49c-5c5fa25f5a84; 9cc20bf0-70d4-47d7-8ee6-e1347b4ca761; b4fb5d2d-e65e-403c-9f45-ca07e0b32e17; c945120d-6fdf-42fc-860e-cd416ffdd1c7; db655d89-937e-44e5-896d-02941ad37508; TCGA-10-0936_treatment9; TCGA-10-0936_treatment8; TCGA-10-0936_treatment3; TCGA-10-0936_treatment5; TCGA-10-0936_treatment; TCGA-10-0936_treatment4; TCGA-10-0936_treatment2; TCGA-10-0936_treatment7; TCGA-10-0936_treatment6; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Hormone Therapy; Chemotherapy; released; released; released; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T21:41:23.243938-06:00; 2025-01-06T21:41:23.243938-06:00; 2025-01-06T21:41:23.243938-06:00; 2025-01-06T21:41:23.243938-06:00; NA; 2025-01-06T21:41:23.243938-06:00; 2025-01-06T21:41:23.243938-06:00; 2025-01-06T21:41:23.243938-06:00; 2025-01-06T21:41:23.243938-06:00; NA; 936; 800; 678; 1007; 194; 62; 615; 194; NA; 750; 225; 1035; 11200; 1800; 1615; 3; 2280; NA; 810; 678; 621; 939; 89; 20; 237; 89; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; 6; 3; 3; 3; NA; NA; NA; NA; NA; Docetaxel; Pegylated Liposomal Doxorubicin Hydrochloride; Carboplatin; Gemcitabine; Paclitaxel; Paclitaxel; Letrozole; Carboplatin; NA; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; NA; NA; Progressive Disease; NA; NA; mg/m2; mg/m2; mg/m2; mg/m2; mg/m2; mg/m2; mg/day; mg/m2","Ovary",25454,"Serous cystadenocarcinoma, NOS","primary",NA,"68108d81-543a-5c73-a998-dd9bd6fdcd9e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2005,"Surgical Resection","C56.9","G3",NA,"black or african american","female","not hispanic or latino","Dead",69,-25454,"014b5a3f-ce4b-5e1b-bb9f-caa0d307e19f",FALSE,1123,NA,"TCGA-10-0936-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-10-0936-01"
"TCGA-13-1511-01A-01R-1565-13","TCGA-13-1511-01A-01R-1565-13","TCGA-13-1511","TCGA-13-1511-01A","TP","Primary solid Tumor","TCGA-13-1511-01A","01","Primary","c24a2f48-af41-4e1b-9e23-fbac94d02da4","Primary Tumor","Not Reported","released","Unknown",1.6,"CD73F0B8-0B90-40D1-B6FE-6046F84E9AB0","TCGA-13-1511",0.4,"Unknown",2.2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 005224eb-a7ef-4611-b6c2-c198667993c9; a02dd2a3-bd70-456c-8b2f-b2eaa2c736dc; d7c83c4a-d7b2-5205-8dc3-85c3c56af640; f6fce6d9-a59c-4de2-a7fa-6ca5fefa7130; TCGA-13-1511_treatment4; TCGA-13-1511_treatment2; TCGA-13-1511_treatment; TCGA-13-1511_treatment3; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T21:22:04.610305-06:00; 2025-01-06T21:22:04.610305-06:00; NA; 2025-01-06T21:22:04.610305-06:00; NA; 186; 46; 186; NA; mg/m2; NA; mg; NA; 67; 21; 67; Intravenous; Intravenous; Intravenous; NA; 6; 2; 6; NA; 800; NA; 600; NA; Gemcitabine; Carboplatin; Carboplatin","Ovary",19258,"Serous cystadenocarcinoma, NOS","primary",NA,"46631da2-f6dd-5b78-8999-4f18d5131f9c","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2008,"Cytology","C56.9","G3",NA,"asian","female","not hispanic or latino","Dead",52,-19258,"e28453c8-ec26-52b0-ab4d-a347b02c3a2f",FALSE,1650,NA,"TCGA-13-1511-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1511-01"
"TCGA-29-1690-01A-01R-1566-13","TCGA-29-1690-01A-01R-1566-13","TCGA-29-1690","TCGA-29-1690-01A","TP","Primary solid Tumor","TCGA-29-1690-01A","01","Primary","50633d92-0d7d-476e-8d4b-9a8de94771a2","Primary Tumor",NA,"released","Unknown",1.3,"a44f0507-fc95-410a-a6b2-b66caacee30e","TCGA-29-1690",0.7,"Unknown",1.4,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 3462407f-36ea-4dd0-9b1d-5e4f8295fb8d; 39935a53-a498-467c-a864-bb9bd5baea7b; 4aed44cf-2a25-43e2-8189-800efbd12ca0; e35001a9-1f76-427e-86ba-434ad53a5b65; e83411da-55fb-57c5-b623-4e184c181a72; TCGA-29-1690_treatment5; TCGA-29-1690_treatment4; TCGA-29-1690_treatment2; TCGA-29-1690_treatment3; TCGA-29-1690_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; no; yes; yes; yes; yes; 2025-01-06T20:29:02.726894-06:00; 2025-01-06T20:29:02.726894-06:00; 2025-01-06T20:29:02.726894-06:00; 2025-01-06T20:29:02.726894-06:00; NA; NA; 500; 350; 75; 175; NA; 8; 8; 91; 91; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; NA; 3; 3; NA; NA; NA; Cyclophosphamide; Carboplatin; Cisplatin; Paclitaxel; NA; mg/m2; mg/m2; mg/m2; mg/m2","Ovary",24319,"Serous cystadenocarcinoma, NOS","primary",NA,"dd1b849b-25d5-5b61-8c30-9bdbb0ea6514","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1993,"Surgical Resection","C56.9","G2",NA,"white","female","not reported","Dead",66,-24319,"bcfa97b6-fdd7-5b5f-8943-3e2bb1b2f8a1",FALSE,1448,NA,"TCGA-29-1690-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1690-01"
"TCGA-13-0888-01A-01R-1564-13","TCGA-13-0888-01A-01R-1564-13","TCGA-13-0888","TCGA-13-0888-01A","TP","Primary solid Tumor","TCGA-13-0888-01A","01","Primary","34cd279f-98ef-49de-8b13-16913f972d4e","Primary Tumor",NA,"released","Unknown",0.8,"DFDEBDE5-C16E-4B29-9986-8EB557648AC5","TCGA-13-0888",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","232; 232; NA; NA; 54; 54; 253; NA; Intravenous; Intravenous; 2708db92-2815-586a-94ce-9660f24951e3; 4c07bb21-e956-43d2-b9d6-e9190b52e02a; 76df10d1-8fc6-431a-b143-ccd4ef0bd3da; d2e9ed07-f2a6-4d50-af15-57cc934a254a; TCGA-13-0888_treatment; TCGA-13-0888_treatment3; TCGA-13-0888_treatment2; TCGA-13-0888_treatment4; Chemotherapy; Chemotherapy; Hormone Therapy; Radiation Therapy, NOS; 8; 8; NA; NA; Carboplatin; Paclitaxel; Letrozole; NA; yes; yes; yes; no; NA; 2025-01-06T20:43:22.243506-06:00; 2025-01-06T20:43:22.243506-06:00; 2025-01-06T20:43:22.243506-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; NA; NA; Treatment Ongoing; NA","Ovary",28498,"Serous cystadenocarcinoma, NOS","primary",NA,"83afec30-398a-5fbb-87e1-c57d34a7da26","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2003,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",78,-28498,"352a0590-c7a1-5b86-8a71-0f34b1ff6d0d",FALSE,2811,NA,"TCGA-13-0888-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0888-01"
"TCGA-61-1910-01A-01R-1567-13","TCGA-61-1910-01A-01R-1567-13","TCGA-61-1910","TCGA-61-1910-01A","TP","Primary solid Tumor","TCGA-61-1910-01A","01","Primary","a8786e7f-5004-43c8-a5a8-fc2fb89d2ab0","Primary Tumor",NA,"released","Unknown",1,"32905714-6e41-4df8-91dd-6d3068475b40","TCGA-61-1910",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","161; NA; 161; 756; NA; 4550; 56; NA; 56; Intravenous; Intravenous; 1e99555d-daab-4a30-8a35-fd0305dbfc65; 507ab98b-e39c-47e5-853e-f0c257db08bf; 80d6ae6b-b047-592e-9704-2f282ea6c50c; TCGA-61-1910_treatment2; TCGA-61-1910_treatment3; TCGA-61-1910_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; NA; 6; Paclitaxel; NA; Carboplatin; yes; no; yes; 2025-01-06T21:20:25.326552-06:00; 2025-01-06T21:20:25.326552-06:00; NA; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; NA; mg","Ovary",20779,"Serous cystadenocarcinoma, NOS","primary",NA,"f94bab54-9a7b-555b-899c-90c46cb49a3f","Ovary","No",TRUE,0,"Stage IIC","Not Reported","Bilateral","not reported",2006,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",56,-20779,"e31f8f34-ab84-5c8c-b48d-12a9d06a7117",FALSE,NA,NA,"TCGA-61-1910-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1910-01"
"TCGA-20-1684-01A-01R-1566-13","TCGA-20-1684-01A-01R-1566-13","TCGA-20-1684","TCGA-20-1684-01A","TP","Primary solid Tumor","TCGA-20-1684-01A","01","Primary","d8ecb5e2-5af0-4a84-8b51-22c395850721","Primary Tumor",NA,"released","Unknown",0.5,"3ce61823-9e89-424f-9ce2-a8987420b2a9","TCGA-20-1684",0.4,"Unknown",1,FALSE,"Tumor","8441/3","120; NA; 120; 120; 60; NA; 15; 6; 42; NA; 42; 42; Intraperitoneal; Intraperitoneal; Intraperitoneal; 068da2d4-5175-46df-a1c3-2d794b2162ca; 20cb2500-82ae-4381-b735-975e481ca0bd; c7c50ae4-9741-5409-a0a1-8dcaade070b8; febef6ff-9a3f-418a-bf43-a22c802c3afb; TCGA-20-1684_treatment2; TCGA-20-1684_treatment4; TCGA-20-1684_treatment; TCGA-20-1684_treatment3; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 4; NA; 4; 4; Paclitaxel; NA; Bevacizumab; Carboplatin; yes; no; yes; yes; 2025-01-06T20:56:10.652342-06:00; 2025-01-06T20:56:10.652342-06:00; NA; 2025-01-06T20:56:10.652342-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; NA; mg/kg; AUC","Ovary",18755,"Serous cystadenocarcinoma, NOS","primary",NA,"86651736-aa3a-555d-bf96-24285ca73665","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",51,-18755,"833acdb5-f0ce-5046-aec5-6eea25c5d804",FALSE,NA,NA,"TCGA-20-1684-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-20-1684-01"
"TCGA-24-1849-01A-01R-1567-13","TCGA-24-1849-01A-01R-1567-13","TCGA-24-1849","TCGA-24-1849-01A","TP","Primary solid Tumor","TCGA-24-1849-01A","01","Primary","121db3fb-cc6b-48bb-8bfe-a582075658fe","Primary Tumor",NA,"released","Unknown",1.4,"a2181913-086c-42a2-99fd-057b17025deb","TCGA-24-1849",0.5,"Unknown",1.8,FALSE,"Tumor","8441/3","141; 141; NA; 696; 3306; NA; 36; 36; NA; Intravenous; Intravenous; 208bbd86-f85c-5a19-b579-739ad05a310c; a772ac55-c808-4a2d-a01b-e61a8ef45be2; e4302081-8c41-438f-b0a3-1e7c8c33d546; TCGA-24-1849_treatment; TCGA-24-1849_treatment2; TCGA-24-1849_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; NA; Docetaxel; Carboplatin; NA; yes; yes; no; NA; 2025-01-06T21:15:49.078792-06:00; 2025-01-06T21:15:49.078792-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; mg; NA","Ovary",29555,"Serous cystadenocarcinoma, NOS","primary",NA,"70ebbaef-4c30-53d2-8f0e-d3492ba1c271","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",80,-29555,"35b4552b-9d9c-59d1-bd1e-e5f0dc255a48",FALSE,NA,NA,"TCGA-24-1849-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1849-01"
"TCGA-61-2111-01A-01R-1568-13","TCGA-61-2111-01A-01R-1568-13","TCGA-61-2111","TCGA-61-2111-01A","TP","Primary solid Tumor","TCGA-61-2111-01A","01","Primary","b469134f-2528-456e-bf69-c5b5a9268145","Primary Tumor","Not Reported","released","Unknown",1.4,"351930bc-ac4d-468e-9fe2-ba6f16c01444","TCGA-61-2111",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 023f5263-440a-4943-bd8a-8d2445e9aded; 5e1aff20-7959-49e0-a6ce-982965f33c82; TCGA-61-2111_treatment13; TCGA-61-2111_treatment12; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:05:45.079810-06:00; 2025-01-06T21:05:45.079810-06:00; Recurrent Disease; Recurrent Disease","Not Reported",24722,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-61-2111_diagnosis","8fcbc3a2-069e-40fc-b3fb-4777a490176b","Not Reported","Yes",FALSE,2205,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",61,-22517,"207b7d58-3bbf-5097-98dd-b566c44fa826",FALSE,NA,NA,"TCGA-61-2111-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2111-01"
"TCGA-13-0900-01B-01R-1565-13","TCGA-13-0900-01B-01R-1565-13","TCGA-13-0900","TCGA-13-0900-01B","TP","Primary solid Tumor","TCGA-13-0900-01B","01","Primary","f9cd355d-0a69-4479-bacd-b281c5056385","Primary Tumor","Not Reported","released","Unknown",0.6,"27A4B579-9123-431C-95B6-FBC5CB5142C9","TCGA-13-0900",0.1,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 467f9681-7ced-4aa0-824c-3bcb4d63abfc; 6fc269ae-92bb-54f9-b556-34237de627ea; ca7b8670-6fe1-44f8-a387-ef915f4fb68c; TCGA-13-0900_treatment3; TCGA-13-0900_treatment; TCGA-13-0900_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T20:41:17.736127-06:00; NA; 2025-01-06T20:41:17.736127-06:00; NA; 162; 162; NA; 38; 38; Intravenous; Intravenous; NA; 6; 6; NA; Carboplatin; Paclitaxel","Ovary",21698,"Serous cystadenocarcinoma, NOS","primary",NA,"0637c309-0ed0-5cbf-a47b-4d33baea8096","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2004,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",59,-21698,"5d5bb297-6177-5d8a-8562-cbfa5c0f119a",FALSE,NA,NA,"TCGA-13-0900-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0900-01"
"TCGA-13-0913-01A-01R-1564-13","TCGA-13-0913-01A-01R-1564-13","TCGA-13-0913","TCGA-13-0913-01A","TP","Primary solid Tumor","TCGA-13-0913-01A","01","Primary","c505b908-c303-4e98-b0c3-d4252afd01c2","Primary Tumor",NA,"released","Unknown",0.6,"E8FB6EA9-586A-452F-B6A6-0746F16B51DB","TCGA-13-0913",0.4,"Unknown",1.3,FALSE,"Tumor","Unknown","","Not Reported",20444,"Unknown","Unknown","TCGA-13-0913_diagnosis","2614be00-e0af-4ade-8eea-b9f54a1490d8","Not Reported","Yes",FALSE,871,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",53,-19573,"7566af4a-1027-5501-b6dd-0c2b437a7790",FALSE,NA,NA,"TCGA-13-0913-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0913-01"
"TCGA-29-2414-02A-01R-1569-13","TCGA-29-2414-02A-01R-1569-13","TCGA-29-2414","TCGA-29-2414-02A","TR","Recurrent Solid Tumor","TCGA-29-2414-02A","02","Recurrence","dffc14ad-f9fc-4d33-b5e2-8c57019816fe","Recurrent Tumor","Not Reported","released","Unknown",0.7,"1A4882EA-818E-4A23-8584-2881D0DE8406","TCGA-29-2414",0.3,"Unknown",1,FALSE,"Tumor","8441/3","6600; 40; 20; 3; NA; NA; 75; 5; 1705; 2256; 3; 2315; 996; 996; 3; 2042; 6a5666f9-cc38-5f1c-a8b6-ec1953ac9ff2; 75d501e6-b6c7-488b-b187-d41a5916f2e6; 7db96c0f-cdf3-4194-8473-0e2e9f4263b0; 9b9cecbe-337f-4881-9df3-6ffa3727ce1f; e16a10a3-1f11-44e1-b272-8e0ce38afb3e; efcc1bfd-9911-4bd3-b3bf-a6e186083ee9; f0de6949-55f2-4189-9854-7df5a2396471; f2a0ab99-98a6-4d7a-ab28-292080b27d7d; TCGA-29-2414_treatment; TCGA-29-2414_treatment5; TCGA-29-2414_treatment3; TCGA-29-2414_treatment6; TCGA-29-2414_treatment7; TCGA-29-2414_treatment8; TCGA-29-2414_treatment2; TCGA-29-2414_treatment4; Radiation, External Beam; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; NA; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; Topotecan; Carboplatin; Paclitaxel; Cisplatin; Carboplatin; yes; yes; yes; yes; yes; yes; yes; yes; NA; 2025-01-06T20:16:13.039296-06:00; 2025-01-06T20:16:13.039296-06:00; 2025-01-06T20:16:13.039296-06:00; 2025-01-06T20:16:13.039296-06:00; 2025-01-06T20:16:13.039296-06:00; 2025-01-06T20:16:13.039296-06:00; 2025-01-06T20:16:13.039296-06:00; Progressive Disease; Progressive Disease; NA; Progressive Disease; Progressive Disease; Progressive Disease; NA; Progressive Disease; Distant Site; NA; NA; Adjuvant; NA; NA; NA; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; cGy; mg/m2; mg/m2; mg/m2; NA; NA; mg/m2; AUC; NA; 2287; 131; 2424; 1171; 1171; 131; 2151; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; 2; 6; 3; NA; NA; 6; 6","Ovary",27417,"Serous cystadenocarcinoma, NOS","primary",NA,"1911c0e4-d523-5681-9cc6-332707c4c25e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",1998,"Surgical Resection","C56.9","G2","R1","white","female","not reported","Dead",75,-27417,"7b9aeb08-3b4c-5661-bec0-b3b74dc9ec8a",FALSE,2621,NA,"TCGA-29-2414-02A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-2414-02"
"TCGA-61-2008-02A-01R-1568-13","TCGA-61-2008-02A-01R-1568-13","TCGA-61-2008","TCGA-61-2008-02A","TR","Recurrent Solid Tumor","TCGA-61-2008-02A","02","Recurrence","9983a90e-9f72-4fe0-9d3b-62d25d3356ee","Recurrent Tumor","Not Reported","released","Unknown",1.5,"614D7B6A-B3B4-4F1B-9762-0749D559247F","TCGA-61-2008",0.3,"Unknown",2,FALSE,"Tumor","8441/3","979; 149; 149; 979; 979; NA; 1260; 690; 3600; 372; 702; NA; 861; 29; 29; 861; 861; NA; Intravenous; Intravenous; Intravenous; Intraperitoneal; Intraperitoneal; Intravenous; 250be9cb-0748-4ce8-9b12-4bde630732da; 272bb86f-8af0-4e53-b5bf-85c34c32cdfa; 58c61cf2-ff51-4029-9532-35c2f6340c86; 8e378e12-53e5-58b2-b236-5632aa905b06; be98b2ae-dfc0-4117-8634-22a7a747aa22; dfe28ad7-c53d-4c03-bc34-9e1c1235e2f3; TCGA-61-2008_treatment4; TCGA-61-2008_treatment2; TCGA-61-2008_treatment5; TCGA-61-2008_treatment; TCGA-61-2008_treatment3; TCGA-61-2008_treatment6; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; 6; 6; 6; NA; Paclitaxel; Docetaxel; Carboplatin; Paclitaxel; Cisplatin; NA; yes; yes; yes; yes; yes; no; 2025-01-06T20:51:08.044808-06:00; 2025-01-06T20:51:08.044808-06:00; 2025-01-06T20:51:08.044808-06:00; NA; 2025-01-06T20:51:08.044808-06:00; 2025-01-06T20:51:08.044808-06:00; Recurrent Disease; NA; NA; Recurrent Disease; Recurrent Disease; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; mg; mg; mg; mg; mg; NA; NA; Adjuvant; Adjuvant; NA; NA; Adjuvant","Ovary",14791,"Serous cystadenocarcinoma, NOS","primary",NA,"4233e6db-8d18-5461-b504-3aa62d11e73f","Ovary","No",TRUE,0,"Stage IIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G2",NA,"asian","female","not hispanic or latino","Alive",40,-14791,"32601890-a62f-5eac-821d-10d86af7637f",FALSE,NA,NA,"TCGA-61-2008-02A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2008-02"
"TCGA-25-1635-01A-01R-1566-13","TCGA-25-1635-01A-01R-1566-13","TCGA-25-1635","TCGA-25-1635-01A","TP","Primary solid Tumor","TCGA-25-1635-01A","01","Primary","8eab6a91-e73b-4555-9915-8ac4b91d9de3","Primary Tumor",NA,"released","Unknown",1.3,"28168C52-FD75-4B43-918B-C48CC8DA9C66","TCGA-25-1635",0.3,"Unknown",1.7,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; NA; NA; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 15cfd467-6fb7-4706-83de-f824bbe4b372; 6c4bddce-4032-4c19-83bf-998a0f7fc10f; 73649ab7-ae3a-5923-8c7b-d9afbaf187f4; b74a13b4-37e3-418d-b17e-e24c1f3b2fd7; d93eea66-4271-441e-9792-f10b63b5ff76; eb5c70cc-6bcb-4142-a229-ca6dd0c35311; TCGA-25-1635_treatment6; TCGA-25-1635_treatment4; TCGA-25-1635_treatment; TCGA-25-1635_treatment3; TCGA-25-1635_treatment5; TCGA-25-1635_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; 2025-01-06T20:28:30.362111-06:00; 2025-01-06T20:28:30.362111-06:00; NA; 2025-01-06T20:28:30.362111-06:00; 2025-01-06T20:28:30.362111-06:00; 2025-01-06T20:28:30.362111-06:00; NA; 233; 233; 741; 741; 233; NA; 24; 24; 614; 614; 24; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; 8; 8; 4; 4; 8; NA; Carboplatin; Gemcitabine Hydrochloride; Paclitaxel; Carboplatin; Paclitaxel; NA; NA; NA; Recurrent Disease; Recurrent Disease; NA","Ovary",26200,"Serous cystadenocarcinoma, NOS","primary",NA,"1b49c382-da56-568d-823a-34afc1fd6a96","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",71,-26200,"79dac28f-6891-5ca1-9a1b-b6b946171961",FALSE,1583,NA,"TCGA-25-1635-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1635-01"
"TCGA-20-1686-01A-01R-1566-13","TCGA-20-1686-01A-01R-1566-13","TCGA-20-1686","TCGA-20-1686-01A","TP","Primary solid Tumor","TCGA-20-1686-01A","01","Primary","13f9890c-e405-4625-888e-496eee30dfb4","Primary Tumor",NA,"released","Unknown",0.4,"c87ff195-1793-455a-bb19-e495a915befe","TCGA-20-1686",0.4,"Unknown",0.8,FALSE,"Tumor","8441/3","131; 131; NA; 175; NA; NA; 26; 26; NA; Intravenous; Intravenous; 216371a2-e571-542c-bb72-ee0f63f7346e; 726f0f27-86ba-4ca4-bc53-c607f8ce649d; 99f01ed4-9620-4c8a-a46f-0eb787128ac6; TCGA-20-1686_treatment; TCGA-20-1686_treatment2; TCGA-20-1686_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; NA; Paclitaxel; Carboplatin; NA; yes; yes; no; NA; 2025-01-06T21:20:42.518422-06:00; 2025-01-06T21:20:42.518422-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg/m2; NA; NA","Ovary",27588,"Serous cystadenocarcinoma, NOS","primary",NA,"1ed1ad50-2936-5821-988a-f9c6e3f2728f","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",75,-27588,"197ab3f9-6726-5731-bfc7-6b08ced01e17",FALSE,NA,NA,"TCGA-20-1686-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-20-1686-01"
"TCGA-57-1586-01A-02R-1567-13","TCGA-57-1586-01A-02R-1567-13","TCGA-57-1586","TCGA-57-1586-01A","TP","Primary solid Tumor","TCGA-57-1586-01A","01","Primary","e4d6fa52-fb29-47ac-aade-8f6020a5b55e","Primary Tumor",NA,"released","Unknown",0.6,"1245d63d-8859-496a-828e-4ccad717c114","TCGA-57-1586",0.2,"Unknown",1.5,FALSE,"Tumor","8441/3","553; NA; 433; 259; 553; 259; 49; 323; 49; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 108a20a1-a196-48cd-b597-4f4dfe859afc; 135fd891-848c-4aff-995d-6745e83d34d3; 33ea9a1b-2515-43f0-ac81-f7fa64e150e7; 85d94bed-00a7-421a-a8bc-64ff87624641; 96ce5d11-414e-43ad-bbfc-88e44ff56bd2; ba37a700-7001-4638-b231-305189a12893; e865eef8-0b9b-4ef3-8b6b-9993506ccbc0; ecb7783c-4d82-4535-9724-05a887cdac52; f6788a24-d566-5385-86e1-ee0fcc2fbb64; TCGA-57-1586_treatment7; TCGA-57-1586_treatment9; TCGA-57-1586_treatment3; TCGA-57-1586_treatment2; TCGA-57-1586_treatment4; TCGA-57-1586_treatment6; TCGA-57-1586_treatment8; TCGA-57-1586_treatment5; TCGA-57-1586_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 1; NA; NA; 4; 1; 4; 8; 3; 8; released; released; released; released; released; released; released; released; released; Carboplatin; NA; Topotecan; Gemcitabine Hydrochloride; Paclitaxel; Cisplatin; Carboplatin; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; yes; no; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T21:36:00.074914-06:00; 2025-01-06T21:36:00.074914-06:00; 2025-01-06T21:36:00.074914-06:00; 2025-01-06T21:36:00.074914-06:00; 2025-01-06T21:36:00.074914-06:00; 2025-01-06T21:36:00.074914-06:00; 2025-01-06T21:36:00.074914-06:00; 2025-01-06T21:36:00.074914-06:00; NA; Progressive Disease; NA; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; NA; Progressive Disease; NA; NA; Adjuvant; NA; NA; NA; NA; Adjuvant; NA; Adjuvant; NA; NA; 542; NA; NA; NA; 163; 406; 163","Ovary",24304,"Serous cystadenocarcinoma, NOS","primary",NA,"09ee5001-6b33-5395-aca0-afdc0186713b","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",66,-24304,"d42e36ed-2e6e-5b2f-a8eb-51b647fce8a9",FALSE,NA,NA,"TCGA-57-1586-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-57-1586-01"
"TCGA-24-0966-01A-01R-1564-13","TCGA-24-0966-01A-01R-1564-13","TCGA-24-0966","TCGA-24-0966-01A","TP","Primary solid Tumor","TCGA-24-0966-01A","01","Primary","67c7b4cb-5fe3-49cf-9aa3-df23717553bb","Primary Tumor",NA,"released","Unknown",0.7,"99D5CA9E-3E3F-4037-96B9-9D4A34C614B3","TCGA-24-0966",0.7,"Unknown",1.3,FALSE,"Tumor","8441/3","120; 120; 120; NA; 1390; 2457; 2456; NA; 21; 71; 21; NA; Intravenous; Intravenous; 4fab6540-16a7-4932-9250-e19a266325bf; 5bee2a4e-1181-4b5f-aea1-9d59f47cddf1; ce67b43c-ed64-51ef-999f-c4ee5733ecb5; f674f495-d0fb-4ea3-a40e-3a2ba11c54be; TCGA-24-0966_treatment2; TCGA-24-0966_treatment3; TCGA-24-0966_treatment; TCGA-24-0966_treatment4; Chemotherapy; Targeted Molecular Therapy; Chemotherapy; Radiation Therapy, NOS; 5; NA; 5; NA; Paclitaxel; Clinical Trial; Carboplatin; NA; yes; yes; yes; no; 2025-01-06T21:25:29.641479-06:00; 2025-01-06T21:25:29.641479-06:00; NA; 2025-01-06T21:25:29.641479-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; mg; mg; NA","Ovary",28529,"Serous cystadenocarcinoma, NOS","primary",NA,"6068ff26-e91d-597d-ae69-4436a0c104bb","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"black or african american","female","not hispanic or latino","Alive",78,-28529,"385531c7-4f02-5ce6-97f6-56ec690678d5",FALSE,NA,NA,"TCGA-24-0966-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-0966-01"
"TCGA-24-1416-01A-01R-1565-13","TCGA-24-1416-01A-01R-1565-13","TCGA-24-1416","TCGA-24-1416-01A","TP","Primary solid Tumor","TCGA-24-1416-01A","01","Primary","7404e874-190e-4353-8755-1d9be35eedb7","Primary Tumor","Not Reported","released","Unknown",0.6,"c5a7b8b5-65b5-47d0-84dc-882024042a6f","TCGA-24-1416",0.5,"Unknown",1.5,FALSE,"Tumor","8441/3","170; 170; NA; 170; 170; 934; 647; NA; 946; 422; 16; 16; NA; 16; 16; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; 07056a2b-c1b3-441a-ac0c-23f4d3093223; 17efca41-1fce-439d-8745-9e3e824638f7; 3306f9c6-9b1c-4bdb-8628-f3dc44fae9c4; b6c3d59a-b00d-5004-b272-f08a9ae2aee4; eec655d9-88e0-4bd8-915b-e5d27f2fdd30; TCGA-24-1416_treatment4; TCGA-24-1416_treatment3; TCGA-24-1416_treatment5; TCGA-24-1416_treatment; TCGA-24-1416_treatment2; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 8; 8; NA; 8; 8; Docetaxel; Paclitaxel; NA; Cisplatin; Carboplatin; yes; yes; no; yes; yes; 2025-01-06T21:13:24.202523-06:00; 2025-01-06T21:13:24.202523-06:00; 2025-01-06T21:13:24.202523-06:00; NA; 2025-01-06T21:13:24.202523-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg; mg; NA; mg; mg","Ovary",12772,"Serous cystadenocarcinoma, NOS","primary",NA,"3bef7a6b-f7be-543c-a896-f3126e11480c","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",34,-12772,"37d34efc-4522-5f67-89af-6ad888895583",FALSE,NA,NA,"TCGA-24-1416-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1416-01"
"TCGA-61-1995-01A-01R-1568-13","TCGA-61-1995-01A-01R-1568-13","TCGA-61-1995","TCGA-61-1995-01A","TP","Primary solid Tumor","TCGA-61-1995-01A","01","Primary","2e1fa816-2b90-4c40-8ab5-617d19736cb0","Primary Tumor","Not Reported","released","Unknown",1.1,"5ea6d43b-376d-43cb-873f-c33ec814a95d","TCGA-61-1995",0.2,"Unknown",1.1,FALSE,"Tumor","8441/3","132; 132; NA; 1311; 3202; NA; 67; 67; NA; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; 44ecbbb3-e9b5-519e-b19b-991a0d510db2; 9d8a776f-5b5b-4df5-9523-0dca2707872c; fe5d9fab-0f07-480b-828a-b38d9f3656e0; TCGA-61-1995_treatment; TCGA-61-1995_treatment2; TCGA-61-1995_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 4; 4; NA; Paclitaxel; Cisplatin; NA; yes; yes; no; NA; 2025-01-06T20:18:33.826099-06:00; 2025-01-06T20:18:33.826099-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; mg; NA","Ovary",16016,"Serous cystadenocarcinoma, NOS","primary",NA,"5a7c82bd-5460-53e5-8b52-19d8586a011c","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",43,-16016,"53fc8603-b3cd-55a5-9034-1c63bbb7089d",FALSE,NA,NA,"TCGA-61-1995-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1995-01"
"TCGA-24-1546-01A-01R-1566-13","TCGA-24-1546-01A-01R-1566-13","TCGA-24-1546","TCGA-24-1546-01A","TP","Primary solid Tumor","TCGA-24-1546-01A","01","Primary","db9720f0-d7ef-469c-ae11-e8f17488126b","Primary Tumor",NA,"released","Unknown",0.4,"d6eec9a6-7bfd-40e2-891e-0a3cd7759ace","TCGA-24-1546",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Intravenous; Intravenous; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 287d5b25-e1ee-5e5b-a4a2-d403b4e54836; cdc67898-5bd9-4e0a-a298-04d74c726625; TCGA-24-1546_treatment; TCGA-24-1546_treatment2; Chemotherapy; Chemotherapy; released; released; Carboplatin; Paclitaxel; yes; yes; NA; 2025-01-06T21:25:14.879066-06:00","Ovary",17130,"Serous cystadenocarcinoma, NOS","primary",NA,"4ec47e19-8ac8-5799-995f-ed82d4ebef47","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1997,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",46,-17130,"8bff82fb-9ffa-5794-8922-4b2771f31589",FALSE,1955,NA,"TCGA-24-1546-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1546-01"
"TCGA-25-1634-01A-01R-1566-13","TCGA-25-1634-01A-01R-1566-13","TCGA-25-1634","TCGA-25-1634-01A","TP","Primary solid Tumor","TCGA-25-1634-01A","01","Primary","c0091bb4-1079-4254-ad42-42ac1ddd7f1e","Primary Tumor",NA,"released","Unknown",1,"F000A224-05C3-4915-8ECD-02BAFE059232","TCGA-25-1634",0.1,"Unknown",1.4,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 18d766a4-6819-4ec0-9be7-8ab497b975a3; fd574d41-0340-4016-a2c5-40e2ba466c67; TCGA-25-1634_treatment6; TCGA-25-1634_treatment7; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; yes; 2025-01-06T20:08:12.765411-06:00; 2025-01-06T20:08:12.765411-06:00; Recurrent Disease; Recurrent Disease","Not Reported",28129,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-25-1634_diagnosis","6b4f6b37-2f6d-4f54-a079-6ab253da3f6a","Not Reported","Yes",FALSE,380,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",75,-27749,"893d4088-f26b-55ea-aa87-aed8cf080262",FALSE,1091,NA,"TCGA-25-1634-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1634-01"
"TCGA-23-1027-01A-02R-1564-13","TCGA-23-1027-01A-02R-1564-13","TCGA-23-1027","TCGA-23-1027-01A","TP","Primary solid Tumor","TCGA-23-1027-01A","01","Primary","ddb8c0dd-c3df-4b78-850d-56b0644e12d7","Primary Tumor",NA,"released","Unknown",0.8,"568C3873-A64C-4D46-8001-EF3EC63750ED","TCGA-23-1027",0.4,"Unknown",0.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2ef6b38f-6932-4ea9-ac4d-b28154ebf239; d52f73c5-7c49-4339-a443-53b56dab6113; TCGA-23-1027_treatment9; TCGA-23-1027_treatment8; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:13:14.552104-06:00; 2025-01-06T21:13:14.552104-06:00; Recurrent Disease; Recurrent Disease","Not Reported",17702,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-23-1027_diagnosis","7032b5c6-acde-41cf-aa8e-2082c88d4406","Not Reported","Yes",FALSE,114,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",48,-17588,"de6818be-e2c7-5255-b1fa-d8444f500277",FALSE,976,NA,"TCGA-23-1027-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1027-01"
"TCGA-13-0884-01B-01R-1565-13","TCGA-13-0884-01B-01R-1565-13","TCGA-13-0884","TCGA-13-0884-01B","TP","Primary solid Tumor","TCGA-13-0884-01B","01","Primary","4aa80346-4292-4863-9891-bb4c218880b3","Primary Tumor","Not Reported","released","Unknown",0.7,"D15552F3-1407-4C01-9B59-DFAC5D4EF095","TCGA-13-0884",0.5,"Unknown",1.3,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 4956cbbb-8c5c-4090-b8ad-6b485dd2e7e8; 58eba621-1e8a-4db2-9689-31d6963bab81; 70d9bf0c-cc4a-4e10-8273-9bec846908cb; 7867df2e-1008-525a-80a2-a852709f7689; 7a07b127-0693-4ed2-afe0-42909955cd56; acc55fc4-07a3-4225-ac1e-66057a165d6d; TCGA-13-0884_treatment6; TCGA-13-0884_treatment4; TCGA-13-0884_treatment2; TCGA-13-0884_treatment; TCGA-13-0884_treatment3; TCGA-13-0884_treatment5; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; 2025-01-06T20:24:59.197201-06:00; 2025-01-06T20:24:59.197201-06:00; 2025-01-06T20:24:59.197201-06:00; NA; 2025-01-06T20:24:59.197201-06:00; 2025-01-06T20:24:59.197201-06:00; NA; 191; 191; 191; 307; 307; NA; 55; 55; 55; 240; 240; Intravenous; Intravenous; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; NA; 6; 6; 6; 4; 4; NA; Carboplatin; Gemcitabine; Paclitaxel; Cisplatin; Paclitaxel; NA; NA; 800; 60; 74; 133; NA; NA; mg/m2; mg/m2; mg/m2; mg/m2","Ovary",14538,"Serous cystadenocarcinoma, NOS","primary",NA,"e48908e4-4f4e-59d5-a1a0-2344695aed5f","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1999,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",39,-14538,"ae611d16-8057-5154-9ece-95a2375c0d0d",FALSE,3260,NA,"TCGA-13-0884-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0884-01"
"TCGA-24-1103-01A-01R-1565-13","TCGA-24-1103-01A-01R-1565-13","TCGA-24-1103","TCGA-24-1103-01A","TP","Primary solid Tumor","TCGA-24-1103-01A","01","Primary","6f9a6f73-285d-4a9c-80eb-5f2ebc1787a4","Primary Tumor",NA,"released","Unknown",1,"B9628222-5530-4A82-9F13-2773173A0C95","TCGA-24-1103",0.6,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 328fcd73-4ced-46d9-b38a-6d7487379303; adc181a0-bbd5-439c-b5d8-5902d06d0e60; TCGA-24-1103_treatment10; TCGA-24-1103_treatment11; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-07T07:17:43.956998-06:00; 2025-01-07T07:17:43.956998-06:00; Recurrent Disease; Recurrent Disease","Not Reported",19261,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1103_diagnosis","a4629077-3ff3-41ff-8358-6170f333c4b1","Not Reported","Yes",FALSE,678,NA,NA,NA,NA,NA,NA,NA,NA,NA,"black or african american","female","not reported","Dead",50,-18583,"70b9fc46-3ebc-5ab0-adbb-162e6a4ea01c",FALSE,1646,NA,"TCGA-24-1103-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1103-01"
"TCGA-29-1766-01A-01R-1567-13","TCGA-29-1766-01A-01R-1567-13","TCGA-29-1766","TCGA-29-1766-01A","TP","Primary solid Tumor","TCGA-29-1766-01A","01","Primary","d3a81bab-cce2-48b3-8eb8-9ef9766af108","Primary Tumor",NA,"released","Unknown",0.5,"fc0a444e-3618-459a-a3ee-58ec9e7e1084","TCGA-29-1766",0.4,"Unknown",1.3,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; ee947167-b6e4-4d0f-810a-6ea65509db1a; fb43e96b-0be6-4183-88f3-ac493daa4c13; TCGA-29-1766_treatment8; TCGA-29-1766_treatment9; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:17:03.900338-06:00; 2025-01-06T21:17:03.900338-06:00; Recurrent Disease; Recurrent Disease","Not Reported",28031,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-29-1766_diagnosis","27883f2f-23df-4430-a4b7-e5ffa15e66e6","Not Reported","Yes",FALSE,672,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",74,-27359,"e3cac892-2a78-5c30-b392-1ef7da8a05b6",FALSE,1199,NA,"TCGA-29-1766-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1766-01"
"TCGA-30-1866-01A-02R-1568-13","TCGA-30-1866-01A-02R-1568-13","TCGA-30-1866","TCGA-30-1866-01A","TP","Primary solid Tumor","TCGA-30-1866-01A","01","Primary","887e9b15-4a8c-4950-8954-b9f6bff18bb1","Primary Tumor","Not Reported","released","Unknown",0.8,"bda3960c-1610-4bff-b60e-b9c8f3a4454a","TCGA-30-1866",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 8158e226-1bab-424d-8762-d1f039d7137b; cb18656b-46c0-46fc-82cc-23bbeef9fe6e; TCGA-30-1866_treatment11; TCGA-30-1866_treatment10; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:48:50.064013-06:00; 2025-01-06T20:48:50.064013-06:00; Recurrent Disease; Recurrent Disease","Not Reported",22847,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-30-1866_diagnosis","51d47fdb-3067-493c-b382-8239cd6d430e","Not Reported","Yes",FALSE,285,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",61,-22562,"279cd324-6a0b-5661-a9fa-20e52a631c31",FALSE,1114,NA,"TCGA-30-1866-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-30-1866-01"
"TCGA-30-1855-01A-01R-1567-13","TCGA-30-1855-01A-01R-1567-13","TCGA-30-1855","TCGA-30-1855-01A","TP","Primary solid Tumor","TCGA-30-1855-01A","01","Primary","74590212-e087-46be-aaf2-43e259aef8e6","Primary Tumor",NA,"released","Unknown",0.6,"cba111de-b005-4460-b4d1-d8b24126d1d3","TCGA-30-1855",0.4,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; f20478d8-cb2b-420d-bb2a-eb1840a030d3; fcb0a9f1-f52d-52c1-a814-5d5107a211c2; TCGA-30-1855_treatment2; TCGA-30-1855_treatment; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; no; 2025-01-06T20:32:22.929021-06:00; NA; NA; NA","Ovary",22394,"Serous cystadenocarcinoma, NOS","primary",NA,"2db40c1c-301c-58b3-8fd4-4144f4d41779","Ovary","No",TRUE,0,"Stage IIIC","Not Reported",NA,"not reported",2001,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",61,-22394,"d4ad8143-9fc3-5b79-9367-651779374b19",FALSE,75,NA,"TCGA-30-1855-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-30-1855-01"
"TCGA-23-1022-01A-01R-1564-13","TCGA-23-1022-01A-01R-1564-13","TCGA-23-1022","TCGA-23-1022-01A","TP","Primary solid Tumor","TCGA-23-1022-01A","01","Primary","65e5e0dc-01e3-43b1-80b5-09762432309e","Primary Tumor",NA,"released","Unknown",0.7,"1A674838-E992-4E9B-82AE-FAFA0AD3BF56","TCGA-23-1022",0.3,"Unknown",0.7,FALSE,"Tumor","8441/3","1378; 937; 162; 1357; 1252; 162; 741; 741; NA; 818; 1560; 640; 2170; 8120; 2500; 2730; 17200; 820; NA; 28; 1378; 853; 29; 1274; 1056; 29; 614; 614; NA; 762; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 0bfaffe7-deea-44df-bf87-d50b0fb74e0e; 58cc0762-c458-48c4-828a-b8084ef9e335; 5eee8d7b-7f8d-591a-8674-7896ce4867ff; 71b6b764-d1c1-4f26-817b-464c5e861d7a; 72903838-3351-46c1-829e-57b2f6057724; 7b39082a-a7bb-460e-b6e3-2dbf2e7c04c0; adb3a4e0-a958-47c9-a469-eecee42ef46c; afe0eb85-dad3-4ea4-8466-a2a84c2c6d60; c6b5fd1a-27d6-4846-9258-db397fd1f456; dcd18ac2-d0e0-4e44-84cd-6d84858a64bc; TCGA-23-1022_treatment3; TCGA-23-1022_treatment9; TCGA-23-1022_treatment; TCGA-23-1022_treatment6; TCGA-23-1022_treatment4; TCGA-23-1022_treatment7; TCGA-23-1022_treatment8; TCGA-23-1022_treatment2; TCGA-23-1022_treatment10; TCGA-23-1022_treatment5; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 1; 10; 7; 5; 7; 7; 12; 12; NA; 5; Gemcitabine; Docetaxel; Paclitaxel; Cyclophosphamide; Carboplatin; Carboplatin; Gemcitabine; Cisplatin; NA; Topotecan; yes; yes; yes; yes; yes; yes; yes; yes; no; yes; 2025-01-06T20:56:49.400010-06:00; 2025-01-06T20:56:49.400010-06:00; NA; 2025-01-06T20:56:49.400010-06:00; 2025-01-06T20:56:49.400010-06:00; 2025-01-06T20:56:49.400010-06:00; 2025-01-06T20:56:49.400010-06:00; 2025-01-06T20:56:49.400010-06:00; 2025-01-06T20:56:49.400010-06:00; 2025-01-06T20:56:49.400010-06:00; Progressive Disease; Recurrent Disease; NA; Progressive Disease; Progressive Disease; NA; Recurrent Disease; Recurrent Disease; NA; Recurrent Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; mg; mg; mg; mg; mg; mg; mg; mg; NA; mg; NA; NA; Adjuvant; NA; NA; Adjuvant; NA; NA; Adjuvant; NA","Ovary",24798,"Serous cystadenocarcinoma, NOS","primary",NA,"0cb11846-7903-535a-926e-9347464dcdd3","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2003,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",67,-24798,"c4eab79f-a23b-5be3-abcc-b2e64f7626dc",FALSE,1511,NA,"TCGA-23-1022-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1022-01"
"TCGA-13-0768-01A-01R-1569-13","TCGA-13-0768-01A-01R-1569-13","TCGA-13-0768","TCGA-13-0768-01A","TP","Primary solid Tumor","TCGA-13-0768-01A","01","Primary","f2b9f258-092d-4f46-a6c3-f5dc86188746","Primary Tumor","Not Reported","released","Unknown",0.7,"7D67D0D3-105C-4A00-B104-106BE26FEE2D","TCGA-13-0768",0.4,"Unknown",0.8,FALSE,"Tumor","8441/3","57; NA; 148; 148; 148; 57; 36; NA; 78; 78; 78; 36; Intravenous; Intraperitoneal; Intraperitoneal; Intravenous; Intravenous; 151c75bf-68c3-4213-9b6e-dd33808d6557; 51fa9a90-8b83-4dc6-8ec1-d6934c2fb6a8; 9f5ff0e6-3960-49d4-8fb6-ed40245b5721; a48cad23-2a24-4d09-bfab-5217a57ec9f9; b31b0776-fe73-5a8b-ae73-4dc7822bd957; b64a1235-0040-4df5-97f7-2faf1babbed2; TCGA-13-0768_treatment4; TCGA-13-0768_treatment6; TCGA-13-0768_treatment3; TCGA-13-0768_treatment2; TCGA-13-0768_treatment; TCGA-13-0768_treatment5; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 2; NA; 4; 4; 4; 2; Carboplatin; NA; Cisplatin; Paclitaxel; Paclitaxel; Paclitaxel; yes; no; yes; yes; yes; yes; 2025-01-06T20:26:01.397872-06:00; 2025-01-06T20:26:01.397872-06:00; 2025-01-06T20:26:01.397872-06:00; 2025-01-06T20:26:01.397872-06:00; NA; 2025-01-06T20:26:01.397872-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; NA; NA; 75; 60; 135; 175; NA; NA; mg/m2; mg/m2; mg/m2; mg/m2","Ovary",26999,"Serous cystadenocarcinoma, NOS","primary",NA,"d5398208-3c8b-5148-b69e-9f403cbb7786","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",73,-26999,"966cbbef-f952-52c3-b48d-c694642a69ee",FALSE,1784,NA,"TCGA-13-0768-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0768-01"
"TCGA-13-1498-01A-01R-1565-13","TCGA-13-1498-01A-01R-1565-13","TCGA-13-1498","TCGA-13-1498-01A","TP","Primary solid Tumor","TCGA-13-1498-01A","01","Primary","b38f209a-000b-4cbf-a4bd-0bc6f027fce3","Primary Tumor","Not Reported","released","Unknown",0.5,"0B03A4B9-61B9-43EA-9E7A-8EE1FF3B31F1","TCGA-13-1498",0.4,"Unknown",1.1,FALSE,"Tumor","Unknown","","Not Reported",27354,"Unknown","Unknown","TCGA-13-1498_diagnosis","54084f8c-e126-47db-9731-fae1b99f770c","Not Reported","Yes",FALSE,534,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",73,-26820,"28950168-4541-54cc-bdd4-8a03516ad698",FALSE,2012,"Ashkenazi Jew","TCGA-13-1498-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1498-01"
"TCGA-04-1337-01A-01R-1564-13","TCGA-04-1337-01A-01R-1564-13","TCGA-04-1337","TCGA-04-1337-01A","TP","Primary solid Tumor","TCGA-04-1337-01A","01","Primary","d8ab03a2-3dc9-433f-b9f3-644f0fb7313f","Primary Tumor",NA,"released","Unknown",1,"BA3A3AFD-9687-4FD3-B43A-2A5E623E3B31","TCGA-04-1337",0.3,"Unknown",1.2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 203e69ba-ee47-43e9-8592-3c248d14f1c0; e50538d0-06ca-523d-b631-9dbc3e96a5f7; TCGA-04-1337_treatment2; TCGA-04-1337_treatment; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; no; 2025-01-06T20:08:58.951359-06:00; NA; NA; NA","Ovary",28626,"Serous cystadenocarcinoma, NOS","primary",NA,"34aa5429-9d9e-5eea-bf66-26acfdbb8a96","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2005,"Surgical Resection","C56.9","G2",NA,"white","female","not hispanic or latino","Dead",78,-28626,"955e097e-08f9-5ef5-8ca0-932e5d45ac9f",FALSE,61,NA,"TCGA-04-1337-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1337-01"
"TCGA-24-1417-01A-01R-1565-13","TCGA-24-1417-01A-01R-1565-13","TCGA-24-1417","TCGA-24-1417-01A","TP","Primary solid Tumor","TCGA-24-1417-01A","01","Primary","1fce45c1-b4e9-40fb-b914-23ec7472aca2","Primary Tumor","Not Reported","released","Unknown",1.1,"4058a172-a0f6-4c91-9c79-aab63525340f","TCGA-24-1417",0.3,"Unknown",1.3,FALSE,"Tumor","8441/3","156; 156; NA; 5500; 2538; NA; 25; 25; NA; Intravenous; Intravenous; 55606813-3cc9-4745-964d-470343421c6f; 58e34a10-744d-5bc5-9e6f-18ccef94b95d; e2ee047e-b2e7-4bd4-ba51-8d7f394ce69c; TCGA-24-1417_treatment2; TCGA-24-1417_treatment; TCGA-24-1417_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 8; 8; NA; Carboplatin; Paclitaxel; NA; yes; yes; no; 2025-01-06T20:13:53.935312-06:00; NA; 2025-01-06T20:13:53.935312-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; mg; NA","Ovary",19775,"Serous cystadenocarcinoma, NOS","primary",NA,"4b027297-035f-56ce-821c-31213eea6b4c","Ovary","No",TRUE,0,"Stage IV","Not Reported","Left","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",54,-19775,"f9e14320-3849-5728-8080-595d28eab5c8",FALSE,NA,NA,"TCGA-24-1417-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1417-01"
"TCGA-29-1705-02A-01R-1567-13","TCGA-29-1705-02A-01R-1567-13","TCGA-29-1705","TCGA-29-1705-02A","TR","Recurrent Solid Tumor","TCGA-29-1705-02A","02","Recurrence","b5163587-a94d-4674-9f11-76a5adc9151d","Recurrent Tumor",NA,"released","Unknown",0.5,"EADA1E69-0CAB-4521-ABE4-035F73ABB54A","TCGA-29-1705",0.4,"Unknown",1.3,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 6075c3d5-72ff-4c45-8bce-36e51d8b325b; ab593490-c14a-4f92-8e8d-c0182cc4c341; dbb1ab80-2d73-427e-bc48-c34784986d76; TCGA-29-1705_treatment12; TCGA-29-1705_treatment11; TCGA-29-1705_treatment13; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; Surgery, NOS; released; released; released; no; yes; yes; 2025-01-06T21:01:19.137786-06:00; 2025-01-06T21:01:19.137786-06:00; 2025-01-06T21:01:19.137786-06:00; Unknown; Unknown; Unknown; NA; NA; 434","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-29-1705_diagnosis","615ac7f3-d11f-45e7-8888-d1cfae3e1a95","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",47,-17530,"3d81138a-577c-5983-a1ce-b5d08a9a5faa",FALSE,555,NA,"TCGA-29-1705-02A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1705-02"
"TCGA-29-1705-01A-01R-1567-13","TCGA-29-1705-01A-01R-1567-13","TCGA-29-1705","TCGA-29-1705-01A","TP","Primary solid Tumor","TCGA-29-1705-01A","01","Primary","fd3e7ba8-21a5-438b-82ee-482ed6905310","Primary Tumor",NA,"released","Unknown",1.1,"e7a899e9-2c61-4bda-874c-0f1b456e5dfc","TCGA-29-1705",0.7,"Unknown",1.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 6075c3d5-72ff-4c45-8bce-36e51d8b325b; ab593490-c14a-4f92-8e8d-c0182cc4c341; dbb1ab80-2d73-427e-bc48-c34784986d76; TCGA-29-1705_treatment12; TCGA-29-1705_treatment11; TCGA-29-1705_treatment13; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; Surgery, NOS; released; released; released; no; yes; yes; 2025-01-06T21:01:19.137786-06:00; 2025-01-06T21:01:19.137786-06:00; 2025-01-06T21:01:19.137786-06:00; Unknown; Unknown; Unknown; NA; NA; 434","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-29-1705_diagnosis","615ac7f3-d11f-45e7-8888-d1cfae3e1a95","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",47,-17530,"3d81138a-577c-5983-a1ce-b5d08a9a5faa",FALSE,555,NA,"TCGA-29-1705-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1705-01"
"TCGA-23-1809-01A-01R-1566-13","TCGA-23-1809-01A-01R-1566-13","TCGA-23-1809","TCGA-23-1809-01A","TP","Primary solid Tumor","TCGA-23-1809-01A","01","Primary","ef7f3a0d-b620-4355-8212-4bad381fe29c","Primary Tumor",NA,"released","Unknown",0.6,"f69b3aba-61df-4fd8-94d7-9bb80692464c","TCGA-23-1809",0.4,"Unknown",0.9,FALSE,"Tumor","8441/3","107; NA; 107; 1898; NA; 1495; 24; NA; 24; Intravenous; Intravenous; 3c25f0d8-7069-4497-9aa7-ab29da1d6b8a; 54de9b84-cd40-4919-9c47-3077078c171a; 5825fcbd-3f5b-5845-8028-b80430d579ff; TCGA-23-1809_treatment2; TCGA-23-1809_treatment3; TCGA-23-1809_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 5; NA; 5; Carboplatin; NA; Paclitaxel; yes; no; yes; 2025-01-06T20:06:33.748987-06:00; 2025-01-06T20:06:33.748987-06:00; NA; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; NA; mg","Ovary",23111,"Serous cystadenocarcinoma, NOS","primary",NA,"ba8c7f10-02ed-5863-a63b-881397fd3c13","Ovary","No",TRUE,0,"Stage IIC","Not Reported","Right","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",63,-23111,"8cd7c35b-a01a-52cd-b6fe-c23edb79cfc4",FALSE,NA,NA,"TCGA-23-1809-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1809-01"
"TCGA-13-1499-01A-01R-1565-13","TCGA-13-1499-01A-01R-1565-13","TCGA-13-1499","TCGA-13-1499-01A","TP","Primary solid Tumor","TCGA-13-1499-01A","01","Primary","16220eed-5ba3-4067-9dcf-d7327a44c05d","Primary Tumor","Not Reported","released","Unknown",1.1,"3FC4A433-FAD1-4CC1-9BD6-A45E2707F6D0","TCGA-13-1499",0.4,"Unknown",2.1,FALSE,"Tumor","8441/3","97; 187; 187; 97; NA; 187; 76; 118; 118; 76; NA; 118; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; 106d89b7-4dcc-4a1a-87d7-d6cc2d8d3da1; 1e907bba-9509-4cf9-b978-7c07bbd402f5; 7e05846e-a31f-4c13-8429-0d0668283828; 89d4ac03-0516-5efe-87d2-b896c064abf1; 9ec94fe6-a90f-4b16-88e6-a4fe753087ba; f40ccf65-dd38-4287-8289-f8c1ab36128d; TCGA-13-1499_treatment3; TCGA-13-1499_treatment2; TCGA-13-1499_treatment4; TCGA-13-1499_treatment; TCGA-13-1499_treatment6; TCGA-13-1499_treatment5; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 2; 4; 4; 2; NA; 4; Carboplatin; Cisplatin; Paclitaxel; Paclitaxel; NA; Paclitaxel; yes; yes; yes; yes; no; yes; 2025-01-06T20:04:23.081352-06:00; 2025-01-06T20:04:23.081352-06:00; 2025-01-06T20:04:23.081352-06:00; NA; 2025-01-06T20:04:23.081352-06:00; 2025-01-06T20:04:23.081352-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; NA; 75; 135; 135; NA; 60; NA; mg/m2; mg/m2; mg/m2; NA; mg/m2","Ovary",20668,"Serous cystadenocarcinoma, NOS","primary",NA,"148128fe-490f-5ecb-9eb0-7bfd1594cfd3","Ovary","No",TRUE,0,"Stage IIIC","Not Reported",NA,"not reported",2005,"Incisional Biopsy","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",56,-20668,"f5853584-62ad-5679-9cb3-8ca4b7d8a998",FALSE,NA,"Ashkenazi Jew","TCGA-13-1499-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1499-01"
"TCGA-25-1317-01A-01R-1565-13","TCGA-25-1317-01A-01R-1565-13","TCGA-25-1317","TCGA-25-1317-01A","TP","Primary solid Tumor","TCGA-25-1317-01A","01","Primary","12be4fe0-391e-4bdd-9af9-33fa7a135975","Primary Tumor","Not Reported","released","Unknown",1.4,"5DC53520-0991-42B6-B10D-0D62C3F92BAD","TCGA-25-1317",0.5,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 3adc1bbe-f24a-4644-9877-5b188529f5dc; e67c125b-2201-4a1b-a20d-5ab2921a4dfc; f4c86966-2794-5f8d-9798-9e283cacfe2c; TCGA-25-1317_treatment3; TCGA-25-1317_treatment2; TCGA-25-1317_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T20:29:58.668190-06:00; 2025-01-06T20:29:58.668190-06:00; NA; NA; 31; 31; NA; 0; 0; Intravenous; Intravenous; NA; 1; 1; NA; Paclitaxel; Carboplatin","Ovary",24199,"Serous cystadenocarcinoma, NOS","primary",NA,"34c73698-1092-5f12-b670-e84b1ca08e3a","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2000,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",66,-24199,"f8742fb7-df55-59c6-9428-0487f950eb36",FALSE,61,NA,"TCGA-25-1317-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1317-01"
"TCGA-29-1693-01A-01R-1567-13","TCGA-29-1693-01A-01R-1567-13","TCGA-29-1693","TCGA-29-1693-01A","TP","Primary solid Tumor","TCGA-29-1693-01A","01","Primary","13caa1a6-03a5-4fcf-9b54-4dfa86fb5c84","Primary Tumor",NA,"released","Unknown",0.7,"90087244-634d-45eb-a877-ff7cc6bd2282","TCGA-29-1693",0.4,"Unknown",0.7,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 4e8d4a77-b68b-42bc-be59-6f9019c67885; b871865b-9442-4d67-a3fe-785238f6d626; TCGA-29-1693_treatment17; TCGA-29-1693_treatment18; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; yes; 2025-01-06T20:15:18.168955-06:00; 2025-01-06T20:15:18.168955-06:00; Recurrent Disease; Recurrent Disease","Not Reported",26994,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-29-1693_diagnosis","657d1f02-4f97-466e-b3f4-266e614a648a","Not Reported","Yes",FALSE,694,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Alive",72,-26300,"0af1dec6-33f4-596f-864c-bc10b4e264f1",FALSE,NA,NA,"TCGA-29-1693-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1693-01"
"TCGA-24-0970-01B-01R-1565-13","TCGA-24-0970-01B-01R-1565-13","TCGA-24-0970","TCGA-24-0970-01B","TP","Primary solid Tumor","TCGA-24-0970-01B","01","Primary","c352a6f8-dee5-473c-a1a4-d85250ac8ddf","Primary Tumor",NA,"released","Unknown",0.8,"50AB91D8-AEC6-46B6-95C1-8F008EE0ED8F","TCGA-24-0970",0.8,"Unknown",2,FALSE,"Tumor","8441/3","314; 314; 314; NA; 152; 1980; 3840; NA; 25; 25; 25; NA; Intravenous; Intravenous; Intravenous; 338e74f4-bc2c-58ab-aad9-ba361960dc59; 53397cb3-f49c-4279-afb6-c87fb23d7b01; a14096cd-db50-4ae4-aa95-3730c785f366; e5d4254f-e95d-4be0-9150-113af951dd24; TCGA-24-0970_treatment; TCGA-24-0970_treatment3; TCGA-24-0970_treatment2; TCGA-24-0970_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 8; 8; 8; NA; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; Carboplatin; NA; yes; yes; yes; no; NA; 2025-01-06T21:43:18.049414-06:00; 2025-01-06T21:43:18.049414-06:00; 2025-01-06T21:43:18.049414-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; mg/m2; mg/m2; NA","Ovary",23276,"Serous cystadenocarcinoma, NOS","primary",NA,"7d9442c7-a63d-5d58-9578-78601010e061","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2005,"Fine Needle Aspiration","C56.9","G3",NA,"white","female","not reported","Dead",63,-23276,"9338f958-a412-5c8f-8b5e-944eec93124c",FALSE,354,NA,"TCGA-24-0970-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-0970-01"
"TCGA-25-1324-01A-01R-1565-13","TCGA-25-1324-01A-01R-1565-13","TCGA-25-1324","TCGA-25-1324-01A","TP","Primary solid Tumor","TCGA-25-1324-01A","01","Primary","fedfb74c-a7cd-4900-bdcb-93bdbd095c89","Primary Tumor","Not Reported","released","Unknown",1,"53AE406F-E6E6-4137-A7B3-01DAFAEDE783","TCGA-25-1324",0.8,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Intravenous; Intravenous; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 17df83aa-1728-42f4-810a-550800f0a18e; 8db7a10d-09d1-45a2-b5b6-f8b7c792b0b4; a14514cb-922d-5a4e-9c43-0e9387795c08; TCGA-25-1324_treatment2; TCGA-25-1324_treatment3; TCGA-25-1324_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; released; released; released; Carboplatin; NA; Paclitaxel; yes; no; yes; 2025-01-06T20:47:54.450196-06:00; 2025-01-06T20:47:54.450196-06:00; NA","Ovary",27090,"Serous cystadenocarcinoma, NOS","primary",NA,"bfdec51d-c323-5a52-8541-41131eef2710","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2001,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",74,-27090,"82f1207d-737a-5fa8-bd7e-a9555193d7ff",FALSE,1035,NA,"TCGA-25-1324-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1324-01"
"TCGA-13-A5FT-01A-11R-A406-31","TCGA-13-A5FT-01A-11R-A406-31","TCGA-13-A5FT","TCGA-13-A5FT-01A","TP","Primary solid Tumor","TCGA-13-A5FT-01A","01","Primary","64bb8411-d52d-4ec9-b6a7-f0c25d8a050a","Primary Tumor",NA,"released","OCT",NA,"B67517DE-A483-4563-8698-51CB95DC5CF1","TCGA-13-A5FT",NA,"Unknown",NA,FALSE,"Tumor","8441/3","117; 111; NA; No; No; NA; 48; 49; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 16eb8992-7b14-4758-894d-0df608b37e05; 762c2a4d-d8c9-5cca-bb9a-17112fcc9206; 8ec70f47-d30b-4348-b010-c5a2b59d67af; TCGA-13-A5FT_treatment2; TCGA-13-A5FT_treatment; TCGA-13-A5FT_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Complete Response; Complete Response; NA; released; released; released; Paclitaxel; Cisplatin; NA; yes; yes; no; 2025-01-06T20:12:43.903740-06:00; NA; 2025-01-06T20:12:43.903740-06:00; NA; NA; Adjuvant","Ovary",24743,"Serous cystadenocarcinoma, NOS","primary",NA,"46512cdd-749b-5942-92b7-1bce1b8021a2","Ovary","No",TRUE,0,"Stage IIIC","No","Bilateral","no",2009,"Surgical Resection","C56.9","G3","RX","black or african american","female","not reported","Alive",67,-24743,"496656d8-5645-5852-b629-f8e4c3b9647e",FALSE,NA,NA,"TCGA-13-A5FT-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,1211,230,"true",NA,NA,NA,NA,"United States",NA,NA,"TCGA-13-A5FT-01"
"TCGA-25-2404-01A-01R-1569-13","TCGA-25-2404-01A-01R-1569-13","TCGA-25-2404","TCGA-25-2404-01A","TP","Primary solid Tumor","TCGA-25-2404-01A","01","Primary","7c1f016a-1728-4496-acbc-97aa89c5ee58","Primary Tumor","Not Reported","released","Unknown",1,"7B13E549-204D-47F8-93EB-D8C5C8D259FA","TCGA-25-2404",0.6,"Unknown",2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2c11798c-3d00-4d64-a3e3-ab93be820fef; 2cae9564-8004-4701-8389-8c770f8a7d0e; TCGA-25-2404_treatment7; TCGA-25-2404_treatment6; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:57:40.066316-06:00; 2025-01-06T20:57:40.066316-06:00; Recurrent Disease; Recurrent Disease","Not Reported",14610,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-25-2404_diagnosis","3d8f4203-7f48-4c30-8322-ca947353deab","Not Reported","Yes",FALSE,426,NA,NA,NA,NA,NA,NA,NA,NA,NA,"american indian or alaska native","female","not hispanic or latino","Dead",38,-14184,"2491559b-7a65-500d-b886-d23b26c6aadd",FALSE,883,NA,"TCGA-25-2404-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-2404-01"
"TCGA-30-1891-01A-01R-1568-13","TCGA-30-1891-01A-01R-1568-13","TCGA-30-1891","TCGA-30-1891-01A","TP","Primary solid Tumor","TCGA-30-1891-01A","01","Primary","8e66ac32-4df0-45b2-915e-37eacd1040a2","Primary Tumor","Not Reported","released","Unknown",0.8,"F2E0C289-3ED3-4876-8BFA-A447AB1DBB2B","TCGA-30-1891",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 105f5bd4-6df5-4c26-9bdb-e378ec91376b; 2b720462-0929-4d60-82c0-96dd541ac986; TCGA-30-1891_treatment15; TCGA-30-1891_treatment14; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:47:17.615700-06:00; 2025-01-06T20:47:17.615700-06:00; Recurrent Disease; Recurrent Disease","Not Reported",22525,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-30-1891_diagnosis","3ced4a1f-57da-4da6-8a55-4ded98135aaf","Not Reported","Yes",FALSE,181,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",61,-22344,"1270303a-3e2c-5099-b188-7454f3ec9414",FALSE,914,NA,"TCGA-30-1891-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-30-1891-01"
"TCGA-57-1585-01A-01R-1566-13","TCGA-57-1585-01A-01R-1566-13","TCGA-57-1585","TCGA-57-1585-01A","TP","Primary solid Tumor","TCGA-57-1585-01A","01","Primary","1e9787c4-b4f7-481a-b44d-cf975ec8bfb7","Primary Tumor",NA,"released","Unknown",0.6,"2c748aca-e5b2-4418-9820-1343293d379f","TCGA-57-1585",0.3,"Unknown",0.8,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 5d7f2c53-09d2-43b4-b8fa-1c22db6c04a9; f72d699b-9f21-5812-b0e3-9187bf1e3bc9; fe7ccb83-627e-4311-aa56-b9fa86f51019; TCGA-57-1585_treatment3; TCGA-57-1585_treatment; TCGA-57-1585_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:09:25.826235-06:00; NA; 2025-01-06T21:09:25.826235-06:00; NA; 53; 53; NA; 18; 18; NA; Paclitaxel; Carboplatin","Ovary",20862,"Serous cystadenocarcinoma, NOS","primary",NA,"b2f8b028-ac9c-5bbc-9a49-f4d0e7331f71","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",57,-20862,"2f038007-2450-5b90-830c-b6054faa83c3",FALSE,53,NA,"TCGA-57-1585-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-57-1585-01"
"TCGA-13-1509-01A-01R-1565-13","TCGA-13-1509-01A-01R-1565-13","TCGA-13-1509","TCGA-13-1509-01A","TP","Primary solid Tumor","TCGA-13-1509-01A","01","Primary","832fbf68-76dc-47f7-b0ac-257d77d69bdf","Primary Tumor","Not Reported","released","Unknown",1.5,"5FB47FA9-299B-4466-A324-20D44C788F8B","TCGA-13-1509",0.4,"Unknown",1.7,FALSE,"Tumor","Unknown","","Not Reported",24059,"Unknown","Unknown","TCGA-13-1509_diagnosis","306eeedd-1dfc-4655-9336-6a54dd578e5f","Not Reported","Yes",FALSE,578,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",64,-23481,"1c90a4f4-86be-5c63-81d0-0a48ef654c51",FALSE,NA,"Ashkenazi Jew","TCGA-13-1509-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1509-01"
"TCGA-25-1632-01A-01R-1566-13","TCGA-25-1632-01A-01R-1566-13","TCGA-25-1632","TCGA-25-1632-01A","TP","Primary solid Tumor","TCGA-25-1632-01A","01","Primary","ed9c97d8-4df2-4ed3-b455-4955d72901a8","Primary Tumor",NA,"released","Unknown",0.8,"F083C2B4-20DE-440F-B6A8-2F332346CECA","TCGA-25-1632",0.3,"Unknown",1.4,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 66e1f0d5-eb8b-4222-aa6a-c5ba4fc76c93; 94799d53-168e-413b-940c-08c4de75c13f; TCGA-25-1632_treatment7; TCGA-25-1632_treatment8; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:46:15.992808-06:00; 2025-01-06T20:46:15.992808-06:00; Recurrent Disease; Recurrent Disease","Not Reported",25530,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-25-1632_diagnosis","03854145-98b4-4997-999d-7303bf40d770","Not Reported","Yes",FALSE,537,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",68,-24993,"ecf4f54b-a69f-5931-8dc3-82641be4e4f4",FALSE,1799,NA,"TCGA-25-1632-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1632-01"
"TCGA-25-1625-01A-01R-1566-13","TCGA-25-1625-01A-01R-1566-13","TCGA-25-1625","TCGA-25-1625-01A","TP","Primary solid Tumor","TCGA-25-1625-01A","01","Primary","4ee39504-ac69-4dd7-b8a4-8d1cc3c20418","Primary Tumor",NA,"released","Unknown",1.3,"BDE314E3-1E2C-440E-8561-A260C1D0933A","TCGA-25-1625",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 073dbeb7-32c5-43bb-98ad-14fdce4c7620; 2cd9b2e9-cc94-4971-baab-54312fc9c91a; 60eea3af-76d1-4183-9bbe-c7e71ef5dbc9; TCGA-25-1625_treatment7; TCGA-25-1625_treatment8; TCGA-25-1625_treatment6; Radiation Therapy, NOS; Surgery, NOS; Pharmaceutical Therapy, NOS; released; released; released; no; yes; yes; 2025-01-06T21:38:58.378080-06:00; 2025-01-06T21:38:58.378080-06:00; 2025-01-06T21:38:58.378080-06:00; Progressive Disease; Progressive Disease; Progressive Disease; NA; 545; NA","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-25-1625_diagnosis","18025cad-1326-4d81-bbe8-8b9f65a20653","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",66,-24298,"06877d4c-0fbc-5556-8685-4c48593f955d",FALSE,840,NA,"TCGA-25-1625-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1625-01"
"TCGA-24-1562-01A-01R-1566-13","TCGA-24-1562-01A-01R-1566-13","TCGA-24-1562","TCGA-24-1562-01A","TP","Primary solid Tumor","TCGA-24-1562-01A","01","Primary","a323f2f5-b250-40a6-a318-084a3933e829","Primary Tumor",NA,"released","Unknown",0.9,"0ce36daf-9512-4860-a5a3-b2ff7f487c5a","TCGA-24-1562",0.5,"Solid Tissue",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2bdafee2-1e92-4b1f-bca9-42f64ad357f4; accadfe5-b236-47f1-8c20-efcf5c53c081; TCGA-24-1562_treatment12; TCGA-24-1562_treatment11; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:15:07.056009-06:00; 2025-01-06T21:15:07.056009-06:00; Recurrent Disease; Recurrent Disease","Not Reported",24976,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1562_diagnosis","1038d518-c555-403e-9629-07af60627542","Not Reported","Yes",FALSE,229,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",67,-24747,"3740a77e-8604-5e34-a9b5-3f155618c3a1",FALSE,1384,NA,"TCGA-24-1562-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1562-01"
"TCGA-30-1853-01A-02R-1567-13","TCGA-30-1853-01A-02R-1567-13","TCGA-30-1853","TCGA-30-1853-01A","TP","Primary solid Tumor","TCGA-30-1853-01A","01","Primary","35817ec6-5c0c-44d7-b5a8-b6de3ab24fdd","Primary Tumor","Not Reported","released","Unknown",0.6,"ded9ba4c-8d3d-450b-a345-772a3e3ae288","TCGA-30-1853",0.4,"Unknown",1,FALSE,"Tumor","8441/3","1011; 126; NA; 778; 778; 126; 932; 40; 175; NA; 5; 175; 5; 580; 950; 42; NA; 669; 669; 42; 886; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 77a013cd-fda7-4fd4-8e2f-8a208c6e7d5d; 7878b72f-6bb4-41df-ad82-ba3f2f61bb1c; 928fb99c-5f7f-471a-930b-0442f1c52af4; 92fcd1cb-811d-50be-9e36-8cfd9f8c6788; bed401e8-ffdf-4581-877e-3795ecb66739; e757d107-ad46-4b01-b70d-968c043f181e; e870d900-784b-4d71-9d16-e7e503cfd563; TCGA-30-1853_treatment4; TCGA-30-1853_treatment5; TCGA-30-1853_treatment7; TCGA-30-1853_treatment; TCGA-30-1853_treatment3; TCGA-30-1853_treatment2; TCGA-30-1853_treatment6; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; NA; Carboplatin; Paclitaxel; Carboplatin; Trabectedin; yes; yes; no; yes; yes; yes; yes; 2025-01-06T20:32:04.960720-06:00; 2025-01-06T20:32:04.960720-06:00; 2025-01-06T20:32:04.960720-06:00; NA; 2025-01-06T20:32:04.960720-06:00; 2025-01-06T20:32:04.960720-06:00; 2025-01-06T20:32:04.960720-06:00; Progressive Disease; NA; NA; Recurrent Disease; Recurrent Disease; NA; Progressive Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; mg/m2; mg/m2; NA; AUC; mg/m2; AUC; mg/m2; NA; 6; NA; 6; 6; 6; 3; NA; Adjuvant; Adjuvant; NA; NA; Adjuvant; NA","Ovary",21404,"Serous cystadenocarcinoma, NOS","primary",NA,"0de0b75a-d428-5237-ac4d-c3078e11272d","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2000,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",58,-21404,"9649f5ae-33a3-5b79-b29f-c90792bbbc57",FALSE,1103,NA,"TCGA-30-1853-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-30-1853-01"
"TCGA-13-1497-01A-01R-1565-13","TCGA-13-1497-01A-01R-1565-13","TCGA-13-1497","TCGA-13-1497-01A","TP","Primary solid Tumor","TCGA-13-1497-01A","01","Primary","87ebfaf3-1ab2-4224-b556-0998a6ac16ff","Primary Tumor","Not Reported","released","Unknown",1.2,"108519AE-4684-4B6E-8A7D-225BFC5084F3","TCGA-13-1497",0.3,"Unknown",1.3,FALSE,"Tumor","Unknown","","Not Reported",18341,"Unknown","Unknown","TCGA-13-1497_diagnosis","055381ca-f580-4a7e-a407-e7e314f6e24a","Not Reported","Yes",FALSE,813,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",47,-17528,"9c931a7a-6e3c-5a87-a410-c936e9789e42",FALSE,NA,NA,"TCGA-13-1497-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1497-01"
"TCGA-36-1569-01A-01R-1566-13","TCGA-36-1569-01A-01R-1566-13","TCGA-36-1569","TCGA-36-1569-01A","TP","Primary solid Tumor","TCGA-36-1569-01A","01","Primary","eacec9c7-f638-4f61-bd7b-a60995267213","Primary Tumor",NA,"released","Unknown",0.9,"52192360-2ACE-401C-9642-B3D6F677362D","TCGA-36-1569",0.4,"Unknown",1.6,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 499ee2db-64c0-5acc-8b37-9c55a09eea9c; 6e1a89ac-2108-4153-a2be-80fed2099326; TCGA-36-1569_treatment; TCGA-36-1569_treatment2; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; Partial Response; NA; released; released; NA; NA; yes; no; NA; 2025-01-06T20:58:49.971883-06:00","Ovary",19151,"Serous cystadenocarcinoma, NOS","primary",NA,"e53d6502-63a5-5b12-b41d-ff5effc62a8e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Cytology","C56.9","G3",NA,"white","female","not reported","Alive",52,-19151,"ccfa0a00-6da8-544e-b65d-fcaddc7d839a",FALSE,NA,NA,"TCGA-36-1569-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-36-1569-01"
"TCGA-20-0987-01A-02R-1564-13","TCGA-20-0987-01A-02R-1564-13","TCGA-20-0987","TCGA-20-0987-01A","TP","Primary solid Tumor","TCGA-20-0987-01A","01","Primary","27a6b2d1-ad0f-4193-b54c-646560930289","Primary Tumor",NA,"released","Unknown",0.6,"EB7C0C99-8A43-4023-B165-4EFFC1FC5800","TCGA-20-0987",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 6d33b084-050c-4e66-88f4-88f6c32480fd; d67070da-5ab1-4dee-8138-c1fd22bcfc0a; TCGA-20-0987_treatment5; TCGA-20-0987_treatment6; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:21:01.338031-06:00; 2025-01-06T21:21:01.338031-06:00; Recurrent Disease; Recurrent Disease","Not Reported",22729,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-20-0987_diagnosis","02b58c15-bd61-4725-9415-296878026063","Not Reported","Yes",FALSE,442,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",61,-22287,"320febbb-04db-59be-aced-d111a47c27ba",FALSE,701,NA,"TCGA-20-0987-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-20-0987-01"
"TCGA-04-1648-01A-01R-1567-13","TCGA-04-1648-01A-01R-1567-13","TCGA-04-1648","TCGA-04-1648-01A","TP","Primary solid Tumor","TCGA-04-1648-01A","01","Primary","bc979254-2b16-43ab-ba8d-7670a3b4ab3a","Primary Tumor",NA,"released","Unknown",0.4,"B35F03FC-84CB-4468-9289-3DB91A6F913E","TCGA-04-1648",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","149; NA; 149; 149; NA; NA; NA; NA; 2544; NA; 23296; 5140; 40; NA; 129; NA; 3; NA; 3; 3; 247; 247; 247; 247; Intravenous; Intravenous; Intravenous; 0c37fd6c-eae4-4848-9daa-662894cbe10f; 5a031f62-efc3-4fbd-a9e5-a024f71576e3; 61f60d4d-5d80-4567-a791-22823ea9f715; b7ec434e-46b6-5ab5-bc2c-91ed3f4eeb4e; bc6ad631-e909-47b0-8be7-4400431506a8; be387329-e062-4975-89e6-0436d21e4526; cb20f2ee-d742-41b3-8291-276a37e5f3dd; d0efee94-b20a-4f31-a2ce-62760bc178a2; TCGA-04-1648_treatment6; TCGA-04-1648_treatment8; TCGA-04-1648_treatment3; TCGA-04-1648_treatment; TCGA-04-1648_treatment2; TCGA-04-1648_treatment4; TCGA-04-1648_treatment5; TCGA-04-1648_treatment7; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Immunotherapy (Including Vaccines); Chemotherapy; Chemotherapy; 8; NA; 8; 8; NA; NA; NA; NA; Paclitaxel; NA; Gemcitabine; Carboplatin; Pegylated Liposomal Doxorubicin Hydrochloride; Bevacizumab; Docetaxel; Topotecan; yes; no; yes; yes; yes; yes; yes; yes; 2025-01-06T21:27:38.079316-06:00; 2025-01-06T21:27:38.079316-06:00; 2025-01-06T21:27:38.079316-06:00; NA; 2025-01-06T21:27:38.079316-06:00; 2025-01-06T21:27:38.079316-06:00; 2025-01-06T21:27:38.079316-06:00; 2025-01-06T21:27:38.079316-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; NA; NA; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; mg; NA; mg; mg; mg; NA; mg; NA; NA; NA; NA; NA; Recurrent Disease; Recurrent Disease; Recurrent Disease; Recurrent Disease","Ovary",21113,"Serous cystadenocarcinoma, NOS","primary",NA,"258aa1d0-810d-53d9-8274-f290e2d22468","Ovary","No",TRUE,0,"Stage IIIC","Not Reported",NA,"not reported",2003,"Cytology","C56.9","G2",NA,"white","female","not reported","Dead",57,-21113,"bf5dd053-0971-5b16-9bd2-9ee9b821551d",FALSE,871,NA,"TCGA-04-1648-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1648-01"
"TCGA-25-1871-01A-01R-1567-13","TCGA-25-1871-01A-01R-1567-13","TCGA-25-1871","TCGA-25-1871-01A","TP","Primary solid Tumor","TCGA-25-1871-01A","01","Primary","19e1d694-4cae-4fd9-92fb-4d8395c8d75a","Primary Tumor","Not Reported","released","Unknown",0.5,"737827A6-C99E-49BE-90AD-004FE8DF11F1","TCGA-25-1871",0.1,"Unknown",0.7,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 56d06c30-3b07-44ef-a483-4152623bf442; 6dab0372-aa5c-4ccd-9faf-ff4d7449d634; TCGA-25-1871_treatment5; TCGA-25-1871_treatment6; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:16:05.251026-06:00; 2025-01-06T21:16:05.251026-06:00; Recurrent Disease; Recurrent Disease","Not Reported",25857,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-25-1871_diagnosis","37eccca5-4beb-49c7-84b5-5129d14e6849","Not Reported","Yes",FALSE,230,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",70,-25627,"11b4e5ef-b402-56df-93fc-234b9948ff8a",FALSE,760,NA,"TCGA-25-1871-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1871-01"
"TCGA-24-1557-01A-01R-1566-13","TCGA-24-1557-01A-01R-1566-13","TCGA-24-1557","TCGA-24-1557-01A","TP","Primary solid Tumor","TCGA-24-1557-01A","01","Primary","fa79b363-380e-48ae-bb82-db395085353c","Primary Tumor",NA,"released","Unknown",0.9,"ec04339c-f1ae-4519-bddf-e60cc1f30d52","TCGA-24-1557",0.5,"Unknown",1.5,FALSE,"Tumor","8441/3","281; 281; 1008; 281; 445; 623; 873; 727; 445; NA; 798; 1154; 1069; 1154; 347; 1008; 623; 15; 6250; 670; 3392; 175; 5350; NA; 1300; 10980; NA; 46; 1300; 424; 2315; 32; 12240; 2600; 27; 27; 875; 27; 368; 462; 765; 644; 368; NA; 754; 1090; 1027; 1090; 300; 875; 462; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 041ea42f-e22d-4236-9e28-cecfd3ae57a8; 1d43c33f-4595-4ed4-b882-725ddea0ff9e; 34b06176-290b-4955-8799-48b75e4e4edb; 41b30e73-70ea-4b9e-9558-1769b3e51e9d; 4bf3f0b1-e365-44a2-a163-98b16144a0a2; 59434b69-199c-460a-8d30-d34805079144; 5a21b3a0-01ca-450b-9479-56d11fee6d52; 5fadaf9b-fb11-4b08-8bf8-cb50347917ab; 6d2e6777-c225-48d0-b979-29b5620d707b; 7d362024-51a3-4dc6-9a7e-041b81d5b4fd; 9d74b695-0355-48ff-809d-d8021d4976d4; bb69ede5-707f-45b8-a4c5-ea3919ba95b2; ce397c25-8282-47da-bf5f-869afc59a4de; dec89cb2-34d7-4cbd-baac-ac8a2391c899; e67a217f-812e-5248-be04-40dd2c35c244; e7cfd7e4-2969-41d5-ba75-cb00a30c8f68; eb4075c3-aa15-436b-81cd-03eda69bee80; TCGA-24-1557_treatment7; TCGA-24-1557_treatment12; TCGA-24-1557_treatment6; TCGA-24-1557_treatment13; TCGA-24-1557_treatment3; TCGA-24-1557_treatment5; TCGA-24-1557_treatment11; TCGA-24-1557_treatment4; TCGA-24-1557_treatment8; TCGA-24-1557_treatment17; TCGA-24-1557_treatment15; TCGA-24-1557_treatment10; TCGA-24-1557_treatment2; TCGA-24-1557_treatment16; TCGA-24-1557_treatment; TCGA-24-1557_treatment9; TCGA-24-1557_treatment14; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Hormone Therapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 4; 12; 7; 8; 3; 8; NA; 4; 3; NA; 3; 4; 3; 4; 3; 7; 8; Topotecan; Carboplatin; Cisplatin; Paclitaxel; Pegylated Liposomal Doxorubicin Hydrochloride; Carboplatin; NA; Paclitaxel; Gemcitabine Hydrochloride; NA; Topotecan; Paclitaxel; Docetaxel; Carboplatin; Topotecan; Gemcitabine Hydrochloride; Paclitaxel; yes; yes; yes; yes; yes; yes; yes; yes; yes; no; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; NA; 2025-01-06T20:54:40.189449-06:00; 2025-01-06T20:54:40.189449-06:00; Adjuvant; Adjuvant; NA; Adjuvant; NA; NA; Palliative; NA; NA; Adjuvant; NA; NA; NA; NA; NA; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; released; released; released; released; released; released; released; mg; mg; mg; mg; mg; mg; NA; mg; mg; NA; mg; mg; mg; mg; mg; mg; mg; NA; NA; Progressive Disease; NA; Progressive Disease; Progressive Disease; NA; Progressive Disease; Progressive Disease; NA; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease","Ovary",17943,"Serous cystadenocarcinoma, NOS","primary",NA,"017a1126-1b80-5060-b971-d27b20147a99","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2000,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",49,-17943,"c20d3b88-776c-5d07-aa24-9bff0c574c2b",FALSE,1213,NA,"TCGA-24-1557-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1557-01"
"TCGA-13-0886-01A-01R-1569-13","TCGA-13-0886-01A-01R-1569-13","TCGA-13-0886","TCGA-13-0886-01A","TP","Primary solid Tumor","TCGA-13-0886-01A","01","Primary","91054520-9955-4d9b-bb06-e0bdd253c687","Primary Tumor",NA,"released","Unknown",0.6,"2FB5824C-F30B-4E0B-B787-CBF93A6A48AE","TCGA-13-0886",0.5,"Unknown",1,FALSE,"Tumor","8441/3","132; NA; 132; 263; 12; NA; 12; 221; Intravenous; Intravenous; Intraperitoneal; 0692cbb4-fb9a-5464-9bb4-3ca610e4a304; c46dd1de-870b-49be-a77a-701e898b56a6; dfc15fde-6a4c-4438-8751-110973b2b55b; eedc03b0-9a57-4ab6-9bc0-05e12aba4261; TCGA-13-0886_treatment; TCGA-13-0886_treatment4; TCGA-13-0886_treatment2; TCGA-13-0886_treatment3; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 6; NA; 6; 3; Carboplatin; NA; Paclitaxel; Cisplatin; yes; no; yes; yes; NA; 2025-01-06T21:11:30.189969-06:00; 2025-01-06T21:11:30.189969-06:00; 2025-01-06T21:11:30.189969-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released","Ovary",24724,"Serous cystadenocarcinoma, NOS","primary",NA,"e3734193-eac9-5df2-9f6d-dfa735dee27b","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",67,-24724,"144fbbef-2227-5cdd-8e21-22114001fe47",FALSE,NA,NA,"TCGA-13-0886-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0886-01"
"TCGA-59-2350-01A-01R-1569-13","TCGA-59-2350-01A-01R-1569-13","TCGA-59-2350","TCGA-59-2350-01A","TP","Primary solid Tumor","TCGA-59-2350-01A","01","Primary","d10b7299-8788-4800-b0a4-e836a18d5def","Primary Tumor","Not Reported","released","Unknown",0.4,"6bd3f7a6-bb9c-42ea-8f20-94db43b51bde","TCGA-59-2350",0.2,"Unknown",0.4,FALSE,"Tumor","8441/3","","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Progression","TCGA-59-2350_diagnosis","12541090-8820-409f-b5de-201518523efe","Not Reported","Yes",FALSE,211,NA,NA,NA,NA,NA,NA,NA,NA,NA,"not reported","female","not reported","Dead",44,NA,"acbb0dbd-a668-5906-9c1c-4d880389bda6",FALSE,679,NA,"TCGA-59-2350-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-59-2350-01"
"TCGA-23-1118-01A-01R-1564-13","TCGA-23-1118-01A-01R-1564-13","TCGA-23-1118","TCGA-23-1118-01A","TP","Primary solid Tumor","TCGA-23-1118-01A","01","Primary","e1be8ad9-1a52-4677-8436-3da22ad12e9a","Primary Tumor",NA,"released","Unknown",0.7,"2f53a2c6-b67a-4966-b300-5e00968b15f3","TCGA-23-1118",0.7,"Unknown",0.8,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 00a2cf45-7811-4d00-9acf-7c896bc7c2af; 85cb3d17-bf01-575b-b9f6-6a789b2f494f; TCGA-23-1118_treatment2; TCGA-23-1118_treatment; Radiation Therapy, NOS; Chemotherapy; released; released; no; yes; 2025-01-06T20:45:22.753217-06:00; NA; NA; 196; NA; 300; NA; 56; Intraperitoneal; NA; 6; NA; Carboplatin; NA; mg","Ovary",16471,"Serous cystadenocarcinoma, NOS","primary",NA,"3e654e05-d3e9-57f4-9bda-b31211ca6a22","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2001,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",45,-16471,"9365e233-5048-5e21-8118-2106e29f75eb",FALSE,NA,NA,"TCGA-23-1118-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1118-01"
"TCGA-61-1738-01A-01R-1567-13","TCGA-61-1738-01A-01R-1567-13","TCGA-61-1738","TCGA-61-1738-01A","TP","Primary solid Tumor","TCGA-61-1738-01A","01","Primary","ce503b11-3be6-4c58-85b6-d987033232e0","Primary Tumor",NA,"released","Unknown",1.2,"05898c76-9832-4724-ada5-ff47eb3838b5","TCGA-61-1738",0.2,"Unknown",1.2,FALSE,"Tumor","8441/3","338; 658; 135; 843; 135; 276; NA; 210; 191; 2376; 6200; 5; 364; NA; 287; 422; 21; 709; 21; 198; NA; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intraperitoneal; 1eaf6e5c-6627-55fb-8f09-f6de63ab34d8; 2f154cd8-20bb-47b8-9ab2-8da6e916fc49; 39c98bee-dbb0-4507-ba04-30016aa477d2; 50d70d6a-8dfa-48a2-afff-0fe8ed742999; 517230c2-9700-472a-bd87-7b1513a42428; 67076a1e-6405-43b8-a413-023cf1f7a7cb; d73ef7e9-7729-4ba3-a534-4bc645fb97fd; TCGA-61-1738_treatment; TCGA-61-1738_treatment3; TCGA-61-1738_treatment5; TCGA-61-1738_treatment2; TCGA-61-1738_treatment6; TCGA-61-1738_treatment4; TCGA-61-1738_treatment7; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 3; 29; 6; 6; 6; 4; NA; Pegylated Liposomal Doxorubicin Hydrochloride; Topotecan; Paclitaxel; Gemcitabine Hydrochloride; Carboplatin; Cisplatin; NA; yes; yes; yes; yes; yes; yes; no; NA; 2025-01-06T21:19:32.849361-06:00; 2025-01-06T21:19:32.849361-06:00; 2025-01-06T21:19:32.849361-06:00; 2025-01-06T21:19:32.849361-06:00; 2025-01-06T21:19:32.849361-06:00; 2025-01-06T21:19:32.849361-06:00; Recurrent Disease; Recurrent Disease; NA; Recurrent Disease; NA; NA; NA; NA; NA; Adjuvant; NA; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; mg; mg; mg; mg/m2; AUC; mg; NA","Ovary",21965,"Serous cystadenocarcinoma, NOS","primary",NA,"5ab9e1b0-8ef3-58e0-9d0d-da2727fd5dc1","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2005,"Surgical Resection","C56.9","G3",NA,"black or african american","female","not reported","Dead",60,-21965,"b3cb6309-cf5e-5396-ad1d-840561b1e2ed",FALSE,1089,NA,"TCGA-61-1738-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1738-01"
"TCGA-04-1361-01A-01R-1565-13","TCGA-04-1361-01A-01R-1565-13","TCGA-04-1361","TCGA-04-1361-01A","TP","Primary solid Tumor","TCGA-04-1361-01A","01","Primary","702cc8d9-38f6-474a-bd7e-e56820c5a5b0","Primary Tumor","Not Reported","released","Unknown",0.4,"5116FD62-7A2C-425A-A99E-D47C1B456961","TCGA-04-1361",0.3,"Unknown",0.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0bc0cf39-f5ea-4cbe-b790-66d6cf291718; 1cb4161e-06c1-45d9-aba0-c2440d321add; TCGA-04-1361_treatment7; TCGA-04-1361_treatment8; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:20:04.054160-06:00; 2025-01-06T20:20:04.054160-06:00; Recurrent Disease; Recurrent Disease","Not Reported",21787,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-04-1361_diagnosis","1dc00dd3-d1cf-495b-9578-f57d02344886","Not Reported","Yes",FALSE,927,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Alive",57,-20860,"7640a9d1-04b1-5950-8139-52e731454d82",FALSE,NA,NA,"TCGA-04-1361-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1361-01"
"TCGA-13-0890-01A-01R-1564-13","TCGA-13-0890-01A-01R-1564-13","TCGA-13-0890","TCGA-13-0890-01A","TP","Primary solid Tumor","TCGA-13-0890-01A","01","Primary","37981859-ba7a-4f93-8fcb-78615e696149","Primary Tumor",NA,"released","Unknown",1.5,"78888517-0ADC-4A78-B7FA-9ACE201795AB","TCGA-13-0890",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 27d66f61-05ad-4f02-ba95-7982abf1c196; 2ca3a348-8e6c-5023-8007-6ba8914c17bc; cc27f9c2-e3aa-42eb-8daa-f765372cb45d; TCGA-13-0890_treatment3; TCGA-13-0890_treatment; TCGA-13-0890_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T20:43:59.577860-06:00; NA; 2025-01-06T20:43:59.577860-06:00; NA; 235; 235; NA; 15; 15; Intravenous; Intravenous; NA; 8; 8; NA; Paclitaxel; Carboplatin; NA; NA; 5; NA; NA; AUC","Ovary",20770,"Serous cystadenocarcinoma, NOS","primary",NA,"a88cf420-1c97-5791-903a-e746648a710e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2003,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",56,-20770,"6960bb68-8fae-5be5-9d7e-982396e47b8d",FALSE,NA,"Ashkenazi Jew","TCGA-13-0890-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0890-01"
"TCGA-24-1563-01A-01R-1566-13","TCGA-24-1563-01A-01R-1566-13","TCGA-24-1563","TCGA-24-1563-01A","TP","Primary solid Tumor","TCGA-24-1563-01A","01","Primary","9347d927-3747-4f06-ab2a-672aefdf48ea","Primary Tumor",NA,"released","Unknown",1.1,"6fdeb714-439d-49d7-aae0-99166a3e8eba","TCGA-24-1563",0.4,"Solid Tissue",1.1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; b55b83cc-90f7-4fec-b863-cc4b7b677d86; ec31d48f-a20f-4977-be27-637a3ccef65f; TCGA-24-1563_treatment13; TCGA-24-1563_treatment12; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:07:28.412431-06:00; 2025-01-06T21:07:28.412431-06:00; Recurrent Disease; Recurrent Disease","Not Reported",24670,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1563_diagnosis","909e3a6d-61df-4c5e-9078-9de93fd9f40a","Not Reported","Yes",FALSE,396,NA,NA,NA,NA,NA,NA,NA,NA,NA,"black or african american","female","not reported","Dead",66,-24274,"f6f97e46-62a4-5b7b-bd32-9be8b0952a2c",FALSE,1451,NA,"TCGA-24-1563-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1563-01"
"TCGA-20-1685-01A-01R-1566-13","TCGA-20-1685-01A-01R-1566-13","TCGA-20-1685","TCGA-20-1685-01A","TP","Primary solid Tumor","TCGA-20-1685-01A","01","Primary","90d6af06-579f-42a2-90f4-bf587e209d70","Primary Tumor",NA,"released","Unknown",0.7,"09b7c163-7ad3-42a2-bc06-32bd55f80327","TCGA-20-1685",0.3,"Unknown",0.8,FALSE,"Tumor","8441/3","144; 144; 144; NA; 39; 39; 39; NA; Intravenous; Intravenous; Intravenous; 0e148de3-7555-5e71-a2c8-49923da30177; 3e67efd2-0355-4091-8c02-19aabd6d6566; 5f3e78cc-6706-40b5-a6db-a2f6319cab2a; f6e00839-ebb1-4575-a9d2-dcb05848047d; TCGA-20-1685_treatment; TCGA-20-1685_treatment3; TCGA-20-1685_treatment2; TCGA-20-1685_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; 6; NA; Carboplatin; Paclitaxel; Bevacizumab; NA; yes; yes; yes; no; NA; 2025-01-06T20:44:39.222579-06:00; 2025-01-06T20:44:39.222579-06:00; 2025-01-06T20:44:39.222579-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; NA; 175; 15; NA; NA; mg/m2; mg/kg; NA","Ovary",16745,"Serous cystadenocarcinoma, NOS","primary",NA,"bb3ebf3b-4ded-57a8-b64e-eea59df41b37","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",45,-16745,"b30231af-aec0-558d-82d5-1c88bcf2176a",FALSE,NA,NA,"TCGA-20-1685-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-20-1685-01"
"TCGA-29-1761-01A-01R-1567-13","TCGA-29-1761-01A-01R-1567-13","TCGA-29-1761","TCGA-29-1761-01A","TP","Primary solid Tumor","TCGA-29-1761-01A","01","Primary","d9939f44-f5d7-469f-b256-4af851190454","Primary Tumor",NA,"released","Unknown",0.5,"63defa27-e729-4514-bdd2-d887c4100854","TCGA-29-1761",0.4,"Unknown",0.9,FALSE,"Tumor","8441/3","202; 202; NA; Adjuvant; Adjuvant; Adjuvant; Intravenous; Intravenous; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1e6a1434-c30c-42cd-b741-99866b474834; 8228dadd-a42b-5674-90c3-3f343a60fdae; 930c30d2-8197-4f0c-8b8a-135527234da1; TCGA-29-1761_treatment2; TCGA-29-1761_treatment; TCGA-29-1761_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 3; 3; NA; released; released; released; Paclitaxel; Carboplatin; NA; yes; yes; no; 2025-01-06T20:31:49.212458-06:00; NA; 2025-01-06T20:31:49.212458-06:00; NA; 49; NA","Ovary",29337,"Serous cystadenocarcinoma, NOS","primary",NA,"d4e1d5f5-41cc-55eb-b085-39c793219da6","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1998,"Surgical Resection","C56.9","G3",NA,"asian","female","not reported","Dead",80,-29337,"5707415c-114a-55b6-9c7a-ffe492bcd227",FALSE,528,NA,"TCGA-29-1761-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1761-01"
"TCGA-61-1724-01A-01R-1568-13","TCGA-61-1724-01A-01R-1568-13","TCGA-61-1724","TCGA-61-1724-01A","TP","Primary solid Tumor","TCGA-61-1724-01A","01","Primary","3545a19f-40bc-4414-8895-2a176f2989fa","Primary Tumor","Not Reported","released","Unknown",1.2,"ec0d70e7-672b-425b-a558-d233e0ef1779","TCGA-61-1724",0.3,"Unknown",1.2,FALSE,"Tumor","8441/3","187; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0d2617c9-0226-4eb1-bf15-4263672dfb23; 6a306ffe-6af7-492e-ba22-62c48a8e2c37; db763293-7ad4-4462-b4b1-39072fc83986; TCGA-61-1724_treatment10; TCGA-61-1724_treatment8; TCGA-61-1724_treatment9; Surgery, NOS; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; released; yes; yes; no; 2025-01-06T21:35:22.378573-06:00; 2025-01-06T21:35:22.378573-06:00; 2025-01-06T21:35:22.378573-06:00; Unknown; Unknown; Unknown","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-61-1724_diagnosis","4e42e060-d17f-4e69-9e42-eee827078056","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",47,-17168,"ea68bd4e-83c7-5ede-a7d8-58a344ab1732",FALSE,637,NA,"TCGA-61-1724-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1724-01"
"TCGA-13-0891-01A-01R-1564-13","TCGA-13-0891-01A-01R-1564-13","TCGA-13-0891","TCGA-13-0891-01A","TP","Primary solid Tumor","TCGA-13-0891-01A","01","Primary","6ff303cc-7d1d-41e5-a839-9f163ba04989","Primary Tumor",NA,"released","Unknown",1.2,"7DF79B3C-8CD7-446D-A13A-BBB69DFE2394","TCGA-13-0891",0.4,"Unknown",1.4,FALSE,"Tumor","8441/3","183; 183; NA; 1050; NA; NA; 71; 71; NA; Intravenous; Intravenous; aec64362-cf2b-4571-81b2-62a23feb6881; ba25d659-2194-544e-8781-bbbc25a11f2a; e59429a3-2fbe-463e-9670-34f9587f0194; TCGA-13-0891_treatment2; TCGA-13-0891_treatment; TCGA-13-0891_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; NA; Paclitaxel; Carboplatin; NA; yes; yes; no; 2025-01-06T21:41:06.888912-06:00; NA; 2025-01-06T21:41:06.888912-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg/m2; NA; NA","Ovary",26886,"Serous cystadenocarcinoma, NOS","primary",NA,"3d1dbced-2a51-54ba-b21b-6492adf26960","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2003,"Fine Needle Aspiration","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",73,-26886,"2fbefc9e-1e10-5799-9005-b6fe7e10fd13",FALSE,3128,"Ashkenazi Jew","TCGA-13-0891-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0891-01"
"TCGA-36-1571-01A-01R-1566-13","TCGA-36-1571-01A-01R-1566-13","TCGA-36-1571","TCGA-36-1571-01A","TP","Primary solid Tumor","TCGA-36-1571-01A","01","Primary","a1d026c2-4d7a-4454-a8e3-30e5c243aba0","Primary Tumor",NA,"released","Unknown",0.9,"cee6fb75-8fcc-4347-824e-b00b96e6e481","TCGA-36-1571",0.9,"Unknown",1.3,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 092195be-77c9-49fc-a221-15400df426a5; 646d175e-254a-42d2-9121-58285f71842c; TCGA-36-1571_treatment7; TCGA-36-1571_treatment6; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:35:15.940494-06:00; 2025-01-06T20:35:15.940494-06:00; Recurrent Disease; Recurrent Disease","Not Reported",19983,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-36-1571_diagnosis","158b6eb3-c035-494a-8b52-ae1d031605f4","Not Reported","Yes",FALSE,375,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",53,-19608,"45064610-c261-5514-8632-f45474cd4857",FALSE,695,NA,"TCGA-36-1571-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-36-1571-01"
"TCGA-29-1785-01A-01R-1567-13","TCGA-29-1785-01A-01R-1567-13","TCGA-29-1785","TCGA-29-1785-01A","TP","Primary solid Tumor","TCGA-29-1785-01A","01","Primary","051e9ab0-af6a-4bd7-8673-c596dc6e78a0","Primary Tumor",NA,"released","Unknown",0.7,"b520ed75-17dd-420f-b444-4436bb03f40f","TCGA-29-1785",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","Adjuvant; NA; Adjuvant; NA; NA; NA; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 4fb9346f-4143-4aba-a35b-26a12001d2af; 609fb1b8-127c-4088-a569-6b599eb5e73e; 658c3d14-78ef-4054-9273-4f07aa6b2a06; a4a4b362-02c4-4d4b-a2a0-81c00379b9fd; b0545a07-4b2b-4339-b93f-19123b25b216; b227d204-66ed-486f-b14e-d619be05211a; e0b65e6b-3e29-4ffd-9278-d3439079bf8a; ed796433-2627-589a-bd13-572865e856d5; TCGA-29-1785_treatment8; TCGA-29-1785_treatment5; TCGA-29-1785_treatment3; TCGA-29-1785_treatment2; TCGA-29-1785_treatment4; TCGA-29-1785_treatment7; TCGA-29-1785_treatment6; TCGA-29-1785_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T20:32:31.950866-06:00; 2025-01-06T20:32:31.950866-06:00; 2025-01-06T20:32:31.950866-06:00; 2025-01-06T20:32:31.950866-06:00; 2025-01-06T20:32:31.950866-06:00; 2025-01-06T20:32:31.950866-06:00; 2025-01-06T20:32:31.950866-06:00; NA; NA; 612; 156; 496; 612; 496; 156; 73; NA; 610; 300; 560; 110; 330; 610; 610; NA; 521; 94; 496; 521; 496; 94; 51; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; 5; 4; 1; 5; 1; 4; 2; NA; Carboplatin; Paclitaxel; Carboplatin; Docetaxel; Paclitaxel; Carboplatin; Carboplatin; NA; Recurrent Disease; NA; Recurrent Disease; Recurrent Disease; Recurrent Disease; NA; NA; NA; mg; mg; mg; mg; mg; mg; mg","Ovary",20417,"Serous cystadenocarcinoma, NOS","primary",NA,"3af0fe9d-b0be-520d-93e2-62c3dde90896","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2006,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",55,-20417,"e84a85c2-be73-5952-b964-921c0feadca1",FALSE,1104,NA,"TCGA-29-1785-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1785-01"
"TCGA-29-1698-01A-01R-1567-13","TCGA-29-1698-01A-01R-1567-13","TCGA-29-1698","TCGA-29-1698-01A","TP","Primary solid Tumor","TCGA-29-1698-01A","01","Primary","f66a6768-2ef9-4318-91fe-8f3498553569","Primary Tumor",NA,"released","Unknown",0.9,"133f2df5-6c22-4653-9d2e-f3d5971502b0","TCGA-29-1698",0.3,"Unknown",1.4,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 11b258b0-acf9-4e85-9e76-9008102a409b; 1ff7c7d3-e59f-4c53-b005-3acca8f6dba8; 33739b65-915f-4e09-9c69-a20621a8c265; TCGA-29-1698_treatment18; TCGA-29-1698_treatment19; TCGA-29-1698_treatment17; Radiation Therapy, NOS; Surgery, NOS; Pharmaceutical Therapy, NOS; released; released; released; no; yes; yes; 2025-01-06T20:32:39.112540-06:00; 2025-01-06T20:32:39.112540-06:00; 2025-01-06T20:32:39.112540-06:00; Unknown; Unknown; Unknown; NA; 181; NA","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-29-1698_diagnosis","0ea5c48d-eb6d-434a-aa9d-95feab6d9185","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"black or african american","female","not reported","Alive",53,-19611,"d905ee3a-476c-595e-9777-0f611cb3caf1",FALSE,NA,NA,"TCGA-29-1698-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1698-01"
"TCGA-24-1418-01A-01R-1565-13","TCGA-24-1418-01A-01R-1565-13","TCGA-24-1418","TCGA-24-1418-01A","TP","Primary solid Tumor","TCGA-24-1418-01A","01","Primary","b40f7345-8f0c-4db7-90ba-424ae5ee22ed","Primary Tumor","Not Reported","released","Unknown",1.2,"14fdb291-ba79-4852-9242-02dc191ca8c5","TCGA-24-1418",0.3,"Unknown",1.2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 019af930-09f5-4bea-a082-84fe3dc740fd; 0db08895-ff4c-42b0-99fe-623dae1f8af7; 726efb55-eb75-5dfe-a418-915bce72ca08; a642d148-6066-400b-b070-fd3927df14dd; TCGA-24-1418_treatment4; TCGA-24-1418_treatment3; TCGA-24-1418_treatment; TCGA-24-1418_treatment2; Radiation Therapy, NOS; Targeted Molecular Therapy; Chemotherapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T20:58:01.650756-06:00; 2025-01-06T20:58:01.650756-06:00; NA; 2025-01-06T20:58:01.650756-06:00; NA; 231; 161; 161; NA; 8459; 2554; 1510; NA; 43; 23; 23; NA; Clinical Trial; Carboplatin; Paclitaxel; NA; mg; mg; mg; Intravenous; Intravenous; NA; NA; 6; 6","Ovary",24842,"Serous cystadenocarcinoma, NOS","primary",NA,"624e0ef7-bfb4-547e-83f8-3468edfbae97","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Fine Needle Aspiration","C56.9","G3",NA,"white","female","not reported","Alive",68,-24842,"f7482f5e-2a1e-5563-bd07-0041884d5457",FALSE,NA,NA,"TCGA-24-1418-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1418-01"
"TCGA-09-1674-01A-01R-1566-13","TCGA-09-1674-01A-01R-1566-13","TCGA-09-1674","TCGA-09-1674-01A","TP","Primary solid Tumor","TCGA-09-1674-01A","01","Primary","59db495c-1778-47a2-b649-968025f08821","Primary Tumor",NA,"released","Unknown",1.5,"d8e0ddd2-304d-4f5e-9225-2cd88ae9984e","TCGA-09-1674",0.7,"Unknown",2.1,FALSE,"Tumor","8441/3","145; 145; NA; 175; NA; NA; 41; 41; NA; Intravenous; Intravenous; 3e8f6157-7a6c-486d-9a97-ee110ac63335; b66b0332-bce1-592f-8563-04297bc31934; f7d5ea32-ab0b-46ba-9add-ff519c046d55; TCGA-09-1674_treatment2; TCGA-09-1674_treatment; TCGA-09-1674_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; NA; Paclitaxel; Carboplatin; NA; yes; yes; no; 2025-01-06T20:10:09.133394-06:00; NA; 2025-01-06T20:10:09.133394-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg/m2; NA; NA","Ovary",28878,"Serous cystadenocarcinoma, NOS","primary",NA,"7ff83dd1-9fd9-5e82-a1c8-181953c5f320","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",79,-28878,"7eefb98f-771a-5ff3-bef3-fe4d7b7f4a10",FALSE,NA,NA,"TCGA-09-1674-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-1674-01"
"TCGA-24-1567-01A-01R-1566-13","TCGA-24-1567-01A-01R-1566-13","TCGA-24-1567","TCGA-24-1567-01A","TP","Primary solid Tumor","TCGA-24-1567-01A","01","Primary","8a3e4430-40be-46e0-bb38-946435911371","Primary Tumor",NA,"released","Unknown",0.3,"90910bbc-49e1-495b-9b06-11056ff401df","TCGA-24-1567",0.3,"Unknown",1.1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 6184abc7-52b8-474c-9c00-40eec9a14054; 9c0e8bfe-59d4-4d58-aee5-c8a921ae5d57; TCGA-24-1567_treatment5; TCGA-24-1567_treatment6; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:31:56.336223-06:00; 2025-01-06T21:31:56.336223-06:00; Recurrent Disease; Recurrent Disease","Not Reported",20162,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1567_diagnosis","729d6f8f-710b-4c86-986c-b9fe559d1c23","Not Reported","Yes",FALSE,319,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",54,-19843,"ace5236c-02a5-559b-a2d3-bea9b6fc13a9",FALSE,524,NA,"TCGA-24-1567-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1567-01"
"TCGA-13-0905-01B-01R-1565-13","TCGA-13-0905-01B-01R-1565-13","TCGA-13-0905","TCGA-13-0905-01B","TP","Primary solid Tumor","TCGA-13-0905-01B","01","Primary","3590ce4c-2c63-42f8-ac73-8d813301ef2d","Primary Tumor","Not Reported","released","Unknown",1,"4EC6E47F-60BD-413E-9371-D70E1E89D0CA","TCGA-13-0905",0.3,"Unknown",1.2,FALSE,"Tumor","Unknown","","Not Reported",20292,"Unknown","Unknown","TCGA-13-0905_diagnosis","0c4ac03b-3c61-44ff-b7d0-600ede24f11b","Not Reported","Yes",FALSE,1535,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",51,-18757,"48698460-7bda-5e2d-bc8b-c4314044aaca",FALSE,NA,NA,"TCGA-13-0905-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0905-01"
"TCGA-13-0726-01A-01R-1564-13","TCGA-13-0726-01A-01R-1564-13","TCGA-13-0726","TCGA-13-0726-01A","TP","Primary solid Tumor","TCGA-13-0726-01A","01","Primary","391c5d58-68fd-4e17-a095-ebb94d32bf58","Primary Tumor","Not Reported","released","Unknown",1,"7165A995-69AE-4D74-9437-02C4730701C1","TCGA-13-0726",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 21f31345-921a-429b-9946-e9b94974e56d; 267baecd-0140-4a0d-9dac-b4c6a5577581; TCGA-13-0726_treatment4; TCGA-13-0726_treatment5; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:24:15.883085-06:00; 2025-01-06T21:24:15.883085-06:00; Recurrent Disease; Recurrent Disease","Not Reported",20526,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-13-0726_diagnosis","2b9277e8-f892-4b03-a950-d7a2999f2a76","Not Reported","Yes",FALSE,392,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",55,-20134,"056db782-ad0b-5cfe-9fe5-55f48edf37d0",FALSE,949,NA,"TCGA-13-0726-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0726-01"
"TCGA-24-1430-01A-01R-1566-13","TCGA-24-1430-01A-01R-1566-13","TCGA-24-1430","TCGA-24-1430-01A","TP","Primary solid Tumor","TCGA-24-1430-01A","01","Primary","eb401991-7a9a-494a-8f7c-072f39e40ec2","Primary Tumor","Not Reported","released","Unknown",1.7,"d0f95ced-e33f-4796-a6a4-3030f8e21761","TCGA-24-1430",0.8,"Unknown",2,FALSE,"Tumor","8441/3","106; 769; 106; 106; NA; 841; 547; 624; 769; 841; 1252; 1960; 5301; 539; NA; 81; 45; 177; 128; 5150; 22; 652; 22; 22; NA; 804; 463; 568; 652; 804; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 203e6089-83fa-465a-96a5-0ee334873fc4; 325d666a-482f-4278-8934-afcd1e4052f5; 3bc01f11-f663-4dee-8b7c-e280b4493e54; 41f374ec-c4b3-463c-ae59-3a5d1f498e07; 48459bde-383b-4c7d-86da-28c2cb819c70; 5b1f79c6-9afc-5ccc-b844-1230f88cf803; 74dfe6fb-7196-4ac2-9d4b-a035365a47ff; b8bee02c-9827-44ac-9095-dd96b8b3cede; b9c8d654-6dbf-4648-8af0-b391640bf458; df6007c1-d9d0-44dd-b778-ae766eca3372; TCGA-24-1430_treatment2; TCGA-24-1430_treatment4; TCGA-24-1430_treatment6; TCGA-24-1430_treatment9; TCGA-24-1430_treatment10; TCGA-24-1430_treatment; TCGA-24-1430_treatment5; TCGA-24-1430_treatment3; TCGA-24-1430_treatment7; TCGA-24-1430_treatment8; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 6; 5; 6; 6; NA; 2; 5; 3; 5; 2; Paclitaxel; Carboplatin; Amifostine; Cisplatin; NA; Pegylated Liposomal Doxorubicin Hydrochloride; Topotecan; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; Gemcitabine Hydrochloride; yes; yes; yes; yes; no; yes; yes; yes; yes; yes; 2025-01-06T21:34:24.600543-06:00; 2025-01-06T21:34:24.600543-06:00; 2025-01-06T21:34:24.600543-06:00; 2025-01-06T21:34:24.600543-06:00; 2025-01-06T21:34:24.600543-06:00; NA; 2025-01-06T21:34:24.600543-06:00; 2025-01-06T21:34:24.600543-06:00; 2025-01-06T21:34:24.600543-06:00; 2025-01-06T21:34:24.600543-06:00; Adjuvant; NA; Adjuvant; Adjuvant; Adjuvant; NA; NA; NA; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; mg; mg; mg; mg; NA; mg; mg; mg; mg; mg; NA; Progressive Disease; NA; NA; NA; Progressive Disease; Recurrent Disease; Progressive Disease; Progressive Disease; Progressive Disease","Ovary",24939,"Serous cystadenocarcinoma, NOS","primary",NA,"2a0f08c5-3c4b-577d-927e-0626042b4204","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2000,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",68,-24939,"a7a4f433-78e4-5763-b441-d0eb0f1eb85f",FALSE,863,NA,"TCGA-24-1430-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1430-01"
"TCGA-36-1576-01A-01R-1566-13","TCGA-36-1576-01A-01R-1566-13","TCGA-36-1576","TCGA-36-1576-01A","TP","Primary solid Tumor","TCGA-36-1576-01A","01","Primary","24ffa457-5765-43c1-8cdd-b50a31dc5b56","Primary Tumor",NA,"released","Unknown",1,"2eb0b46a-ecd3-43b4-bfc2-e1c5e6101d1f","TCGA-36-1576",0.4,"Unknown",2.6,FALSE,"Tumor","8441/3","222; NA; 222; 3648; NA; 2528; 12; NA; 12; Intravenous; Intravenous; 0fbd411f-0552-42d5-a43a-3fac6bba3b02; 65650e0d-211e-4464-bba6-132817ff1a71; dff8e585-7ede-5263-b007-1a6ec4555f91; TCGA-36-1576_treatment2; TCGA-36-1576_treatment3; TCGA-36-1576_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 8; NA; 8; Carboplatin; NA; Paclitaxel; yes; no; yes; 2025-01-06T20:34:19.152566-06:00; 2025-01-06T20:34:19.152566-06:00; NA; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; NA; mg","Ovary",27778,"Serous cystadenocarcinoma, NOS","primary",NA,"12f10f5c-d361-5f22-9b2e-011d487caa6b","Ovary","No",TRUE,0,"Stage IIIC","Not Reported",NA,"not reported",2006,"Surgical Resection","C56.9","G3",NA,"not reported","female","not reported","Alive",76,-27778,"c18e2936-9d87-546c-a5a8-35e127f24d64",FALSE,NA,NA,"TCGA-36-1576-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-36-1576-01"
"TCGA-25-2401-01A-01R-1569-13","TCGA-25-2401-01A-01R-1569-13","TCGA-25-2401","TCGA-25-2401-01A","TP","Primary solid Tumor","TCGA-25-2401-01A","01","Primary","efc25de9-e672-4b44-9003-5b277a47a625","Primary Tumor","Not Reported","released","Unknown",1,"5B192072-1F11-4316-AC39-81085F7E425D","TCGA-25-2401",0.3,"Unknown",1.8,FALSE,"Tumor","8441/3","Adjuvant; 2025-01-08T13:15:37.188206-06:00; d51b968c-33f8-5c0c-a1e2-7f32f53f231f; TCGA-25-2401_treatment; Radiation Therapy, NOS; released; NA; no; NA","Ovary",23711,"Serous cystadenocarcinoma, NOS","primary",NA,"012f225f-1cb8-5962-a806-b05cca31ffd9","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",64,-23711,"61b69ecd-1137-5c6b-8e08-e9acae100eb2",FALSE,90,NA,"TCGA-25-2401-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-2401-01"
"TCGA-04-1517-01A-01R-1565-13","TCGA-04-1517-01A-01R-1565-13","TCGA-04-1517","TCGA-04-1517-01A","TP","Primary solid Tumor","TCGA-04-1517-01A","01","Primary","bb9d5cff-b801-49c7-b319-86c8d1e78b32","Primary Tumor",NA,"released","Unknown",0.9,"ED992763-74E1-466F-A71A-AC0455AD40F6","TCGA-04-1517",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 4764c147-0298-4b15-ac89-741c08f87f0c; 7c95667c-882e-4fe1-ae7c-35b4eae5f379; TCGA-04-1517_treatment7; TCGA-04-1517_treatment6; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:19:30.404352-06:00; 2025-01-06T20:19:30.404352-06:00; Recurrent Disease; Recurrent Disease","Not Reported",29394,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-04-1517_diagnosis","663c06e7-5a5e-4e97-bf48-b89fc761b77f","Not Reported","Yes",FALSE,349,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",79,-29045,"475ebd3e-0dfc-5d80-aa9a-145aa1385328",FALSE,608,NA,"TCGA-04-1517-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1517-01"
"TCGA-13-0919-01A-01R-1564-13","TCGA-13-0919-01A-01R-1564-13","TCGA-13-0919","TCGA-13-0919-01A","TP","Primary solid Tumor","TCGA-13-0919-01A","01","Primary","7be971a8-031f-4dc0-a883-e1976f74eb21","Primary Tumor",NA,"released","Unknown",0.8,"CE2BB148-051E-4D43-B645-B7EA2A64A1CE","TCGA-13-0919",0.4,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1307f035-868d-422e-bf2c-a12f4cb6b676; beddb3a2-4b7f-5012-827a-292cb976b5a8; da46507a-35bf-4bca-9097-4be9f9db0f12; TCGA-13-0919_treatment3; TCGA-13-0919_treatment; TCGA-13-0919_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:29:46.208185-06:00; NA; 2025-01-06T21:29:46.208185-06:00; NA; 160; 160; NA; 5; 175; NA; 42; 42; Intravenous; Intravenous; NA; 6; 6; NA; Carboplatin; Paclitaxel; NA; AUC; mg/m2","Ovary",19337,"Serous cystadenocarcinoma, NOS","primary",NA,"d224cf7c-e190-56a6-bbe1-38e2134e4739","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",52,-19337,"fe9c6beb-795a-5dfc-a75b-f7e489b3a0c7",FALSE,NA,NA,"TCGA-13-0919-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0919-01"
"TCGA-24-1413-01A-01R-1565-13","TCGA-24-1413-01A-01R-1565-13","TCGA-24-1413","TCGA-24-1413-01A","TP","Primary solid Tumor","TCGA-24-1413-01A","01","Primary","c20183e0-600b-4d1d-975f-2b6e43c35d0d","Primary Tumor","Not Reported","released","Unknown",0.6,"2ca18d08-e930-4244-a0d5-316dfbca0fb4","TCGA-24-1413",0.4,"Unknown",1.1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; d0dc6dab-a6b2-4a19-af37-071410cbd5fa; d3c5b21a-960c-5ddb-a798-7eb73176d614; d60a093e-acbf-4ec8-a078-af9530c887be; TCGA-24-1413_treatment3; TCGA-24-1413_treatment; TCGA-24-1413_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T20:27:52.313877-06:00; NA; 2025-01-06T20:27:52.313877-06:00; NA; 145; 145; NA; 1340; 3864; NA; 34; 34; Intravenous; Intravenous; NA; 6; 6; NA; Paclitaxel; Carboplatin; NA; mg; mg","Ovary",18846,"Serous cystadenocarcinoma, NOS","primary",NA,"7ad436d5-5f18-51e6-a99d-d533a2c7e2cc","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",51,-18846,"74a17d97-ff76-50a8-858a-cc082f7219c2",FALSE,NA,NA,"TCGA-24-1413-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1413-01"
"TCGA-13-0725-01A-01R-1564-13","TCGA-13-0725-01A-01R-1564-13","TCGA-13-0725","TCGA-13-0725-01A","TP","Primary solid Tumor","TCGA-13-0725-01A","01","Primary","4a52777f-e23f-49f8-b853-be84b9a74bda","Primary Tumor","Not Reported","released","Unknown",1,"A6CD74F2-47A0-4790-BB81-6C636DA16ADC","TCGA-13-0725",0.5,"Unknown",1.5,FALSE,"Tumor","8441/3","131; NA; 131; 215; 15; NA; 15; 190; Intravenous; Intravenous; Intraperitoneal; 3bae5da7-1f71-4294-ac34-52d8bbda7ba5; 59bd4288-9081-4c76-8865-54dd0f37fc0a; d2a7c89b-5c15-4b20-88bb-4d1ce3b02f68; f02227b1-3a4c-5751-86f1-a116d2791b03; TCGA-13-0725_treatment3; TCGA-13-0725_treatment4; TCGA-13-0725_treatment2; TCGA-13-0725_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 6; NA; 6; 2; Carboplatin; NA; Paclitaxel; Cisplatin; yes; no; yes; yes; 2025-01-06T20:22:27.783943-06:00; 2025-01-06T20:22:27.783943-06:00; 2025-01-06T20:22:27.783943-06:00; NA; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; NA; NA; 175; 75; NA; NA; mg/m2; mg/m2","Ovary",16086,"Serous cystadenocarcinoma, NOS","primary",NA,"5f3845f7-ab3b-5c4b-94b1-84a7afef4150","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2002,"Cytology","C56.9","G3",NA,"white","female","hispanic or latino","Dead",44,-16086,"7e7cc471-edf6-5cd4-aee4-062c81eadd47",FALSE,377,NA,"TCGA-13-0725-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0725-01"
"TCGA-24-2023-01A-01R-1567-13","TCGA-24-2023-01A-01R-1567-13","TCGA-24-2023","TCGA-24-2023-01A","TP","Primary solid Tumor","TCGA-24-2023-01A","01","Primary","3ab5e7ea-fc93-4a73-b43d-c3c74ad48bdb","Primary Tumor","Not Reported","released","Unknown",1,"2a255fa6-65cd-4fb7-9d08-1b6aadd6682b","TCGA-24-2023",0.5,"Unknown",1.2,FALSE,"Tumor","8441/3","214; 502; 214; NA; 502; 1245; 1245; 2151; 3000; 5775; NA; 450; 2100; 2740; 6; 273; 6; NA; 273; 1126; 1126; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 13f840e8-656a-5562-86e9-db457e4e02ca; 1c8538da-3a1e-4044-a893-66f03f76884c; 4491e28f-2a38-4c61-a85f-7bb63c634a07; 6102e2ad-f893-4bad-b3c9-0960d0ce1d39; 763ece27-bc88-4020-9783-5100e0bf7441; b4df2539-5d11-48fa-841b-ef1061338e2d; be9a9bed-cf10-4274-ac9f-279b3335cded; TCGA-24-2023_treatment; TCGA-24-2023_treatment2; TCGA-24-2023_treatment5; TCGA-24-2023_treatment7; TCGA-24-2023_treatment4; TCGA-24-2023_treatment3; TCGA-24-2023_treatment6; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; 8; 8; 8; NA; 8; 6; 6; Paclitaxel; Cyclophosphamide; Carboplatin; NA; Cisplatin; Paclitaxel; Carboplatin; yes; yes; yes; no; yes; yes; yes; NA; 2025-01-06T21:15:29.086187-06:00; 2025-01-06T21:15:29.086187-06:00; 2025-01-06T21:15:29.086187-06:00; 2025-01-06T21:15:29.086187-06:00; 2025-01-06T21:15:29.086187-06:00; 2025-01-06T21:15:29.086187-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; mg; mg; mg; NA; mg; mg; mg; NA; NA; NA; NA; NA; Recurrent Disease; Recurrent Disease","Ovary",19901,"Serous cystadenocarcinoma, NOS","primary",NA,"04bf3f6d-f3c0-510b-a8eb-a46860525c7f","Ovary","No",TRUE,0,"Stage IIIA","Not Reported","Bilateral","not reported",1994,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",54,-19901,"324846aa-8368-59b7-8d95-4373adb15ded",FALSE,1364,NA,"TCGA-24-2023-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2023-01"
"TCGA-13-0883-01A-02R-1569-13","TCGA-13-0883-01A-02R-1569-13","TCGA-13-0883","TCGA-13-0883-01A","TP","Primary solid Tumor","TCGA-13-0883-01A","01","Primary","c084ec17-62a3-43d7-bc0d-ab806bcd35a3","Primary Tumor",NA,"released","Unknown",1.1,"7AC6471C-1BA0-4AA5-9A2E-70413C9768F8","TCGA-13-0883",0.4,"Unknown",1.4,FALSE,"Tumor","8441/3","350; NA; 143; 143; 75; NA; NA; 175; 227; NA; 31; 31; Intraperitoneal; Intravenous; Intravenous; 027e878c-a4fd-4bdc-a372-f25f31a487f7; 303f2bd5-edf8-4f07-99c9-d30c65cf20fc; aa138e2d-759a-59fa-85ed-c7a2a5d7e157; e10e56b1-8cf7-4006-b757-b5e7c5dcd901; TCGA-13-0883_treatment2; TCGA-13-0883_treatment4; TCGA-13-0883_treatment; TCGA-13-0883_treatment3; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 6; NA; 6; 6; Cisplatin; NA; Carboplatin; Paclitaxel; yes; no; yes; yes; 2025-01-06T21:04:05.146804-06:00; 2025-01-06T21:04:05.146804-06:00; NA; 2025-01-06T21:04:05.146804-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; NA; NA; mg/m2","Ovary",22395,"Serous cystadenocarcinoma, NOS","primary",NA,"1ca82c95-b632-5780-9c0b-cc470669922c","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2002,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",61,-22395,"580cfffe-92f6-5401-9167-dac54793bc2e",FALSE,2097,"Ashkenazi Jew","TCGA-13-0883-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0883-01"
"TCGA-23-1024-01A-02R-1564-13","TCGA-23-1024-01A-02R-1564-13","TCGA-23-1024","TCGA-23-1024-01A","TP","Primary solid Tumor","TCGA-23-1024-01A","01","Primary","96430cd1-1f32-4d4e-ae16-e39df6405739","Primary Tumor",NA,"released","Unknown",0.4,"1CCE5978-6A4D-427A-9875-47617F6A4258","TCGA-23-1024",0.2,"Unknown",0.8,FALSE,"Tumor","8441/3","304; 304; NA; 304; 529; 776; 1608; NA; 541; 2556; 13; 13; NA; 13; 224; Intraperitoneal; Intraperitoneal; Intraperitoneal; Intravenous; 1ede6ca5-3de4-56d3-913b-e27419c8b222; 367a6467-9d57-474c-9d25-c3121c3f17fe; a26bdbab-74a3-4ca0-bd54-116d24146c09; cb2efeb9-58c7-4790-99dd-66d2e496f353; cda2540c-6c06-40a4-a66c-754971058269; TCGA-23-1024_treatment; TCGA-23-1024_treatment2; TCGA-23-1024_treatment5; TCGA-23-1024_treatment4; TCGA-23-1024_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 6; 6; NA; 6; 12; Cisplatin; Paclitaxel; NA; Carboplatin; Paclitaxel; yes; yes; no; yes; yes; NA; 2025-01-06T20:07:01.889570-06:00; 2025-01-06T20:07:01.889570-06:00; 2025-01-06T20:07:01.889570-06:00; 2025-01-06T20:07:01.889570-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Consolidation Therapy; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg; mg; NA; mg; mg; NA; NA; NA; NA; Not Reported","Ovary",19052,"Serous cystadenocarcinoma, NOS","primary",NA,"4daaa455-5886-55af-9373-8912838020b3","Ovary","No",TRUE,0,"Stage IV","Not Reported","Right","not reported",2007,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",52,-19052,"83b2a085-d35c-5c1c-a5a5-d0125b3fc24d",FALSE,NA,"Ashkenazi Jew","TCGA-23-1024-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1024-01"
"TCGA-13-0897-01A-01R-1564-13","TCGA-13-0897-01A-01R-1564-13","TCGA-13-0897","TCGA-13-0897-01A","TP","Primary solid Tumor","TCGA-13-0897-01A","01","Primary","daabfedb-ac0a-4bc9-b145-9bef04bdd66f","Primary Tumor",NA,"released","Unknown",0.5,"058A5354-D36C-4398-AC2C-12447FDB0966","TCGA-13-0897",0.5,"Unknown",1.1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 419e6fe4-8965-4f48-9654-c6f88f55aa77; b6ff30d8-eeec-465f-9f91-e2c600036bfd; e68d17d1-0609-48e5-9c38-d84686b7f671; TCGA-13-0897_treatment7; TCGA-13-0897_treatment6; TCGA-13-0897_treatment8; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; Surgery, NOS; released; released; released; no; yes; yes; 2025-01-06T20:55:47.516133-06:00; 2025-01-06T20:55:47.516133-06:00; 2025-01-06T20:55:47.516133-06:00; Unknown; Unknown; Unknown; NA; NA; 568","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-13-0897_diagnosis","10a61e90-a19e-466e-baf1-8b3af1a7ff7a","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",54,-19894,"98f76dc4-21fd-5024-915b-f6c36aa533ae",FALSE,2182,"Ashkenazi Jew","TCGA-13-0897-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0897-01"
"TCGA-10-0927-01A-02R-1564-13","TCGA-10-0927-01A-02R-1564-13","TCGA-10-0927","TCGA-10-0927-01A","TP","Primary solid Tumor","TCGA-10-0927-01A","01","Primary","97efbf70-83ef-49aa-ac3a-f0d0067a2a10","Primary Tumor",NA,"released","Unknown",0.7,"3d93f935-2a93-4987-99c6-0b75e2e59cd3","TCGA-10-0927",0.6,"Unknown",1.1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 5e4bbf04-ad3e-4ce6-9227-83be3c61e5e1; 935ac982-f3e8-4831-8995-0e978c7613eb; TCGA-10-0927_treatment11; TCGA-10-0927_treatment10; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:26:39.272372-06:00; 2025-01-06T21:26:39.272372-06:00; Recurrent Disease; Recurrent Disease","Not Reported",24983,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-10-0927_diagnosis","192ddbac-4c56-418c-b705-345d5e1a5f09","Not Reported","Yes",FALSE,1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,"not reported","female","hispanic or latino","Dead",65,-23982,"76e6cd60-baff-5f8f-8ad0-ad492278a8ef",FALSE,2490,NA,"TCGA-10-0927-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-10-0927-01"
"TCGA-25-1328-01A-01R-1565-13","TCGA-25-1328-01A-01R-1565-13","TCGA-25-1328","TCGA-25-1328-01A","TP","Primary solid Tumor","TCGA-25-1328-01A","01","Primary","1ff50970-b13c-4aef-bfb7-fb1b516ff079","Primary Tumor","Not Reported","released","Unknown",1.8,"A2DA7EB3-8E42-4E86-9352-99673F51AEFF","TCGA-25-1328",1,"Unknown",2.8,FALSE,"Tumor","8441/3","244; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 3a14544b-66f9-41b6-94a0-d8d12bb4555c; e7841ccd-1532-40aa-9f22-2eabbf4e7de2; f9a5a575-cd5e-4978-a73e-587910b05fb2; TCGA-25-1328_treatment11; TCGA-25-1328_treatment10; TCGA-25-1328_treatment9; Surgery, NOS; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; released; yes; no; yes; 2025-01-06T20:28:51.123855-06:00; 2025-01-06T20:28:51.123855-06:00; 2025-01-06T20:28:51.123855-06:00; Unknown; Unknown; Unknown","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-25-1328_diagnosis","6a07eef1-02f2-4c27-8eb3-78849e7b2e79","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",38,-13911,"04824ef8-fadb-546a-bfc0-957cf62e574e",FALSE,2009,NA,"TCGA-25-1328-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1328-01"
"TCGA-23-1110-01A-01R-1564-13","TCGA-23-1110-01A-01R-1564-13","TCGA-23-1110","TCGA-23-1110-01A","TP","Primary solid Tumor","TCGA-23-1110-01A","01","Primary","5adca90e-f8ae-4a74-9c7f-a2b64fda2b31","Primary Tumor",NA,"released","Unknown",0.8,"07361efd-0b7d-4dcb-afe3-464200f59ac0","TCGA-23-1110",0.6,"Unknown",0.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 7a5bff3a-77be-4bd8-a1d8-e56fe7beb3ad; d038fa3c-7326-4994-913a-4496c79bba61; TCGA-23-1110_treatment6; TCGA-23-1110_treatment7; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:56:27.453322-06:00; 2025-01-06T20:56:27.453322-06:00; Recurrent Disease; Recurrent Disease","Not Reported",15709,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-23-1110_diagnosis","05c99f23-b56f-4234-bcb3-a4ad8dd8275f","Not Reported","Yes",FALSE,326,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","hispanic or latino","Alive",42,-15383,"bb0f6ffa-ac50-5de2-be4c-54c7494ab86f",FALSE,NA,NA,"TCGA-23-1110-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1110-01"
"TCGA-61-2009-01A-01R-1568-13","TCGA-61-2009-01A-01R-1568-13","TCGA-61-2009","TCGA-61-2009-01A","TP","Primary solid Tumor","TCGA-61-2009-01A","01","Primary","8832fa0d-1bd8-42a9-b002-1a02500d48eb","Primary Tumor","Not Reported","released","Unknown",2,"39de8c59-e593-47d3-932d-575a4537b4dc","TCGA-61-2009",0.2,"Unknown",2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; cd3dccd6-ec73-4eaa-b553-8043be761df6; da6b78c6-acaf-40c3-8ee9-196ff387239e; e4faacf8-3792-4050-9597-7a524817ef32; TCGA-61-2009_treatment13; TCGA-61-2009_treatment15; TCGA-61-2009_treatment14; Pharmaceutical Therapy, NOS; Surgery, NOS; Radiation Therapy, NOS; released; released; released; yes; yes; no; 2025-01-06T21:36:40.955008-06:00; 2025-01-06T21:36:40.955008-06:00; 2025-01-06T21:36:40.955008-06:00; Unknown; Unknown; Unknown; NA; 819; NA","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Unknown","TCGA-61-2009_diagnosis","8c541cd8-ed56-4bbf-88ab-c9aa1c70b67e","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",65,-23772,"c2e9ac12-63d8-5aff-8006-3a819ceb9302",FALSE,NA,NA,"TCGA-61-2009-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2009-01"
"TCGA-13-1488-01A-01R-1565-13","TCGA-13-1488-01A-01R-1565-13","TCGA-13-1488","TCGA-13-1488-01A","TP","Primary solid Tumor","TCGA-13-1488-01A","01","Primary","22461884-5fdb-4188-a469-5dfa55a2823e","Primary Tumor","Not Reported","released","Unknown",1,"79A91E41-0B59-4328-B7BB-2B4EEAD46A89","TCGA-13-1488",0.4,"Unknown",2.3,FALSE,"Tumor","8441/3","165; NA; 165; 175; NA; NA; 8; NA; 8; Intravenous; Intravenous; 1773f89d-ed73-5734-a705-e5272bf0c60c; bdf62272-486f-458a-b712-1aa4f83eebbf; f30f1096-75cc-408f-9cea-f727f72634e0; TCGA-13-1488_treatment; TCGA-13-1488_treatment3; TCGA-13-1488_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 8; NA; 8; Paclitaxel; NA; Carboplatin; yes; no; yes; NA; 2025-01-06T21:28:29.365398-06:00; 2025-01-06T21:28:29.365398-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg/m2; NA; NA","Ovary",21726,"Serous cystadenocarcinoma, NOS","primary",NA,"04ce8f92-1262-5b87-9371-5b7f0e7d3f5f","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2002,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",59,-21726,"b6bd947a-dae0-5ef3-905e-02630b777a39",FALSE,2154,NA,"TCGA-13-1488-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1488-01"
"TCGA-23-1026-01B-01R-1569-13","TCGA-23-1026-01B-01R-1569-13","TCGA-23-1026","TCGA-23-1026-01B","TP","Primary solid Tumor","TCGA-23-1026-01B","01","Primary","30d07f1e-0899-4d8f-9bd9-abe572affc8c","Primary Tumor",NA,"released","Unknown",0.7,"E41E1018-422B-4B4A-8732-C9389847830D","TCGA-23-1026",0.4,"Unknown",0.8,FALSE,"Tumor","8441/3","108; 936; 936; NA; 108; 1560; 520; 5648; NA; 3420; 7; 866; 866; NA; 7; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intravenous; 6d3785bf-c3d1-46d2-ab7e-9a0c599a4f19; a20eb4ed-953f-4e5a-83e7-ae0d96813a06; abcd3aa9-29eb-52a2-a30b-9378a2110059; ba1d4a77-776b-4c88-8025-e42a16399294; c080e577-f2ce-47eb-96ca-654154cd3162; TCGA-23-1026_treatment3; TCGA-23-1026_treatment4; TCGA-23-1026_treatment; TCGA-23-1026_treatment5; TCGA-23-1026_treatment2; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; 5; 5; NA; 6; Paclitaxel; Cisplatin; Gemcitabine; NA; Carboplatin; yes; yes; yes; no; yes; 2025-01-06T20:06:52.550014-06:00; 2025-01-06T20:06:52.550014-06:00; NA; 2025-01-06T20:06:52.550014-06:00; 2025-01-06T20:06:52.550014-06:00; Adjuvant; NA; NA; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg; mg; mg; NA; mg; NA; Recurrent Disease; Recurrent Disease; NA; NA","Ovary",16442,"Serous cystadenocarcinoma, NOS","primary",NA,"0a5bc544-d5cc-57d6-85e2-fd38deb2fccb","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",45,-16442,"c1602427-bdf1-51ea-b682-09a7e2a740c1",FALSE,NA,NA,"TCGA-23-1026-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1026-01"
"TCGA-13-1487-01A-01R-1565-13","TCGA-13-1487-01A-01R-1565-13","TCGA-13-1487","TCGA-13-1487-01A","TP","Primary solid Tumor","TCGA-13-1487-01A","01","Primary","bff12f06-dabc-4424-ac53-65ca01d0a406","Primary Tumor","Not Reported","released","Unknown",1,"30C193A0-7AB5-445D-AD37-3661A89DC06A","TCGA-13-1487",0.4,"Unknown",1.4,FALSE,"Tumor","8441/3","412; 208; NA; 129; 129; 135; 75; NA; 75; 300; 257; 208; NA; 17; 17; Intravenous; Intraperitoneal; Intravenous; Intravenous; 1c09ace5-9961-4498-8f0e-52b6f269eada; 649e57e1-55fb-4c60-8c88-a08b38dd294b; aefcf7ba-41ad-4ef2-bb2f-23a96633e0d8; ca824dc1-b7f2-47ab-950c-881911e7b16b; f3bec8f1-1367-5073-a080-dae1f9d758dd; TCGA-13-1487_treatment3; TCGA-13-1487_treatment2; TCGA-13-1487_treatment5; TCGA-13-1487_treatment4; TCGA-13-1487_treatment; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 6; 1; NA; 6; 6; Paclitaxel; Cisplatin; NA; Docetaxel; Carboplatin; yes; yes; no; yes; yes; 2025-01-06T20:05:20.939344-06:00; 2025-01-06T20:05:20.939344-06:00; 2025-01-06T20:05:20.939344-06:00; 2025-01-06T20:05:20.939344-06:00; NA; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg/m2; mg/m2; NA; mg/m2; mg/m2","Ovary",27176,"Serous cystadenocarcinoma, NOS","primary",NA,"f2bef3a1-e2c5-5c6f-8f16-e34d476c1a86","Ovary","No",TRUE,0,"Stage IV","Not Reported",NA,"not reported",2002,"Surgical Resection","C56.9","GX",NA,"white","female","not hispanic or latino","Dead",74,-27176,"d660ec1a-93b8-5ce7-9a60-49c9ec945ce8",FALSE,681,NA,"TCGA-13-1487-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1487-01"
"TCGA-29-1774-01A-01R-1567-13","TCGA-29-1774-01A-01R-1567-13","TCGA-29-1774","TCGA-29-1774-01A","TP","Primary solid Tumor","TCGA-29-1774-01A","01","Primary","145c1cbf-1d36-4439-896b-afabfcc8d864","Primary Tumor",NA,"released","Unknown",1,"8d8dd2f0-09d8-42a2-84e0-4209e45e2330","TCGA-29-1774",1,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1ad73947-a6a6-4329-9307-a99ac941d511; 559d6335-b989-4d8b-bf2f-e7eee52df1e4; TCGA-29-1774_treatment8; TCGA-29-1774_treatment7; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:29:27.486549-06:00; 2025-01-06T21:29:27.486549-06:00; Recurrent Disease; Recurrent Disease","Not Reported",30225,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-29-1774_diagnosis","6da4fb09-fc5a-402e-9ed6-cf5cb628762b","Not Reported","Yes",FALSE,234,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",82,-29991,"1d15823e-4daa-5758-8481-cfa43f826e1e",FALSE,NA,NA,"TCGA-29-1774-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1774-01"
"TCGA-24-1564-01A-01R-1566-13","TCGA-24-1564-01A-01R-1566-13","TCGA-24-1564","TCGA-24-1564-01A","TP","Primary solid Tumor","TCGA-24-1564-01A","01","Primary","e370c642-1d03-4f08-8bd4-1c99dae80679","Primary Tumor",NA,"released","Unknown",1,"fa1c8286-2e55-4137-93ae-c19d470ce2e4","TCGA-24-1564",0.4,"Solid Tissue",1.4,FALSE,"Tumor","8441/3","406; NA; 295; 295; NA; 463; 624; 568; 624; 116; 116; 295; 33; NA; 5080; 5080; 20; 136; 2462; 1496; 1500; 779; 1396; 1200; 333; NA; 248; 248; 736; 435; 589; 499; 589; 8; 8; 248; Intravenous; Intravenous; Intravenous; Oral; Intravenous; Intravenous; Intravenous; Oral; Intravenous; Intravenous; Intravenous; 1b5f9f14-98f9-485d-9cfe-34ae3b34ad38; 223471a9-7d76-54de-b753-01e84ad6be87; 3b5b1164-0577-4f53-8780-76ed8c8dfc84; 6e743e05-1e27-49cb-bcdf-0922cb45feda; 939a330c-747e-4e50-83f8-b02648740e4f; 9d8f06fc-24aa-4d0b-aaf9-190bdf262663; a2fa824b-c072-48de-905b-5821ba9bf08a; a6d6d5af-9060-4549-bff3-f33f321d0821; c5322b17-5be1-46d2-93db-8b6319462704; e1973295-b7b1-4f65-8b03-d88adae9e88b; ef979a6b-9734-4d58-9b1f-81ae653dc54e; f1e890be-5279-4163-9268-24f147417082; TCGA-24-1564_treatment12; TCGA-24-1564_treatment; TCGA-24-1564_treatment10; TCGA-24-1564_treatment5; TCGA-24-1564_treatment11; TCGA-24-1564_treatment7; TCGA-24-1564_treatment8; TCGA-24-1564_treatment3; TCGA-24-1564_treatment6; TCGA-24-1564_treatment2; TCGA-24-1564_treatment4; TCGA-24-1564_treatment9; Chemotherapy; Radiation, External Beam; Chemotherapy; Chemotherapy; Hormone Therapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 4; NA; 4; 4; NA; 2; 2; 11; 2; 6; 6; 4; Topotecan; NA; Carboplatin; Amifostine; Tamoxifen; Pegylated Liposomal Doxorubicin Hydrochloride; Gemcitabine Hydrochloride; Paclitaxel; Etoposide; Cisplatin; Paclitaxel; Paclitaxel; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T20:48:27.876036-06:00; NA; 2025-01-06T20:48:27.876036-06:00; 2025-01-06T20:48:27.876036-06:00; 2025-01-06T20:48:27.876036-06:00; 2025-01-06T20:48:27.876036-06:00; 2025-01-06T20:48:27.876036-06:00; 2025-01-06T20:48:27.876036-06:00; 2025-01-06T20:48:27.876036-06:00; 2025-01-06T20:48:27.876036-06:00; 2025-01-06T20:48:27.876036-06:00; 2025-01-06T20:48:27.876036-06:00; Progressive Disease; Progressive Disease; Recurrent Disease; Recurrent Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; NA; NA; Recurrent Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; released; released; mg; NA; mg; mg; mg; mg; mg; mg; mg; mg; mg; mg; Primary Tumor Field; NA; NA; NA; NA; NA; NA; NA; NA; NA; Adjuvant; Adjuvant; NA","Ovary",24668,"Serous cystadenocarcinoma, NOS","primary",NA,"049c7bc3-3d4a-5872-8d4a-eaffbf8187f5","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1997,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",67,-24668,"3a32c00c-98b2-5f28-ac70-dc47e5e99798",FALSE,787,NA,"TCGA-24-1564-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1564-01"
"TCGA-61-1721-01A-01R-1569-13","TCGA-61-1721-01A-01R-1569-13","TCGA-61-1721","TCGA-61-1721-01A","TP","Primary solid Tumor","TCGA-61-1721-01A","01","Primary","a65361d0-e9ae-4d90-bbf7-70bc213d263e","Primary Tumor","Not Reported","released","Unknown",0.9,"f44d906c-f069-45e6-9cc4-49eb0da74226","TCGA-61-1721",0.3,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; Neoadjuvant; Adjuvant; Neoadjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 20531ffd-84b6-45f3-87a1-0c23173633d4; 205b9f44-7c5a-4e95-b48e-610b7726da53; 317421ae-09b2-5042-acb5-8e8b08650fd1; 36296aa4-7bc1-47f4-83ae-be0c3eeb3fa7; 72e450e1-d820-423f-8421-77a261eb9d9c; TCGA-61-1721_treatment5; TCGA-61-1721_treatment3; TCGA-61-1721_treatment; TCGA-61-1721_treatment4; TCGA-61-1721_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; no; yes; yes; yes; yes; 2025-01-06T20:40:19.470987-06:00; 2025-01-06T20:40:19.470987-06:00; NA; 2025-01-06T20:40:19.470987-06:00; 2025-01-06T20:40:19.470987-06:00; NA; 338; 317; 338; 317; NA; 3960; 528; 1782; 786; NA; 2; 193; 2; 193; Intravenous; Intraperitoneal; Intravenous; Intravenous; Intraperitoneal; Intravenous; NA; 6; 6; 6; 6; NA; Carboplatin; Oxaliplatin; Paclitaxel; Docetaxel; NA; Not Reported; NA; Not Reported; NA; NA; mg; mg; mg; mg","Ovary",13894,"Serous cystadenocarcinoma, NOS","primary",NA,"dcf90374-280a-5d2e-992f-9c76e9acd8e3","Ovary","Yes",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2008,"Excisional Biopsy","C56.9","G1",NA,"white","female","not hispanic or latino","Alive",38,-13894,"1eb55aba-7ecf-530a-91c4-218735f5c0e5",FALSE,NA,NA,"TCGA-61-1721-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1721-01"
"TCGA-09-2044-01B-01R-1568-13","TCGA-09-2044-01B-01R-1568-13","TCGA-09-2044","TCGA-09-2044-01B","TP","Primary solid Tumor","TCGA-09-2044-01B","01","Primary","1f60c05e-f171-4815-b0da-40aa1b24f300","Primary Tumor","Not Reported","released","Unknown",1.4,"42d7c4ad-b379-4dc0-ba67-16aa6ead89d9","TCGA-09-2044",0.4,"Unknown",1.8,FALSE,"Tumor","8441/3","151; 151; NA; 32; 32; NA; Intravenous; Intravenous; 154fbe2f-d112-5bb8-8427-fb209bdab068; 1849a009-4c73-4e95-b81a-908e567d0c29; c2262968-6643-46a6-8c31-dcf3291add40; TCGA-09-2044_treatment; TCGA-09-2044_treatment2; TCGA-09-2044_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; NA; Carboplatin; Paclitaxel; NA; yes; yes; no; NA; 2025-01-06T20:54:14.676587-06:00; 2025-01-06T20:54:14.676587-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released","Ovary",28231,"Serous cystadenocarcinoma, NOS","primary",NA,"44bb6d41-522c-5051-b9a5-d0fb8e4f3d93","Ovary","No",TRUE,0,"Stage IIB","Not Reported","Right","not reported",2009,"Surgical Resection","C56.9","G3",NA,"asian","female","not hispanic or latino","Alive",77,-28231,"1d738d5b-91e3-54ea-8834-4818e8cc11ed",FALSE,NA,NA,"TCGA-09-2044-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-2044-01"
"TCGA-31-1953-01A-01R-1568-13","TCGA-31-1953-01A-01R-1568-13","TCGA-31-1953","TCGA-31-1953-01A","TP","Primary solid Tumor","TCGA-31-1953-01A","01","Primary","0918328b-5726-4429-a7dc-bb4d4869575b","Primary Tumor","Not Reported","released","Unknown",0.5,"c824400d-b062-4a04-b805-f717426d688e","TCGA-31-1953",0.1,"Unknown",1,FALSE,"Tumor","8441/3","65; NA; NA; NA; 65; 840; NA; NA; NA; 1350; 23; NA; 100; 100; 23; Intravenous; Intravenous; Intravenous; Intravenous; 17c4216b-0dbb-576d-bec5-8806fd89f076; 4aa4dd2b-f2c9-4b6b-940c-a8ea32114ebf; 69499c5b-e264-4b39-8d85-a5c63b50b778; a7ef8d30-76d5-4de3-b2df-9907511a9612; f89419f4-2685-485f-8384-1e3e99a9bd4d; TCGA-31-1953_treatment; TCGA-31-1953_treatment5; TCGA-31-1953_treatment2; TCGA-31-1953_treatment3; TCGA-31-1953_treatment4; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; 3; NA; NA; NA; 3; Paclitaxel; NA; Paclitaxel; Carboplatin; Carboplatin; yes; no; yes; yes; yes; NA; 2025-01-06T20:17:01.872683-06:00; 2025-01-06T20:17:01.872683-06:00; 2025-01-06T20:17:01.872683-06:00; 2025-01-06T20:17:01.872683-06:00; Adjuvant; Adjuvant; NA; NA; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg; NA; NA; NA; mg; NA; NA; Treatment Ongoing; Treatment Ongoing; NA; NA; NA; Progressive Disease; Progressive Disease; NA","Ovary",19064,"Serous cystadenocarcinoma, NOS","primary",NA,"afe49009-fc98-5b1d-9903-ccc3d9c5d4fb","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"asian","female","not hispanic or latino","Alive",52,-19064,"3bd53964-0f52-57a9-8645-6b78d6e3b5ce",FALSE,NA,NA,"TCGA-31-1953-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-31-1953-01"
"TCGA-04-1347-01A-01R-1564-13","TCGA-04-1347-01A-01R-1564-13","TCGA-04-1347","TCGA-04-1347-01A","TP","Primary solid Tumor","TCGA-04-1347-01A","01","Primary","4c4747d9-c0bc-486e-b88c-5c1b8214d4de","Primary Tumor",NA,"released","Unknown",1,"18BFB10C-5EDC-4253-A2A8-93533CB4B471","TCGA-04-1347",0.1,"Unknown",1.1,FALSE,"Tumor","8441/3","173; 173; 173; NA; 173; 2400; 1764; 200; NA; 750; 19; 19; 19; NA; 19; Intravenous; Intravenous; Intravenous; Intravenous; 4ae6ca26-c093-4f6d-a861-b02fad2ca673; 767a0eff-c49f-561c-9def-532f6d7b1aeb; 96a0affe-342c-445d-90cf-a6212780da1b; d4a03c3a-8c0c-4f2b-97ff-078a9a0f98af; d7846e08-b0c6-4b33-b3a8-bd1c3553084a; TCGA-04-1347_treatment3; TCGA-04-1347_treatment; TCGA-04-1347_treatment4; TCGA-04-1347_treatment5; TCGA-04-1347_treatment2; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; 6; 2; NA; 2; Carboplatin; Paclitaxel; Docetaxel; NA; Carboplatin; yes; yes; yes; no; yes; 2025-01-06T20:09:50.573319-06:00; NA; 2025-01-06T20:09:50.573319-06:00; 2025-01-06T20:09:50.573319-06:00; 2025-01-06T20:09:50.573319-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg; mg; mg; NA; mg","Ovary",29695,"Serous cystadenocarcinoma, NOS","primary",NA,"603b066e-4598-53b0-8ea1-c4772b8e2165","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2004,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",81,-29695,"cef50119-cfb0-5a18-84b4-6b9a87c26e3f",FALSE,NA,NA,"TCGA-04-1347-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1347-01"
"TCGA-13-1495-01A-01R-1565-13","TCGA-13-1495-01A-01R-1565-13","TCGA-13-1495","TCGA-13-1495-01A","TP","Primary solid Tumor","TCGA-13-1495-01A","01","Primary","98675894-f21c-4dc4-b822-a6e52634d470","Primary Tumor","Not Reported","released","Unknown",1.5,"51F0A8BF-0E86-402D-BE9F-D41771ED98A3","TCGA-13-1495",0.4,"Unknown",2.1,FALSE,"Tumor","8441/3","984; 2025-01-08T13:15:37.188206-06:00; 5e52ddcb-b9e7-4da5-8587-e3855399de01; TCGA-13-1495_treatment7; Surgery, NOS; released; yes; 2025-01-06T20:23:18.570663-06:00; Progressive Disease","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-13-1495_diagnosis","1524c79d-3af4-406e-867a-c4ea3d573f3b","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",60,-22046,"1cb753ba-3ecc-572a-8d29-c4ed3c9a35f4",FALSE,2749,NA,"TCGA-13-1495-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1495-01"
"TCGA-24-1104-01A-01R-1565-13","TCGA-24-1104-01A-01R-1565-13","TCGA-24-1104","TCGA-24-1104-01A","TP","Primary solid Tumor","TCGA-24-1104-01A","01","Primary","fce206e4-6f50-466b-800c-7e295ea56124","Primary Tumor",NA,"released","Unknown",1,"4991D5F7-0259-430F-AFF7-1307DF563E41","TCGA-24-1104",0.7,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 6a4aa787-279c-41ca-bc7e-06a39efa9ce1; aee42219-aa22-4f9f-8344-ff29a4f1268d; TCGA-24-1104_treatment10; TCGA-24-1104_treatment9; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; yes; yes; 2025-01-06T20:54:50.942436-06:00; 2025-01-06T20:54:50.942436-06:00; Recurrent Disease; Recurrent Disease","Not Reported",21486,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1104_diagnosis","0873cccd-2a97-4273-853e-70877183474b","Not Reported","Yes",FALSE,959,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",56,-20527,"2ab1be5c-ffea-5f82-b277-6ac057112641",FALSE,1933,NA,"TCGA-24-1104-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1104-01"
"TCGA-24-1603-01A-01R-1566-13","TCGA-24-1603-01A-01R-1566-13","TCGA-24-1603","TCGA-24-1603-01A","TP","Primary solid Tumor","TCGA-24-1603-01A","01","Primary","bb14a720-4899-48d9-a57b-e1fd2aa9d8ec","Primary Tumor",NA,"released","Unknown",1,"b5ea4cb8-5f2a-4a6d-88ed-f36c1b12e3f9","TCGA-24-1603",0.7,"Solid Tissue",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 7dc97a98-55ba-4fd2-b7cf-5e33fc9844bf; cbeb1bab-d528-43c2-8937-d268d48bef30; TCGA-24-1603_treatment16; TCGA-24-1603_treatment15; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:21:26.474942-06:00; 2025-01-06T21:21:26.474942-06:00; Recurrent Disease; Recurrent Disease","Not Reported",20673,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1603_diagnosis","678b7443-7a17-4ef9-83e1-9a49db07593c","Not Reported","Yes",FALSE,992,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",53,-19681,"d5969403-73a4-5315-a0c2-0c82873ad345",FALSE,2742,NA,"TCGA-24-1603-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1603-01"
"TCGA-25-1870-01A-01R-1567-13","TCGA-25-1870-01A-01R-1567-13","TCGA-25-1870","TCGA-25-1870-01A","TP","Primary solid Tumor","TCGA-25-1870-01A","01","Primary","b6eb7ad6-2676-416e-b165-0cf683116793","Primary Tumor","Not Reported","released","Unknown",0.4,"5F2EF344-7BE6-4D1A-90F8-8CA796C232B3","TCGA-25-1870",0.2,"Unknown",0.8,FALSE,"Tumor","8441/3","243; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2443142b-eec2-4fbd-8c11-018fb716137a; 613fc65e-9f68-4076-9b1c-2f7cab8f7afd; c3236f90-87d6-4163-8f79-324bc6f984ce; TCGA-25-1870_treatment10; TCGA-25-1870_treatment9; TCGA-25-1870_treatment8; Surgery, NOS; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; released; yes; no; yes; 2025-01-06T21:15:50.396069-06:00; 2025-01-06T21:15:50.396069-06:00; 2025-01-06T21:15:50.396069-06:00; Progressive Disease; Progressive Disease; Progressive Disease","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-25-1870_diagnosis","73ceeddf-dccc-4da2-acee-f09cd687c0f6","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",59,-21550,"c0bb7234-e6e9-5243-a3ab-3e33ef23ba66",FALSE,455,NA,"TCGA-25-1870-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1870-01"
"TCGA-13-0766-01A-02R-1564-13","TCGA-13-0766-01A-02R-1564-13","TCGA-13-0766","TCGA-13-0766-01A","TP","Primary solid Tumor","TCGA-13-0766-01A","01","Primary","03e8c3f2-99b6-40da-862a-e8263475c434","Primary Tumor","Not Reported","released","Unknown",0.9,"7F283E4B-70F9-4834-866C-B91024C74EA3","TCGA-13-0766",0.3,"Unknown",1.7,FALSE,"Tumor","8441/3","","Not Reported",16199,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-13-0766_diagnosis","2fd3290b-6b2a-4fad-93e6-5a5e302a5d10","Not Reported","Yes",FALSE,628,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",42,-15571,"e30ceb01-2a0d-5f44-bc94-3364ba25f4fc",FALSE,1725,NA,"TCGA-13-0766-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0766-01"
"TCGA-30-1892-01A-01R-1568-13","TCGA-30-1892-01A-01R-1568-13","TCGA-30-1892","TCGA-30-1892-01A","TP","Primary solid Tumor","TCGA-30-1892-01A","01","Primary","5b68e68c-3cbf-4506-ac94-4b23b3daba70","Primary Tumor","Not Reported","released","Unknown",0.7,"fb7c966c-9b16-4781-9c01-2db480c88d63","TCGA-30-1892",0.3,"Unknown",1.2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 14266037-2190-48b1-84a0-330b0561d8e9; e3fe813f-4c33-42fb-9a04-34f16d899b55; TCGA-30-1892_treatment15; TCGA-30-1892_treatment14; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:51:59.716525-06:00; 2025-01-06T20:51:59.716525-06:00; Recurrent Disease; Recurrent Disease","Not Reported",19509,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-30-1892_diagnosis","234fadaf-c0d9-49c3-893e-fd05f7046ba1","Not Reported","Yes",FALSE,253,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",52,-19256,"caf0b95d-2121-5698-a1cf-f4408b39c118",FALSE,1484,NA,"TCGA-30-1892-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-30-1892-01"
"TCGA-61-2101-01A-01R-1568-13","TCGA-61-2101-01A-01R-1568-13","TCGA-61-2101","TCGA-61-2101-01A","TP","Primary solid Tumor","TCGA-61-2101-01A","01","Primary","46d32513-dc68-4261-8e1b-26d407b6546a","Primary Tumor","Not Reported","released","Unknown",0.4,"b9d85995-85dd-4b00-b93f-3387cd018475","TCGA-61-2101",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","1190; 1251; 1129; 152; 2; 1159; 1309; 733; 152; 1220; 733; 1103; 2; 1319; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0dfe3e5d-7fad-415e-bd8c-f2a8439e476e; 1219b49d-3b60-434b-a177-6cf2b44c7be1; 12961344-2b40-4122-ae47-25b5bf3705cb; 215561ca-48af-4d44-a9ff-7783cd43b3da; 24ae518b-4b79-4688-a044-5c1633c9498f; 3c269e0a-117f-4ed0-b279-aa33a864f798; 420624e8-613c-5017-8e58-2363bfb58d49; 5ee8d7c9-5a2b-480c-8b74-ae11df4fcf79; 99545768-a347-4122-9c55-a7c2873ca9ec; a008b8e8-64e7-4489-bbea-37c1581c8235; bd63d595-0f0f-4e7c-8730-c311a2576c1f; db4cc135-e327-49bc-95b0-5191d894dee2; ead30eab-4fa4-416d-a8d3-45527707be2c; f452c737-2355-44b0-8764-b16cdc16aa3c; TCGA-61-2101_treatment11; TCGA-61-2101_treatment6; TCGA-61-2101_treatment13; TCGA-61-2101_treatment12; TCGA-61-2101_treatment9; TCGA-61-2101_treatment8; TCGA-61-2101_treatment; TCGA-61-2101_treatment10; TCGA-61-2101_treatment4; TCGA-61-2101_treatment7; TCGA-61-2101_treatment14; TCGA-61-2101_treatment5; TCGA-61-2101_treatment3; TCGA-61-2101_treatment2; Chemotherapy; Chemotherapy; Immunotherapy (Including Vaccines); Chemotherapy; Chemotherapy; Chemotherapy; Radiation, External Beam; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation, External Beam; released; released; released; released; released; released; released; released; released; released; released; released; released; released; Gemcitabine Hydrochloride; Etoposide; Recombinant Interleukin-12; Carboplatin; Cisplatin; Altretamine; NA; Gemcitabine; Paclitaxel; Pegylated Liposomal Doxorubicin Hydrochloride; Altretamine; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; NA; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T21:06:38.174439-06:00; 2025-01-06T21:06:38.174439-06:00; 2025-01-06T21:06:38.174439-06:00; 2025-01-06T21:06:38.174439-06:00; 2025-01-06T21:06:38.174439-06:00; 2025-01-06T21:06:38.174439-06:00; NA; 2025-01-06T21:06:38.174439-06:00; 2025-01-06T21:06:38.174439-06:00; 2025-01-06T21:06:38.174439-06:00; 2025-01-06T21:06:38.174439-06:00; 2025-01-06T21:06:38.174439-06:00; 2025-01-06T21:06:38.174439-06:00; 2025-01-06T21:06:38.174439-06:00; Progressive Disease; Progressive Disease; Progressive Disease; NA; NA; Progressive Disease; NA; Progressive Disease; NA; Progressive Disease; Progressive Disease; Progressive Disease; NA; NA; NA; NA; 300; 3050; 762; NA; 600; 1420; 1200; NA; 800; NA; 1800; 1960; Intraperitoneal; Intravenous; Intravenous; Intravenous; Intravenous; NA; NA; mg/kg; mg; mg; NA; cGy; mg; mg; NA; mg; NA; mg; cGy; NA; NA; NA; 221; 117; NA; 1327; NA; 221; NA; NA; NA; 117; 1327; NA; NA; NA; 4; 6; NA; NA; NA; 4; NA; NA; NA; 6; NA; NA; NA; NA; Adjuvant; Adjuvant; NA; Palliative; NA; Adjuvant; NA; NA; NA; Adjuvant; Palliative; NA; NA; NA; NA; NA; NA; 2; NA; NA; NA; NA; NA; NA; 7; Locoregional Site; Primary Tumor Field","Ovary",20287,"Serous cystadenocarcinoma, NOS","primary",NA,"bcf6dd1a-9c55-5d62-950c-9c3e804897d1","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1999,"Surgical Resection","C56.9","G2",NA,"white","female","not hispanic or latino","Dead",55,-20287,"b7c5d9f0-7661-5b83-b542-63db349c7ce3",FALSE,1688,NA,"TCGA-61-2101-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2101-01"
"TCGA-61-1900-01A-01R-1567-13","TCGA-61-1900-01A-01R-1567-13","TCGA-61-1900","TCGA-61-1900-01A","TP","Primary solid Tumor","TCGA-61-1900-01A","01","Primary","fb634d39-a4fe-493e-a982-2e360e69cbd2","Primary Tumor",NA,"released","Unknown",0.9,"b0dd202d-16dc-42ec-ad83-6f02b37b919f","TCGA-61-1900",0.6,"Unknown",1.5,FALSE,"Tumor","8441/3","76; NA; 76; 76; 75; NA; 250; 135; 35; NA; 35; 35; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; 50d4f01f-a356-572e-8d49-b21789af5f5b; 675fec84-a1c9-42c2-a4c4-923784df645b; b4f25a47-e370-40c1-b662-22fae2723eec; f39a623b-d142-4681-bf05-214dcd67cb7b; TCGA-61-1900_treatment; TCGA-61-1900_treatment4; TCGA-61-1900_treatment3; TCGA-61-1900_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 2; NA; 2; 2; Paclitaxel; NA; Paclitaxel; Cisplatin; yes; no; yes; yes; NA; 2025-01-06T20:51:05.743399-06:00; 2025-01-06T20:51:05.743399-06:00; 2025-01-06T20:51:05.743399-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; NA; mg; mg","Ovary",18963,"Serous cystadenocarcinoma, NOS","primary",NA,"c6b4d84c-73bf-54db-b28c-a0e675a19216","Ovary","No",TRUE,0,"Stage IIIB","Not Reported","Bilateral","not reported",2008,"Cytology","C56.9","G3",NA,"black or african american","female","not hispanic or latino","Alive",51,-18963,"22cfffda-6e29-57b4-9e79-7c5e73abe719",FALSE,NA,NA,"TCGA-61-1900-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1900-01"
"TCGA-25-2400-01A-01R-1569-13","TCGA-25-2400-01A-01R-1569-13","TCGA-25-2400","TCGA-25-2400-01A","TP","Primary solid Tumor","TCGA-25-2400-01A","01","Primary","b5e8849b-9002-4b65-a2ea-6a46c04aba4a","Primary Tumor","Not Reported","released","Unknown",1.1,"0C87DA7B-EBA1-4998-88D5-6DF2B0E6A40C","TCGA-25-2400",0.5,"Unknown",1.1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2b769a28-f29a-4a58-bf22-4fb52cc12a21; 773d32f0-2559-48d7-8ccb-acf9b75024af; TCGA-25-2400_treatment6; TCGA-25-2400_treatment7; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:35:41.853388-06:00; 2025-01-06T21:35:41.853388-06:00; Recurrent Disease; Recurrent Disease","Not Reported",28366,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-25-2400_diagnosis","84aace27-28e2-4c2d-bd5f-6d006468d4c4","Not Reported","Yes",FALSE,577,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",76,-27789,"3c33fcef-becb-52f1-8639-ed1171c7abf6",FALSE,1278,NA,"TCGA-25-2400-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-2400-01"
"TCGA-29-2427-01A-01R-1569-13","TCGA-29-2427-01A-01R-1569-13","TCGA-29-2427","TCGA-29-2427-01A","TP","Primary solid Tumor","TCGA-29-2427-01A","01","Primary","41b8564a-48df-44ab-9242-8d1d89697658","Primary Tumor","Not Reported","released","Unknown",1,"b53536ca-770c-4482-b2f7-4284d804db2e","TCGA-29-2427",0.5,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 4d1fe40b-8c0e-473e-8bed-93476d9b7f99; faaf835c-197b-4473-bc27-38ba06d63f78; TCGA-29-2427_treatment9; TCGA-29-2427_treatment8; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:29:06.619746-06:00; 2025-01-06T21:29:06.619746-06:00; Recurrent Disease; Recurrent Disease","Not Reported",23522,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-29-2427_diagnosis","d9519259-0396-4b46-984a-95d3dfe606f6","Not Reported","Yes",FALSE,1582,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Alive",60,-21940,"4444344c-f573-5cad-9e24-348cf054c8ca",FALSE,NA,NA,"TCGA-29-2427-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-2427-01"
"TCGA-29-1784-01A-02R-1567-13","TCGA-29-1784-01A-02R-1567-13","TCGA-29-1784","TCGA-29-1784-01A","TP","Primary solid Tumor","TCGA-29-1784-01A","01","Primary","90c52b7a-a0fb-4e5f-9c80-ee94516ab8d9","Primary Tumor",NA,"released","Unknown",1,"e4614e5d-eb1f-4ac7-a17f-105936745e80","TCGA-29-1784",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","59; 136; NA; 17; 24; 300; 3330; NA; 270; 2480; 59; 17; NA; 17; 23; Intravenous; Intravenous; Intravenous; Intravenous; 23d48b9a-e5f7-5aee-bb22-0a3c67d096a5; 78fc38df-b24c-47c8-b94e-83028092e483; a6a379db-4e93-4004-a3d7-a876247acd8b; e46f10f9-2355-4990-aeea-5e5345b45b21; f5e90ba6-a600-47b1-9125-ac98f8f8981d; TCGA-29-1784_treatment; TCGA-29-1784_treatment4; TCGA-29-1784_treatment5; TCGA-29-1784_treatment2; TCGA-29-1784_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 1; 6; NA; 1; 1; Nab-paclitaxel; Carboplatin; NA; Paclitaxel; Gemcitabine Hydrochloride; yes; yes; no; yes; yes; NA; 2025-01-06T21:00:59.545941-06:00; 2025-01-06T21:00:59.545941-06:00; 2025-01-06T21:00:59.545941-06:00; 2025-01-06T21:00:59.545941-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg; mg; NA; mg; mg","Ovary",20210,"Serous cystadenocarcinoma, NOS","primary",NA,"3e3aadeb-f781-5f50-86b3-d49f1aa93c4f","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",55,-20210,"331533e8-2b22-538a-bb92-3ba7f81c58a2",FALSE,NA,NA,"TCGA-29-1784-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1784-01"
"TCGA-24-1558-01A-01R-1566-13","TCGA-24-1558-01A-01R-1566-13","TCGA-24-1558","TCGA-24-1558-01A","TP","Primary solid Tumor","TCGA-24-1558-01A","01","Primary","3e8bd387-4fda-4623-924e-314267c55eea","Primary Tumor",NA,"released","Unknown",1,"62143e5f-4452-47ca-a67c-cd87036424b1","TCGA-24-1558",0.9,"Unknown",1.9,FALSE,"Tumor","8441/3","487; NA; 588; 382; 247; 247; 382; 247; 277; NA; 11810; 3600; 44; 14; 524; 1800; 403; NA; 515; 316; 37; 37; 316; 37; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 0563b68b-beaa-4507-87d6-51231025c82c; 0f2adf95-1701-4d75-8da6-7fcdec862fc7; 13443c28-f67e-41a1-9113-b4fd4c4cdfa4; 3f1affec-eeab-40e7-96de-2a956516eefa; 5e803842-33be-5620-ac0b-2cfd048621d8; 80f229b9-2f48-4103-b81d-221c06a86467; e20283cd-ed7e-4842-9ab9-d8cdf1b9887e; ff1faaaa-8290-4a11-bd63-d7e9aaa0dc06; TCGA-24-1558_treatment7; TCGA-24-1558_treatment8; TCGA-24-1558_treatment3; TCGA-24-1558_treatment4; TCGA-24-1558_treatment; TCGA-24-1558_treatment5; TCGA-24-1558_treatment2; TCGA-24-1558_treatment6; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 4; NA; 4; 4; 10; 10; 4; 10; Pegylated Liposomal Doxorubicin Hydrochloride; NA; Gemcitabine; Gemcitabine; Carboplatin; Topotecan; Docetaxel; Paclitaxel; yes; no; yes; yes; yes; yes; yes; yes; 2025-01-06T21:33:56.286465-06:00; 2025-01-06T21:33:56.286465-06:00; 2025-01-06T21:33:56.286465-06:00; 2025-01-06T21:33:56.286465-06:00; NA; 2025-01-06T21:33:56.286465-06:00; 2025-01-06T21:33:56.286465-06:00; 2025-01-06T21:33:56.286465-06:00; Progressive Disease; NA; Progressive Disease; Persistent Disease; NA; NA; Persistent Disease; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; mg; NA; mg; mg; mg; mg; mg; mg; NA; Adjuvant; NA; Not Reported; Adjuvant; Adjuvant; Not Reported; Adjuvant","Ovary",27004,"Serous cystadenocarcinoma, NOS","primary",NA,"2c050cd3-82f7-5809-b295-340ecf3cb89c","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2000,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",73,-27004,"58103f7a-0d5a-5c6b-b9cb-6214466a0c34",FALSE,594,NA,"TCGA-24-1558-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1558-01"
"TCGA-24-1842-01A-01R-1567-13","TCGA-24-1842-01A-01R-1567-13","TCGA-24-1842","TCGA-24-1842-01A","TP","Primary solid Tumor","TCGA-24-1842-01A","01","Primary","8c53c83d-85c8-49b5-8838-cb0585c894b2","Primary Tumor",NA,"released","Unknown",0.7,"3465aae7-0664-44e5-a27f-c02fd73526a1","TCGA-24-1842",0.7,"Unknown",1.5,FALSE,"Tumor","8441/3","253; NA; 253; 253; 4355; NA; 2043; 14331; 24; NA; 24; 43; Intravenous; Intravenous; 127e6b3e-d997-41e1-aaaa-003ef60b1b63; 605c71cc-1e60-4059-bc6a-fc9a0f52914f; 835bdafc-d17f-4cf8-9f88-11991c1b0b0a; c994f920-7c4b-5e02-8f9e-f14efe9b945e; TCGA-24-1842_treatment2; TCGA-24-1842_treatment4; TCGA-24-1842_treatment3; TCGA-24-1842_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Targeted Molecular Therapy; 6; NA; 6; NA; Carboplatin; NA; Paclitaxel; Clinical Trial; yes; no; yes; yes; 2025-01-06T21:33:01.793537-06:00; 2025-01-06T21:33:01.793537-06:00; 2025-01-06T21:33:01.793537-06:00; NA; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; NA; mg; mg","Ovary",18227,"Serous cystadenocarcinoma, NOS","primary",NA,"53645a91-09b0-52fe-a6c3-029904ef194e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",49,-18227,"1002b6b2-c01e-55fc-80a0-ffb1512d7c36",FALSE,NA,NA,"TCGA-24-1842-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1842-01"
"TCGA-61-2002-01A-01R-1568-13","TCGA-61-2002-01A-01R-1568-13","TCGA-61-2002","TCGA-61-2002-01A","TP","Primary solid Tumor","TCGA-61-2002-01A","01","Primary","c9aa3e59-a10a-4e4c-b8cb-40d970f43df7","Primary Tumor","Not Reported","released","Unknown",0.4,"8030b8aa-9686-45b3-bf39-1889a6b8b36f","TCGA-61-2002",0.2,"Unknown",1.2,FALSE,"Tumor","8441/3","558; NA; 129; 129; 563; 6600; NA; 4800; 1668; 924; 400; NA; 24; 24; 157; Intravenous; Intravenous; Intravenous; Intravenous; 27bc5369-25f4-42a4-959b-11735c1da79a; 3a1b776c-3054-43dc-a13b-1e73e4a69d1d; 534ebbb8-601a-4fa0-87cc-d920e1db5600; 77095dda-43e6-5a0a-bcb5-fb3ab57e2fec; abb02569-9219-4bf4-a4a8-fb18f7bc01d2; TCGA-61-2002_treatment3; TCGA-61-2002_treatment5; TCGA-61-2002_treatment4; TCGA-61-2002_treatment; TCGA-61-2002_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; 10; NA; 6; 6; 14; Bevacizumab; NA; Carboplatin; Paclitaxel; Doxorubicin; yes; no; yes; yes; yes; 2025-01-06T21:42:06.559329-06:00; 2025-01-06T21:42:06.559329-06:00; 2025-01-06T21:42:06.559329-06:00; NA; 2025-01-06T21:42:06.559329-06:00; Progressive Disease; NA; NA; NA; Progressive Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg; NA; mg; mg; mg; NA; Adjuvant; Adjuvant; Adjuvant; NA","Ovary",17115,"Serous cystadenocarcinoma, NOS","primary",NA,"578ddcf5-2778-5527-9652-d17bc06c620c","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",46,-17115,"eaf6457d-9150-5a07-a240-9aabc2e07928",FALSE,NA,NA,"TCGA-61-2002-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2002-01"
"TCGA-57-1993-01A-01R-1568-13","TCGA-57-1993-01A-01R-1568-13","TCGA-57-1993","TCGA-57-1993-01A","TP","Primary solid Tumor","TCGA-57-1993-01A","01","Primary","41dbed72-2bd8-4e94-9e20-ba18211bdcbc","Primary Tumor","Not Reported","released","Unknown",0.5,"55495e3a-6052-4fb1-b8a9-10b54dcdfbea","TCGA-57-1993",0.5,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 62; 62; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 5bc14705-278b-445b-bb6a-dfbfbf7ce1a8; 86b00aca-8e27-53cc-9482-58183bc3d7cc; fad3f565-7842-4e5a-92c4-a89dacd90c32; TCGA-57-1993_treatment2; TCGA-57-1993_treatment; TCGA-57-1993_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; released; released; released; Paclitaxel; Carboplatin; NA; yes; yes; no; 2025-01-06T21:10:38.536275-06:00; NA; 2025-01-06T21:10:38.536275-06:00","Ovary",20498,"Serous cystadenocarcinoma, NOS","primary",NA,"3d3ca882-be6d-531d-8a29-55d8eb0f5f55","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G3","R0","white","female","not hispanic or latino","Alive",56,-20498,"ca281c52-a2d4-5e1b-8bd2-7d277fd5297b",FALSE,NA,NA,"TCGA-57-1993-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-57-1993-01"
"TCGA-24-1545-01A-01R-1566-13","TCGA-24-1545-01A-01R-1566-13","TCGA-24-1545","TCGA-24-1545-01A","TP","Primary solid Tumor","TCGA-24-1545-01A","01","Primary","ed59c414-e594-44c8-b920-159336d45b4f","Primary Tumor",NA,"released","Unknown",1,"0D1CB67F-57E1-4234-AA1A-5EF0E6EC3975","TCGA-24-1545",0.5,"Unknown",1.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; b792d936-d07a-4d06-8976-e9c2acb26f5c; cb1c4334-ced3-4b64-93d5-4a216dee2729; TCGA-24-1545_treatment10; TCGA-24-1545_treatment9; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:59:58.404717-06:00; 2025-01-06T20:59:58.404717-06:00; Recurrent Disease; Recurrent Disease","Not Reported",26321,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1545_diagnosis","ea41988c-1e9c-4a6f-8ac4-1e492cbd7607","Not Reported","Yes",FALSE,861,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",69,-25460,"1d9ea521-4431-55d4-8082-d86421ddebe7",FALSE,1746,NA,"TCGA-24-1545-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1545-01"
"TCGA-04-1365-01A-01R-1565-13","TCGA-04-1365-01A-01R-1565-13","TCGA-04-1365","TCGA-04-1365-01A","TP","Primary solid Tumor","TCGA-04-1365-01A","01","Primary","c91df211-f021-40ea-aa79-9fe01a309ad8","Primary Tumor","Not Reported","released","Unknown",1.2,"049FC54E-4D17-4B68-9E41-268529C9F18F","TCGA-04-1365",0.6,"Unknown",1.2,FALSE,"Tumor","8441/3","947; 189; 189; 947; NA; 947; 947; 947; 21; 21; 947; NA; 947; 947; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 12f9ff7b-605d-48d4-b8f7-a4e563beca3b; 30ad66dd-c720-4e90-8888-2194448007d4; 5c924e77-3ff0-5b67-9f21-44d930d43e93; adec6593-fcc4-4d16-990d-0a532622e53e; b6223261-6c6c-4e89-b19a-2f28564c4f29; c763474e-aef7-48d5-ba9c-1d5e0c70bfb1; c78558fa-3293-4b2a-816b-9ad3e54d2ff3; TCGA-04-1365_treatment2; TCGA-04-1365_treatment5; TCGA-04-1365_treatment; TCGA-04-1365_treatment6; TCGA-04-1365_treatment7; TCGA-04-1365_treatment4; TCGA-04-1365_treatment3; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 1; 8; 8; 2; NA; 6; 4; Carboplatin; Gemcitabine; Carboplatin; Carboplatin; NA; Carboplatin; Carboplatin; yes; yes; yes; yes; no; yes; yes; 2025-01-06T21:26:20.046772-06:00; 2025-01-06T21:26:20.046772-06:00; NA; 2025-01-06T21:26:20.046772-06:00; 2025-01-06T21:26:20.046772-06:00; 2025-01-06T21:26:20.046772-06:00; 2025-01-06T21:26:20.046772-06:00; Progressive Disease; NA; NA; Progressive Disease; NA; Progressive Disease; Progressive Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; NA; 11760; 6; 4; NA; 5; 5; NA; Adjuvant; Adjuvant; NA; Adjuvant; NA; NA; NA; mg; AUC; AUC; NA; AUC; AUC","Ovary",31925,"Serous cystadenocarcinoma, NOS","primary",NA,"2dd073be-5331-55f3-bb9b-aa2a4a04d8b8","Ovary","No",TRUE,0,"Stage IIIB","Not Reported","Left","not reported",2003,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",87,-31925,"ad52a183-6a6a-50ad-8f74-a12962008af9",TRUE,NA,NA,"TCGA-04-1365-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1365-01"
"TCGA-29-1783-01A-01R-1567-13","TCGA-29-1783-01A-01R-1567-13","TCGA-29-1783","TCGA-29-1783-01A","TP","Primary solid Tumor","TCGA-29-1783-01A","01","Primary","7d811a29-b303-453e-9c0e-91ae12907510","Primary Tumor",NA,"released","Unknown",1,"6ebf4763-bb2a-4ef5-ab22-23460980df1c","TCGA-29-1783",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 076a4351-0022-4e5a-9dcb-8769322b4ea2; 8bb26b30-d110-496a-ac95-ea733e9513e9; 9a548d66-d94b-4360-8c4e-2b4c85808e13; f66ffc46-9d26-52f7-9fde-2f846ac8beb9; TCGA-29-1783_treatment4; TCGA-29-1783_treatment3; TCGA-29-1783_treatment2; TCGA-29-1783_treatment; Radiation Therapy, NOS; Chemotherapy; Targeted Molecular Therapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T20:29:38.027636-06:00; 2025-01-06T20:29:38.027636-06:00; 2025-01-06T20:29:38.027636-06:00; NA; NA; 156; 430; 156; NA; 1623; 9750; 4536; NA; 30; 52; 30; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; NA; 6; NA; 6; NA; Paclitaxel; Bevacizumab; Carboplatin; NA; mg; mg; mg","Ovary",21284,"Serous cystadenocarcinoma, NOS","primary",NA,"76e57c55-e185-57fb-8980-6ccd1a2ee446","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",58,-21284,"fd7dbd5b-6da2-5b5c-9857-6f220f063c51",FALSE,NA,NA,"TCGA-29-1783-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1783-01"
"TCGA-13-1510-01A-02R-1565-13","TCGA-13-1510-01A-02R-1565-13","TCGA-13-1510","TCGA-13-1510-01A","TP","Primary solid Tumor","TCGA-13-1510-01A","01","Primary","557f7cab-8204-4295-831e-9a8cacf72231","Primary Tumor","Not Reported","released","Unknown",1.1,"D6FA84A0-0DE4-42F8-9D15-9EDA4115AE4D","TCGA-13-1510",0.4,"Unknown",2,FALSE,"Tumor","Unknown","","Not Reported",23897,"Unknown","Unknown","TCGA-13-1510_diagnosis","c87ea609-1d93-4150-a138-6bb571e1c677","Not Reported","Yes",FALSE,1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",62,-22708,"d5a00182-83dc-5ef7-9d6a-3caf42ebc893",FALSE,1359,NA,"TCGA-13-1510-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1510-01"
"TCGA-13-0801-01A-01R-1564-13","TCGA-13-0801-01A-01R-1564-13","TCGA-13-0801","TCGA-13-0801-01A","TP","Primary solid Tumor","TCGA-13-0801-01A","01","Primary","dfaf19b4-03b4-49d3-b39f-01aaeb897a2a","Primary Tumor","Not Reported","released","Unknown",0.6,"FA63535E-7499-41E3-AFB1-98EB18DA7371","TCGA-13-0801",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","144; 144; NA; 144; 32; 32; NA; 32; Intravenous; Intraperitoneal; Intraperitoneal; 94acb906-c80b-54ca-9199-5e88c45d41d9; 9af8b654-ca4d-403c-8299-895fb269988f; d47c112f-c7b3-4504-afb2-8fc74188e9f1; f02bc20b-9795-43fa-aea0-b399aa5a623f; TCGA-13-0801_treatment; TCGA-13-0801_treatment2; TCGA-13-0801_treatment4; TCGA-13-0801_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; 6; NA; 6; Paclitaxel; Paclitaxel; NA; Cisplatin; yes; yes; no; yes; NA; 2025-01-06T20:12:35.388721-06:00; 2025-01-06T20:12:35.388721-06:00; 2025-01-06T20:12:35.388721-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released","Ovary",16812,"Serous cystadenocarcinoma, NOS","primary",NA,"6d02c417-f8de-5616-9116-d5ca3ede4004","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Cytology","C56.9","G3",NA,"black or african american","female","not hispanic or latino","Dead",46,-16812,"7bbb9196-227a-56c9-83d2-215537f27f32",FALSE,1399,NA,"TCGA-13-0801-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0801-01"
"TCGA-04-1332-01A-01R-1564-13","TCGA-04-1332-01A-01R-1564-13","TCGA-04-1332","TCGA-04-1332-01A","TP","Primary solid Tumor","TCGA-04-1332-01A","01","Primary","b8243412-b7b4-4a7b-b823-4b33488ff429","Primary Tumor",NA,"released","Unknown",0.6,"97ED2B5D-4349-40FE-A612-949EBBF108C4","TCGA-04-1332",0.5,"Unknown",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2e2274e1-5dbb-4f12-b890-b15463d4008d; 49c9720b-db0c-4cfb-b763-d618ceacfb40; TCGA-04-1332_treatment14; TCGA-04-1332_treatment15; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:52:56.316450-06:00; 2025-01-06T20:52:56.316450-06:00; Recurrent Disease; Recurrent Disease","Not Reported",26179,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-04-1332_diagnosis","36c3ac04-81eb-4379-b954-1e4e1a0c6dfe","Not Reported","Yes",FALSE,393,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",70,-25786,"b30355c0-e9f5-5b9d-88e5-05f6e7ec84d8",FALSE,1247,NA,"TCGA-04-1332-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1332-01"
"TCGA-13-0899-01A-01R-1564-13","TCGA-13-0899-01A-01R-1564-13","TCGA-13-0899","TCGA-13-0899-01A","TP","Primary solid Tumor","TCGA-13-0899-01A","01","Primary","d14005f6-55df-422b-a152-3c313b8df92f","Primary Tumor",NA,"released","Unknown",1.3,"AB15D325-CCD6-452F-8662-158E3153AFC4","TCGA-13-0899",0.5,"Unknown",1.6,FALSE,"Tumor","8441/3","126; 126; NA; 1050; NA; NA; 16; 16; NA; Intravenous; Intravenous; 2e4dc611-2eae-5df7-8df5-1cb73dce374a; 4c4048f0-fde5-4edf-aa69-c1e0be4c4fc5; ac95baaf-2e95-4fe6-b5a1-4957925cbaa4; TCGA-13-0899_treatment; TCGA-13-0899_treatment2; TCGA-13-0899_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; NA; Paclitaxel; Carboplatin; NA; yes; yes; no; NA; 2025-01-06T20:05:40.664596-06:00; 2025-01-06T20:05:40.664596-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg/m2; NA; NA","Ovary",22031,"Serous cystadenocarcinoma, NOS","primary",NA,"39542801-2152-5d8a-85de-8d641a606424","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",60,-22031,"cb83a315-81d1-5941-9ecb-26ee6ebcbe64",FALSE,2012,NA,"TCGA-13-0899-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0899-01"
"TCGA-61-1914-01A-01R-1567-13","TCGA-61-1914-01A-01R-1567-13","TCGA-61-1914","TCGA-61-1914-01A","TP","Primary solid Tumor","TCGA-61-1914-01A","01","Primary","98f6fcfd-df24-422f-a14d-144fd1a02849","Primary Tumor",NA,"released","Unknown",1,"b634b2cf-9e8d-4dd4-8442-337c22522a43","TCGA-61-1914",0.4,"Unknown",1.2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 65badab2-c2de-4ce2-bd79-24176e7bf331; e3498d5d-a409-4bc8-9b1a-3ec500b86323; TCGA-61-1914_treatment7; TCGA-61-1914_treatment8; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:50:42.711638-06:00; 2025-01-06T20:50:42.711638-06:00; Recurrent Disease; Recurrent Disease","Not Reported",25524,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-61-1914_diagnosis","89709f38-3db6-4fd7-ba99-cf6a5b0cd01d","Not Reported","Yes",FALSE,1674,NA,NA,NA,NA,NA,NA,NA,NA,NA,"not reported","female","not reported","Alive",65,-23850,"2133f718-5c09-5c22-a386-00330e432c86",FALSE,NA,NA,"TCGA-61-1914-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1914-01"
"TCGA-25-2391-01A-01R-1569-13","TCGA-25-2391-01A-01R-1569-13","TCGA-25-2391","TCGA-25-2391-01A","TP","Primary solid Tumor","TCGA-25-2391-01A","01","Primary","2179798c-4fd4-4434-b1d5-1453f6054fa2","Primary Tumor","Not Reported","released","Unknown",1,"32AC761D-67A0-46C5-AB01-AE9BBE7307CA","TCGA-25-2391",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","153; 153; NA; 153; 31; 31; NA; 31; Intravenous; Intravenous; Intravenous; 0e489603-9d4e-4e3d-a436-97d44d20f02b; 42ae62e3-b52d-5a77-b8f1-a4b696c24efa; 93b988af-e9a2-4600-93be-2b8ec798655f; e236dda1-afdf-469f-8744-19374fd1263f; TCGA-25-2391_treatment3; TCGA-25-2391_treatment; TCGA-25-2391_treatment4; TCGA-25-2391_treatment2; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 1; 5; NA; 6; Docetaxel; Paclitaxel; NA; Carboplatin; yes; yes; no; yes; 2025-01-06T21:37:06.870086-06:00; NA; 2025-01-06T21:37:06.870086-06:00; 2025-01-06T21:37:06.870086-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released","Ovary",20939,"Serous cystadenocarcinoma, NOS","primary",NA,"33b6e169-a746-5ca1-ab5c-eeaa38b79c2b","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2003,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",57,-20939,"8b704245-4ea7-56dc-bc6e-04c1ea8b05a8",FALSE,1492,NA,"TCGA-25-2391-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-2391-01"
"TCGA-09-2051-01A-01R-1568-13","TCGA-09-2051-01A-01R-1568-13","TCGA-09-2051","TCGA-09-2051-01A","TP","Primary solid Tumor","TCGA-09-2051-01A","01","Primary","c46d2ade-620c-44a6-93ba-8edda9909c1b","Primary Tumor","Not Reported","released","Unknown",0.7,"242a1ff3-05ad-4623-b5aa-9bb556e2cfa9","TCGA-09-2051",0.3,"Unknown",0.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 3bacd4bf-071c-4f2d-bbd1-f46f72d3da6c; 738babb1-270f-4688-b6ad-476cbbedd568; TCGA-09-2051_treatment12; TCGA-09-2051_treatment11; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:23:02.309774-06:00; 2025-01-06T21:23:02.309774-06:00; Recurrent Disease; Recurrent Disease","Not Reported",16233,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-09-2051_diagnosis","11f82d0c-412a-4a32-97fd-947a654dd675","Not Reported","Yes",FALSE,583,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",42,-15650,"d24768bc-31cf-5dee-8acb-c094538cc104",FALSE,NA,"Ashkenazi Jew","TCGA-09-2051-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-2051-01"
"TCGA-61-2097-01A-02R-1568-13","TCGA-61-2097-01A-02R-1568-13","TCGA-61-2097","TCGA-61-2097-01A","TP","Primary solid Tumor","TCGA-61-2097-01A","01","Primary","dfcd4fbd-4441-40aa-a36a-13383c8d7f1a","Primary Tumor","Not Reported","released","Unknown",2,"6d23149d-a9b0-422f-a560-bc1b4a3b99d6","TCGA-61-2097",0.5,"Unknown",2,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; 48; 48; 48; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 79e0b57b-cd69-46cf-9b77-a4c9571e08a7; a077e56e-400d-5b49-bbed-86e4b3016516; b0bd1422-1409-4ade-b86c-bef25f4ccdc7; ef5a2f73-a263-46fc-bc53-94a5f3d2987e; TCGA-61-2097_treatment2; TCGA-61-2097_treatment; TCGA-61-2097_treatment3; TCGA-61-2097_treatment4; Immunotherapy (Including Vaccines); Chemotherapy; Chemotherapy; Radiation Therapy, NOS; released; released; released; released; Recombinant Interferon Gamma; Carboplatin; Paclitaxel; NA; yes; yes; yes; no; 2025-01-06T21:42:21.111742-06:00; NA; 2025-01-06T21:42:21.111742-06:00; 2025-01-06T21:42:21.111742-06:00; NA; 167; 167; NA; NA; 3060; 1814; NA; Intravenous; Intravenous; NA; 6; 6; NA; NA; mg; mg; NA","Ovary",25961,"Serous cystadenocarcinoma, NOS","primary",NA,"2ebeca9d-6570-5225-9bf4-a8868ccddcef","Ovary","No",TRUE,0,"Stage IIC","Not Reported","Bilateral","not reported",2003,"Surgical Resection","C56.9","G2",NA,"white","female","not reported","Alive",71,-25961,"0cec735d-2aa7-5693-9b29-92c27b94bc05",FALSE,NA,NA,"TCGA-61-2097-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2097-01"
"TCGA-61-2113-01A-01R-1568-13","TCGA-61-2113-01A-01R-1568-13","TCGA-61-2113","TCGA-61-2113-01A","TP","Primary solid Tumor","TCGA-61-2113-01A","01","Primary","9ba8451e-7ffc-43f2-b602-8ce8764dfc14","Primary Tumor","Not Reported","released","Unknown",0.8,"d10e1b61-73c4-4ab7-bc4b-8c7827856602","TCGA-61-2113",0.4,"Unknown",1.6,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 37b0adbb-686e-44da-8c83-38910836aee6; 3999740a-8498-424a-9bee-deeb4ebd66ef; TCGA-61-2113_treatment6; TCGA-61-2113_treatment5; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:39:58.737424-06:00; 2025-01-06T20:39:58.737424-06:00; Recurrent Disease; Recurrent Disease","Not Reported",20013,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-61-2113_diagnosis","5207d1ec-7edf-4f0c-88d3-128b8f193353","Not Reported","Yes",FALSE,291,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",53,-19722,"74216962-1bf9-5e6b-8285-3865c6655eac",FALSE,676,NA,"TCGA-61-2113-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2113-01"
"TCGA-61-2003-01A-01R-1568-13","TCGA-61-2003-01A-01R-1568-13","TCGA-61-2003","TCGA-61-2003-01A","TP","Primary solid Tumor","TCGA-61-2003-01A","01","Primary","74826da0-ddc4-49b0-bcb5-591691f4f8d6","Primary Tumor","Not Reported","released","Unknown",1.4,"79c66510-6e38-470f-9e91-d774665d39a6","TCGA-61-2003",0.2,"Unknown",1.5,FALSE,"Tumor","8441/3","122; 52; NA; 52; 122; 52; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 00c29751-5832-4ae3-9037-ea030ac0855f; 322070a9-b213-4341-9aaa-68b9cd07e9c4; 354e5ce7-a1ff-40a1-bde8-5d67059ea432; 82ae9fb4-8dfa-420b-b76a-f37aba37befe; 82bf33a9-33b0-5f3c-a260-0f9e0bc340ec; c4748631-2f0f-4764-98cc-989fd8cd1f28; TCGA-61-2003_treatment3; TCGA-61-2003_treatment4; TCGA-61-2003_treatment6; TCGA-61-2003_treatment2; TCGA-61-2003_treatment; TCGA-61-2003_treatment5; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; Gemcitabine; Paclitaxel; NA; Carboplatin; Carboplatin; Paclitaxel; yes; yes; no; yes; yes; yes; 2025-01-06T21:19:08.923043-06:00; 2025-01-06T21:19:08.923043-06:00; 2025-01-06T21:19:08.923043-06:00; 2025-01-06T21:19:08.923043-06:00; NA; 2025-01-06T21:19:08.923043-06:00; Progressive Disease; NA; NA; NA; Progressive Disease; NA; NA; 121; NA; 121; NA; 121; NA; Adjuvant; Adjuvant; Adjuvant; NA; Adjuvant; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal","Ovary",19605,"Serous cystadenocarcinoma, NOS","primary",NA,"ad8f87df-db51-56a1-840d-89f7e394ab23","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Cytology","C56.9","G2",NA,"white","female","not hispanic or latino","Alive",53,-19605,"08fce3da-3c8e-5e7f-9af4-734444e2919c",FALSE,NA,NA,"TCGA-61-2003-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2003-01"
"TCGA-23-1107-01A-01R-1564-13","TCGA-23-1107-01A-01R-1564-13","TCGA-23-1107","TCGA-23-1107-01A","TP","Primary solid Tumor","TCGA-23-1107-01A","01","Primary","255026d7-92a8-46f3-95ca-d1128e8ec3db","Primary Tumor",NA,"released","Unknown",0.6,"700802e6-8058-4485-8210-3e5b8f10bbf3","TCGA-23-1107",0.6,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 73b0ab2b-8e76-4b2a-beef-4b54c6d1f81e; ff33860a-fae6-5bfe-abe3-29eb0f909303; TCGA-23-1107_treatment2; TCGA-23-1107_treatment; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; no; 2025-01-06T21:42:40.186729-06:00; NA; NA; NA","Ovary",21561,"Serous cystadenocarcinoma, NOS","primary",NA,"c5596e3d-d994-5f01-98ef-e04beffcc90b","Ovary","No",TRUE,0,"Stage IV","Not Reported","Left","not reported",1999,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",59,-21561,"a11794df-2f45-5422-bff0-439ff680ce2d",FALSE,9,NA,"TCGA-23-1107-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1107-01"
"TCGA-24-2026-01A-01R-1567-13","TCGA-24-2026-01A-01R-1567-13","TCGA-24-2026","TCGA-24-2026-01A","TP","Primary solid Tumor","TCGA-24-2026-01A","01","Primary","fe8b3cb8-15ce-4d0c-b168-d8d3db4be176","Primary Tumor","Not Reported","released","Unknown",1,"7fc3cf2f-b132-4dce-b16a-2b4a1162da14","TCGA-24-2026",1,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 5fd7e2ef-9e7f-4cfd-9d31-bfc423645b08; 65c0746e-3c0a-4df2-9a09-e3afb8829a94; 68f6ac27-3f36-54a2-b22a-4c15522f35dc; TCGA-24-2026_treatment3; TCGA-24-2026_treatment2; TCGA-24-2026_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T20:27:25.445638-06:00; 2025-01-06T20:27:25.445638-06:00; NA; NA; 23; 23; Intravenous; Intravenous; NA; Cisplatin; Paclitaxel","Ovary",29050,"Serous cystadenocarcinoma, NOS","primary",NA,"d2d82e4b-87db-5610-a968-930933e83fb7","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1995,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",79,-29050,"108043f3-cc98-5a3e-9410-f2aea4bf95ec",FALSE,1059,NA,"TCGA-24-2026-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2026-01"
"TCGA-61-1907-01A-01R-1567-13","TCGA-61-1907-01A-01R-1567-13","TCGA-61-1907","TCGA-61-1907-01A","TP","Primary solid Tumor","TCGA-61-1907-01A","01","Primary","0230bc74-adc5-4443-ac9e-342d7f344ce7","Primary Tumor",NA,"released","Unknown",0.9,"ae7e4795-496e-47d0-ad60-cec04e5876b0","TCGA-61-1907",0.4,"Unknown",1.6,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; ac13bacd-d807-4fd0-aed0-cb88443daae6; e429d8e4-acbc-4173-9c1a-a3049bc3cbaf; TCGA-61-1907_treatment7; TCGA-61-1907_treatment6; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:39:53.501115-06:00; 2025-01-06T20:39:53.501115-06:00; Recurrent Disease; Recurrent Disease","Not Reported",23947,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-61-1907_diagnosis","f16b6307-d859-488f-8eed-f42a9f6115b1","Not Reported","Yes",FALSE,743,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",63,-23204,"6bdcf0d2-e322-541f-990b-836a67d89453",FALSE,NA,NA,"TCGA-61-1907-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1907-01"
"TCGA-24-1844-01A-01R-1567-13","TCGA-24-1844-01A-01R-1567-13","TCGA-24-1844","TCGA-24-1844-01A","TP","Primary solid Tumor","TCGA-24-1844-01A","01","Primary","8ea52904-f56c-4c1f-b8a4-9906805001ff","Primary Tumor",NA,"released","Unknown",1,"5fd30c3c-9734-40dd-b81e-ae3f364c8fa8","TCGA-24-1844",0.4,"Unknown",1.1,FALSE,"Tumor","8441/3","134; NA; 134; 134; 405; NA; 1285; 2660; 24; NA; 24; 24; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; 2099c7d2-d8b3-42dd-b3cd-8aab764448f8; 5a2e3428-5268-46de-a3eb-bf67e1b89741; cdc87da0-37fe-53d8-9ce0-60d6f76618d9; d79e4c59-4d71-4155-8e42-34963719d247; TCGA-24-1844_treatment3; TCGA-24-1844_treatment4; TCGA-24-1844_treatment; TCGA-24-1844_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 5; NA; 5; 5; Docetaxel; NA; Paclitaxel; Carboplatin; yes; no; yes; yes; 2025-01-06T21:00:19.605745-06:00; 2025-01-06T21:00:19.605745-06:00; NA; 2025-01-06T21:00:19.605745-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; NA; mg; mg","Ovary",23542,"Serous cystadenocarcinoma, NOS","primary",NA,"250e6c30-98ff-51b3-bc1f-cb87719b253c","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2009,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",64,-23542,"1364e963-dbbb-5881-a86a-ad660efa2898",FALSE,NA,NA,"TCGA-24-1844-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1844-01"
"TCGA-09-1665-01B-01R-1566-13","TCGA-09-1665-01B-01R-1566-13","TCGA-09-1665","TCGA-09-1665-01B","TP","Primary solid Tumor","TCGA-09-1665-01B","01","Primary","d66fb62f-8483-459c-999e-d5b64b835e11","Primary Tumor",NA,"released","Unknown",0.6,"0e311879-9b25-453d-b41a-7cc3048bb05e","TCGA-09-1665",0.6,"Unknown",1.5,FALSE,"Tumor","8441/3","792; 1022; 208; 208; 483; 778; 917; 33; 33; 400; 259ed336-fe51-5bcd-8647-917135d01f8f; 6a76a51e-1c97-4ce9-9d78-a03de7ab59b3; 9309bdbf-5836-4b26-bf2a-51aae6b1998c; c1847ccb-52de-46d7-84a2-c7e7bb36f060; e529732a-b0f3-4d4f-8901-86b3db6ba069; TCGA-09-1665_treatment; TCGA-09-1665_treatment4; TCGA-09-1665_treatment5; TCGA-09-1665_treatment2; TCGA-09-1665_treatment3; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Hormone Therapy; NA; Carboplatin; Carboplatin; Paclitaxel; Tamoxifen; yes; yes; yes; yes; yes; NA; 2025-01-06T20:21:09.771109-06:00; 2025-01-06T20:21:09.771109-06:00; 2025-01-06T20:21:09.771109-06:00; 2025-01-06T20:21:09.771109-06:00; Progressive Disease; Progressive Disease; NA; NA; Recurrent Disease; Distant Site; NA; NA; Adjuvant; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; NA; 6; 6; 175; NA; Intravenous; Intravenous; Intravenous; NA; 6; 6; 6; NA; NA; AUC; AUC; mg/m2; NA","Ovary",27010,"Serous cystadenocarcinoma, NOS","primary",NA,"36ea240f-5e4c-59a4-858e-ff2127a15b98","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2002,"Surgical Resection","C56.9","G2",NA,"white","female","not hispanic or latino","Dead",73,-27010,"4b2e1ed3-d88a-581c-a432-bcfc88178a7a",FALSE,1266,NA,"TCGA-09-1665-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-1665-01"
"TCGA-24-1425-01A-02R-1566-13","TCGA-24-1425-01A-02R-1566-13","TCGA-24-1425","TCGA-24-1425-01A","TP","Primary solid Tumor","TCGA-24-1425-01A","01","Primary","7d0d7e28-9530-4d03-9041-aeca61ecf42c","Primary Tumor",NA,"released","Unknown",0.8,"06592570-be8f-49d4-a42f-068ad60efe34","TCGA-24-1425",0.4,"Solid Tissue",1.5,FALSE,"Tumor","8441/3","145; NA; 145; 145; 5065; NA; 553; 832; 27; NA; 27; 27; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; 1d95f428-88d0-47b0-bed1-5e668a570a82; 89a0a221-2313-4fa0-84bb-2c0b014fefb8; c64cf399-ed54-418b-96b1-1793f1052484; c8533376-0d48-5ff0-a8f4-86f4bd19a3bf; TCGA-24-1425_treatment2; TCGA-24-1425_treatment4; TCGA-24-1425_treatment3; TCGA-24-1425_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 6; NA; 6; 6; Carboplatin; NA; Paclitaxel; Docetaxel; yes; no; yes; yes; 2025-01-06T21:08:04.326326-06:00; 2025-01-06T21:08:04.326326-06:00; 2025-01-06T21:08:04.326326-06:00; NA; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; NA; mg; mg","Ovary",16764,"Serous cystadenocarcinoma, NOS","primary",NA,"a4520404-b3dd-59ab-a30e-b3073be4407c","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",45,-16764,"aedc9d93-ac86-5686-a44b-83c6a60b6bcb",FALSE,NA,NA,"TCGA-24-1425-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1425-01"
"TCGA-13-1492-01A-01R-1565-13","TCGA-13-1492-01A-01R-1565-13","TCGA-13-1492","TCGA-13-1492-01A","TP","Primary solid Tumor","TCGA-13-1492-01A","01","Primary","e66d5c81-a9e3-4642-9bcb-655372f247a5","Primary Tumor","Not Reported","released","Unknown",1.2,"566BE185-8A2E-43C4-9762-65216AB9AC44","TCGA-13-1492",0.4,"Unknown",2.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 6ba210eb-987a-4e54-8093-270066aed6c2; bc3d82c5-b314-50ed-802b-3b50c6bdf997; c0ea6284-466e-4a19-b3a7-596c5efe88bb; TCGA-13-1492_treatment3; TCGA-13-1492_treatment; TCGA-13-1492_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:30:49.698185-06:00; NA; 2025-01-06T21:30:49.698185-06:00; NA; 247; 247; NA; 48; 48; Intravenous; Intravenous; NA; 7; 7; NA; Carboplatin; Paclitaxel; NA; NA; 175; NA; NA; mg/m2","Ovary",24332,"Serous cystadenocarcinoma, NOS","primary",NA,"a182868e-521c-5039-8b4e-1c047fbbfd11","Ovary","No",TRUE,0,"Stage IIIC","Not Reported",NA,"not reported",2002,"Fine Needle Aspiration","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",66,-24332,"71d375c1-b32a-5221-950d-48517ae1bf94",FALSE,3819,NA,"TCGA-13-1492-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1492-01"
"TCGA-24-1105-01A-01R-1565-13","TCGA-24-1105-01A-01R-1565-13","TCGA-24-1105","TCGA-24-1105-01A","TP","Primary solid Tumor","TCGA-24-1105-01A","01","Primary","ae4aa065-8b1d-42a3-98ef-357e19c1f1e1","Primary Tumor",NA,"released","Unknown",1,"DE593AFC-BC21-4183-94A6-B8BA9931B70F","TCGA-24-1105",0.8,"Unknown",1.4,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 7dd7dfa9-30e1-46b1-ae5d-e22f09e3dbdd; d794b4ee-4b25-4058-9313-383c2003e1c6; TCGA-24-1105_treatment16; TCGA-24-1105_treatment17; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; yes; 2025-01-06T20:57:43.820673-06:00; 2025-01-06T20:57:43.820673-06:00; Recurrent Disease; Recurrent Disease","Not Reported",13657,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1105_diagnosis","8e692e6f-0c8f-438b-8d44-2e189906cd0a","Not Reported","Yes",FALSE,470,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",36,-13187,"8580420d-47dd-59ce-8343-b6d4b53415e6",FALSE,1442,NA,"TCGA-24-1105-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1105-01"
"TCGA-25-1323-01A-01R-1565-13","TCGA-25-1323-01A-01R-1565-13","TCGA-25-1323","TCGA-25-1323-01A","TP","Primary solid Tumor","TCGA-25-1323-01A","01","Primary","b1d85c32-1698-44ed-a4e2-707611a3889c","Primary Tumor","Not Reported","released","Unknown",2,"AFE55BB2-F0FC-4B39-A61A-2287B62354AD","TCGA-25-1323",0.6,"Unknown",2.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 891774d9-9510-46af-b6be-d3d2e7d4e2b2; 9e7c21cc-77e7-40b9-82a2-f3da724edcc4; TCGA-25-1323_treatment5; TCGA-25-1323_treatment6; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:37:22.659011-06:00; 2025-01-06T21:37:22.659011-06:00; Progressive Disease; Progressive Disease","Not Reported",26967,"Serous cystadenocarcinoma, NOS","Progression","TCGA-25-1323_diagnosis","454cb5f3-dd08-4638-b9cf-3ddb39988a72","Not Reported","Yes",FALSE,365,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",72,-26602,"b7f1ad25-47b4-5bb3-8f7d-332afedb0764",FALSE,395,NA,"TCGA-25-1323-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1323-01"
"TCGA-24-1551-01A-01R-1566-13","TCGA-24-1551-01A-01R-1566-13","TCGA-24-1551","TCGA-24-1551-01A","TP","Primary solid Tumor","TCGA-24-1551-01A","01","Primary","a081a22a-184f-44af-92cf-674c7d349e03","Primary Tumor",NA,"released","Unknown",0.7,"474ac527-45a2-4258-bec4-0a48a3b80742","TCGA-24-1551",0.5,"Solid Tissue",1.2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2e8f549a-15a4-416c-ade9-43c402f2132a; ec987fa6-69c2-4420-9a04-cbd0649cc049; TCGA-24-1551_treatment9; TCGA-24-1551_treatment10; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:48:32.363542-06:00; 2025-01-06T20:48:32.363542-06:00; Recurrent Disease; Recurrent Disease","Not Reported",20425,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1551_diagnosis","3d4895e1-00ae-44ca-a588-46a16a7e2b88","Not Reported","Yes",FALSE,764,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",53,-19661,"ca38c8a5-7219-5217-8608-05cd8bd450f7",FALSE,1579,NA,"TCGA-24-1551-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1551-01"
"TCGA-25-1316-01A-01R-1565-13","TCGA-25-1316-01A-01R-1565-13","TCGA-25-1316","TCGA-25-1316-01A","TP","Primary solid Tumor","TCGA-25-1316-01A","01","Primary","fdf5e5b9-8d6c-4581-93d4-bedae0bf371d","Primary Tumor","Not Reported","released","Unknown",2.5,"B766CB7E-C4EC-489C-AEF0-BE28132D5BA5","TCGA-25-1316",1.5,"Unknown",3,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0b7bb02d-d027-4418-a50c-2ef1228b5095; 8e28bb3e-4bda-45a1-8344-8eb3fac2c2b5; 9ffd597a-dcc4-59f7-97dc-c7f403419f02; f4cfc8c4-51de-4532-9b7b-3a7ea2d6dd0c; TCGA-25-1316_treatment4; TCGA-25-1316_treatment2; TCGA-25-1316_treatment; TCGA-25-1316_treatment3; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T20:49:29.454869-06:00; 2025-01-06T20:49:29.454869-06:00; NA; 2025-01-06T20:49:29.454869-06:00; NA; 214; 214; 406; NA; 61; 61; 276; Intravenous; Intravenous; Intravenous; NA; Paclitaxel; Carboplatin; Topotecan; NA; NA; NA; 6; NA; NA; NA; Progressive Disease","Ovary",20331,"Serous cystadenocarcinoma, NOS","primary",NA,"01932ba3-2753-5aa5-b4bc-15b1972bc184","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2000,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",55,-20331,"8f0f2afc-3c1a-5e58-bdac-9601041f917b",FALSE,1279,NA,"TCGA-25-1316-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1316-01"
"TCGA-10-0931-01A-01R-1564-13","TCGA-10-0931-01A-01R-1564-13","TCGA-10-0931","TCGA-10-0931-01A","TP","Primary solid Tumor","TCGA-10-0931-01A","01","Primary","f46d6e67-40ef-4a8c-99fc-700d8e598131","Primary Tumor",NA,"released","Unknown",0.5,"45d8f828-6dfb-4e68-8282-f2ee74671461","TCGA-10-0931",0.5,"Unknown",0.5,FALSE,"Tumor","8441/3","509; 124; 666; 932; 383; 124; 124; 666; 848; 666; 509; 848; NA; 1632; 2268; 420; 231; 1880; NA; 2430; 440; 24; 1840; 3240; 14000; NA; 386; 19; 538; 876; 335; 19; 19; 538; 792; 538; 386; 792; NA; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 01f9dd21-25c9-454b-9205-f2c458d2f8a7; 0c1dc48a-b18e-4b8e-bd35-b4822eb06c5e; 14c75b55-acf4-417b-a32c-8552bc9f43e5; 16c1e0eb-78f8-4707-9119-7dd2969fe7b1; 1e8264ab-317c-4d55-b2f6-9ed253448e4e; 24db6c59-4d7d-47fb-8e7d-1a19c5bfa33d; 587aee78-3f41-4627-8417-5ed3e096e1f8; 7889d6e0-a465-4848-8999-ab4007017d3d; 8d683a71-955c-40a9-98d6-28d8a94b9a23; 96b3fa9a-cc3d-4568-83e2-6acd1c365980; 9f28ef7c-ec38-53e3-9538-b454efcde173; b93e42be-0cd0-4690-8542-dc74d9256e59; febc92cf-e3cb-4f90-ac0a-82b326cee6e3; TCGA-10-0931_treatment8; TCGA-10-0931_treatment2; TCGA-10-0931_treatment6; TCGA-10-0931_treatment9; TCGA-10-0931_treatment7; TCGA-10-0931_treatment3; TCGA-10-0931_treatment11; TCGA-10-0931_treatment10; TCGA-10-0931_treatment12; TCGA-10-0931_treatment5; TCGA-10-0931_treatment; TCGA-10-0931_treatment4; TCGA-10-0931_treatment13; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Hormone Therapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Targeted Molecular Therapy; Radiation Therapy, NOS; 6; 6; 6; 3; NA; 6; 6; 4; 3; 8; 6; NA; NA; Paclitaxel; Trastuzumab; Docetaxel; Pegylated Liposomal Doxorubicin Hydrochloride; Tamoxifen; Carboplatin; Paclitaxel; Docetaxel; Topotecan; Carboplatin; Carboplatin; Gefitinib; NA; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; no; 2025-01-06T21:40:01.826449-06:00; 2025-01-06T21:40:01.826449-06:00; 2025-01-06T21:40:01.826449-06:00; 2025-01-06T21:40:01.826449-06:00; 2025-01-06T21:40:01.826449-06:00; 2025-01-06T21:40:01.826449-06:00; 2025-01-06T21:40:01.826449-06:00; 2025-01-06T21:40:01.826449-06:00; 2025-01-06T21:40:01.826449-06:00; 2025-01-06T21:40:01.826449-06:00; NA; 2025-01-06T21:40:01.826449-06:00; 2025-01-06T21:40:01.826449-06:00; Recurrent Disease; NA; Recurrent Disease; Recurrent Disease; Recurrent Disease; NA; NA; Recurrent Disease; Recurrent Disease; Recurrent Disease; Recurrent Disease; Recurrent Disease; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; released; released; released; mg/m2; mg/m2; mg; mg/m2; mg/m2; NA; mg/m2; mg/m2; mg/m2; mg/m2; mg/m2; mg/m2; NA; NA; Adjuvant; NA; NA; NA; Adjuvant; Adjuvant; NA; NA; NA; NA; NA; Adjuvant","Ovary",16262,"Serous cystadenocarcinoma, NOS","primary",NA,"da8e8e22-7514-538e-8029-9f2dd1dbf55e","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",44,-16262,"9d30f62d-cadc-5d3f-8505-00561713c897",FALSE,1000,NA,"TCGA-10-0931-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-10-0931-01"
"TCGA-04-1362-01A-01R-1565-13","TCGA-04-1362-01A-01R-1565-13","TCGA-04-1362","TCGA-04-1362-01A","TP","Primary solid Tumor","TCGA-04-1362-01A","01","Primary","2cd492fc-4e79-4483-a8d6-31c0156c50c9","Primary Tumor","Not Reported","released","Unknown",1,"D3757F96-E669-4D0E-BBCB-41696AB72004","TCGA-04-1362",0.6,"Unknown",1.2,FALSE,"Tumor","8441/3","Adjuvant; NA; Adjuvant; Adjuvant; NA; NA; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 22f286ad-bc2b-4fee-866d-23d5963532cf; 2347f080-a9b6-41d9-a181-4759650f6811; 506cdf3e-cfd6-45e6-80fe-381d2db0264b; 6cfcfadd-2adf-4f1f-b290-c71d67900355; 741a3197-32c7-4893-b112-c3b94b02baa2; 75086b0f-7c17-4bbd-a68a-cddaaf2ef392; e4570351-8389-5e5a-a13c-13883ddf03a2; TCGA-04-1362_treatment7; TCGA-04-1362_treatment2; TCGA-04-1362_treatment6; TCGA-04-1362_treatment3; TCGA-04-1362_treatment5; TCGA-04-1362_treatment4; TCGA-04-1362_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; yes; 2025-01-06T20:43:01.867823-06:00; 2025-01-06T20:43:01.867823-06:00; 2025-01-06T20:43:01.867823-06:00; 2025-01-06T20:43:01.867823-06:00; 2025-01-06T20:43:01.867823-06:00; 2025-01-06T20:43:01.867823-06:00; NA; NA; 658; 7; 7; 658; 658; 7; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; Carboplatin; Gemcitabine; Paclitaxel; Topotecan; Pegylated Liposomal Doxorubicin Hydrochloride; Carboplatin; NA; Progressive Disease; NA; NA; Progressive Disease; Progressive Disease; NA; NA; NA; 172; 172; NA; NA; 172; NA; NA; 13856; 1689; NA; NA; 2593; NA; NA; 6; 6; NA; NA; 6; NA; NA; mg; mg; NA; NA; mg","Ovary",21745,"Serous cystadenocarcinoma, NOS","primary",NA,"6c650e4b-ae78-596e-8ff7-657d4f6db775","Ovary","No",TRUE,0,"Stage IIC","Not Reported","Bilateral","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",59,-21745,"508c36c3-7b48-5032-937e-d91e566e31a6",FALSE,1348,NA,"TCGA-04-1362-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1362-01"
"TCGA-04-1651-01A-01R-1567-13","TCGA-04-1651-01A-01R-1567-13","TCGA-04-1651","TCGA-04-1651-01A","TP","Primary solid Tumor","TCGA-04-1651-01A","01","Primary","7d9f2d6d-3ec6-4fed-9d3a-52e813bd8be6","Primary Tumor",NA,"released","Unknown",0.4,"703BEFE1-07E0-48AE-826E-133A59F97068","TCGA-04-1651",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 57dcf1aa-9de3-4396-b484-b59017d377e2; da3c9cf1-676c-4e94-b541-5171d70eecda; TCGA-04-1651_treatment8; TCGA-04-1651_treatment7; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:19:43.833354-06:00; 2025-01-06T20:19:43.833354-06:00; Recurrent Disease; Recurrent Disease","Not Reported",20618,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-04-1651_diagnosis","5514e5c4-d795-4a5f-ab87-936148ec4ec7","Not Reported","Yes",FALSE,990,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",53,-19628,"3b99b3f1-6556-5121-8085-9073925eba9d",FALSE,1102,NA,"TCGA-04-1651-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1651-01"
"TCGA-13-0800-01A-01R-1564-13","TCGA-13-0800-01A-01R-1564-13","TCGA-13-0800","TCGA-13-0800-01A","TP","Primary solid Tumor","TCGA-13-0800-01A","01","Primary","a99995e3-8d0b-453a-b604-206218279b71","Primary Tumor","Not Reported","released","Unknown",0.9,"E3206F00-3BC6-44B4-848E-F2ED70E094BD","TCGA-13-0800",0.3,"Unknown",1.5,FALSE,"Tumor","Unknown","","Not Reported",20483,"Unknown","Unknown","TCGA-13-0800_diagnosis","6fd200ed-0824-4ad4-9ab0-3a8f25da1069","Not Reported","Yes",FALSE,1396,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",52,-19087,"5f1fb8da-be94-5c96-95df-d92366f4f2cd",FALSE,NA,NA,"TCGA-13-0800-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0800-01"
"TCGA-29-1688-01A-01R-1566-13","TCGA-29-1688-01A-01R-1566-13","TCGA-29-1688","TCGA-29-1688-01A","TP","Primary solid Tumor","TCGA-29-1688-01A","01","Primary","3385e66c-5764-4260-929f-b653a23c7afb","Primary Tumor",NA,"released","Unknown",1.5,"cb2bd608-b9d4-497e-9058-2269dc86b5b3","TCGA-29-1688",0.5,"Unknown",2.5,FALSE,"Tumor","8441/3","Distant Site; Palliative; NA; NA; NA; Adjuvant; NA; NA; NA; NA; NA; NA; NA; NA; NA; Adjuvant; NA; 2235; 1719; 197; 197; NA; NA; NA; 743; 743; NA; 1900; NA; 1900; NA; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 041496d3-ca85-527c-8ad9-c68f439ff33e; 057af198-d6ec-4ee9-87db-7a3043dacc9c; 1c70ec62-b18b-4083-867d-9831176ec26e; 3118faa4-87df-4734-a129-3cd741f62f62; 46118353-3f79-4b57-b926-a3847cf8b62d; 49a3ef4a-1529-4c32-9c4f-464c2ea241ae; 81a67a72-8505-4b6d-8635-5b20eece7e11; 97ce1490-775a-4c72-a418-814605a38385; 99b621da-b576-4308-a607-81abea762a3f; 9debaa58-8658-4a2a-8d58-6ababcbb5e17; a2d86c89-3d5a-4053-b65f-a04dfaab0f3a; a462ed40-249b-43a0-b524-5cfdc5f9099b; b3671444-b9b7-44b1-a136-c22aa86f6744; c05c99f0-8278-4419-83f0-78017841a298; c811e457-a297-436b-a7d2-c967fda9c42d; dcb21ccb-96d9-429c-9117-3b3186fb4a85; TCGA-29-1688_treatment; TCGA-29-1688_treatment4; TCGA-29-1688_treatment7; TCGA-29-1688_treatment15; TCGA-29-1688_treatment2; TCGA-29-1688_treatment9; TCGA-29-1688_treatment16; TCGA-29-1688_treatment12; TCGA-29-1688_treatment10; TCGA-29-1688_treatment5; TCGA-29-1688_treatment8; TCGA-29-1688_treatment13; TCGA-29-1688_treatment14; TCGA-29-1688_treatment6; TCGA-29-1688_treatment3; TCGA-29-1688_treatment11; Radiation, External Beam; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; released; released; released; released; released; released; released; released; released; released; NA; Docetaxel; Etoposide; Cisplatin; Cisplatin; Etoposide; Etoposide; Cyclophosphamide; Carboplatin; Carboplatin; Paclitaxel; Topotecan; Carboplatin; Cyclophosphamide; Cyclophosphamide; Altretamine; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; NA; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; 2025-01-06T20:16:09.544676-06:00; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intravenous; Oral; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intravenous; Intraperitoneal; Intravenous; NA; 6; 6; 6; NA; 3; NA; 6; 6; NA; NA; NA; NA; NA; NA; NA; NA; Progressive Disease; Progressive Disease; Progressive Disease; NA; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; Progressive Disease; NA; Progressive Disease; NA; NA; NA; NA; NA; NA; NA; NA; NA; 2395; NA; NA; NA; 2395; NA; NA; NA; NA; NA; NA; NA; NA; NA; NA; NA; NA; 175; NA; 5; NA; NA; NA; NA; NA; NA; NA; NA; NA; NA; NA; NA; NA; mg/m2; NA; AUC; NA; NA; NA","Ovary",14574,"Serous cystadenocarcinoma, NOS","primary",NA,"167fdc87-5221-5292-9ca8-de9c2fc60e5b","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1992,"Surgical Resection","C56.9","G2",NA,"white","female","not reported","Dead",39,-14574,"99a2d09f-0a52-5f26-8588-75ce3c50c76b",FALSE,2400,NA,"TCGA-29-1688-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1688-01"
"TCGA-36-1574-01A-01R-1566-13","TCGA-36-1574-01A-01R-1566-13","TCGA-36-1574","TCGA-36-1574-01A","TP","Primary solid Tumor","TCGA-36-1574-01A","01","Primary","353b6c00-ebfe-4650-8379-f46c8fe3e9cf","Primary Tumor",NA,"released","Unknown",0.5,"174e0ef6-e8bc-4c43-8253-ee6d3ff9c1ce","TCGA-36-1574",0.4,"Unknown",0.7,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 68db22fe-7b9b-4009-8ea8-a2bc99445a65; cf439282-6042-4e32-9385-9a871347dca3; fa6eed8c-3187-56b6-83a7-e6424af3c8ae; TCGA-36-1574_treatment3; TCGA-36-1574_treatment2; TCGA-36-1574_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T20:33:59.133576-06:00; 2025-01-06T20:33:59.133576-06:00; NA; NA; 204; 204; NA; 15; 15; Intravenous; Intravenous; NA; 8; 8; NA; Paclitaxel; Carboplatin","Ovary",17847,"Serous cystadenocarcinoma, NOS","primary",NA,"c26a3c0e-765f-5b6f-be27-9e886aeaad31","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G3",NA,"asian","female","not reported","Alive",48,-17847,"46847140-fc89-5fa9-934e-d1c3ec70f956",FALSE,NA,NA,"TCGA-36-1574-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-36-1574-01"
"TCGA-13-1483-01A-01R-1565-13","TCGA-13-1483-01A-01R-1565-13","TCGA-13-1483","TCGA-13-1483-01A","TP","Primary solid Tumor","TCGA-13-1483-01A","01","Primary","ee7d5c16-fb34-4500-87f4-c920f797d9f5","Primary Tumor","Not Reported","released","Unknown",1.4,"c5f81fb7-5cdc-4c0a-8d5a-74e93a11b7db","TCGA-13-1483",0.4,"Unknown",1.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 5226d610-e8cf-48bd-a6f3-8891693388c3; f1757f9d-7ec5-4b4d-a0e5-1b7b7c700553; TCGA-13-1483_treatment6; TCGA-13-1483_treatment5; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:28:02.145310-06:00; 2025-01-06T21:28:02.145310-06:00; Recurrent Disease; Recurrent Disease","Not Reported",22639,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-13-1483_diagnosis","117df4e6-fe1e-40b0-abd0-de7cbf783e0e","Not Reported","Yes",FALSE,297,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",61,-22342,"1b6e413d-3075-5578-96e1-c7441bed86cd",FALSE,895,NA,"TCGA-13-1483-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1483-01"
"TCGA-24-2262-01A-01R-1568-13","TCGA-24-2262-01A-01R-1568-13","TCGA-24-2262","TCGA-24-2262-01A","TP","Primary solid Tumor","TCGA-24-2262-01A","01","Primary","c8767fb2-1e4a-42de-b648-847d4a5df78b","Primary Tumor","Not Reported","released","Unknown",0.6,"d58b58ac-365c-43d0-a893-0becfb6e9fff","TCGA-24-2262",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 7616810e-f532-4cce-ae69-734b02a6b5a2; e6ec155b-d287-5959-b056-11401a70ba01; TCGA-24-2262_treatment2; TCGA-24-2262_treatment; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; no; 2025-01-06T21:35:01.865860-06:00; NA; NA; NA","Ovary",20861,"Serous cystadenocarcinoma, NOS","primary",NA,"d5a8ef4a-e9fb-5014-939c-b0fcf9d6a2e5","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",1992,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",57,-20861,"354360d8-cfa6-5226-8582-8db9bf3e8ee9",FALSE,11,NA,"TCGA-24-2262-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2262-01"
"TCGA-29-1702-01A-01R-1567-13","TCGA-29-1702-01A-01R-1567-13","TCGA-29-1702","TCGA-29-1702-01A","TP","Primary solid Tumor","TCGA-29-1702-01A","01","Primary","7150c48b-144f-40f0-b4d0-e4b34e35556d","Primary Tumor",NA,"released","Unknown",0.7,"f825bb6c-afc2-48ea-9286-09c09c7e9918","TCGA-29-1702",0.5,"Unknown",1.2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; ac5c2a6d-86b0-477c-928c-f477c7b2a1fa; bf7e6bd4-e6fb-4596-9400-c890f73b6319; TCGA-29-1702_treatment6; TCGA-29-1702_treatment7; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:34:39.464562-06:00; 2025-01-06T20:34:39.464562-06:00; Recurrent Disease; Recurrent Disease","Not Reported",31196,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-29-1702_diagnosis","4562b29b-0220-4064-ab16-4c9e1d32902e","Not Reported","Yes",FALSE,286,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",84,-30910,"10173208-9da8-5d9c-abe6-266dc021e80f",FALSE,728,NA,"TCGA-29-1702-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1702-01"
"TCGA-13-2060-01A-01R-1568-13","TCGA-13-2060-01A-01R-1568-13","TCGA-13-2060","TCGA-13-2060-01A","TP","Primary solid Tumor","TCGA-13-2060-01A","01","Primary","bffd965b-885f-4914-b25b-a993338acaad","Primary Tumor","Not Reported","released","Unknown",1.5,"F6986C14-4627-424E-81C5-74E1CE38D52D","TCGA-13-2060",0.5,"Unknown",2.5,FALSE,"Tumor","8441/3","143; 143; 143; NA; 75; 135; 600; NA; 31; 31; 31; NA; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; 3b289c5a-3774-50a6-8cda-424d24af7b96; 422167c4-17c5-4004-ab92-7ee66db13280; 4b559942-befc-4819-9f59-146fc87dabd4; 9ad776f8-ccae-47d7-9d2a-efa6d8898a51; TCGA-13-2060_treatment; TCGA-13-2060_treatment2; TCGA-13-2060_treatment3; TCGA-13-2060_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; 6; NA; Cisplatin; Paclitaxel; Paclitaxel; NA; yes; yes; yes; no; NA; 2025-01-06T21:42:02.926704-06:00; 2025-01-06T21:42:02.926704-06:00; 2025-01-06T21:42:02.926704-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; mg/m2; mg/m2; NA","Ovary",18635,"Serous cystadenocarcinoma, NOS","primary",NA,"31073de8-aadc-57d6-99a1-0a6b4d438bb9","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2009,"Cytology","C56.9","G3",NA,"white","female","not reported","Alive",51,-18635,"b78eb8ff-ab78-5321-aa85-a563f3b4d1fb",FALSE,NA,NA,"TCGA-13-2060-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-2060-01"
"TCGA-09-0369-01A-01R-1564-13","TCGA-09-0369-01A-01R-1564-13","TCGA-09-0369","TCGA-09-0369-01A","TP","Primary solid Tumor","TCGA-09-0369-01A","01","Primary","effbbc75-67d0-4d2b-bef5-00ed066b0885","Primary Tumor","Not Reported","released","Unknown",NA,"c052e190-b5c2-44bf-b5b0-2b37cde18cee","TCGA-09-0369",NA,"Unknown",NA,FALSE,"Tumor","8441/3","298; 74; 99; 74; 99; 446; 78; NA; 40; 175; NA; NA; 1000; NA; 80; NA; 298; 8; 99; 8; 99; 310; 78; NA; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 1b8e92fe-3116-4247-af2c-46766c540d39; 347072d1-9959-41fd-b347-270d19bc4942; 35a52e70-cfdd-42db-8097-5afc68a05c51; 6d5b4e3d-f52a-45b2-94f0-085148e276ed; 702913e1-f549-5908-ba73-05f3a66fc72e; d4862ff4-752e-457e-bf40-ab3552c89683; d92c3bbc-c955-4ee7-aa32-ba26eba2b7c1; f63cf101-5dbd-46b0-8545-03419be997a7; TCGA-09-0369_treatment6; TCGA-09-0369_treatment4; TCGA-09-0369_treatment2; TCGA-09-0369_treatment3; TCGA-09-0369_treatment; TCGA-09-0369_treatment7; TCGA-09-0369_treatment5; TCGA-09-0369_treatment8; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 1; 4; 1; 4; 1; NA; 1; NA; Pegylated Liposomal Doxorubicin Hydrochloride; Paclitaxel; Carboplatin; Carboplatin; Gemcitabine; Topotecan; Docetaxel; NA; yes; yes; yes; yes; yes; yes; yes; no; 2025-01-06T20:12:07.239857-06:00; 2025-01-06T20:12:07.239857-06:00; 2025-01-06T20:12:07.239857-06:00; 2025-01-06T20:12:07.239857-06:00; NA; 2025-01-06T20:12:07.239857-06:00; 2025-01-06T20:12:07.239857-06:00; 2025-01-06T20:12:07.239857-06:00; Recurrent Disease; NA; NA; NA; NA; Recurrent Disease; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; mg/m2; mg/m2; NA; NA; mg/m2; NA; mg; NA; NA; Adjuvant; Adjuvant; Adjuvant; Adjuvant; NA; Adjuvant; Adjuvant","Ovary",20705,"Serous cystadenocarcinoma, NOS","primary",NA,"2ccc9ded-6131-5138-ac74-27f15e75a761","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2003,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",56,-20705,"91435668-d5f8-5c6b-8afd-e3e973f0a0aa",FALSE,1082,NA,"TCGA-09-0369-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-0369-01"
"TCGA-61-2012-01A-01R-1568-13","TCGA-61-2012-01A-01R-1568-13","TCGA-61-2012","TCGA-61-2012-01A","TP","Primary solid Tumor","TCGA-61-2012-01A","01","Primary","0befd656-457c-4fa2-81c0-6c5a56f70196","Primary Tumor","Not Reported","released","Unknown",0.6,"534e3236-b9e7-4b0b-a2a3-2fc3a96fac81","TCGA-61-2012",0.4,"Unknown",1.6,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 29; 29; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 537a2b9f-65ee-4e24-acca-60c743cacc5e; 7aad98b3-a724-40d4-8219-c1b22cbea8d0; da579c57-8052-52c0-90de-1bb0c90d7898; TCGA-61-2012_treatment3; TCGA-61-2012_treatment2; TCGA-61-2012_treatment; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; released; released; released; Paclitaxel; Carboplatin; NA; yes; yes; yes; 2025-01-06T20:40:18.790436-06:00; 2025-01-06T20:40:18.790436-06:00; NA","Ovary",29830,"Serous cystadenocarcinoma, NOS","primary",NA,"c2f4be9a-f3ef-5c78-b92f-88a7763041f2","Ovary","No",TRUE,0,"Stage IIC","Not Reported","Left","not reported",2006,"Surgical Resection","C56.9","G2",NA,"white","female","not hispanic or latino","Alive",81,-29830,"8498c00e-74f7-5fcf-b735-19fa805babfc",FALSE,NA,NA,"TCGA-61-2012-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2012-01"
"TCGA-24-1847-01A-01R-1566-13","TCGA-24-1847-01A-01R-1566-13","TCGA-24-1847","TCGA-24-1847-01A","TP","Primary solid Tumor","TCGA-24-1847-01A","01","Primary","f1989bf4-c884-430d-a075-679f7b4a4b07","Primary Tumor",NA,"released","Unknown",0.9,"20d96d45-40d3-44ad-a9e8-fdc7e545ed5d","TCGA-24-1847",0.3,"Unknown",1,FALSE,"Tumor","8441/3","143; 143; NA; 143; 862; 687; NA; 733; 28; 28; NA; 28; Intraperitoneal; Intraperitoneal; Intravenous; 1f6e6b25-750f-46b8-808e-b5da4dd5eccc; 5b59d74a-2379-49f3-9474-c1120ad126c0; acbecc65-9c5a-4dd8-8d96-d12543543c69; bdef78fe-9ed5-575c-9c8f-1337cd8ecdd5; TCGA-24-1847_treatment3; TCGA-24-1847_treatment2; TCGA-24-1847_treatment4; TCGA-24-1847_treatment; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; 6; NA; 6; Cisplatin; Paclitaxel; NA; Docetaxel; yes; yes; no; yes; 2025-01-06T20:27:36.030606-06:00; 2025-01-06T20:27:36.030606-06:00; 2025-01-06T20:27:36.030606-06:00; NA; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; mg; NA; mg","Ovary",16529,"Serous cystadenocarcinoma, NOS","primary",NA,"3384bda3-487e-5148-92d7-620f7ed61f10","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2009,"Excisional Biopsy","C56.9","G3",NA,"white","female","not reported","Alive",45,-16529,"7dff2c76-7f44-5910-806b-2355bc702bbf",FALSE,NA,NA,"TCGA-24-1847-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1847-01"
"TCGA-25-2397-01A-01R-1569-13","TCGA-25-2397-01A-01R-1569-13","TCGA-25-2397","TCGA-25-2397-01A","TP","Primary solid Tumor","TCGA-25-2397-01A","01","Primary","6ba4eb6f-f6dc-441d-879a-7e27dc903c7f","Primary Tumor","Not Reported","released","Unknown",1.3,"D67C4E1F-6A68-4EE6-B143-22038C05C926","TCGA-25-2397",0.7,"Unknown",2.2,FALSE,"Tumor","8441/3","Adjuvant; 2025-01-08T13:15:37.188206-06:00; 127f7a00-acf1-5504-83f2-8ab4651c1be8; TCGA-25-2397_treatment; Radiation Therapy, NOS; released; NA; no; NA","Ovary",21581,"Serous cystadenocarcinoma, NOS","primary",NA,"6ebe67e6-e13c-5b7f-b1b0-a64ed14ec771","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",59,-21581,"e9fd5616-7956-5538-a35d-f4e76dc57e64",FALSE,365,NA,"TCGA-25-2397-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-2397-01"
"TCGA-31-1950-01A-01R-1568-13","TCGA-31-1950-01A-01R-1568-13","TCGA-31-1950","TCGA-31-1950-01A","TP","Primary solid Tumor","TCGA-31-1950-01A","01","Primary","5ce49570-ce22-4370-9d38-6cf43f808e81","Primary Tumor","Not Reported","released","Unknown",0.9,"4ed80cbd-e56d-4d09-b8ac-2b6535346b73","TCGA-31-1950",0.2,"Unknown",1.2,FALSE,"Tumor","8441/3","571; NA; 144; 1440; NA; 3300; 431; NA; 33; Intravenous; Intravenous; 0b4b1ab2-75a9-5a17-aa6e-00429fdae651; 5169d1ff-2ee6-4e77-bbc5-fd903710723e; 8d0855eb-5fc6-45f4-a03c-d7deceef8370; TCGA-31-1950_treatment; TCGA-31-1950_treatment3; TCGA-31-1950_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 18; NA; 6; Paclitaxel; NA; Carboplatin; yes; no; yes; NA; 2025-01-06T20:17:20.473406-06:00; 2025-01-06T20:17:20.473406-06:00; Recurrent Disease; NA; NA; NA; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; NA; mg","Ovary",28100,"Serous cystadenocarcinoma, NOS","primary",NA,"c87e9e32-50c5-54fd-8808-7ca57c0c7543","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Surgical Resection","C56.9","G2",NA,"white","female","not hispanic or latino","Alive",76,-28100,"2e01658c-ae7d-592e-8f7b-a56b8851c913",FALSE,NA,NA,"TCGA-31-1950-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-31-1950-01"
"TCGA-23-1029-01B-01R-1567-13","TCGA-23-1029-01B-01R-1567-13","TCGA-23-1029","TCGA-23-1029-01B","TP","Primary solid Tumor","TCGA-23-1029-01B","01","Primary","5e13d3ce-ac89-4316-94a1-8395bd56fbfa","Primary Tumor",NA,"released","Unknown",0.8,"89E1F403-12CB-442A-9588-CF5C0AC0E0A6","TCGA-23-1029",0.3,"Unknown",0.8,FALSE,"Tumor","8441/3","78; NA; 78; 1212; NA; 375; 30; NA; 30; Intraperitoneal; Intravenous; Intraperitoneal; Intravenous; 06f0f0d2-b145-53d0-92bf-9bac4e55328c; 1a34cb57-ce8a-4d69-8d4f-9210fb502fcf; 42e7fe3e-7eb0-4301-933a-97d7eb1c7944; TCGA-23-1029_treatment; TCGA-23-1029_treatment3; TCGA-23-1029_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 3; NA; 3; Paclitaxel; NA; Cisplatin; yes; no; yes; NA; 2025-01-06T20:56:47.697387-06:00; 2025-01-06T20:56:47.697387-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; NA; mg","Ovary",16889,"Serous cystadenocarcinoma, NOS","primary",NA,"d9297888-91e7-5eb6-9a85-03216ab39514","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2007,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",46,-16889,"47da8915-429e-5f86-a3b6-e4843fb7c2fb",FALSE,NA,NA,"TCGA-23-1029-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1029-01"
"TCGA-09-1666-01A-01R-1566-13","TCGA-09-1666-01A-01R-1566-13","TCGA-09-1666","TCGA-09-1666-01A","TP","Primary solid Tumor","TCGA-09-1666-01A","01","Primary","77ab9685-021c-4d99-8980-79bec534828e","Primary Tumor",NA,"released","Unknown",0.6,"2de50dd9-b607-4a87-baae-468c4bf43205","TCGA-09-1666",0.6,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 3855879e-c166-4563-9302-eba37cd48f99; b5efa45b-7e48-4802-8a6b-0c0cbf4cb774; TCGA-09-1666_treatment14; TCGA-09-1666_treatment13; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:11:03.176706-06:00; 2025-01-06T20:11:03.176706-06:00; Recurrent Disease; Recurrent Disease","Not Reported",21546,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-09-1666_diagnosis","18444f35-98f2-4fd5-bbc7-ad49d879917c","Not Reported","Yes",FALSE,480,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",57,-21066,"365f1918-1b27-5ca8-8eb2-e4ba49ddcfeb",FALSE,NA,NA,"TCGA-09-1666-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-1666-01"
"TCGA-13-1501-01A-01R-1565-13","TCGA-13-1501-01A-01R-1565-13","TCGA-13-1501","TCGA-13-1501-01A","TP","Primary solid Tumor","TCGA-13-1501-01A","01","Primary","7579e91b-80df-4ab7-a775-e33418d17b1f","Primary Tumor","Not Reported","released","Unknown",1.2,"7D27D441-D069-4674-A761-299E315D67C1","TCGA-13-1501",0.4,"Unknown",1.5,FALSE,"Tumor","Unknown","","Not Reported",18785,"Unknown","Unknown","TCGA-13-1501_diagnosis","4d1851c9-a412-4b26-ad0c-81a11f711b85","Not Reported","Yes",FALSE,392,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",50,-18393,"e89502e6-68a4-5a1d-a6c1-13aa96457707",FALSE,1314,NA,"TCGA-13-1501-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1501-01"
"TCGA-24-0968-01A-01R-1569-13","TCGA-24-0968-01A-01R-1569-13","TCGA-24-0968","TCGA-24-0968-01A","TP","Primary solid Tumor","TCGA-24-0968-01A","01","Primary","bd548e12-22a8-471f-b13f-fd7ea5e4e406","Primary Tumor",NA,"released","Unknown",0.8,"887A21BF-12C4-47C7-A48D-A7FAA05C57B2","TCGA-24-0968",0.6,"Unknown",1.2,FALSE,"Tumor","8441/3","Not Reported; NA; Adjuvant; Adjuvant; Adjuvant; NA; Not Reported; NA; Not Reported; Intravenous; Oral; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0a5693ff-ef6f-46c6-9e98-4018c1bcbec1; 259e6b96-e880-450d-8bd2-b46b4bea39e2; 448a8278-2bd2-4e2e-bbcb-a6cf4200aaef; 61e1d46c-c869-4063-8b1b-efc2ce293e23; 77444232-b616-4fdc-9dfb-76251663f28f; 7df4f6c6-efca-4440-b81f-e56ab7cf87d8; 83813074-0fee-4ab1-983d-73030b6c54f7; 8d2c6479-f37b-5d93-b863-876e8fa63988; fb8ff040-0242-46c3-8f72-5e1d0ac657e2; TCGA-24-0968_treatment8; TCGA-24-0968_treatment5; TCGA-24-0968_treatment2; TCGA-24-0968_treatment9; TCGA-24-0968_treatment6; TCGA-24-0968_treatment7; TCGA-24-0968_treatment3; TCGA-24-0968_treatment; TCGA-24-0968_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 1; NA; 5; NA; 5; 4; 1; 4; 1; released; released; released; released; released; released; released; released; released; Pegylated Liposomal Doxorubicin Hydrochloride; Cyclophosphamide; Carboplatin; NA; Paclitaxel; Vinorelbine Tartrate; Cisplatin; Topotecan; Gemcitabine Hydrochloride; yes; yes; yes; no; yes; yes; yes; yes; yes; 2025-01-06T20:27:40.311009-06:00; 2025-01-06T20:27:40.311009-06:00; 2025-01-06T20:27:40.311009-06:00; 2025-01-06T20:27:40.311009-06:00; 2025-01-06T20:27:40.311009-06:00; 2025-01-06T20:27:40.311009-06:00; 2025-01-06T20:27:40.311009-06:00; NA; 2025-01-06T20:27:40.311009-06:00; Persistent Disease; Progressive Disease; NA; NA; NA; Progressive Disease; Persistent Disease; Progressive Disease; Persistent Disease; NA; 50; 2790; NA; 1378; NA; NA; NA; NA; NA; mg/day; mg; NA; mg; NA; NA; NA; NA; NA; NA; 119; NA; 119; NA; NA; NA; NA; NA; NA; 35; NA; 35; NA; NA; NA; NA","Ovary",21664,"Serous cystadenocarcinoma, NOS","primary",NA,"87361581-dac1-527d-bb58-01c4d69a5e91","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2005,"Cytology","C56.9","G3",NA,"white","female","not reported","Dead",59,-21664,"df7b1d1e-430e-5b44-b7fe-e7cadded22e0",FALSE,NA,NA,"TCGA-24-0968-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-0968-01"
"TCGA-24-1419-01A-01R-1565-13","TCGA-24-1419-01A-01R-1565-13","TCGA-24-1419","TCGA-24-1419-01A","TP","Primary solid Tumor","TCGA-24-1419-01A","01","Primary","92d562df-4a58-43da-8811-843d3d3c9438","Primary Tumor","Not Reported","released","Unknown",1.2,"0a8c75aa-8031-4f1d-9dba-9029b009d677","TCGA-24-1419",0.3,"Unknown",1.8,FALSE,"Tumor","8441/3","131; 121; NA; NA; 806; 3882; 478; NA; 17; 17; 197; NA; Intravenous; Intravenous; Intravenous; 0f4a1fac-8450-4791-9d6d-bc258fa915d0; 38f759a7-11ca-4404-92ff-210fd99eae1d; 9d51deb3-1711-5307-8b2d-811f88bca941; c9c3c288-be02-47ad-b1d0-32238952d967; TCGA-24-1419_treatment3; TCGA-24-1419_treatment2; TCGA-24-1419_treatment; TCGA-24-1419_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; 2; NA; Docetaxel; Carboplatin; Paclitaxel; NA; yes; yes; yes; no; 2025-01-06T20:07:36.202203-06:00; 2025-01-06T20:07:36.202203-06:00; NA; 2025-01-06T20:07:36.202203-06:00; Adjuvant; Adjuvant; Consolidation Therapy; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; mg; mg; NA; NA; NA; Not Reported; NA; NA; NA; Treatment Ongoing; NA","Ovary",22659,"Serous cystadenocarcinoma, NOS","primary",NA,"0e5dd5f1-3f97-56e1-a043-2c72b348edc7","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",62,-22659,"3f13178e-a4ea-57f8-a075-e6c7d1ca68bd",FALSE,NA,NA,"TCGA-24-1419-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1419-01"
"TCGA-13-0762-01A-01R-1564-13","TCGA-13-0762-01A-01R-1564-13","TCGA-13-0762","TCGA-13-0762-01A","TP","Primary solid Tumor","TCGA-13-0762-01A","01","Primary","b76ac1b8-f934-45d1-a7d1-780f99a79584","Primary Tumor","Not Reported","released","Unknown",0.8,"5FC6D44F-6057-4014-9800-86050279F42E","TCGA-13-0762",0.2,"Unknown",1.1,FALSE,"Tumor","8441/3","141; NA; 141; 141; 135; NA; 75; 60; 28; NA; 28; 28; Intravenous; Intravenous; Intraperitoneal; 07cfc00a-4e59-4313-b2b8-6ee20ebcca2d; 0fa14d2a-9a14-4f1c-990f-95c65e40508e; bca2d4a7-9197-54e5-977c-c66c5ac81669; dfe09f97-1c99-424c-a632-43dfd1eec2a0; TCGA-13-0762_treatment2; TCGA-13-0762_treatment4; TCGA-13-0762_treatment; TCGA-13-0762_treatment3; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; 6; NA; 6; 6; Paclitaxel; NA; Cisplatin; Paclitaxel; yes; no; yes; yes; 2025-01-06T20:36:36.789033-06:00; 2025-01-06T20:36:36.789033-06:00; NA; 2025-01-06T20:36:36.789033-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; NA; mg/m2; mg/m2","Ovary",23960,"Serous cystadenocarcinoma, NOS","primary",NA,"814eacd3-27a0-5c0c-b4f7-18f4355ab3c4","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2006,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",65,-23960,"35416893-69c6-54f9-881e-2201d801d116",FALSE,NA,"Ashkenazi Jew","TCGA-13-0762-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0762-01"
"TCGA-09-1670-01A-01R-1566-13","TCGA-09-1670-01A-01R-1566-13","TCGA-09-1670","TCGA-09-1670-01A","TP","Primary solid Tumor","TCGA-09-1670-01A","01","Primary","1ad76860-b19e-45ac-b81a-bb0bdac2b5ab","Primary Tumor",NA,"released","Unknown",0.5,"5cc85cd9-99c4-4087-bdc5-8039b0369538","TCGA-09-1670",0.4,"Unknown",1.6,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 35d92549-68d0-43ae-8d0a-afbe538b8c39; 95da0672-c7d9-4ce2-b2c2-da571d47c56d; 9d01671a-f866-4718-afd3-6abd6305a976; ed415d17-e6ec-504f-a7da-248bb4055e92; TCGA-09-1670_treatment4; TCGA-09-1670_treatment3; TCGA-09-1670_treatment2; TCGA-09-1670_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; no; yes; yes; yes; 2025-01-06T20:21:19.782289-06:00; 2025-01-06T20:21:19.782289-06:00; 2025-01-06T20:21:19.782289-06:00; NA; NA; 179; 179; NA; NA; 74; 74; NA; Intravenous; Intravenous; Intravenous; NA; 6; 6; NA; NA; Carboplatin; Paclitaxel; Paclitaxel; NA; NA; 175; NA; NA; NA; mg/m2; NA","Ovary",21147,"Serous cystadenocarcinoma, NOS","primary",NA,"35db92e7-eaa8-5d22-ba3a-cde96978732d","Ovary","No",TRUE,0,"Stage IIIA","Not Reported","Bilateral","not reported",2005,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Alive",57,-21147,"6b43a657-6688-5c19-a029-98a9960eb782",FALSE,NA,NA,"TCGA-09-1670-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-1670-01"
"TCGA-09-0364-01A-02R-1564-13","TCGA-09-0364-01A-02R-1564-13","TCGA-09-0364","TCGA-09-0364-01A","TP","Primary solid Tumor","TCGA-09-0364-01A","01","Primary","469795c3-7cfa-4b95-9b0f-3fc7a3336f22","Primary Tumor","Not Reported","released","Unknown",NA,"27b9efd3-7748-4deb-96a2-3869a19bfa6f","TCGA-09-0364",NA,"Unknown",NA,FALSE,"Tumor","8441/3","188; 188; 538; 31; 31; 502; Intravenous; Intravenous; 17124546-d814-416e-86bd-5cc2fa98d27f; d6d8179e-734f-4b94-98f1-7e9afd49d174; dabdbfb4-d19e-5d16-b464-b9a38486eafd; TCGA-09-0364_treatment2; TCGA-09-0364_treatment3; TCGA-09-0364_treatment; Chemotherapy; Chemotherapy; Radiation, External Beam; 6; 6; NA; Carboplatin; Paclitaxel; NA; yes; yes; yes; 2025-01-06T20:42:19.827368-06:00; 2025-01-06T20:42:19.827368-06:00; NA; Adjuvant; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; NA; 125; 4400; NA; mg/m2; cGy; NA; NA; Recurrent Disease; Locoregional Site","Ovary",29262,"Serous cystadenocarcinoma, NOS","primary",NA,"42b4a2fe-7c3d-5839-b189-e22b4b061c28","Ovary","No",TRUE,0,"Stage IIC","Not Reported","Right","not reported",1998,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",80,-29262,"96fdbdf8-56b5-569a-b4f2-a155e1ed249d",FALSE,887,NA,"TCGA-09-0364-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-0364-01"
"TCGA-57-1994-01A-01R-1568-13","TCGA-57-1994-01A-01R-1568-13","TCGA-57-1994","TCGA-57-1994-01A","TP","Primary solid Tumor","TCGA-57-1994-01A","01","Primary","a2667408-6465-4258-9e68-f88ec3cd7b7d","Primary Tumor","Not Reported","released","Unknown",0.5,"54c3dd01-b473-424f-987a-c5d6e972e9bb","TCGA-57-1994",0.4,"Unknown",0.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 11b280e8-d263-5ead-afac-b43658b894c3; 6ccb730d-ebb7-4e4a-aeb8-f22a9dbff266; TCGA-57-1994_treatment; TCGA-57-1994_treatment2; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; NA; NA; no; no; NA; 2025-01-06T21:10:21.940931-06:00","Ovary",23062,"Serous cystadenocarcinoma, NOS","primary",NA,"f930091a-6f43-5cce-960e-931dad13eb66","Ovary","No",TRUE,0,NA,"Not Reported",NA,"not reported",2004,"Surgical Resection","C56.9",NA,NA,"white","female","not reported","Alive",63,-23062,"bd5457d3-56e5-5b22-9a6c-7e0490fffb31",FALSE,NA,NA,"TCGA-57-1994-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-57-1994-01"
"TCGA-10-0934-01A-02R-1564-13","TCGA-10-0934-01A-02R-1564-13","TCGA-10-0934","TCGA-10-0934-01A","TP","Primary solid Tumor","TCGA-10-0934-01A","01","Primary","27a33c2d-6704-4164-aa5b-894665dea55f","Primary Tumor",NA,"released","Unknown",0.6,"a5c94c47-086b-4d69-a03f-74df709fdc56","TCGA-10-0934",0.4,"Unknown",0.9,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 4944116f-84f9-42e7-a5e0-3c2266b1f286; 8cfae8a1-af22-4599-bf46-751a8e793e7d; TCGA-10-0934_treatment5; TCGA-10-0934_treatment4; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:41:29.065941-06:00; 2025-01-06T21:41:29.065941-06:00; Recurrent Disease; Recurrent Disease","Not Reported",18713,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-10-0934_diagnosis","5a326266-0b05-4139-a976-80f38b7148ef","Not Reported","Yes",FALSE,111,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",50,-18602,"bebf0413-27c1-5758-8bfb-0168b5a20b99",FALSE,204,NA,"TCGA-10-0934-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-10-0934-01"
"TCGA-24-1436-01A-01R-1566-13","TCGA-24-1436-01A-01R-1566-13","TCGA-24-1436","TCGA-24-1436-01A","TP","Primary solid Tumor","TCGA-24-1436-01A","01","Primary","e1eda97e-24fe-4dc8-92eb-080399b1d82d","Primary Tumor","Not Reported","released","Unknown",0.7,"621d3f29-b555-4767-83dd-a6989af0be12","TCGA-24-1436",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","223; 135; 135; NA; 28; 1282; 2730; NA; 157; 24; 24; NA; Intravenous; Intravenous; Intravenous; 0050cb2b-28bb-4645-a16e-2ee1752e53bc; 4cca1b40-400e-579f-8430-9ad31c25a430; 6590b155-1b6a-4a7e-82bd-c910ce78277b; b9ee71ac-5e7c-4de6-9682-02fffd3d7e40; TCGA-24-1436_treatment3; TCGA-24-1436_treatment; TCGA-24-1436_treatment2; TCGA-24-1436_treatment4; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 3; 5; 5; NA; Topotecan; Paclitaxel; Carboplatin; NA; yes; yes; yes; no; 2025-01-06T21:43:35.804728-06:00; NA; 2025-01-06T21:43:35.804728-06:00; 2025-01-06T21:43:35.804728-06:00; Progressive Disease; NA; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg; mg; mg; NA; NA; Adjuvant; Adjuvant; Adjuvant","Ovary",20881,"Serous cystadenocarcinoma, NOS","primary",NA,"c1b7821e-d547-564e-bd56-2021a2829cce","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",1999,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",57,-20881,"a0107c28-a218-5aa9-a28b-c327f9ff8509",FALSE,260,NA,"TCGA-24-1436-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1436-01"
"TCGA-25-1626-01A-01R-1566-13","TCGA-25-1626-01A-01R-1566-13","TCGA-25-1626","TCGA-25-1626-01A","TP","Primary solid Tumor","TCGA-25-1626-01A","01","Primary","1b396d98-af47-49c3-bf45-9f26ed32d71c","Primary Tumor",NA,"released","Unknown",0.5,"4B54A1C9-6F08-435B-B85F-736D4278EA82","TCGA-25-1626",0.4,"Unknown",1.4,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0d21c667-3bb5-4b64-9c04-08c97904c6c4; f05f08b3-aa92-43a2-a991-06241180517e; TCGA-25-1626_treatment7; TCGA-25-1626_treatment6; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:38:14.915387-06:00; 2025-01-06T21:38:14.915387-06:00; Recurrent Disease; Recurrent Disease","Not Reported",24250,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-25-1626_diagnosis","1254dff9-5886-45a2-b812-2b8d435d21b0","Not Reported","Yes",FALSE,318,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",65,-23932,"7a6939c1-85fa-5b74-b9c5-60e18347c35a",FALSE,518,NA,"TCGA-25-1626-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1626-01"
"TCGA-61-2102-01A-01R-1568-13","TCGA-61-2102-01A-01R-1568-13","TCGA-61-2102","TCGA-61-2102-01A","TP","Primary solid Tumor","TCGA-61-2102-01A","01","Primary","d800778e-cc83-4447-9cfa-ca29adeacb8f","Primary Tumor","Not Reported","released","Unknown",0.5,"f0521e47-1cc3-4f72-9efd-3d128f57e614","TCGA-61-2102",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 549486da-c014-49a4-a9c9-2f3432dbf42c; cd51846a-5d75-4bb0-8e07-f8d7ae61e9af; fb9a5e5e-2e41-553f-884d-4c76f7b94700; TCGA-61-2102_treatment3; TCGA-61-2102_treatment2; TCGA-61-2102_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T21:20:20.473139-06:00; 2025-01-06T21:20:20.473139-06:00; NA; NA; 14; 14; Intravenous; Intravenous; NA; Carboplatin; Paclitaxel","Ovary",27256,"Serous cystadenocarcinoma, NOS","primary",NA,"84670ab1-8300-5eb8-b801-8c98bdb6bb25","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",1999,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",74,-27256,"59f2314e-8e36-5351-b82e-da8dc14da71e",FALSE,197,NA,"TCGA-61-2102-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2102-01"
"TCGA-29-1768-01A-01R-1567-13","TCGA-29-1768-01A-01R-1567-13","TCGA-29-1768","TCGA-29-1768-01A","TP","Primary solid Tumor","TCGA-29-1768-01A","01","Primary","f21ac7ce-b8b2-4c44-be65-4c4abf8a86c4","Primary Tumor",NA,"released","Unknown",0.5,"12d9b343-a52d-4a36-ba7b-31bfeb66da50","TCGA-29-1768",0.4,"Unknown",1,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; NA; Adjuvant; Adjuvant; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 191af10d-d92a-461f-8637-ea4ba242aeb9; 4f251ebd-6d1c-552c-b671-fdc13d5ad0b6; 5b43ad1c-8fc3-4398-ba52-60ef3179bb07; 8ecac2ea-3398-413d-a9b3-6d8a725867c3; c64f2f49-5e30-4df5-afee-71c5685dc965; ee03c54b-ba34-4691-9a1c-b8d86f7c9af0; f751b4ec-3560-477b-b8af-dd22f9c13755; TCGA-29-1768_treatment7; TCGA-29-1768_treatment; TCGA-29-1768_treatment6; TCGA-29-1768_treatment3; TCGA-29-1768_treatment4; TCGA-29-1768_treatment5; TCGA-29-1768_treatment2; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Targeted Molecular Therapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; yes; 2025-01-06T21:17:18.212691-06:00; NA; 2025-01-06T21:17:18.212691-06:00; 2025-01-06T21:17:18.212691-06:00; 2025-01-06T21:17:18.212691-06:00; 2025-01-06T21:17:18.212691-06:00; 2025-01-06T21:17:18.212691-06:00; NA; 124; 719; 252; 103; 719; 915; NA; 348; 675; 1493; 816; 1200; 80; NA; 19; 551; 40; 19; 551; 827; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; 6; 9; NA; 5; 9; 3; NA; Paclitaxel; Carboplatin; Clinical Trial; Carboplatin; Gemcitabine; Doxorubicin; NA; mg; mg; mg; mg; mg; mg; NA; NA; Recurrent Disease; NA; NA; Recurrent Disease; Progressive Disease","Ovary",18396,"Serous cystadenocarcinoma, NOS","primary",NA,"302790a0-c173-5320-8b25-111b75f0f6eb","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2006,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",50,-18396,"b5de4fa5-1048-53ef-a848-07a9f6060389",FALSE,952,NA,"TCGA-29-1768-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1768-01"
"TCGA-13-0911-01A-01R-1564-13","TCGA-13-0911-01A-01R-1564-13","TCGA-13-0911","TCGA-13-0911-01A","TP","Primary solid Tumor","TCGA-13-0911-01A","01","Primary","b4fb23b6-d4a0-409a-9728-174c871270e3","Primary Tumor",NA,"released","Unknown",1,"0DE80BC5-8AA8-423A-B99B-9CD9883F27C2","TCGA-13-0911",0.8,"Unknown",1.5,FALSE,"Tumor","Unknown","","Not Reported",20555,"Unknown","Unknown","TCGA-13-0911_diagnosis","145184d3-08d1-45ba-bf30-7912694cfb8d","Not Reported","Yes",FALSE,279,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",55,-20276,"d9f04340-86d7-54c3-9770-ba6f4a98c85b",FALSE,1355,NA,"TCGA-13-0911-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0911-01"
"TCGA-13-0727-01A-01R-1564-13","TCGA-13-0727-01A-01R-1564-13","TCGA-13-0727","TCGA-13-0727-01A","TP","Primary solid Tumor","TCGA-13-0727-01A","01","Primary","6fcd7bb8-6cb0-4797-a5b5-d3ec4911a279","Primary Tumor","Not Reported","released","Unknown",0.9,"EA3709B4-0C79-4CF5-A7D6-DB9F08DD74B5","TCGA-13-0727",0.3,"Unknown",1.2,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 7d89e70b-1efb-470a-b2e4-35d1da51ef32; d963b702-856f-46ef-884d-cbb0ba348ffa; TCGA-13-0727_treatment6; TCGA-13-0727_treatment5; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:06:00.037169-06:00; 2025-01-06T20:06:00.037169-06:00; Recurrent Disease; Recurrent Disease","Not Reported",26438,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-13-0727_diagnosis","a279743b-f104-4e69-8432-8750d8765d6f","Not Reported","Yes",FALSE,253,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",71,-26185,"c607c1f9-1240-5281-9ad1-0481bf7a2684",FALSE,462,NA,"TCGA-13-0727-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0727-01"
"TCGA-10-0933-01A-01R-1569-13","TCGA-10-0933-01A-01R-1569-13","TCGA-10-0933","TCGA-10-0933-01A","TP","Primary solid Tumor","TCGA-10-0933-01A","01","Primary","1d568bd2-d658-40fa-a341-daa4d2a5bb22","Primary Tumor",NA,"released","Unknown",0.4,"f973309d-55dd-489b-a7ca-9348666a9129","TCGA-10-0933",0.4,"Unknown",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; d9d6478a-2222-4019-baf8-2fc8b60ae52f; dfe4658d-2ae6-4203-a047-8edb7cfbcea6; TCGA-10-0933_treatment5; TCGA-10-0933_treatment4; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:27:00.788265-06:00; 2025-01-06T21:27:00.788265-06:00; Recurrent Disease; Recurrent Disease","Not Reported",28789,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-10-0933_diagnosis","a6373a41-1101-4772-adde-27ef75b65d91","Not Reported","Yes",FALSE,356,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",77,-28433,"5dcb5210-ad8c-5ee3-806a-4305cfba74e6",FALSE,446,NA,"TCGA-10-0933-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-10-0933-01"
"TCGA-04-1341-01A-01R-1564-13","TCGA-04-1341-01A-01R-1564-13","TCGA-04-1341","TCGA-04-1341-01A","TP","Primary solid Tumor","TCGA-04-1341-01A","01","Primary","8873baff-198d-4e4c-9d6d-18ee9d164f0d","Primary Tumor",NA,"released","Unknown",1,"9DB095E5-19F0-4ECE-9E54-2F030190FDB5","TCGA-04-1341",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; 2025-01-08T13:15:37.188206-06:00; 0d68a73c-3842-5432-bb95-10b03c23f67f; TCGA-04-1341_treatment; Radiation Therapy, NOS; released; NA; no; NA","Ovary",31215,"Serous cystadenocarcinoma, NOS","primary",NA,"20316fd4-aca7-57fa-9966-4076874a372f","Ovary","No",TRUE,0,NA,"Not Reported",NA,"not reported",2006,NA,"C56.9","G3",NA,"white","female","not hispanic or latino","Alive",85,-31215,"a6a82dbe-deda-5ed3-81b8-4300e0617345",FALSE,NA,NA,"TCGA-04-1341-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1341-01"
"TCGA-09-0367-01A-01R-1564-13","TCGA-09-0367-01A-01R-1564-13","TCGA-09-0367","TCGA-09-0367-01A","TP","Primary solid Tumor","TCGA-09-0367-01A","01","Primary","593a4322-bd6f-49d3-9fc6-0f56a1943664","Primary Tumor","Not Reported","released","Unknown",NA,"8a24fe8a-9f7f-4fbf-86c7-704427ccaf89","TCGA-09-0367",NA,"Unknown",NA,FALSE,"Tumor","8441/3","92; 92; NA; NA; 9; 9; NA; 153; Intravenous; Intravenous; Intravenous; 17e9db1b-f599-449d-8a45-f82c0a6874f2; 468cac62-c860-5e8f-b4b0-f22c7544080f; 7e1961d7-4312-4248-aa61-4efae22f6697; c23cb7e2-f2f2-46de-811a-b25fcb3eed33; TCGA-09-0367_treatment2; TCGA-09-0367_treatment; TCGA-09-0367_treatment4; TCGA-09-0367_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 5; 5; NA; 4; Carboplatin; Paclitaxel; NA; Gemcitabine; yes; yes; no; yes; 2025-01-06T21:39:20.489667-06:00; NA; 2025-01-06T21:39:20.489667-06:00; 2025-01-06T21:39:20.489667-06:00; Adjuvant; Adjuvant; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; NA; 175; NA; 1145; NA; mg/m2; NA; mg","Ovary",24473,"Serous cystadenocarcinoma, NOS","primary",NA,"3b0fadff-1eaa-5a35-9045-24288b57a3dd","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2001,"Surgical Resection","C56.9","G3",NA,"native hawaiian or other pacific islander","female","not hispanic or latino","Dead",67,-24473,"51e8191f-bc19-5752-94b7-b3a4ea24578f",FALSE,547,NA,"TCGA-09-0367-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-0367-01"
"TCGA-04-1343-01A-01R-1564-13","TCGA-04-1343-01A-01R-1564-13","TCGA-04-1343","TCGA-04-1343-01A","TP","Primary solid Tumor","TCGA-04-1343-01A","01","Primary","1d8b4c59-7500-4951-80bc-bfd7a035b876","Primary Tumor",NA,"released","Unknown",0.6,"E62828D9-A46C-498F-9976-CC430D16057E","TCGA-04-1343",0.4,"Unknown",1,FALSE,"Tumor","8441/3","323; 323; 170; 170; 354; 262; 170; 262; NA; 262; 262; 50; 50; 323; 170; 50; 170; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0a294ee7-808f-43fc-a4aa-3810346ace6f; 11b727cb-d596-4d37-979c-35dd35c18740; 1a7a6396-27a8-48f9-a39d-5e299397e004; 36480907-4106-42cd-9737-eecf33a87557; 3a42b4ee-f935-5ed4-a090-fd63bb17beb5; a923e63a-228d-4f5e-9a90-782d1a63dd52; b9ae122b-8e83-40c4-8b01-160db0e8e912; ec734cef-bdb2-4dd5-a9ec-380f44d04b08; edfe6b0c-ffbf-4013-af01-7e3fb00b8fc1; TCGA-04-1343_treatment8; TCGA-04-1343_treatment5; TCGA-04-1343_treatment7; TCGA-04-1343_treatment3; TCGA-04-1343_treatment; TCGA-04-1343_treatment4; TCGA-04-1343_treatment2; TCGA-04-1343_treatment6; TCGA-04-1343_treatment9; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 4; 4; 5; 5; NA; 2; 5; 2; NA; released; released; released; released; released; released; released; released; released; Vinorelbine Tartrate; Topotecan; Carboplatin; Gemcitabine; Topotecan; Carboplatin; Paclitaxel; Docetaxel; NA; yes; yes; yes; yes; yes; yes; yes; yes; no; 2025-01-06T20:42:42.392715-06:00; 2025-01-06T20:42:42.392715-06:00; 2025-01-06T20:42:42.392715-06:00; 2025-01-06T20:42:42.392715-06:00; NA; 2025-01-06T20:42:42.392715-06:00; 2025-01-06T20:42:42.392715-06:00; 2025-01-06T20:42:42.392715-06:00; 2025-01-06T20:42:42.392715-06:00; Progressive Disease; Progressive Disease; NA; NA; Progressive Disease; Progressive Disease; NA; Progressive Disease; NA; NA; NA; 5; 800; NA; NA; 175; NA; NA; Intravenous; Intravenous; Intravenous; NA; NA; Adjuvant; Adjuvant; NA; NA; Adjuvant; NA; Adjuvant; NA; NA; AUC; mg/m2; NA; NA; mg/m2; NA; NA","Ovary",26428,"Serous cystadenocarcinoma, NOS","primary",NA,"bd744f83-779b-5ca5-af2b-45670de8fcec","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2002,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",72,-26428,"f71d969e-38e8-523e-8db7-d8b2e3f0ae0c",FALSE,361,NA,"TCGA-04-1343-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1343-01"
"TCGA-13-0795-01A-01R-1564-13","TCGA-13-0795-01A-01R-1564-13","TCGA-13-0795","TCGA-13-0795-01A","TP","Primary solid Tumor","TCGA-13-0795-01A","01","Primary","61ef4d54-bfa5-4d62-89bc-2717eabc741b","Primary Tumor","Not Reported","released","Unknown",0.9,"B98206EC-73D1-404F-B497-BAD6C817D9B7","TCGA-13-0795",0.3,"Unknown",1.4,FALSE,"Tumor","8441/3","205; 205; NA; 175; NA; NA; 101; 101; NA; Intravenous; Intravenous; 32f57f01-37d2-437b-beb2-962c2da15f13; 61f9e645-1126-57fe-8301-cdfbba84acac; 899e9ac7-b154-4227-82fd-0af59272db89; TCGA-13-0795_treatment2; TCGA-13-0795_treatment; TCGA-13-0795_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 6; 6; NA; Paclitaxel; Carboplatin; NA; yes; yes; no; 2025-01-06T21:41:43.348922-06:00; NA; 2025-01-06T21:41:43.348922-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg/m2; NA; NA","Ovary",24403,"Serous cystadenocarcinoma, NOS","primary",NA,"049f6c9e-4b02-5c39-ad7f-5f357c226bc5","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2007,"Fine Needle Aspiration","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",66,-24403,"765b568d-c940-5239-92dc-26c4c0431db1",FALSE,619,NA,"TCGA-13-0795-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0795-01"
"TCGA-13-1481-01A-01R-1565-13","TCGA-13-1481-01A-01R-1565-13","TCGA-13-1481","TCGA-13-1481-01A","TP","Primary solid Tumor","TCGA-13-1481-01A","01","Primary","d0021cbe-9f70-47cf-a8ae-f9e07c55f73e","Primary Tumor","Not Reported","released","Unknown",1.3,"4832CBA4-9482-4A2A-A9E1-4E8489B0F157","TCGA-13-1481",0.4,"Unknown",1.4,FALSE,"Tumor","8441/3","242; 131; NA; 131; 198; 11; NA; 11; Intraperitoneal; Intravenous; Intravenous; 59a108b5-57c4-5efc-b34f-97cd49df570c; 9f848a6a-9e86-4a61-82ef-5bf10f16d76f; afe86459-325d-4aa8-b408-e711b86f942b; f35ffa58-18cf-4730-96c9-07907f59fa17; TCGA-13-1481_treatment; TCGA-13-1481_treatment3; TCGA-13-1481_treatment4; TCGA-13-1481_treatment2; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 3; 6; NA; 6; Cisplatin; Carboplatin; NA; Paclitaxel; yes; yes; no; yes; NA; 2025-01-06T21:31:42.452711-06:00; 2025-01-06T21:31:42.452711-06:00; 2025-01-06T21:31:42.452711-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; NA; NA; NA; 175; NA; NA; NA; mg/m2","Ovary",27898,"Serous cystadenocarcinoma, NOS","primary",NA,"6876be41-0a9d-5d46-b658-88ac8875f007","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2000,"Cytology","C56.9","G2",NA,"white","female","not hispanic or latino","Dead",76,-27898,"3feefab3-b78e-5f51-a8f7-b0601937c6dc",FALSE,2648,NA,"TCGA-13-1481-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1481-01"
"TCGA-29-1703-01A-01R-1567-13","TCGA-29-1703-01A-01R-1567-13","TCGA-29-1703","TCGA-29-1703-01A","TP","Primary solid Tumor","TCGA-29-1703-01A","01","Primary","d86b5d2b-9a8e-4bfa-9549-12fd45e8c296","Primary Tumor",NA,"released","Unknown",1,"c8397af0-67d2-4e69-993b-7349657e9953","TCGA-29-1703",0.4,"Unknown",1.4,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 38e1d347-f75e-43cc-95fb-b0b365177b47; 8d1953ac-15b1-4166-8291-1085f0c12c07; TCGA-29-1703_treatment14; TCGA-29-1703_treatment15; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:16:47.059786-06:00; 2025-01-06T21:16:47.059786-06:00; Recurrent Disease; Recurrent Disease","Not Reported",20946,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-29-1703_diagnosis","0d1ae180-6e6d-47bc-8741-41dbc17c5e2b","Not Reported","Yes",FALSE,324,NA,NA,NA,NA,NA,NA,NA,NA,NA,"black or african american","female","not reported","Dead",56,-20622,"d3239bb4-63cb-5ba3-911b-f8ef467f8bb5",FALSE,1815,NA,"TCGA-29-1703-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-29-1703-01"
"TCGA-25-2393-01A-01R-1569-13","TCGA-25-2393-01A-01R-1569-13","TCGA-25-2393","TCGA-25-2393-01A","TP","Primary solid Tumor","TCGA-25-2393-01A","01","Primary","e69d97a1-39ab-49a6-9f73-5be13fa49d30","Primary Tumor","Not Reported","released","Unknown",0.7,"0B780E04-2DE3-4C56-9B93-1919F4BBE5D4","TCGA-25-2393",0.3,"Unknown",1.3,FALSE,"Tumor","8441/3","123; 517; NA; 123; 31; 305; NA; 31; Intravenous; Intravenous; Intravenous; 01f77f81-c3b9-4a94-9e4e-940cbe0d0e51; 741660b1-377a-46a2-9228-5997f90230bd; 7f236410-a19b-46b8-bbac-f12a0ee3bfcc; ebf44a84-1696-59f7-9b25-926975930d32; TCGA-25-2393_treatment2; TCGA-25-2393_treatment3; TCGA-25-2393_treatment4; TCGA-25-2393_treatment; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; 8; NA; 6; Carboplatin; Pegylated Liposomal Doxorubicin Hydrochloride; NA; Paclitaxel; yes; yes; no; yes; 2025-01-06T21:16:26.664779-06:00; 2025-01-06T21:16:26.664779-06:00; 2025-01-06T21:16:26.664779-06:00; NA; Adjuvant; NA; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; NA; Recurrent Disease; NA; NA","Ovary",29585,"Serous cystadenocarcinoma, NOS","primary",NA,"635b00aa-baef-5228-96e1-96c52b8da8a3","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2003,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",80,-29585,"d287eb95-3746-5617-b7a4-31ccca93dffb",FALSE,1157,NA,"TCGA-25-2393-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-2393-01"
"TCGA-25-1322-01A-01R-1565-13","TCGA-25-1322-01A-01R-1565-13","TCGA-25-1322","TCGA-25-1322-01A","TP","Primary solid Tumor","TCGA-25-1322-01A","01","Primary","9bc6ca0e-c74a-49f7-be04-6546e56e8ba2","Primary Tumor","Not Reported","released","Unknown",1.8,"6EAF4358-51F9-4999-A219-39178418CC9C","TCGA-25-1322",0.8,"Unknown",2.6,FALSE,"Tumor","8441/3","91; 91; NA; 30; 30; NA; Intravenous; Intravenous; 0552af02-bfa2-562e-a1c2-e127329c9904; 4caf2e83-ef64-4910-94bf-0d82bc556152; d9532dfc-9ef1-44c2-93dc-999d90fdaf5b; TCGA-25-1322_treatment; TCGA-25-1322_treatment2; TCGA-25-1322_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; 3; 3; NA; Carboplatin; Paclitaxel; NA; yes; yes; no; NA; 2025-01-06T20:49:13.311605-06:00; 2025-01-06T20:49:13.311605-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released","Ovary",22646,"Serous cystadenocarcinoma, NOS","primary",NA,"d7d5faf4-cb8e-5db8-9a9c-7894070b7ead","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2001,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",62,-22646,"895829cd-984f-5029-ac7d-de8de3feb97f",FALSE,91,NA,"TCGA-25-1322-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1322-01"
"TCGA-04-1655-01A-01R-1566-13","TCGA-04-1655-01A-01R-1566-13","TCGA-04-1655","TCGA-04-1655-01A","TP","Primary solid Tumor","TCGA-04-1655-01A","01","Primary","43d20453-c167-4893-819d-754785da9a71","Primary Tumor",NA,"released","Unknown",0.6,"D808763E-D67C-460C-B5D6-85CC5C1C05BC","TCGA-04-1655",0.4,"Unknown",1.1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 03e6dcdf-19cc-4849-9dd4-82ab5aa75878; 60afafb6-a148-483b-b041-8c3454f0e188; TCGA-04-1655_treatment8; TCGA-04-1655_treatment7; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:10:32.931630-06:00; 2025-01-06T20:10:32.931630-06:00; Recurrent Disease; Recurrent Disease","Not Reported",18807,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-04-1655_diagnosis","751fa9ad-d1b7-4963-ad79-e260badb795d","Not Reported","Yes",FALSE,819,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",49,-17988,"f5f5b470-d479-571a-9747-9f299b78084b",FALSE,1380,NA,"TCGA-04-1655-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1655-01"
"TCGA-09-1661-01B-01R-1566-13","TCGA-09-1661-01B-01R-1566-13","TCGA-09-1661","TCGA-09-1661-01B","TP","Primary solid Tumor","TCGA-09-1661-01B","01","Primary","a7e17e91-e9d2-4118-8215-86546f8e2feb","Primary Tumor",NA,"released","Unknown",0.4,"1910251f-8c5c-4067-91dc-87bfdaf77283","TCGA-09-1661",0.1,"Unknown",0.6,FALSE,"Tumor","8441/3","940; 165; 332; 165; 641; 766; 1052; NA; 709; 70; 135; 40; 192; 20; 800; 30; NA; NA; 828; 58; 213; 58; 498; 758; 1017; NA; 641; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 1d474cd7-e665-48cf-b123-d3533280e587; 3b4c753c-2b7c-5f2d-8b7d-751e0bc8d35e; 4b8e0ef8-443b-4f9d-b68a-d31488563ce7; 7a641015-f525-455e-85a1-c9cf32636532; 7bebb859-d3b3-4885-bb05-860a4aa4a0c4; 8911f2be-7326-41ba-8e5b-bbb363a96a07; aed3a0df-8a3e-4f4a-ac5a-19ae36357ecf; cd501125-82b2-4e46-8c95-103d89e3ef02; d9fd26e3-4729-4cce-af9d-8bc8dd985f14; TCGA-09-1661_treatment3; TCGA-09-1661_treatment; TCGA-09-1661_treatment7; TCGA-09-1661_treatment4; TCGA-09-1661_treatment8; TCGA-09-1661_treatment2; TCGA-09-1661_treatment6; TCGA-09-1661_treatment9; TCGA-09-1661_treatment5; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Hormone Therapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 17; 6; 4; 6; NA; 1; 5; NA; 4; Paclitaxel; Paclitaxel; Pegylated Liposomal Doxorubicin Hydrochloride; Carboplatin; Tamoxifen; Gemcitabine; Docetaxel; NA; Carboplatin; yes; yes; yes; yes; yes; yes; yes; no; yes; 2025-01-06T21:39:10.584093-06:00; NA; 2025-01-06T21:39:10.584093-06:00; 2025-01-06T21:39:10.584093-06:00; 2025-01-06T21:39:10.584093-06:00; 2025-01-06T21:39:10.584093-06:00; 2025-01-06T21:39:10.584093-06:00; 2025-01-06T21:39:10.584093-06:00; 2025-01-06T21:39:10.584093-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; mg/m2; mg; mg/m2; mg; mg; mg/m2; mg/m2; NA; NA; NA; Adjuvant; NA; Adjuvant; NA; NA; NA; Adjuvant; NA","Ovary",27486,"Serous cystadenocarcinoma, NOS","primary",NA,"28f74326-0db8-5d53-bab2-b64acfa0aa64","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2000,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",75,-27486,"7d5dcebc-ff09-52ee-aedc-34d4ec8683e2",FALSE,1169,NA,"TCGA-09-1661-01B","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-09-1661-01"
"TCGA-13-0924-01A-01R-1564-13","TCGA-13-0924-01A-01R-1564-13","TCGA-13-0924","TCGA-13-0924-01A","TP","Primary solid Tumor","TCGA-13-0924-01A","01","Primary","5be2767c-8f8e-4b30-a3fa-bfbcce461c5c","Primary Tumor",NA,"released","Unknown",NA,"2EA17F21-1594-430A-97E3-29C5F49CB3BC","TCGA-13-0924",NA,"Unknown",NA,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 1c2a9638-4ab5-4cf9-9d22-fe9987229d06; 2faff6a9-9bea-53eb-9127-0273d6838332; 3474d606-293a-4fa9-b71b-4777f36bdedd; c4f7b9e7-5c58-4e3b-aa1d-d8b100c51126; d2949494-eeb4-437a-bf83-d9be85c8d223; TCGA-13-0924_treatment5; TCGA-13-0924_treatment; TCGA-13-0924_treatment3; TCGA-13-0924_treatment2; TCGA-13-0924_treatment4; Radiation Therapy, NOS; Targeted Molecular Therapy; Chemotherapy; Chemotherapy; Targeted Molecular Therapy; released; released; released; released; released; no; yes; yes; yes; yes; 2025-01-06T21:31:24.303348-06:00; NA; 2025-01-06T21:31:24.303348-06:00; 2025-01-06T21:31:24.303348-06:00; 2025-01-06T21:31:24.303348-06:00; NA; 143; 143; 143; 213; NA; 920; NA; 175; 15; NA; 60; 38; 38; 164; NA; Clinical Trial; Carboplatin; Paclitaxel; Clinical Trial; NA; mg; NA; mg/m2; mg/kg; Intravenous; Intravenous; NA; NA; 6; 6; NA","Ovary",16670,"Serous cystadenocarcinoma, NOS","primary",NA,"5fece8ec-73b8-509c-8a0c-0f513822d210","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2008,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",45,-16670,"2bf5429c-69b5-528e-ba15-0b4626f97010",FALSE,NA,"Ashkenazi Jew","TCGA-13-0924-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0924-01"
"TCGA-23-1120-01A-02R-1565-13","TCGA-23-1120-01A-02R-1565-13","TCGA-23-1120","TCGA-23-1120-01A","TP","Primary solid Tumor","TCGA-23-1120-01A","01","Primary","6fc497cb-41c0-487c-b527-b33a9af83ef2","Primary Tumor",NA,"released","Unknown",0.8,"e12ef7d5-6fa8-46fa-bedc-da6ddbbecc37","TCGA-23-1120",0.6,"Unknown",1.8,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 00993f0c-e31e-4e16-a6c8-dc730268d924; 0c6ffdd4-bb6f-404d-99a9-215713236262; b15fe942-b529-546b-a2da-c3bc718654e9; TCGA-23-1120_treatment3; TCGA-23-1120_treatment2; TCGA-23-1120_treatment; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; released; released; released; no; yes; yes; 2025-01-06T20:26:09.838340-06:00; 2025-01-06T20:26:09.838340-06:00; NA; NA; 146; 146; NA; 700; 2090; NA; 63; 63; Intraperitoneal; Intraperitoneal; NA; 5; 5; NA; Cisplatin; Paclitaxel; NA; mg; mg","Ovary",22148,"Serous cystadenocarcinoma, NOS","primary",NA,"efacf32e-acbf-5aa1-bc08-b71cd624aea2","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Right","not reported",2008,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",60,-22148,"46d2a0a9-20fb-5a03-b80b-113e9217d392",FALSE,NA,NA,"TCGA-23-1120-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1120-01"
"TCGA-04-1357-01A-01R-1565-13","TCGA-04-1357-01A-01R-1565-13","TCGA-04-1357","TCGA-04-1357-01A","TP","Primary solid Tumor","TCGA-04-1357-01A","01","Primary","45893b0e-301f-474a-b390-936d7d74f57e","Primary Tumor","Not Reported","released","Unknown",0.6,"D1D902A3-DF76-4623-B2E7-88FFA9E1542F","TCGA-04-1357",0.6,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 8cb06eb9-9055-4e88-95c8-0246feec2116; ad9e2c2c-271c-5716-a98c-7fd282c7ccfd; TCGA-04-1357_treatment2; TCGA-04-1357_treatment; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:52:41.947739-06:00; NA; NA; Not Reported; NA; NA","Ovary",18999,"Serous cystadenocarcinoma, NOS","primary",NA,"8c7d9620-74be-55aa-a89c-500df4e535a1","Ovary","No",TRUE,0,"Stage IIIB","Not Reported",NA,"not reported",2005,NA,"C56.9","G3",NA,"not reported","female","not reported","Alive",52,-18999,"d7683fcc-e135-5577-a315-c40ebae61ab8",FALSE,NA,NA,"TCGA-04-1357-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1357-01"
"TCGA-25-1627-01A-01R-1566-13","TCGA-25-1627-01A-01R-1566-13","TCGA-25-1627","TCGA-25-1627-01A","TP","Primary solid Tumor","TCGA-25-1627-01A","01","Primary","c405e873-8ef5-43f6-8065-830fdb99825d","Primary Tumor",NA,"released","Unknown",1,"FB36B0F9-6519-4CF5-9A74-F7015FD405FF","TCGA-25-1627",0.3,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 7f8fd9a1-9d68-5d75-850b-b199877c0d1d; bb6c814f-d04d-47e1-8e56-4951e54c0db4; TCGA-25-1627_treatment; TCGA-25-1627_treatment2; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; Not Reported; NA; released; released; NA; NA; yes; no; NA; 2025-01-06T20:08:23.811288-06:00","Ovary",26784,"Serous cystadenocarcinoma, NOS","primary",NA,"b0bdaa93-0778-58a1-a5ab-dd9f0efa3171","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2003,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",73,-26784,"f17d6310-6505-5f0f-a62b-1a1f807f9e50",FALSE,394,NA,"TCGA-25-1627-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-25-1627-01"
"TCGA-61-1919-01A-01R-1568-13","TCGA-61-1919-01A-01R-1568-13","TCGA-61-1919","TCGA-61-1919-01A","TP","Primary solid Tumor","TCGA-61-1919-01A","01","Primary","207be628-ffc8-4eb6-88b3-1705a3ee2ab5","Primary Tumor","Not Reported","released","Unknown",0.8,"240a49a3-b611-4949-b3b9-3799d8c0dc46","TCGA-61-1919",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 03223c84-530f-518f-ad2f-990a1386e1b2; 4a61d7ed-10b8-488c-9a4a-c9bc020ae912; TCGA-61-1919_treatment; TCGA-61-1919_treatment2; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; Complete Response; NA; released; released; NA; NA; yes; no; NA; 2025-01-06T21:42:37.725943-06:00","Ovary",21199,"Serous cystadenocarcinoma, NOS","primary",NA,"41c9c74c-e5f7-5f95-b067-21508c7d5999","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2001,"Surgical Resection","C56.9","G2",NA,"white","female","not hispanic or latino","Dead",58,-21199,"23c0b61b-61e7-5f1e-8ed1-2e01f6ec1a56",FALSE,1161,NA,"TCGA-61-1919-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-1919-01"
"TCGA-24-1565-01A-01R-1566-13","TCGA-24-1565-01A-01R-1566-13","TCGA-24-1565","TCGA-24-1565-01A","TP","Primary solid Tumor","TCGA-24-1565-01A","01","Primary","6feb1257-da6f-4a70-bbd1-f3aa843ef72a","Primary Tumor",NA,"released","Unknown",0.7,"f424905e-3dc2-4e37-b6c4-8a77c7ce817b","TCGA-24-1565",0.4,"Solid Tissue",0.8,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 377206a0-9893-4eda-9abb-6d1e31e21ea4; d6a4211d-320d-45f9-9e89-77c0a03f05c6; TCGA-24-1565_treatment6; TCGA-24-1565_treatment5; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:15:09.569164-06:00; 2025-01-06T21:15:09.569164-06:00; Recurrent Disease; Recurrent Disease","Not Reported",27193,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-24-1565_diagnosis","92cebb47-506c-453c-9300-27a945763627","Not Reported","Yes",FALSE,145,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not reported","Dead",74,-27048,"ff23d451-c438-5f18-9951-f4adc6b0744f",FALSE,312,NA,"TCGA-24-1565-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-1565-01"
"TCGA-23-1028-01A-01R-1564-13","TCGA-23-1028-01A-01R-1564-13","TCGA-23-1028","TCGA-23-1028-01A","TP","Primary solid Tumor","TCGA-23-1028-01A","01","Primary","4363b3c8-bfdb-4668-b72a-d15ed0f5bfff","Primary Tumor",NA,"released","Unknown",0.6,"CCD0A1B3-DE92-473C-AA1B-8EE25DE408A2","TCGA-23-1028",0.4,"Unknown",0.8,FALSE,"Tumor","8441/3","1461; 1335; 110; 859; 1153; 859; 1006; 229; 1461; 1461; NA; 1489; 110; 1489; 2667; 418; 1600; 2802; 10; 846; 41; 201; 1552; 525; NA; 3100; 2900; 100; 1363; 1112; 26; 749; 1140; 749; 908; 173; 1461; 1461; NA; 1468; 26; 1468; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 071eb24a-94ac-4c74-8375-7aaec1eeb119; 07d18b90-62cf-4ef7-ab04-775e709e852c; 1c95739b-b7c9-479a-be12-ec9e9cf74001; 518d9ab4-2ac4-4edb-9229-0796f5598b73; 549dc9d3-e2f5-4d8a-b9e3-136c21f18f69; 9d88e2ab-cba3-43bc-b301-4d1eb26a70e1; a6463587-2697-4b7a-aaab-8c5421cd004f; a66174fd-178d-511f-9c97-9a42c2cc621e; a864308f-df06-42cd-91a0-e44041f064af; b6c8f3f0-3016-474f-9f61-a9d43c88afef; cc10f5ee-35f6-4c47-9e4a-329b8a04c42f; ce925375-3896-4368-b001-78846a003960; d701e49c-97b4-4cc0-871b-da37cca160a4; d854e904-ce09-43f8-b801-e642fc1200b0; TCGA-23-1028_treatment13; TCGA-23-1028_treatment4; TCGA-23-1028_treatment12; TCGA-23-1028_treatment3; TCGA-23-1028_treatment11; TCGA-23-1028_treatment2; TCGA-23-1028_treatment10; TCGA-23-1028_treatment; TCGA-23-1028_treatment6; TCGA-23-1028_treatment9; TCGA-23-1028_treatment14; TCGA-23-1028_treatment8; TCGA-23-1028_treatment7; TCGA-23-1028_treatment5; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; 5; 8; 4; 6; 3; 6; 11; 3; 1; 1; NA; 2; 4; 2; Carboplatin; Doxorubicin; Paclitaxel; Carboplatin; Topotecan; Docetaxel; Topotecan; Doxorubicin; Gemcitabine; Carboplatin; NA; Gemcitabine; Carboplatin; Cisplatin; yes; yes; yes; yes; yes; yes; yes; yes; yes; yes; no; yes; yes; yes; 2025-01-06T20:45:30.884266-06:00; 2025-01-06T20:45:30.884266-06:00; 2025-01-06T20:45:30.884266-06:00; 2025-01-06T20:45:30.884266-06:00; 2025-01-06T20:45:30.884266-06:00; 2025-01-06T20:45:30.884266-06:00; 2025-01-06T20:45:30.884266-06:00; NA; 2025-01-06T20:45:30.884266-06:00; 2025-01-06T20:45:30.884266-06:00; 2025-01-06T20:45:30.884266-06:00; 2025-01-06T20:45:30.884266-06:00; 2025-01-06T20:45:30.884266-06:00; 2025-01-06T20:45:30.884266-06:00; Progressive Disease; Progressive Disease; NA; Recurrent Disease; Progressive Disease; Recurrent Disease; Progressive Disease; Recurrent Disease; Progressive Disease; Progressive Disease; NA; Progressive Disease; NA; Progressive Disease; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; released; released; released; released; released; released; released; mg; mg; mg; mg; mg; mg; mg; mg; mg; mg; NA; mg; mg; mg; NA; NA; Adjuvant; NA; NA; NA; NA; NA; NA; NA; Adjuvant; NA; Adjuvant; NA","Ovary",16018,"Serous cystadenocarcinoma, NOS","primary",NA,"26b720a3-88e1-5202-a2e2-08f958ebe521","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",2004,"Surgical Resection","C56.9","G3",NA,"white","female","hispanic or latino","Alive",43,-16018,"c98a0351-dc5f-5f3c-984f-638eae453300",FALSE,NA,NA,"TCGA-23-1028-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-1028-01"
"TCGA-23-2078-01A-01R-1568-13","TCGA-23-2078-01A-01R-1568-13","TCGA-23-2078","TCGA-23-2078-01A","TP","Primary solid Tumor","TCGA-23-2078-01A","01","Primary","dc3d8cea-908f-423f-976d-150bb1050063","Primary Tumor","Not Reported","released","Unknown",0.6,"19ed5fbe-17e1-43f3-bfa0-32f474a00be8","TCGA-23-2078",0.5,"Unknown",0.9,FALSE,"Tumor","8441/3","149; NA; 149; 3240; NA; 1980; 35; NA; 35; Intravenous; Intravenous; 17e4fc0d-a5b6-5818-bdc4-8e2779727abd; 8cc24f53-23fc-4940-9e5c-c8bb120448b3; 94101f76-ccda-47fe-9a21-ed770e8c5da3; TCGA-23-2078_treatment; TCGA-23-2078_treatment3; TCGA-23-2078_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; NA; 6; Carboplatin; NA; Paclitaxel; yes; no; yes; NA; 2025-01-06T20:13:02.873305-06:00; 2025-01-06T20:13:02.873305-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; NA; mg","Ovary",24223,"Serous cystadenocarcinoma, NOS","primary",NA,"2d20c4d9-3e33-5e7a-90e1-7a4f1dbae09a","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2001,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",66,-24223,"ff617d73-37ba-5c86-9928-ca9ee553692f",FALSE,NA,"Ashkenazi Jew","TCGA-23-2078-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-2078-01"
"TCGA-3P-A9WA-01A-11R-A406-31","TCGA-3P-A9WA-01A-11R-A406-31","TCGA-3P-A9WA","TCGA-3P-A9WA-01A","TP","Primary solid Tumor","TCGA-3P-A9WA-01A","01","Primary","b9e88fa0-fb6d-43c1-b879-bfdc95da9be1","Primary Tumor",NA,"released","Unknown",NA,"4B2E4D3D-128A-49DD-AE0B-ACFC78615B16","TCGA-3P-A9WA",NA,"Unknown",NA,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; e3f10f8a-e44b-4416-86a8-10cf273b1af1; e9a5289c-8b46-4518-b1d4-f825d3f8a4ff; f92ff414-5657-40ca-9d28-d0c339b15661; TCGA-3P-A9WA_treatment5; TCGA-3P-A9WA_treatment4; TCGA-3P-A9WA_treatment6; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; Surgery, NOS; released; released; released; no; no; yes; 2025-01-06T20:37:19.971515-06:00; 2025-01-06T20:37:19.971515-06:00; 2025-01-06T20:37:19.971515-06:00; Uterus; NA; NA; 54","Uterus, NOS",20215,"Serous cystadenocarcinoma, NOS","Synchronous primary",NA,"8fdd4a53-c065-4923-93c3-1111e4140dab","Not Reported",NA,FALSE,4,"Stage IIB",NA,NA,NA,NA,NA,NA,NA,NA,"black or african american","female","not hispanic or latino","Alive",55,-20211,"edad4644-d80b-5b6f-9928-cd2b29f1035b",FALSE,NA,NA,"TCGA-3P-A9WA-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,126,660,"false","T2b","N0","MX",NA,"United States",NA,"2009","TCGA-3P-A9WA-01"
"TCGA-23-2077-01A-01R-1568-13","TCGA-23-2077-01A-01R-1568-13","TCGA-23-2077","TCGA-23-2077-01A","TP","Primary solid Tumor","TCGA-23-2077-01A","01","Primary","70944721-dbf3-4a65-ae98-a008a48ba55e","Primary Tumor","Not Reported","released","Unknown",0.9,"55589297-f28e-422c-beee-6cb19a2350be","TCGA-23-2077",0.4,"Unknown",1.1,FALSE,"Tumor","8441/3","1622; 1758; NA; 155; 1622; 1758; 155; 275; 2206; NA; 751; 460; 600; 3300; 1622; 1653; NA; 22; 1622; 1653; 22; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; 1fc0c417-516c-472e-a684-b7880cadbe50; 8ded9bb3-ca7f-413f-8f27-598d4b792898; 8e36b9d2-5015-4d75-9e6c-00f64f833902; b3dafbc4-eb4d-5509-9216-2626b9466861; c45adac0-26bf-4fc7-af9f-115ae721985c; dcca4279-b91b-4bf7-9313-453b52df4e10; e98a1cf7-811b-462d-8d2e-00410e8df3d3; TCGA-23-2077_treatment6; TCGA-23-2077_treatment3; TCGA-23-2077_treatment7; TCGA-23-2077_treatment; TCGA-23-2077_treatment4; TCGA-23-2077_treatment5; TCGA-23-2077_treatment2; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; 1; 5; NA; 6; 1; 5; 6; Paclitaxel; Carboplatin; NA; Paclitaxel; Carboplatin; Docetaxel; Carboplatin; yes; yes; no; yes; yes; yes; yes; 2025-01-06T20:57:04.284030-06:00; 2025-01-06T20:57:04.284030-06:00; 2025-01-06T20:57:04.284030-06:00; NA; 2025-01-06T20:57:04.284030-06:00; 2025-01-06T20:57:04.284030-06:00; 2025-01-06T20:57:04.284030-06:00; Recurrent Disease; Recurrent Disease; NA; NA; Recurrent Disease; Recurrent Disease; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; released; released; mg; mg; NA; mg; mg; mg; mg; NA; NA; Adjuvant; Adjuvant; NA; NA; Adjuvant","Ovary",16552,"Serous cystadenocarcinoma, NOS","primary",NA,"11764381-ed45-5beb-b0c8-dec64df1b651","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",1999,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",45,-16552,"0710e66b-9d53-5515-b2cb-efd06694efa5",FALSE,NA,NA,"TCGA-23-2077-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-23-2077-01"
"TCGA-31-1946-01A-01R-1568-13","TCGA-31-1946-01A-01R-1568-13","TCGA-31-1946","TCGA-31-1946-01A","TP","Primary solid Tumor","TCGA-31-1946-01A","01","Primary","d445f92f-5b61-4131-b474-f0ce49e52379","Primary Tumor","Not Reported","released","Unknown",0.9,"5ef31a8f-38e7-486b-8efc-99cd8c1ec06d","TCGA-31-1946",0.3,"Unknown",1,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 0be5c320-def7-4c0c-b75b-b69213cb6b8f; f72bc4a1-188f-4c8c-8d87-b1413d8f74cb; TCGA-31-1946_treatment9; TCGA-31-1946_treatment10; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:08:32.379560-06:00; 2025-01-06T20:08:32.379560-06:00; Recurrent Disease; Recurrent Disease","Not Reported",11810,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-31-1946_diagnosis","1a230ef7-744d-4447-94df-5244ee86153e","Not Reported","Yes",FALSE,664,NA,NA,NA,NA,NA,NA,NA,NA,NA,"not reported","female","not reported","Alive",30,-11146,"52037f73-8727-533e-ad4c-c42bb53d20a2",FALSE,NA,NA,"TCGA-31-1946-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-31-1946-01"
"TCGA-04-1348-01A-01R-1565-13","TCGA-04-1348-01A-01R-1565-13","TCGA-04-1348","TCGA-04-1348-01A","TP","Primary solid Tumor","TCGA-04-1348-01A","01","Primary","cdaa3a57-c3e7-4858-a048-8f75b882dde7","Primary Tumor","Not Reported","released","Unknown",1,"51B558EF-C11B-41A7-A7BF-15D201506006","TCGA-04-1348",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 5665f199-e877-49d1-84ee-c6e4e05e509e; afb9566a-60a3-4e0d-97de-50feb52cecf7; TCGA-04-1348_treatment10; TCGA-04-1348_treatment11; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:04:14.989125-06:00; 2025-01-06T20:04:14.989125-06:00; Recurrent Disease; Recurrent Disease","Not Reported",16811,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-04-1348_diagnosis","40655e62-6371-44b4-884f-db83ec4e47f9","Not Reported","Yes",FALSE,575,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","hispanic or latino","Dead",44,-16236,"6c0da9cf-4281-50f8-8be6-cdae39813f3b",FALSE,1483,NA,"TCGA-04-1348-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1348-01"
"TCGA-57-1584-01A-01R-1566-13","TCGA-57-1584-01A-01R-1566-13","TCGA-57-1584","TCGA-57-1584-01A","TP","Primary solid Tumor","TCGA-57-1584-01A","01","Primary","99287cbc-e4d4-4d24-b373-7865b7905727","Primary Tumor",NA,"released","Unknown",1,"3e4b484e-4727-444f-b2bc-c32d5d1ad815","TCGA-57-1584",0.8,"Unknown",2.3,FALSE,"Tumor","8441/3","532; NA; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 8d324b0b-68c6-4b1c-813e-158b65799c06; 9d6b8912-62bf-49f4-bc6e-a9b7b31b27af; f7f40dc2-3ba5-490e-af78-28a1aaa0b7e1; TCGA-57-1584_treatment8; TCGA-57-1584_treatment7; TCGA-57-1584_treatment6; Surgery, NOS; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; released; yes; no; yes; 2025-01-06T21:02:20.021605-06:00; 2025-01-06T21:02:20.021605-06:00; 2025-01-06T21:02:20.021605-06:00; Progressive Disease; Progressive Disease; Progressive Disease","Not Reported",NA,"Serous cystadenocarcinoma, NOS","metastasis","TCGA-57-1584_diagnosis","0fa8841b-323a-44df-93f5-deb6fab06394","Not Reported","Yes",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Alive",47,-17263,"7330b127-a51c-583d-a55b-d390f16ea0c2",FALSE,NA,NA,"TCGA-57-1584-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-57-1584-01"
"TCGA-36-1581-01A-01R-1566-13","TCGA-36-1581-01A-01R-1566-13","TCGA-36-1581","TCGA-36-1581-01A","TP","Primary solid Tumor","TCGA-36-1581-01A","01","Primary","3d547b69-ceaa-49c1-8ea9-03a32b3fac90","Primary Tumor",NA,"released","Unknown",0.6,"6512ef01-a2fb-4fd8-9e1a-b59855c256de","TCGA-36-1581",0.6,"Unknown",1.7,FALSE,"Tumor","8441/3","141; NA; 141; 4639; NA; 2313; 29; NA; 29; Intravenous; Intravenous; 0adc4703-4ee1-52fa-b1ca-e461ad689029; 186d095c-78c0-4f35-bdb3-aea0ece8763e; 72788b35-1c77-430b-b38f-deac68b164c6; TCGA-36-1581_treatment; TCGA-36-1581_treatment3; TCGA-36-1581_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; NA; 6; Carboplatin; NA; Paclitaxel; yes; no; yes; NA; 2025-01-06T21:01:41.543899-06:00; 2025-01-06T21:01:41.543899-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg; NA; mg","Ovary",23272,"Serous cystadenocarcinoma, NOS","primary",NA,"241ae640-2769-5065-97aa-05298c7b1b9b","Ovary","No",TRUE,0,"Stage IIC","Not Reported","Left","not reported",2007,"Cytology","C56.9","G3",NA,"white","female","not reported","Alive",63,-23272,"45b3ff78-a16c-5228-a88f-e0777a316c9f",FALSE,NA,NA,"TCGA-36-1581-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-36-1581-01"
"TCGA-13-1407-01A-01R-1565-13","TCGA-13-1407-01A-01R-1565-13","TCGA-13-1407","TCGA-13-1407-01A","TP","Primary solid Tumor","TCGA-13-1407-01A","01","Primary","f7011673-3a61-4450-b6b9-043ef33ac682","Primary Tumor","Not Reported","released","Unknown",0.7,"CCAF94A8-AA26-46FE-B3D3-22C9B750344A","TCGA-13-1407",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","184; NA; 184; 175; NA; NA; 42; NA; 42; Intravenous; Intravenous; 4f45a2d2-8d3a-4e75-8279-2659fa84efc4; 816c4cf7-823c-4a1d-92c4-8b40d4b295b0; c01352be-2ef4-5b20-9594-a127ad0d4767; TCGA-13-1407_treatment2; TCGA-13-1407_treatment3; TCGA-13-1407_treatment; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 7; NA; 7; Paclitaxel; NA; Carboplatin; yes; no; yes; 2025-01-06T20:21:47.046053-06:00; 2025-01-06T20:21:47.046053-06:00; NA; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; mg/m2; NA; NA","Ovary",18896,"Serous cystadenocarcinoma, NOS","primary",NA,"3b851cf3-1472-5cb5-8f7a-4543fadcd62d","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2008,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",51,-18896,"ce1b2666-1364-5381-ae68-062a3cc7e5d5",FALSE,NA,NA,"TCGA-13-1407-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1407-01"
"TCGA-13-1496-01A-01R-1565-13","TCGA-13-1496-01A-01R-1565-13","TCGA-13-1496","TCGA-13-1496-01A","TP","Primary solid Tumor","TCGA-13-1496-01A","01","Primary","7423b7ef-05e4-4b6c-bad0-bb815d6cfa9a","Primary Tumor","Not Reported","released","Unknown",1,"BCDD1BDE-689B-455D-81A7-C2522417E055","TCGA-13-1496",0.3,"Unknown",1.1,FALSE,"Tumor","8441/3","33; NA; 33; 33; NA; 33; Intravenous; Intravenous; 1339ccd3-c639-5b24-b8b2-186a748b9abb; 2f9b5970-3b7f-42a3-ab40-bdb9b72f3e5e; 5a6c364b-1dcc-4750-8142-2bcb8db9c98c; TCGA-13-1496_treatment; TCGA-13-1496_treatment3; TCGA-13-1496_treatment2; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 1; NA; 1; Carboplatin; NA; Paclitaxel; yes; no; yes; NA; 2025-01-06T21:11:12.528063-06:00; 2025-01-06T21:11:12.528063-06:00; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; NA; NA; 175; NA; NA; mg/m2","Ovary",23993,"Serous cystadenocarcinoma, NOS","primary",NA,"7a1b6225-2e8d-59d5-a142-bc7ed5306fb5","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2004,"Cytology","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",65,-23993,"4d5dbb4c-1d7f-5cdf-b9db-1585b9627eb6",FALSE,129,NA,"TCGA-13-1496-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1496-01"
"TCGA-13-1482-01A-01R-1565-13","TCGA-13-1482-01A-01R-1565-13","TCGA-13-1482","TCGA-13-1482-01A","TP","Primary solid Tumor","TCGA-13-1482-01A","01","Primary","2067e680-a491-40d4-ba54-2fb7f46698e4","Primary Tumor","Not Reported","released","Unknown",1.3,"58881EFF-AD88-4A0D-BC66-31E2B04D4B8C","TCGA-13-1482",0.4,"Unknown",1.3,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 4f90be16-fb8a-47ec-bd81-2a10f00cd49e; 54cb99cf-dc18-4d07-ac27-0795bcb6a14e; TCGA-13-1482_treatment4; TCGA-13-1482_treatment5; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T20:44:23.821806-06:00; 2025-01-06T20:44:23.821806-06:00; Recurrent Disease; Recurrent Disease","Not Reported",19780,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-13-1482_diagnosis","48b4aca0-1d7e-432c-9e26-973999a36969","Not Reported","Yes",FALSE,602,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",52,-19178,"5bce3e7c-4446-514f-bcfe-66719143e11c",FALSE,1877,NA,"TCGA-13-1482-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-1482-01"
"TCGA-61-2109-01A-01R-1568-13","TCGA-61-2109-01A-01R-1568-13","TCGA-61-2109","TCGA-61-2109-01A","TP","Primary solid Tumor","TCGA-61-2109-01A","01","Primary","98198891-a060-4107-b56d-61f19ac5fab5","Primary Tumor","Not Reported","released","Unknown",0.8,"c16bfe93-016f-49d4-8895-05b9055344c9","TCGA-61-2109",0.2,"Unknown",1.7,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; c1820c5b-aca9-46e0-baae-34b9dda4af74; c34bb3cc-3f21-47bb-99bf-0963814c3ac3; TCGA-61-2109_treatment6; TCGA-61-2109_treatment7; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; released; released; yes; no; 2025-01-06T21:18:50.055409-06:00; 2025-01-06T21:18:50.055409-06:00; Recurrent Disease; Recurrent Disease","Not Reported",15365,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-61-2109_diagnosis","a2ece225-4550-4e28-9886-2e5365ae0ba4","Not Reported","Yes",FALSE,465,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",40,-14900,"0fc3268e-adb3-5388-9bfd-2e6056af74e5",FALSE,629,NA,"TCGA-61-2109-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2109-01"
"TCGA-36-1578-01A-01R-1566-13","TCGA-36-1578-01A-01R-1566-13","TCGA-36-1578","TCGA-36-1578-01A","TP","Primary solid Tumor","TCGA-36-1578-01A","01","Primary","25d8f564-9ba7-4336-9b92-038fc26dcbd1","Primary Tumor",NA,"released","Unknown",0.6,"6BD44F43-7D75-4DF3-891D-7E08291F020C","TCGA-36-1578",0.5,"Unknown",0.6,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 616147d4-ed52-4658-85a8-2d9e14ff138e; b100c3e7-e85e-47d4-b548-fa3a8cc447e6; TCGA-36-1578_treatment6; TCGA-36-1578_treatment5; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T21:09:07.404554-06:00; 2025-01-06T21:09:07.404554-06:00; Recurrent Disease; Recurrent Disease","Not Reported",23639,"Serous cystadenocarcinoma, NOS","recurrence","TCGA-36-1578_diagnosis","c6993902-a6e8-4742-b549-5e7cfc22a72f","Not Reported","Yes",FALSE,310,NA,NA,NA,NA,NA,NA,NA,NA,NA,"asian","female","not hispanic or latino","Alive",63,-23329,"753ed5fb-e73a-5641-941d-45f244e4c82e",FALSE,NA,NA,"TCGA-36-1578-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-36-1578-01"
"TCGA-24-2020-01A-01R-1567-13","TCGA-24-2020-01A-01R-1567-13","TCGA-24-2020","TCGA-24-2020-01A","TP","Primary solid Tumor","TCGA-24-2020-01A","01","Primary","871fc478-cf3f-43c2-8aea-0db7c777abe1","Primary Tumor","Not Reported","released","Unknown",0.8,"4f529d42-acb0-4c02-bd0f-d4a650655df8","TCGA-24-2020",0.4,"Unknown",1.1,FALSE,"Tumor","8441/3","Adjuvant; NA; NA; NA; NA; Adjuvant; NA; Adjuvant; Adjuvant; NA; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 37b13ff2-7b4e-490b-bb86-231abe506b08; 485e1f0b-2921-43cc-9209-2d289735c0f9; 5170fed0-6c99-5fee-a14e-53b3d62e774d; 539cfdca-9d99-4b0b-92fd-3b136b0cf7e0; 6ecb12ae-a87d-49b2-a057-0e300cb64100; 7bcb2ad1-0358-4292-b39d-cf30b526ed1f; 94253363-d734-4718-9d22-037b23016f8d; 9e3a2702-dbfc-4b15-af2d-c48988f0b6ef; f6979143-7316-4283-8bd7-8fd901aa60b4; fe7267ee-a46c-4d51-af0c-e4262812853a; TCGA-24-2020_treatment10; TCGA-24-2020_treatment8; TCGA-24-2020_treatment; TCGA-24-2020_treatment5; TCGA-24-2020_treatment2; TCGA-24-2020_treatment6; TCGA-24-2020_treatment3; TCGA-24-2020_treatment7; TCGA-24-2020_treatment9; TCGA-24-2020_treatment4; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; Chemotherapy; released; released; released; released; released; released; released; released; released; released; no; yes; yes; yes; yes; yes; yes; yes; yes; yes; 2025-01-06T21:14:14.516565-06:00; 2025-01-06T21:14:14.516565-06:00; NA; 2025-01-06T21:14:14.516565-06:00; 2025-01-06T21:14:14.516565-06:00; 2025-01-06T21:14:14.516565-06:00; 2025-01-06T21:14:14.516565-06:00; 2025-01-06T21:14:14.516565-06:00; 2025-01-06T21:14:14.516565-06:00; 2025-01-06T21:14:14.516565-06:00; NA; 2757; 2085; 940; 940; 414; 1555; 414; 176; 2298; NA; 2593; 1905; 745; 745; 274; 1381; 274; 44; 2235; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; Intravenous; NA; 6; 7; 8; 8; 7; 7; 7; 6; 3; NA; Carboplatin; Pegylated Liposomal Doxorubicin Hydrochloride; Carboplatin; Paclitaxel; Paclitaxel; Topotecan; Carboplatin; Cisplatin; Paclitaxel; NA; Recurrent Disease; Recurrent Disease; Recurrent Disease; Recurrent Disease; NA; Recurrent Disease; NA; NA; Recurrent Disease; NA; NA; 504; 2496; 3024; 1836; 77; 2013; 1032; 1225; NA; NA; mg; mg; mg; mg; mg; mg; mg; mg","Ovary",24682,"Serous cystadenocarcinoma, NOS","primary",NA,"2a7a1bf4-1fe5-5d1d-ad8f-a06bdfbe0774","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",1994,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",67,-24682,"bc3036a7-e795-5db4-9293-f25c1dd954ff",FALSE,4624,NA,"TCGA-24-2020-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2020-01"
"TCGA-36-1577-01A-01R-1566-13","TCGA-36-1577-01A-01R-1566-13","TCGA-36-1577","TCGA-36-1577-01A","TP","Primary solid Tumor","TCGA-36-1577-01A","01","Primary","73a2a82b-c87c-4c04-8cfe-cc679379b28d","Primary Tumor",NA,"released","Unknown",0.6,"0c55b26c-ccf8-4223-9f5e-157bbdf6e5dc","TCGA-36-1577",0.6,"Unknown",1.7,FALSE,"Tumor","8441/3","156; 84; 156; 84; 2250; 1833; 2250; 744; 111; 28; 111; 28; 2d6749d7-4bc8-4941-8193-d5d76ba4a5c2; 32939098-9279-4c7a-afa3-a74bab651621; cfd3536f-c38b-5edf-a9c8-7361ace4c9f7; ee6fcda8-ac96-492a-9b68-5cd3b1ed2d21; TCGA-36-1577_treatment2; TCGA-36-1577_treatment3; TCGA-36-1577_treatment; TCGA-36-1577_treatment4; Radiation, External Beam; Chemotherapy; Radiation, External Beam; Chemotherapy; yes; yes; yes; yes; 22; NA; 11; NA; 2025-01-06T20:36:55.372740-06:00; 2025-01-06T20:36:55.372740-06:00; NA; 2025-01-06T20:36:55.372740-06:00; Primary Tumor Field; Primary Tumor Field; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; cGy; mg; cGy; mg; NA; mg; NA; mg; Intravenous; Intravenous; NA; 3; NA; 3; NA; 611; NA; 248; NA; Carboplatin; NA; Paclitaxel","Ovary",15804,"Serous cystadenocarcinoma, NOS","primary",NA,"e3059d66-192a-578d-8167-ccefae83a110","Ovary","No",TRUE,0,"Stage IIC","Not Reported","Bilateral","not reported",2007,"Cytology","C56.9","G2",NA,"asian","female","not reported","Alive",43,-15804,"0aeca69b-62e8-51ea-b312-dc3e2ba3237c",FALSE,NA,NA,"TCGA-36-1577-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-36-1577-01"
"TCGA-24-2261-01A-01R-1568-13","TCGA-24-2261-01A-01R-1568-13","TCGA-24-2261","TCGA-24-2261-01A","TP","Primary solid Tumor","TCGA-24-2261-01A","01","Primary","7bcd356d-7031-44b1-b1d7-8d8f60f0caff","Primary Tumor","Not Reported","released","Unknown",1.4,"6145afd6-e7d7-47bc-a659-ac84c3434e86","TCGA-24-2261",0.4,"Unknown",1.7,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 6ca13c64-9d4e-436b-9258-49ce72526334; be9eddb1-e95e-5731-90c8-be143d3f79d6; TCGA-24-2261_treatment2; TCGA-24-2261_treatment; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; no; 2025-01-06T21:44:09.955726-06:00; NA; NA; NA","Ovary",27897,"Serous cystadenocarcinoma, NOS","primary",NA,"98810cc1-7704-5e6c-8b7c-fbd3eaa7803b","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Left","not reported",1992,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",76,-27897,"ff97c3b6-41e4-5f1e-a06b-1dfb04a62127",FALSE,24,NA,"TCGA-24-2261-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-24-2261-01"
"TCGA-59-2354-01A-01R-1569-13","TCGA-59-2354-01A-01R-1569-13","TCGA-59-2354","TCGA-59-2354-01A","TP","Primary solid Tumor","TCGA-59-2354-01A","01","Primary","7ce668a0-da92-4201-9f07-2c5b02df2c88","Primary Tumor","Not Reported","released","Unknown",1,"cbdd4d6e-0df4-4abd-af75-b3a66bdba9cc","TCGA-59-2354",0.3,"Unknown",2.4,FALSE,"Tumor","8441/3","2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 45a2565f-9be8-4d56-921d-a25d796b1f8f; b5696de2-6e85-4a95-9a0c-f19685c00a80; TCGA-59-2354_treatment4; TCGA-59-2354_treatment3; Radiation Therapy, NOS; Pharmaceutical Therapy, NOS; released; released; no; yes; 2025-01-06T20:38:37.946587-06:00; 2025-01-06T20:38:37.946587-06:00; Progressive Disease; Progressive Disease","Not Reported",NA,"Serous cystadenocarcinoma, NOS","Progression","TCGA-59-2354_diagnosis","1a99e81a-0fd9-4996-b994-99842226692b","Not Reported","Yes",FALSE,462,NA,NA,NA,NA,NA,NA,NA,NA,NA,"white","female","not hispanic or latino","Dead",63,NA,"87faef0a-06fb-53fa-b2e6-7ac6f4cb94c1",FALSE,1046,NA,"TCGA-59-2354-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-59-2354-01"
"TCGA-13-0760-01A-01R-1564-13","TCGA-13-0760-01A-01R-1564-13","TCGA-13-0760","TCGA-13-0760-01A","TP","Primary solid Tumor","TCGA-13-0760-01A","01","Primary","f6508c57-7de6-489b-9615-12c56dc8d8af","Primary Tumor","Not Reported","released","Unknown",0.9,"B0F10C14-A8D9-4885-921C-735B68AF493D","TCGA-13-0760",0.4,"Unknown",1.5,FALSE,"Tumor","8441/3","Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 16d4d5b9-a87f-5014-9c9d-f47adced18a6; c9190dfd-69f9-479e-8a38-2b4468687132; TCGA-13-0760_treatment; TCGA-13-0760_treatment2; Pharmaceutical Therapy, NOS; Radiation Therapy, NOS; Not Reported; NA; released; released; NA; NA; yes; no; NA; 2025-01-06T20:09:30.909506-06:00","Ovary",23036,"Serous cystadenocarcinoma, NOS","primary",NA,"d11f1746-a660-5998-8830-1b5d634182a1","Ovary","No",TRUE,0,"Stage IV","Not Reported","Bilateral","not reported",2006,"Incisional Biopsy","C56.9","G3",NA,"white","female","not hispanic or latino","Dead",63,-23036,"a21a3737-2000-5301-893e-32381b15763d",FALSE,351,NA,"TCGA-13-0760-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0760-01"
"TCGA-13-0906-01A-01R-1564-13","TCGA-13-0906-01A-01R-1564-13","TCGA-13-0906","TCGA-13-0906-01A","TP","Primary solid Tumor","TCGA-13-0906-01A","01","Primary","a0c48680-3caf-49bd-b495-c9fd3a9cbe76","Primary Tumor",NA,"released","Unknown",1,"D75790B2-C93F-4723-B691-84EE94656FF1","TCGA-13-0906",0.4,"Unknown",1.1,FALSE,"Tumor","8441/3","147; 147; NA; 147; 135; 75; NA; 60; 35; 35; NA; 35; Intravenous; Intraperitoneal; Intraperitoneal; 53bebc61-4550-5f45-bb1b-f109e2496117; 5d2f76d6-1761-42dc-b6f2-bb30d355449b; 7fc17858-a4f7-4e8d-85cb-1c0a05dd500d; cf09a65a-765f-48a4-be44-cb61301af5d0; TCGA-13-0906_treatment; TCGA-13-0906_treatment2; TCGA-13-0906_treatment4; TCGA-13-0906_treatment3; Chemotherapy; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; 6; 6; NA; 6; Paclitaxel; Cisplatin; NA; Paclitaxel; yes; yes; no; yes; NA; 2025-01-06T21:41:49.413750-06:00; 2025-01-06T21:41:49.413750-06:00; 2025-01-06T21:41:49.413750-06:00; Adjuvant; Adjuvant; Adjuvant; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; mg/m2; mg/m2; NA; mg/m2","Ovary",18383,"Serous cystadenocarcinoma, NOS","primary",NA,"74976cb2-5ac3-5764-a813-40be781e4353","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2005,"Surgical Resection","C56.9","G3",NA,"white","female","not hispanic or latino","Alive",50,-18383,"2669e329-d864-59c4-b6a0-2629d82ac5ee",FALSE,NA,NA,"TCGA-13-0906-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0906-01"
"TCGA-10-0926-01A-01R-1564-13","TCGA-10-0926-01A-01R-1564-13","TCGA-10-0926","TCGA-10-0926-01A","TP","Primary solid Tumor","TCGA-10-0926-01A","01","Primary","1c7e0067-e266-4967-9322-5967e112888e","Primary Tumor",NA,"released","Unknown",0.8,"b940b1b3-8278-400e-b43a-e7897e0361b7","TCGA-10-0926",0.6,"Unknown",1,FALSE,"Tumor","8441/3","143; NA; 143; 729; NA; 4500; NA; 860; 975; 22920; 8; 273; 8; 290; 232; Intravenous; Intravenous; Intravenous; Intravenous; 2347024d-46c4-4b07-8934-ffe89e89dbe8; 3da69122-0d80-507f-80d5-7c5abfc59d16; 59f9bd8d-11dc-4d69-b653-e427394e44c9; abca861c-ffaa-4953-9ab6-14e39e88f66f; af0d1a91-3030-46ef-a3b1-10fbd6440d16; TCGA-10-0926_treatment4; TCGA-10-0926_treatment; TCGA-10-0926_treatment3; TCGA-10-0926_treatment2; TCGA-10-0926_treatment5; Chemotherapy; Radiation Therapy, NOS; Chemotherapy; Chemotherapy; Immunotherapy (Including Vaccines); 6; NA; 6; 13; NA; Carboplatin; NA; Paclitaxel; Pegylated Liposomal Doxorubicin Hydrochloride; Recombinant Interleukin-12; yes; yes; yes; yes; yes; 2025-01-06T20:53:34.773261-06:00; NA; 2025-01-06T20:53:34.773261-06:00; 2025-01-06T20:53:34.773261-06:00; 2025-01-06T20:53:34.773261-06:00; Progressive Disease; NA; Progressive Disease; Recurrent Disease; Progressive Disease; Adjuvant; NA; Adjuvant; NA; Adjuvant; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; 2025-01-08T13:15:37.188206-06:00; released; released; released; released; released; mg; NA; mg; mg; mg","Ovary",23307,"Serous cystadenocarcinoma, NOS","primary",NA,"71ac222a-9ac1-59e1-9ee0-70f90b4db4f0","Ovary","No",TRUE,0,"Stage IIIC","Not Reported","Bilateral","not reported",2000,"Surgical Resection","C56.9","G3",NA,"white","female","not reported","Dead",63,-23307,"4b183665-721a-5e26-a141-269b36017af8",FALSE,788,NA,"TCGA-10-0926-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-10-0926-01"
"TCGA-04-1519-01A-01R-1565-13","TCGA-04-1519-01A-01R-1565-13","TCGA-04-1519","TCGA-04-1519-01A","TP","Primary solid Tumor","TCGA-04-1519-01A","01","Primary","ef8a2e99-c991-4d51-81ba-34f9a57949b8","Primary Tumor",NA,"released","Unknown",0.4,"53840C6E-E1AA-415E-BB85-8E1B8976F45C","TCGA-04-1519",0.4,"Unknown",1.3,FALSE,"Tumor","8441/3","Adjuvant; 2025-01-08T13:15:37.188206-06:00; cc88078d-f903-5f2e-8c76-a5404d8c8966; TCGA-04-1519_treatment; Radiation Therapy, NOS; released; NA; unknown; NA","Ovary",17671,"Serous cystadenocarcinoma, NOS","primary",NA,"942ad6a8-7831-5c90-9f54-5783643971c4","Ovary","No",TRUE,0,"Stage IIIC","Not Reported",NA,"not reported",2007,NA,"C56.9","G3",NA,"not reported","female","not reported","Alive",48,-17671,"3f483df1-55d7-5848-ad8c-8ba70f3f0607",FALSE,NA,NA,"TCGA-04-1519-01A","Ovary; Retroperitoneum and peritoneum","TCGA-OV","Cystic, Mucinous and Serous Neoplasms; Not Reported","Ovarian Serous Cystadenocarcinoma",TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-04-1519-01"
